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Abstract 
 
The fruit fly Drosophila melanogaster is recognized as the most widely established 
genetic model of immunity of the contemporary scientific era, exhibiting a high 
degree of conservation between Drosophila and mammalian innate immunity 
genes. However, whilst the majority of Drosophila immunity studies have 
previously been performed in adults and larvae, the embryo has recently emerged 
as a potentially viable model system; aiding in vivo studies and providing a more 
amenable system to undertake live imaging, hence evading many of the caveats 
associated with current immunity models. This project aimed to further develop 
the Drosophila embryo as a more potent and insightful immunity model, focusing 
on the immune response to bacterial infection.  
 
Initial results demonstrated that the Stage 15 Drosophila embryo was able to 
mount a relatively robust immune response to bacterial infection. This included 
induction of antimicrobial peptide (AMP) genes upon a range of bacterial stimuli; a 
response which was able to effectively discriminate between differential types of 
bacterial infection via the characterized Drosophila systemic immunity pathways. 
Live-imaging studies also showed that the cellular immune response was 
functional within the Stage 15 embryo. Subsequently, immune competence was 
shown to arise at approximately mid-embryogenesis, under the control of 20-
hydroxyecdysone (20-HE) signaling, as demonstrated by the partial rescue of 
AMP expression and bacterial clearance in early stage embryos upon 20-HE co-
administration with infective agents. Further analysis of the global transcriptional 
response of the Drosophila embryo to infection and damage via microarray 
studies confirmed the immune potential of this system, but also permitted the 
identification of genes upregulated uniquely upon Gram-positive or Gram-negative 
infection. Moreover, wounding via sterile laser ablation induced significant 
upregulation of a subset of AMP genes and the a network of cuticular genes, 
providing an insight into the embryonic damage response. Parallel analysis of the 
hemocyte transcriptional profile upon infection and damage elucidated that these 
immune cells may play a role regulation of the immune response via 20-HE 
signaling and production of ROS, although this remains subject to further 
validation. As such, transcriptional profile analysis of the embryo has been 
successful in identifying candidate genes for further validation and study.  
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Chapter 1 – Introduction 
 
1.1 Drosophila as a Model of Immunity !
Drosophila has long been considered as an effective and potent model for 
studying and deciphering immune mechanisms (Lemaitre and Hoffmann, 
2007). One of the earliest indications of Drosophila host defense against 
pathogens was upon the discovery of antibacterial factors in the fly 
hemolymph by Boman et al., (1972), demonstrating the existence of some 
inducible defense upon infection and giving the first insight that Drosophila 
could be applied more widely as a model of immunity. However, the wide 
application of Drosophila as an immune model can potentially be attributed to 
the high degree of conservation between the immune genes of the fly and 
those of mammalian systems (Hoffmann, 2003); for instance, the observation 
that Toll signaling components were able to regulate Drosophila innate 
immunity (Lemaitre et al., 1996) facilitated the discovery of the existence of 
Toll-like receptors (TLRs) in mammalian systems that performed a 
homologous role (Medzhitov et al., 1997). The recognition of the importance of 
this discovery is highlighted by this work being awarded the Nobel Prize in 
Physiology or Medicine in 2011 (Nobel Media AB, 2013). Thus by investigating 
the immune response in Drosophila, it is possible gain novel insight into the 
more complex mammalian immune response.  
      
Thus far, knowledge of the Drosophila immune response has been procured 
via analysis of the host response after injection of pathogen or septic injury in 
larvae or adult flies (Tzou et al., 2002). This response has been demonstrated 
to be complex, with oligonucleotide microarray studies revealing that several 
hundred genes are modulated in adult Drosophila after septic injury and fungal 
infection (De Gregorio et al., 2001; Irving et al., 2001; De Gregorio et al., 
2002). Moreover, the Drosophila system has the advantage of being 
genetically tractable, as well as allowing the possibility to infect large numbers 
of animals in a short time with highly reproducible results (Tzou et al., 2002). 
Aside from in vivo infection studies, in vitro screens utilizing the Drosophila 
! "!
Schneider 2 (S2) cell line have also become a crucial cornerstone of fly 
immunity studies. The primary cultures that form this cell line were isolated by 
Schneider (1972), from embryos between 20-24h old. S2 cells were shown to 
grow in a loose monolayer and be “macrophage-like” in appearance 
(Schneider, 1972). S2 cells subsequently found application to define and 
characterise pattern recognition receptors that are present on hemocytes, the 
Drosophila equivalent of mammalian macrophage (Ramet et al., 2001; Ramet 
et al., 2002), as well as encompassing an effective system to investigate the 
infection mechanisms employed by a variety of human bacterial pathogens 
(Cheng and Portnoy, 2003; Cheng et al., 2005; Derre et al., 2007). Another 
Drosophila cell line commonly used in immunity studies is the Malignant Blood 
Neoplasm 2 (mbn-2) line. This tumourous hemocyte line was originally derived 
from larvae with the mutation lethal (2) malignant blood neoplasm, which 
exhibit excessive hemocyte proliferation (Samakovlis et al., 1992).   
     
Subsequently, Drosophila immune models have been employed in a wide 
range of studies involving both Gram-positive and Gram-negative bacterial 
species. For instance, Blow et al. (2005) elucidated that infection of Drosophila 
with Vibrio cholerae, a Gram-negative bacteria and the causative agent of 
human cholera, very closely modeled the infection observed in humans, 
exhibiting many of the key traits of the disease. The study did not only provide 
confirmation of the cholera toxin as the key virulence factor, but also the use of 
Drosophila permitted the demonstration of the mechanism of action of the 
cholera toxin in a whole, live organism for the first time (Blow et al., 2005), 
hence highlighting the potential use of Drosophila as an accurate and 
inexpensive model to study host susceptibility. Moreover, Needham et al., 
(2004) used female adult Drosophila as a model host to aid the identification of 
two attenuated strains of Staphylococcus aureus, pheP and perR, and their 
subsequent infective potential. The study elucidated that not only that S. 
aureus was able to proliferate systemically within the fly, resulting in fly death 
(Needham et al., 2004), but also that the flies could be rescued via antibiotic 
treatment. Many other Gram-positive bacterial species were also shown to kill 
Drosophila within this model, including Streptococcus pneumoniae, Listeria 
monocytogenes and Streptococcus pyogenes (Needham et al., 2004), which 
! "!
are causative agents of meningitis, food poisoning and scarlet fever 
respectively in humans (Rang et al., 2003). Drosophila adults have also been 
employed to uncover further mechanistic details of immune signaling 
pathways (Rutschman et al., 2000; Michel et al., 2001; Rutschman et al., 
2001); for instance, screens of mutagenized Drosophila adult males performed 
by Ligoxygakis et al. (2002) resulted in the identification of Persephone, the 
first serine protease that was demonstrated to act upstream of the core Toll 
signaling pathway. Furthermore, S2 cells have been used to study the effects 
of the L. monocytogenes virulence protein listeriolysin O on intercytosolic 
growth and cell-to-cell spread (Cheng and Portnoy, 2003), as well as to 
conduct a genome wide RNA interference (RNAi) screen to identify host 
factors required for L. monocytogenes intracellular pathogenesis (Agaisse et 
al., 2005) This further demonstrated the power of Drosophila as a high-
throughput model system for studying bacterial infection. 
    
Conversely, the infection need not be solely bacterial. Schneider and 
Shahabuddin (2000) demonstrated that a close relative of the malaria parasite, 
the protozoan Plasmodium gallinaceum, could effectively develop in 
Drosophila, with the formation of infectious sporozoites that demonstrate 
highly similar kinetics seen in other host species, such as the mosquito Aedes 
aegypti, thus substantiating results. Moreover, it was argued that the 
Drosophila system could be used for defining the genetic pathways required 
for both vector competence and the parasite sexual cycle (Schenider and 
Shahbuddin, 2000). Additionally, previous studies have used Drosophila as a 
high-throughput model to assess antifungal drug efficacy against Aspergillus 
virulence (Lionakis et al., 2005) and Drosophila S2 culture cells have been 
used to gain greater insight into alphanodaviral RNA replication and the 
resulting upregulation of glycerophospholipid metabolism genes via 
transcriptomic studies (Castorena et al., 2010). Therefore, the power of 
Drosophila as an immunity model is clear, enabling studies of a diverse range 
of pathogen types. Moreover, its wide application has facilitated the in-depth 
characterization of much of the Drosophila immune system itself, in turn 
providing novel insight into the complex mammalian immune response.  
 
! "!
1.2 The Drosophila Immune System 
1.21 Overview of the Drosophila Immune System 
 
The Drosophila immune system itself consists solely of innate immune 
defense mechanisms, starkly lacking an equivalent of the adaptive immune 
reactions observed in vertebrate species (Hoffmann, 2003) and can be broadly 
sub-divided into two branches: the systemic and the cellular immune 
responses, as displayed in Figure 1.1. The systemic, or humoral, response is 
mediated within the fat body of the fly, the equivalent of the mammalian liver 
(Uvell and Engstrom, 2007), and refers to the challenge-induced synthesis and 
secretion of antimicrobial peptides (AMPs) (Lemaitre and Hoffmann, 2007). 
Two distinct pathways within the fat body recognize bacterial factors 
circulating in the hemolymph, such as peptidoglycan (PGN) (Gendrin et al., 
2009): these are the Toll and Immune Deficiency (IMD) pathways (Lemaitre 
and Hoffmann, 2007). Via these pathways, transcription factors, such as 
orthologs of Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B cells 
(NF!B), are activated to induce the expression of AMPs, which are 
subsequently secreted into the hemolymph to kill invading bacteria (Lemaitre 
and Hoffmann, 2007).  
      
In contrast, the cellular response is mediated predominantly by hemocytes. 
The majority of these cells, more specifically termed plasmatocytes, are the 
Drosophila equivalent of mammalian macrophages (Kadandale et al., 2010). 
These cells are actin-rich, and highly motile (Wood and Jacinto, 2007) and are 
crucial in mediating phagocytosis (Williams, 2007). Hemocytes also play roles 
in encapsulation, opsonisation and coagulation to further contribute to the 
cellular branch of the Drosophila immune response (Williams, 2007). 
Moreover, there is some evidence that hemocytes can interact with the 
systemic branch of the immune response, to further synergise and promote 
the production of AMPs (Agaisse et al., 2003; Brennan et al., 2007; Charroux 
and Royet, 2009; Shia et al., 2009). Whilst the characterization of the systemic 
response has been extensive, and much is known regarding the mechanisms 
of its regulation and activation, relatively little is known about how the cellular 
! "!
response is mediated and the precise role of the hemocyte during this 
process.  
 
In addition to these two major immune branches, it is also necessary to 
consider the individual immune response mediated by epithelial tissue and the 
local immune response. Tissues that are in constant contact with the external 
environment have been demonstrated to locally express AMPs (Ferrandon et 
al., 1998; Tzou et al., 2000), as well as reactive oxygen species (ROS), which 
are directly toxic to microbes and hence render pathogens inactive (Cerenius 
and Söderhäll, 2004; Kounatidis and Ligoxygakis, 2012).  
 
 
           
 
 
Figure 1.1: An Overview of the Drosophila Immune System. The immune response in 
Drosophila consists of two major branches: the systemic and cellular responses, mediated by 
the fat body and hemocytes, the Drosophila equivalent of the mammalian liver and 
macrophages, respectively. The systemic response is activated when circulating bacterial 
factors are recognized by the Toll and Immune deficiency (IMD) pathways; these activate 
NF!B analogues to induce expression of anti-microbial peptides (AMPs). Hemocytes can 
feedback to the fat body to promote the systemic response, and are also implicated in other 
distinct immune processes. There is also a peripheral local response, where AMP expression 
is localized to specific tissues.  
! "!
Therefore, the Drosophila immune response is multi-faceted, displaying a 
range of host mechanisms to successfully eliminate invading pathogens which 
are analogous to many of the innate immunity mechanisms observed in 
mammalian systems, such as the clearance of bacteria by professional 
phagocytes and the production of AMPs (Yang et al., 2001; Selsted and 
Ouellette, 2005).         
 
1.2.2 Antimicrobial Peptides 
 
The most prominent protein effectors of the Drosophila immune response are 
the AMPs. AMPs are small cationic proteins, with a diverse range of activities 
against bacteria and fungi (Imler and Bulet, 2005). The definition of an AMP 
itself includes all peptides that can kill microbes, but does not encompass 
enzymes that neutralize microbes via hydrolytic activity (Maroti et al., 2011). 
Of the range of AMPs currently characterised, some exhibit a narrow spectrum 
of activity, whilst others are able to react to a large range of Gram-negative 
and Gram-positive bacteria, as well as fungi, viruses and parasites (Maroti et 
al., 2011). Some AMPs, such as Drosomycin, are chemically highly stable due 
to the presence of intramolecular disulphide bridges within their secondary 
structure and can be detected in the hemolymph for several weeks post-
challenge (Uttenweiler-Joseph et al., 1998). It has been suggested by Wei et 
al., (2009) that precise regulation of transient AMP expression can be 
attributed to the stability of individual AMP mRNA transcripts, creating a 
dynamic and balanced system of systemic AMP production. AMPs with a 
broader antimicrobial spectrum were shown to have transcripts that decayed 
more quickly (Wei et al., 2009). However, compared to other components of 
the immune response, AMPs as a whole are deployed relatively rapidly (Shai, 
2002). This is crucial to the host survival, as other branches of the immune 
response may occur relatively slowly in comparison to the kinetics of microbial 
proliferation and as such would allow the infection to grow un-checked (Shai, 
2002). Moreover, the fact that AMP genes are conserved throughout the 
animal and plant kingdoms would suggest that AMPs played a crucial and 
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fundamental role in the evolution of complex multicellular organisms (Zasloff, 
2002). 
       
The precise mechanism of AMP damage and microbial killing is still somewhat 
controversial. Their microbicidal mechanism of action has been extensively 
characterised in vitro (Brogden, 2005), but any comprehensive picture of how 
these proteins operate in vivo has remained elusive (Junell et al., 2010). What 
is clear is that peptide-mediating killing can be rapid; in fact some linear !-
helical antimicrobial peptides kill bacteria so rapidly that it can make 
characterization of the steps preceding cell death very difficult (Boman, 1995). 
Several hypotheses have suggested that transmembrane pore formation may 
hold the key to AMP action (Brogden, 2005). Within this process, AMPs must 
be attracted to bacterial surfaces, probably due to electrostatic attractive 
forces between the positively charged AMP and negatively charged outer 
leaflet of the bacterial lipid bilayer (Zaslof, 2002). Once sufficiently close to the 
bacterial surface, AMPs must traverse the capsular polysaccharide landscape 
before they can effectively interact with the outer membrane (Brogden, 2005). 
They are consequently free to interact with the lipid bilayers, and many models 
exist which postulate how this may occur. The central elements of these 
models include binding of AMPs to the bacterial membrane, insertion of AMPs 
into the bilayer and the subsequent formation of a transmembrane pore, 
leading to bacterial cell lysis and elimination (Brogden, 2005). Nevertheless, 
the actual mechanism of pore formation appears to differ depending on the 
genre of AMP; some AMPs have been shown to form a ‘barrel’ type pore 
composed of ! helices around a central pore (Yang et al., 2001), whereas 
others induce a ‘toroidal’ pore whereby peptide inserts into the membrane and 
causes continual bending of the lipid monolayers (Matsuzaki et al., 1996). 
Moreover, an alternative model suggests that AMPs may also disrupt bacterial 
membranes in a detergent-like manner (Almedia and Pokorny, 2009), whereby 
‘carpet’ coverage of the target cell in AMP molecules leads to membrane 
disintegration (Shai, 1999; Ladokhin and White, 2001). There is also 
increasing evidence that AMPs may also have intracellular targets. For 
example, Drosocin has been demonstrated to bind to DnaK, a heat shock 
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protein (Otvos et al., 2000), as well as preventing the refolding of misfolded 
proteins (Kragol et al., 2001). Other intracellular AMP action could potentially 
include the inhibition of bacterial cell wall synthesis (Brotz et al., 1998), 
alteration of the cytoplasmic membrane and inhibition of septum formation 
(Salomon et al., 1992; Shi et al., 1996; Subbalakshmi et al., 1998), inhibition of 
DNA, RNA or protein synthesis (Lehrer et al., 1989; Yonezawa et al., 1992; 
Boman et al., 1993; Park et al., 1998; Subbalakshmi et al., 1998; Patrzykat et 
al., 2002) and activation of autolysin and phospholipases (Bierbaum and Sahl, 
1987; Zhao and Kinnunen, 2003).   
       
 
Table 1.1: Drosophila Antimicrobial Peptides and their Effectiveness 













Attacins 4 Gram-negative 
bacteria 
ND 
Cecropins 4 Gram-negative 
bacteria 
20.0 
Defensin 1 Gram-positive 
bacteria 
1.00 
Diptericins 2 Gram-negative 
bacteria 
0.50 
Drosocin 1 Gram negative 
bacteria 
40.0 




Metchnikowin 1 Fungi 10.0 
 
A range of antimicrobial peptides (AMPs) is expressed by Drosophila in response to Gram-
negative and Gram-positive, as well as fungal pathogens, with hemolymph concentrations 
varying in the micromolar concentration range post infection (ND, not determined) (Lemaitre 
and Hoffmann, 2007).  
 
      
There are currently 20 characterised immune-inducible AMPs in Drosophila, 
grouped into 7 classes, as depicted in Table 1.1 (Maroti et al., 2011). The 
Drosophila antimicrobial response is not aspecific; it is able to distinguish 
between various classes of microorganisms (Lemaitre et al., 1997). Thus, 
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dependent on the nature of the pathogen, specific AMPs will be induced to 
effectively aid the clearance of the infection. In Drosophila, the AMPs can 
generally be sub-divided into those responsive to Gram-negative infections 
and those stimulated by Gram-positive and fungal species (Lemaitre et al., 
1997). Yet, it remains a major challenge to understand the relative 
contributions of individual AMPs towards the total host defense and the 
potential synergy between different individual AMPs (Lemaitre and Hoffmann, 
2007).  
 
A. Gram-negative AMPs 
Of the 20 different AMPs identified within the Drosophila genome, those that 
are induced in response to infection by Gram-negative bacterial pathogens 
comprise Attacins, Cecropins, Diptericins and Drosocin. Whilst there is only 
one copy of the Drosocin (Drc) gene contained within the Drosophila genome 
(Bulet et al., 1993; Charlet et al., 1996), the others are encoded by multi-gene 
families (Deng et al., 2009).  
      
Attacins are one of the most taxonomically widespread AMP classes (Ando et 
al., 1987; Sugiyama et al., 1995; Lazzaro and Clark, 2001). Att genes were 
first identified in the genome of Drosophila by Åsling et al., 1995, who were 
able to isolate a gene sequence from Drosophila which showed sequence 
homology to AttA genes from other insect species. Subsequently, they were 
able to localize two Att genes to the second Drosophila chromosome, which 
were later termed AttA and AttB (Åsling et al., 1995). Basic Local Alignment 
Search Tool (BLAST) studies also permitted the discovery of two further 
isoforms, termed AttC and AttD (Hedengren et al., 2000; Lazzaro and Clark, 
2001). In terms of structure, Att proteins are Glycine-rich (Hedengren et al., 
2000) and approximately 190 amino acids in length (Lazzaro and Clark, 2001). 
In solution, they adopt a random coil structure (Gunne et al., 1990). This 
feature may be attributed to the lack disulphide bonds in the secondary 
structure of Att, and the resulting lack of conformational constraint may in turn 
allow relatively free amino acid substitution (Lazzaro and Clark, 2001). 
Regarding gene structure, AttA and AttB exhibit 96% sequence identity, and 
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Lazzaro and Clark (2001) reported that they were arranged in a head-to-tail 
fashion, separated by 1.1kb. On the other hand, AttC is located further 
upstream and only shows 67-73% sequence identity to AttA (Hedengren et al., 
2000; Lazzaro and Clark, 2001). Consequently, Lazzaro and Clark (2001) 
postulated that AttC may be differently targeted or processed compared to 
AttA and AttB, although the relatively high degree of sequence similarity may 
infer some common function for all three isoforms. Even further removed is 
AttD, which only demonstrates 33% sequence identity to AttA (Lazzaro and 
Clark, 2001) and is located on the third Drosophila chromosome (Hedengren 
et al., 2000). Moreover, AttD appears to exhibit a truncation at the 5’ end of the 
gene, in comparison to the other Att isoforms (Hedengren et al., 2000). Thus it 
lacks the N-terminal signal and the propeptide sequences that are required for 
activation (Hedengren et al., 2000) and it is questionable whether the resulting 
protein is subsequently secreted and functional as an AMP. However, 
regardless of these differences in structure, there is little or no expression of 
any Att isoform in unchallenged flies; only upon immune challenge with Gram-
negative bacterial species are they strongly induced, at approximately 6 hours 
post infection (Hedengren et al., 2000). 
      
Drosophila Diptericins are another group of AMPs that are glycine-rich and 
bear some sequence homology to Attacins, suggesting a common origin 
(Wicker et al., 1990). Initially, only one Diptericin (Dpt) gene was identified 
within the Drosophila genome (Imler and Bulet, 2005). This gene produces an 
83-residue product, with an O-glycosylation on a threonine residue within its 
N-terminal domain (Imler and Bulet, 2005). The expression of this gene was 
subsequently demonstrated to follow classical acute phase response kinetics 
upon E. coli infection (Wicker et al., 1990), concordant with the discovery that 
specific motifs in the proximal Dpt promoter exhibited homology to the 
mammalian cis-regulatory sequences involved in expression of acute phase 
response genes (Georgel et al., 1993). Moreover, Dpt was demonstrated to 
exhibit antibacterial activity against E. coli, and was shown to be upregulated 
in Drosophila adults and larvae from 2 hours post inoculation (Wicker et al., 
1990). More recently, a second novel Dpt-like gene was partially sequenced 
(Lee et al., 2001; Imler and Bulet, 2005). This novel gene was determined to 
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be a paralog of Dpt (Lee et al., 2001), and subsequently was designated DptB 
(Imler and Bulet, 2005). Similar to its paralog, DptB is rapidly induced upon 
infection with E. coli and secreted specifically from the fat body (Lee et al., 
2001). Moreover, its proximal promoter region exhibited features that are 
typically associated with the correct expression of antibacterial genes, such as 
!B binding sites (Lee et al., 2001).  
      
Another AMP class induced by Gram-negative microbes is the Cecropin multi-
gene family. Cecropins are 29-42 amino acid residues in size; they are linear 
and cysteine-free AMPs (Imler and Bulet, 2005). The Drosophila Cecropin 
(Cec) locus was originally cloned by Kylsten et al. (1990), and it was 
consequently discovered that this region contained a dense cluster of three 
functional cecropin genes, termed CecA1, A2 and B, and two pseudogenes, 
annotated Cec!1 and Cec!2 (Samakovlis et al., 1990; Samakovlis et al., 
1992). All three of the functional genes were strongly induced in 3rd instar 
larvae, pupae and adults upon infection with Enterobacter cloacae, from 
typically undetectable basal levels (Samakovlis et al., 1990). However, a 
relatively low level of Cec transcript was detected in early pupae and 
occasionally a low, variable expression in adults (Samakovlis et al., 1990). 
CecB appeared to be less inducible in larvae and adults, and instead 
appeared to be preferentially induced in early pupae, due to induction of CecB 
by residing gut bacteria (Samakovlis et al., 1990). As with the other Gram-
negative AMPs, the primary site of production of the Cec family members was 
determined to be the fat body, with studies also identifying approximately 5-
10% of the hemocyte population that express Cec transcript (Samakovlis et 
al., 1990). Subsequent studies also elucidated the presence of a fourth Cec 
gene, approximately 3kb upstream of CecB. The subsequently termed CecC 
was then cloned and demonstrated to show a similar pattern of expression to 
CecB, both basally and upon induction with bacteria (Tryselius et al., 1992). 
However, whilst expression upon infection is localized to the fat body, that 
during metamorphosis may be sited at the hindgut and more specific fat body 
foci (Tryselius et al., 1992). It is also noteworthy that, whilst Cec genes are 
preferentially induced by Gram-negative microbes, such as E. coli, they are 
! "#!
also weakly induced by Gram-positive bacterial species and fungi (Lemaitre et 
al., 1997; Ekengren and Hultmark, 1999).  
      
On the other hand, Drosocin (Drc) does not exhibit the multi-gene family of the 
other Gram-negative responsive AMPs; as mentioned above, only one copy of 
the Drc gene has been characterised in the Drosophila genome to date (Bulet 
et al., 1993). Drc is much smaller than other AMPs, consisting of only 19 
amino acid residues (Charlet et al., 1996). Amongst its other structural 
features, it has been shown to be proline-rich and carries an O-glycosylated 
substitution at Thr11 (Bulet et al., 1996); a feature that it shares with DptA 
(Imler and Bulet, 2005). It is thought that this substitution may affect the 
conformation of Drc protein random coil turns in aqueous solution (McManus 
et al., 1999) and thus may represent a post-translational modification, which is 
required for full antibacterial activity of the protein (Bulet et al., 1993; Bulet et 
al., 1996; Charlet et al., 1996). Similar to the other Gram-negative AMP genes, 
Drc is not constitutively expressed in naïve, unchallenged larvae, pupae or 
adult flies (Charlet et al., 1996). Upon infection by septic injury, rapid and 
intense Drc expression is observed in the fat body, with kinetics comparable to 
those of the Dpt genes (Charlet et al., 1996). The mbn-2 cell line was also 
shown to express Drc after treatment with lipopolysaccharide, a component of 
Gram-negative bacterial cell walls (Charlet et al., 1996), suggesting that 
hemocytes may also express Drc upon infection. However, this in vitro 
prediction was not concordant with in vivo infection studies using transgenic 
Drc-lacZ flies (Charlet et al., 1996), thus the capacity for hemocytes to express 
Drc upon infection remains contentious.  
 
B. Gram-positive and fungal AMPs 
Conversely, upon infection with Gram-positive bacterial or fungal infection a 
set of AMPs, distinct from those induced by Gram-negative bacteria, is 
induced. This comprises the Drosomycins, Metchnikowin and Defensin. Whilst 
there only single copies of the Metchnikowin (Mtk) and Defensin (Def) genes 
within the Drosophila genome (Levashina et al., 1995; Dimarcq et al., 1994), 
the Drosomycin (Drs) gene is clustered with 6 additional genes that show 
highly similar sequence homology (Deng et al., 2009). Whilst other forms of 
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Def have been reported to be present in many other insects, Drs and Mtk are 
specific to Drosophila (Imler and Bulet, 2005).  
      
Drosomycin is a 44 amino acid residue protein, whose 4 intramolecular 
disulfide bridges form a cysteine-stabilised !" motif (Michaut et al., 1996; 
Landon et al., 1997). This conforms a great degree of stability on the Drs 
protein, and hence it is detectable for up to three weeks post challenge in flies 
(Utterweiler-Joseph et al., 1998). Drs is constitutively expressed in Drosophila 
adults and larvae (Lemaitre et al., 1997; Levy et al., 2004), but is further 
upregulated by immune challenge (Deng et al., 2009). Some early studies 
argued that Drs was solely induced by filamentous fungal infection, and not by 
challenge with either Gram-positive bacteria or yeast (Fehlbaum et al., 1994), 
but subsequent studies have discovered that induction of Drs is also possible 
via immune challenge with a variety of Gram-positive bacteria in Drosophila 
adults (Bischoff et al., 2004). Moreover, Drosophila larvae challenged with 
Gram-negative bacteria were also able to weakly upregulate Drs (Lemaitre et 
al., 1997). As mentioned above, Drs forms part of a multi-gene cluster on the 
3L chromosome arm (Jiggins and Kim, 2005; Yang et al., 2006). The other 6 
members of this cluster are genes that display high sequence homology to the 
Drs gene, and hence have been termed Dro1, Dro2, Dro3, Dro4, Dro5 and 
Dro6 (Deng et al., 2009). The predicted structures of these genes also contain 
cysteine residues which may promote the formation of disulphide bridges and 
hence lead to structure stabilization (Landon et al., 1997). Expression of these 
genes in E. coli and purification of the resulting proteins lead to the isolation of 
peptides with antifungal activity, with the exception of that originating from 
Dro6 (Yang et al., 2006). However, despite their similarities in structure and 
activity, these Drs-like genes are not necessarily co-expressed during the 
individual phases of the Drosophila lifecycle. For example, whilst Drs ad Dro2 
were discovered to be expressed in larvae, pupae and adult flies, Dro3, Dro4 
and Dro5 were shown only to be expressed in the larval and adult stages of 
the Drosophila lifecycle (Tian et al., 2008). Dro1 and Dro6 expression was not 
detected in any stage of the Drosophila lifecycle (Tian et al., 2008). Moreover, 
knowledge concerning the Drs-like genes is relatively limited; the expression 
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and regulation of each member in response to microbial challenge or damage 
has not been fully characterised (Tian et al., 2008). Some studies have sought 
to rectify this deficit; Deng et al. (2009) investigated the expression patterns of 
Drs family members to injury and microbial infection in Drosophila adults. Drs, 
Dro2, Dro3, Dro4 and Dro5 showed constitutive expression (Deng et al., 
2009), consistent with previous work focusing solely on Drs (Levy et al., 2004). 
Dro2, Dro3 and Dro5 were upregulated by simple injury, whereas Drs was 
discovered to be the only family member to be further induced upon microbial 
challenge (Deng et al., 2009). In concordance with previous work (Tian et al., 
2008), Dro1 and Dro6 were not transcribed upon any microbial or injury 
treatments (Deng et al., 2009). These results mirror the discovery of binding 
sites for NF!B-related elements within the promoter regions of Drs, Dro2, Dro3 
and Dro5 (Deng et al., 2009), although the precise mechanism responsible for 
this differential regulation upon infection and damage is yet to be determined.  
      
In contrast to Drs, Def is selectively effective against Gram-positive bacterial 
species (Dimarcq et al., 1994). Structurally, it is a 40-residue peptide, with 
three internal disulphide bridges (Imler and Bulet, 2005). Only one Def gene 
has been identified in Drosophila (Imler and Bulet, 2005) and studies have 
shown that Def expression post infection occurs predominantly in the fat body 
(Dimarcq et al., 1994). It is possible that Def expression may also be sited 
within hemocytes upon microbial challenge, when considering that LPS was 
able to induce Def expression in the mbn-2 cell line (Dimarcq et al., 1994). In 
terms of microbicial action, changes in physiological salt concentration may 
have an effect on Def activity in Drosophila, considering that other 
homologous insect Defensins, such as from the blowfly Protophormia, cause 
dramatic bacterial lysis at micromolar concentrations when physiological salt 
concentration is low (Imler and Bulet, 2005). It has been postulated that this 
may enable disruption of the permeability of bacterial membranes, resulting in 
a partial depolarization of the inner membrane, a decrease in cytoplasmic ATP 
and thus inhibition of respiration (Cociancich et al., 1993).  
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The final class of Gram-positive AMP consists of Mtk; a proline-rich AMP 
(Levashina et al., 1995), which is transcribed from a single gene (Imler and 
Bulet, 2005). In terms of other structural features, it is a linear 26 amino acid 
peptide that lacks cysteine residues (Imler and Bulet, 2005). Mtk in not 
detectable in unchallenged 3rd instar larvae and pupae, and detected at very 
low basal levels in unchallenged adult flies (Levashina et al., 1995). However, 
the expression of Mtk is the subject of much divided opinion within the 
scientific literature. Some studies show that immune stimulation with LPS was 
sufficient to strongly drive transcription of Mtk at all stages of development 
investigated; after 3 hours in 3rd instar larvae, 8 hours in pupae and 6 hours in 
adult flies (Levashina et al., 1995). Other literature has suggested that Mtk is 
strongly induced in flies with either Gram-negative bacteria, Gram-positive 
bacteria or fungal pathogens (Levashina et al., 1995; Lemaitre et al., 1997), 
with the highest levels of expression exhibited in flies infected with Gram-
positive bacteria and fungal species (Lemaitre et al., 1997). Furthermore, 
during its purification Mtk was reported to affect the growth of the filamentous 
fungi Neurospora crassa, as well as that of the Gram-positive bacterium 
Micrococcus luteus, but the resulting recombinant Mtk was found only to 
exhibit antifungal activity (Imler and Bulet, 2005). Therefore, Mtk has now 
been classed by many as simply an antifungal agent (Imler and Bulet, 2005). 
Regardless of actual immune stimulus, Levashina et al. (1998) used a 
transgenic Drosophila Mtk-GFP fusion line to demonstrate that expression of 
Mtk occurs within the fat body of 3rd instar larvae and adult flies after immune 
challenge, as well as in some populations of hemocytes in specific 3rd instar 
larvae. The protein itself has been noted for its stability and persistence within 
the Drosophila system; for instance, high levels are maintained for 2 to 3 days 
after infection with the entomopathogenic fungus Beauveria bassiana 
(Lemaitre et al., 1997). 
 
Accordingly, AMPs form a cornerstone of the Drosophila systemic immune 
response, representing a major mechanism by which the insect is able to 
effectively fight a wide range of pathogens, although the precise mechanism 
by which this is mediated requires some clarification. Moreover, understanding 
how production of these peptides is mediated via the systemic immunity 
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pathways has given novel insight into how innate immunity is regulated. This 
view is perpetually expanding, hence demonstrating the complexity of the 
innate immune response itself.  
 
1.3 Systemic Immunity Signaling Pathways !
1.3.1 The Immune Deficiency (IMD) Pathway 
A. Pathway Overview  
The IMD pathway was initially identified via a mutation named immune 
deficiency (Lemaitre and Hoffmann, 2007), which in turn severely impaired the 
expression of a variety of Gram-negative AMPs, and marginally impaired Drs 
induction. As a result, these flies often succumbed to Gram-negative bacterial 
infection, but were more resistant to fungi and Gram-positive bacteria, leading 
to the confirmation that the systemic IMD pathway activation was specific only 
to Gram-negative bacterial pathogens, such as E. coli (Lemaitre et al., 1995). 
More recent studies have elucidated that circulating meso-diaminopimelic acid 
(DAP)-type peptidoglycan typical of Gram-negative bacteria is detected by 
peptidoglycan recognition proteins (PGRPs) (Kaneko et al., 2004; Stenbak et 
al., 2004). These receptors consequently recruit and signal via the IMD 
adaptor, which interacts with the Drosophila Fas-Associated Death Domain 
(dFADD). As a result, dFADD binds the caspase Dredd. The Drosophila I!B 
Kinase (IKK) complex phosphorylates Relish, which has been proposed to aid 
the cleavage of Relish by Dredd (Silverman et al., 2000; Erturk-Hasdemir et 
al., 2009). The resulting cleavage allows the subsequently released Relish to 
translocate to the nucleus and facilitate the transcription of Gram-negative 
AMP genes, such as Dpt and Drc. Moreover, the activation of the IKK complex 
itself is postulated to be activated in an IMD dependant fashion, facilitated by 
dIAP2, an Inhibitor of Apoptosis Protein, and dTAK1, a Mitogen-Activated 
Protein 3 Kinase, but the precise mechanisms that link these components are 
currently unknown (as reviewed in Lemaitre and Hoffmann, 2007). 
Furthermore, the molecular organization of the pathway is currently poorly 
understood due to a lack of information concerning the subcellular localization 
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of many pathway components, thus ensuring the difficulty in performance of 
epistatic analyses (as reviewed in Lemaitre and Hoffmann, 2007). A schematic 
of the IMD pathway is depicted in Figure 1.2.     
 
B. Recognition 
IMD pathway activation is achieved through the recognition of DAP-type PGN 
(Leulier et al., 2003; Choe et al., 2005), which is a component of most Gram-
negative species’ cell walls, although members of some Gram-positive genera 
such as Listeria and Bacillus also have cell walls comprised of this material 
and hence are able to activate IMD signaling (Lemaitre et al., 1997; Stenbak et 
al., 2004; Kleino and Silverman, 2013). This recognition and subsequent 
initiation of IMD signaling is mediated via the receptors PGRP-LC, a 
transmembrane receptor, and PGRP-LE, a circulating extracellular and 
intracellular receptor (Kaneko et al., 2006), which act synergistically 
(Takehana et al., 2004).  
      
There are three alternative splice variants of PGRP-LC, which result in three 
proteins with identical transmembrane and cytoplasmic regions, but different 
PGRP domains (Werner et al., 2003; Stenbak et al., 2004): these are referred 
to as PGRP-LCx, LCy and LCa. PGRP-LCx and PGRPLCa are relatively well 
characterised and have been shown to display differential binding specificities 
for DAP-type PGN (Kleino and Silverman, 2013). Kleino and Silverman (2013) 
propose that the polyvalent nature of the DAP-type PGN ligand may cluster 
multiple PGRP-LCx receptors to facilitate downstream signaling events. 
PGRP-LCa is not able to bind DAP-type PGN in the same manner, due to the 
absence of a cleft of sufficient depth to accommodate the polymeric nature of 
PGN (Kleino and Silverman, 2013). Thus it has been shown that this variant is 
able to bind a monomeric fragment of DAP-type PGN, termed tracheal 
cytotoxin (TCT) via PGRP-LCx, forming a ligand-induced heterodimer (Chang 
et al., 2004; Kaneko et al., 2005; Mellroth et al., 2005; Chang et al., 2006). 
Conversely, the precise function of PGRP-LCy has not been fully determined, 
but recent research suggests that it may function as an antagonist of the IMD 
response (Werner et al., 2003; Neyen et al., 2012). In contrast, PGRP-LE is 
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able to recognize DAP-type PGN that enters the host cell cytoplasm, through 
an as of yet unidentified mechanism (Kaneko and Silverman, 2005; Yano and 
Kurata, 2011), or that originating from intracellular pathogens (Yano et al., 
2008). PGRP-LE is also able to cooperate with extracellular domains of 
PGRP-LC in the recognition of extracellular DAP-type PGN and TCT 
(Takehana et al., 2002; Kaneko et al., 2006; Lim et al., 2006). Despite our 
understanding of how these receptors are able to bind their bacterial ligand is 
expanding, it is currently unclear how DAP-type PGN binding elicits 
downstream IMD signaling. However, there are suggestions that the N and C-
termini regions of the PGRPs may play a role in regulating this process (Choe 
et al., 2005; Maillet et al., 2008) and that conformational change of receptors 
and multimerisation may be required to interact with downstream signaling 
adaptors (Kleino and Silverman, 2013).  
      
In addition, other PGRP isoforms are also able to act as negative regulators of 
IMD signaling. Receptor isoforms, such as PGRP-LB, -SC1 and -SC2, have 
amidase activity (Mellroth et al., 2005; Zaidman-Remy et al., 2006) and are 
hence able to degrade DAP-type PGN to attenuate IMD pathway activation 
(Mellroth et al., 2003; Bischoff et al., 2006). PGRP-LB is initially expressed in 
fat body tissue and is subsequently secreted and circulates in the hemolymph 
(Zaidman-Remy et al., 2006). Similarly, PGRP-SC1/2 are expressed in the gut 
epithelial tissue and released into the lumen (Kleino and Silverman, 2013). 
Moreover, PGRP-LF is also able to downregulate IMD signaling (Persson et 
al., 2007; Maillet et al., 2008; Basbous et al., 2011), although precisely how 
this isoform facilitates such a response is uncertain. Some evidence would 
suggest that PGRP-LF acts as a decoy receptor (Persson et al., 2007), 
whereas other data would suggest that this isoform is not able to bind PGN but 
binds PGRP-LCx to compete for a place within the its multimers, hence 
directly blocking signal transduction (Basbous et al., 2011). 
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Figure 1.2: An Overview of the Immune Deficiency (IMD) Activation in the Drosophila fat 
body. PGRP-LC and -LE recognize Gram-negative bacterial factors circulating in the 
hemolymph, including DAP-type peptidoglycan (DAP-type PGN) and signal to the IMD 
adaptor, which via interaction with the death domains (DD) of dFADD activates the Dredd 
caspase. Dredd and Sickie interact with Relish (Rel) -49 and Rel-68 thus causing release of 
the Rel transcription factor. This is then able to translocate to the nucleus and induce the 
expression of Gram-negative specific AMPs. IMD may also become ubiquitinated by 
Drosophila Inhibitor of Apoptosis 2 (dIAP2), leading to the recruitment of the dTak/Tab2 
complex and subsequently facilitating the activation of Relish by the IKK complex (Key/Ird5). 
Among the potential negative regulators of the pathway, PGRP isoforms may act as decoy 
receptors or amidases to attenutate signaling. Dnr1 may inhibit Dredd activity and Caspar 
plays a role in the inhibition of Rel. Furthermore, activation of JNK by the dTak/Tab2 complex 
may lead to the recruitment of activation protein 1 (AP-1) to a repressor complex, to 
downregulation AMP gene transcription.  
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C. Signaling 
The IMD adaptor, which encodes a death domain-containing protein similar to 
that of the mammalian tumour necrosis factor receptor (Georgel et al., 2001), 
is responsible for integrating the signals from PGRP-LC and –LE to initiate 
downstream signaling events. Subsequently, IMD interacts via its Death 
Domain (DD) with dFADD (Naitza et al., 2002) and in turn dFADD is able to 
recruit Dredd, a caspase 8 homologue, to the complex via an interaction 
between their Death Effector Domains (DEDs) (Hu and Yang, 2000), although 
the precise mechanism of Dredd activation is not clear. Furthermore, it is not 
clear how the individual components of the complex are recruited to the 
plasma membrane from their basal localisation in the nucleus (Gomez-
Angelats and Cidlowski, 2003; Screaton et al., 2003; Boyer et al., 2011). 
Whatever the precise mechanism of signal transduction, these events 
culminate in the phosphorylation and cleavage of the transcription factor 
Relish by Dredd (Ertürk-Hasdemir et al., 2009). In vitro studies using S2 cells 
has revealed that a novel gene termed Sickie is also required for Relish 
cleavage, potentially supporting Relish activation by Dredd (Foley and 
O’Farrell, 2004). Relish itself is composed of an N-terminal NF!B domain 
(Rel68) and a C-terminal ankyrin-repeat domain (Rel49) (Kleino and 
Silverman, 2013). Rel68, which acts as the IMD pathway transcription factor, 
is endoproteolytically cleaved and then able to translocate to the nucleus and 
initiate the transcription of target genes, such as the AMPs Drc and Dpt 
(Stöven et al., 2000).  
      
In addition, Dredd also has a role in activation of an alternative IMD signaling 
pathway. Dredd has been shown to cleave IMD and thus expose a binding 
motif for dIAP2, a ubiquitin E3 ligase (Paquette et al., 2010). This further 
drives the rapid polyubiquitination of IMD by other E2 ubiquitin conjugating 
enzymes, such as Bendless and Effete (Zhou et al., 2005; Paquette et al., 
2010). Once ubiquitinated, IMD is able to recruit the dTak/Tab2 complex via 
the zinc finger domain of Tab2 (Kanayama et al., 2004) and also potentially 
the ubiquitination linkers (Kulathu et al., 2009). The activated dTak/Tab2 
complex is then postulated to phosphorylate and activate the IKK complex 
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(Kleino and Silverman, 2013). The IKK complex itself comprises two subunits: 
Immune Response 5 (Ird5), a catalytic subunit, and Kenny, the regulatory 
subunit. These are required for the subsequent activation of Relish. Both 
subunits are required to mediate successful Relish cleavage (Silverman et al., 
2000; Stöven et al., 2003). However, for complete phosphorylation, hence 
activation of Relish and successful target gene transcription in vitro, Ird5 
activity must remain intact (Ertürk-Hasdemir et al., 2009). Whether this link 
holds true for in vivo scenarios remains to be validated.  
      
Whilst dTak/Tab2 has been implicated in Relish cleavage, the complex has 
also been perceived to play a role in the activation of Jun-N-terminal Kinase 
(JNK) via the JNK-kinase Hemipterous (Kleino and Silverman, 2013). 
However, the role of JNK within the IMD pathway is somewhat controversial. 
Some reports have cited that JNK plays the role of a negative regulator, 
mediating the recruitment of Activator Protein 1 (AP-1) to a repressor complex; 
to dampen down AMP gene expression upon chronic immune signaling (Kim 
et al., 2007). In contrast, other studies have shown that JNK signaling is 
integral for AMP gene induction (Delaney et al., 2006). Hence, with conflicting 
evidence, further research is required to resolve the true role of JNK within the 
IMD signaling pathway.  
      
Despite the need for clarification on the precise nature of some of the 
molecular mechanisms behind aspects of IMD signaling, it has been well 
documented that the result of these combined signaling cascades is a 
systemic immune response that is generated on an extremely rapid timescale 
to a bacterial stimulus. For instance, the ubiquitination of IMD, as well as the 
phosphorylation and subsequent translocation of Relish to the nucleus, occurs 
within minutes after the initial bacterial stimulus (Paquette et al., 2010). As 
such, the expression of target AMP genes peaks within a timescale of hours 
after stimulus (Lemaitre et al., 1997; Vodovar et al., 2005; Valanne et al., 
2007).  
      
Whilst IMD signaling is acknowledged to be rapid, there are also mechanisms 
by which signaling can be attenuated or inhibited. Defense repressor 1 (Dnr1) 
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has been postulated to physically interact with and inhibit Dredd activity (Foley 
and O’Farrell, 2004; Guntermann et al., 2009). Whilst the precise manner in 
which this inhibition is mediated remains elusive, Dnr1 mutations have been 
shown to lead to enhanced IMD signaling and increased AMP expression in 
the fly brain upon infection (Cao et al., 2013). Another negative IMD 
modulator, Caspar, has been demonstrated to inhibit the cleavage of Relish by 
Dredd and hence attenuate the transcription of AMP genes, both in the 
presence and absence of a bacterial stimulus (Kim et al., 2006), suggesting 
that it is required for constitutive pathway activation.  
 
 
1.3.2 The Toll Pathway 
A. Pathway Overview 
The Toll pathway, an evolutionarily conserved cascade between Drosophila 
and the Toll-like pathway in mammalian systems, is triggered by a variety of 
fungal and Gram-positive bacterial pathogens (as reviewed in Lemaitre and 
Hoffmann, 2007). Recognition of invading pathogens via factors such as 
Lysine (Lys)-type peptidoglycan and !-1,3-glucan by PGRPs, as well as Gram 
Negative Bacteria-Binding Proteins (GNBPs), leads to the cleavage and 
subsequent activation of the extracellular cytokine Spatzle (Spz). This in turn 
activates the transmembrane receptor Toll, ensuring the receptor’s own 
dimerisation (Lemaitre and Hoffmann, 2007). As a result, Pelle Kinase is 
recruited and in turn induces degradation of Cactus, the Drosophila equivalent 
of I"B, although the precise mechanism by which this is achieved remains 
elusive (Lemaitre and Hoffmann, 2007; Valanne et al., 2011). Consequently, 
the Dorsal and Dif transcription factors are released from their complex with 
Cactus and are able to translocate to the nucleus and activate the transcription 
of target genes, such as Drs and Def (Lemaitre and Hoffmann, 2007). It has 
been shown that loss of function or deletion of any Toll components causes an 
immune deficient phenotype, including a typical lack of Drs expression, 
leading to increased susceptibility to Gram-positive and fungal infections 
(Rutschmann et al., 2002). In contrast to IMD pathway signaling, that of the 
Toll pathway is often more chronic, with activation of the pathway within hours 
! "#!
of recognition of a bacterial stimulus and the transcription of effector genes 
perpetuated for several days (Lemaitre et al., 1997).  
 
B. Recognition 
In terms of pathogen recognition and activation of Toll signaling, it is 
postulated that three distinct upstream cascades may be induced, depending 
on the activating microbe (Figure 1.3). In the major cascade, Gram-positive 
bacterial species and fungal cells are respectively recognized via their Lys-
type PGN or !-1,3-glucan present in their cell walls (Valanne et al., 2011). A 
range of PGRPs and GNBPs are able to recognize these moieties. GNBP3 
has been demonstrated to be responsible for recognition of yeast species via 
binding to !-1,3-glucan (Gottar et al., 2006), whereas PGRP-SA, PGRP-SD 
and GNBP-1 seem to more specifically recognize Lys-type PGN (Valanne et 
al., 2011). Upon the recognition of Lys-type PGN, PGRP-SA and GNBP-1 
form a complex (Michel et al., 2001; Gobert et al., 2003; Pili-Floury et al., 
2004). However, the precise mechanism of how this event then translates into 
initiation of the subsequent signaling cascade remains elusive. Some evidence 
suggests that forming this complex activates GNBP-1 to hydrolyse the PGN to 
produce glycan-reducing ends, which are subsequently presented to PGRP-
SA (Wang et al., 2006). Other studies suggest that this is not the case as 
GNBP-1 appears to lack enzymatic activity, and in fact may play a role as a 
linker between PGRP-SA and the remainder of the signaling cascade (Buchon 
et al., 2009). Little is also known about the role of PGRP-SD in Toll pathway 
activation; it appears to function as a receptor for both Gram-positive and 
Gram-negative bacteria (Leone et al., 2008), with some partial redundancy to 
the PGRP-SA-GNBP-1 complex (Bischoff et al., 2004).  
      
Fungal and Gram-positive bacterial recognition signaling is subsequently 
integrated by Modular Serine Protease (modSP); this protease provides the 
link between recognition and a signaling cascade consisting of the serine 
proteases Grass, Spirit, Spheroide and Sphinx 1/2 (Kambris et al., 2006; 
Buchon et al., 2009). The end result of this serine protease cascade is that 
Spatzle-processing enzyme (SPE) is activated and Spz, the ligand for core 
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Toll signaling, is processed to its active form (DeLotto and DeLotto, 1998; 
Jang et al., 2006). Spz is secreted in an inactive precursor form, consisting of 
a C-terminal region and a prodomain (DeLotto and DeLotto, 1998). The 
prodomain shields the hydrophobic C-terminal region (Arnot et al., 2010) and 
activation via prodomain cleavage induces a conformational change that 
results in the hydrophobic regions being exposed and available for binding to 
the Toll receptor (Arnot et al., 2010). Thus far, two models concerning the 
binding of Spz to the Toll receptor have been postulated; firstly, it was 
suggested that one Spz dimer binds a dimerised pair of Toll receptors (Weber 
et al., 2005), but a newer model implies that two Spz dimers may bind to a Toll 
receptor dimer, with one Spz pair binding to each N terminus of the receptor 
(Gangloff et al., 2008). Currently, nine Toll receptors have been characterised 
in Drosophila, with all sharing a similar molecular structure comprising a 
Leucine-rich ectodomain with Cysteine-rich flanking motifs (Valanne et al., 
2011). Toll-1 is the isoform which thus far has shown to be responsible for the 
production of AMPs (Valanne et al., 2011), but Toll-5 and Toll-9 may also play 
roles, having been previously implicated in Drs and Mtk expression (Imler et 
al., 2000; Tauszig et al., 2000; Luo et al., 2001; Ooi et al., 2002).  
     
As mentioned previously, other upstream signaling cascades also leads to the 
activation of Spz; one such pathway is facilitated by the protease Persephone 
(Psh). Psh is able to detect virulence factors from fungal and Gram-positive 
bacterial species, which leads to its proteolytic maturation, after which Psh is 
able to activate SPE leading to the activation of Toll receptors in the manner 
described above (Gottar et al., 2006; El Chamy et al., 2008). It should also be 
noted that Toll signaling plays a critical role in development, as well as being 
an immune signaling cascade. Dorsal-ventral patterning. Thus, in a third 
pathway Spz is processed into its active form by a separate serine protease 
cascade, including Gastrulation Defective, Snake and Easter (Chasan et al., 
1992; Hong and Hashimoto, 1995), with the independent sulfotransferase Pipe 
required for the activation of the ventral signal in the oocyte (Cho et al., 2010).  
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C. Core Toll signaling 
Upstream signaling events merge upon the cleavage and activation of Spz 
and its binding to the Toll receptor, thus signaling after this forms the core Toll 
pathway (Figure 1.4). The activated Toll receptor subsequently binds the 
adaptor protein MyD88 via its intracellular (TIR) domains (Horng and 
Medzhitov, 2001; Tauszig-Delamasure et al., 2002; Sun et al., 2002). Another 
adaptor protein, Tube, and Pelle kinase are recruited to form a heterotrimer 
through DD interactions (Xiao et al., 1999; Sun et al., 2002; Moncrieffe et al., 
2008), with Tube acting as a conduit between MyD88 and Pelle (Sun et al., 
2002). Moreover, Pellino, a Pelle/IL-1R-associated kinase interacting protein, 
has been shown to act as a positive regulator of Toll signaling, without which 
Drs expression is impaired (Haghayeghi et al., 2010). However, the precise 
molecular mechanism by which this Pellino-mediated regulation is facilitated is 
presently unclear.       
       
Subsequently, the inhibitory protein Cactus is phosphorylated and degraded; 
upon basal conditions, Cactus is bound to and thus inhibits the activity of the 
Toll pathway transcription factors Dif and Dorsal (Valanne et al., 2011). It is 
not clear precisely how the phosphorylation and degradation of Cactus is 
mediated, but it has been speculated that this action is performed by Pelle 
(Towb et al., 2001; Huang et al., 2010) or some other so-called “Cactus 
kinase” which has yet to be identified. Further speculation of how this 
mechanism functions involves G Protein-couple reception kinase 2 (Gprk2), 
which was identified as a regulator of the Toll pathway in an RNAi screen 
using S2 cells (Valanne et al., 2010) and shown to be crucial for hemocyte 
activation in vivo (Valanne et al., 2011). Gprk2 interacts with Cactus in S2 cells 
but is not involved in its degradation (Valanne et al., 2010), thus its precise 
function remains unknown. Nevertheless, with the consequent removal of 
Cactus, Dif and Dorsal are thus free to translocate to the nucleus (Wu and 
Anderson, 1998) and induce the transcription of target genes. In addition, 
another transcription factor, Deformed epiderminal autoregulatory factor 1 
(Deaf1), has been determined to bind to the Drs and Mtk promoters and is 
required for full Drs expression and to effectively defend against fungal 
infections (Reed et al., 2008).  
! "#!
      
 
Figure 1.3: Recognition of Fungal and Gram-positive pathogens and downstream Toll 
signaling. Three pathways lead to the activation of Spatzle (spz), the ligand for the Toll 
pathway. Virulence factors, such as bacterial or fungal proteases, induce the activation of the 
protease Persephone, which in turn activated Spatzle-processing enzyme (SPE) to remove 
the prodomain of the ligand, activating Spz dimers and allowing their binding to the Toll 
receptor. Fungi and Gram-positive bacteria are recognized by their !-glucan and Lysine-type 
peptidoglycan (Lys- type PGN) via peptidoglycan recognition proteins (PGRP) SD and SA, 
and Gram-negative binding proteins (GNBP) 3 and 1. This event initiates a serine protease 
signaling cascade, involving Modular Serine Protease (modSP), Grass, Sphinx, Spirit and 
Spheroid. This results in the activation of SPE. Normal developmental events, such as Dorsal-
Ventral patterning, also require Toll pathway signaling and this is achieve via the direct 
activation of Spz via a separate protease cascade involving Gastrulation Defective, Snake and 
Easter.       
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Figure 1.4: Schematic of the Core Toll Signaling Pathway. Dimerisation and hence 
activation of the Toll receptor leads to the recruitment of adaptor proteins MyD88 and Tube, 
via interactions between the intracellular (TIR) and Death Domains (DD) of the receptor and 
adaptors. This leads to the recruitment of Pelle kinase via DD interactions. Pellino is a positive 
regulator of Toll signaling via its interaction with Pelle kinase. Cactus is phosphorylated 
potentially by Pelle or some other yet unnamed ‘Cactus kinase’, thus releasing the 
transcription factors Dif and Dorsal from its inhibition. Grpk2 is a regulator of the Toll pathway 
and may associate with Cactus, although its precise function is unknown. These transcription 
factors are subsequently able to translocate to the nucleus and induce AMP gene expression. 
Deaf1 is required to induce Toll pathway genes that are downstream of the Dif/Dorsal 
promoter such as Mtk and Drs.  
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1.3.3 Cross-talk between the IMD and Toll pathways 
      
It is also speculative whether the Toll pathway may in some manner synergise 
with the IMD pathway, via the formation of Relish/Dif heterodimers (Bangham 
et al., 2006); to support this notion, Drs expression has been seen to receive a 
significant input from the IMD pathway in the systemic response (Lemaitre and 
Hoffmann, 2007), and as noted above is solely expressed as a result of IMD 
pathway activation in the local immune response. Moreover, some 
components may also act independently of the Toll pathway; Matskevich et al. 
(2010) have shown that GNBP-3 assembles phenoloxidase antifungal defense 
complexes, independent of its Toll pathway function. Therefore, it is clear that 
despite a wealth of knowledge concerning both the Toll and IMD pathways, 
that much still requires clarification in terms of precise biochemical 
mechanisms of pathway components, and pathway synergism.  
 
1.3.4 The Janus Kinase /Signal Transducer and Activator of Transcription 
(JAK/STAT) pathway 
      
Whilst the roles that IMD and Toll signaling play within the systemic immune 
response to bacterial infection have been relatively well characterized, recent 
research has highlighted that other signaling pathways may also contribute to 
this branch of the immune response. One example of these is the JAK/STAT 
pathway. The JAK/STAT pathway itself consists of a receptor, Domeless, 
which is activated by three closely related cytokine-like ligands, which show 
homology to human interleukins; these are termed Unpaired, Unpaired 2 and 
Unpaired 3 (Upd, Upd2 and Upd3) respectively (Agaisse et al., 2003), as 
depicted in Figure 1.5 Upon ligand binding, Domeless subsequently signals to 
a JAK termed Hopscotch, resulting in the dimerization and ensuing activation 
of the transcription factor STAT92E (Lemaitre and Hoffmann, 2007). This 
complex can then translocate to the nucleus to induce gene transcription.  
      
The JAK/STAT pathway was originally identified as a potential immune 
pathway via JAK/STAT deficient flies; this line showed a particular sensitivity 
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to the Drosophila C virus (Dostert et al., 2005). Moreover, in the Anopheles 
mosquito model, it has been shown that after immune challenge with E. coli or 
M. luteus that the corresponding STAT component relocated to the nuclei of 
fat body cells (Barillas-Mury et al., 1999). In parallel, Drosophila models 
demonstrated that Upd3 and STAT were expressed in the gut after challenge 
with the bacterium Serratia marcescens (Cronin et al., 2009). Consequently, in 
Drosophila the activation of this pathway was shown to regulate the 
expression of a subset of immune-responsive genes, predominately the 
Turandot stress genes and the gene encoding the complement-like protein 
Tep2 (Lemaitre and Hoffmann, 2007). The Turandot (tot) genes currently have 
no specifically assigned function, but numerous stress conditions, in particular 
septic injury, have been shown to be pivotal to their induction (Levy et al., 
2004).  
 
However, it has also been suggested that activation of JAK/STAT can lead to 
proliferation (Buchon et al., 2009), whereby stem cell proliferation is induced 
via the JAK/STAT pathway through the release of Upd3 from damaged cells. 
Buchon et al. (2009) observed this phenomenon in enterocytes of Drosophila 
adults infected with Erwinia carotovora carotovora 15 (Ecc15), a Gram-
negative bacterium, highlighting the role of JAK/STAT in the regulation of 
epithelial renewal upon infection. Moreover, Pastor-Pareja et al. (2008) verified 
that all three Upd isoforms were upregulated in mechanically wounded wing 
discs and tumours induced in Drosophila larvae. As a result of ligand 
secretion, a systemic amplification of the response was observed, with 
JAK/STAT signaling shown to be activated in hemocytes in response to 
wounds and tumours, which was subsequently required for their proliferation 
(Pastor-Pareja et al., 2008). Thus, it has been postulated that the JAK/STAT 
pathway could respond to tissue damage, but it should be noted that the exact 
role this pathway plays within the total host defense remains to be determined 
(Lemaitre and Hoffmann, 2007).  
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Figure 1.5: An Overview of the JAK-STAT pathway in Drosophila. The receptor Domeless 
is activated by its cytokine-like ligand, Upd3, which leads to the recruitment and activation of 
Hopscotch (hop), a JAK. This subsequently leads to the activation of STAT92E via 
phosphorylation and dimerisation, and STAT92E dimers translocate to the nucleus to induce 




1.3.5 The JNK pathway 
      
Aside from its role in IMD signaling, where it has been postulated to induce the 
expression of AMPs (Kallio et al., 2005), JNK signaling has previously been 
demonstrated to regulate not only many Drosophila developmental processes, 
but also processes that are required for damage resolution. For instance, JNK 
signaling is necessary for proper wound healing of the epidermis (Lemaitre 
and Hoffmann, 2007) and upregulation of JNK activity has also been observed 
as a result of tissue damage following the induction of cancerous tumours or 
wounding in Drosophila larval discs (Pastor-Pareja, et al., 2008). In terms of 
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infection, dTak1 has been shown to activate Basket, the Drosophila equivalent 
of JNK, in response to bacteria (Boutros et al., 2002). Subsequently, JNK-
dependent immune genes have also been shown to have a role in 
cytoskeleton remodeling, perhaps suggesting a role in hemocyte activation 
(Boutros et al., 2002). Furthermore, infection of the gut with C. albicans is able 
to promote high levels of gut cell death; a phenomenon that was partially 
attributed to activation of JNK signaling by fungal proteases (Glittenberg et al., 
2011), suggesting that infection has a direct effect on JNK signaling in 
Drosophila. Thus, whilst it is clear that infection has a significant impact on 
JNK signaling, and in particular highlighting the complex nature of cross-talk 
within Drosophila systemic immune, more research is required to clarify its 
precise role within the overall immune response in Drosophila.  
 
 
1.3.6 Other proposed pathways and signaling mediators 
      
Aside from the key pathways described above, other novel modulators of the 
immune response have been identified, some of which represent novel 
mechanisms of regulating innate immunity, independent of IMD and Toll 
signaling. For instance, the transcription factor of the insulin-like growth factor 
signaling cascade, forkhead box subgroup O (FOXO), which is a key regulator 
of the stress response to starvation (Mattilla et al., 2009), adapting metabolism 
to suit nutrient conditions (Hafen, 2004) and longevity and ageing (Vermeulen 
and Loeschcke, 2007), has also been demonstrated to regulate AMP 
activation independent of both the IMD and Toll pathways (Becker et al., 
2010). This FOXO-driven AMP activation could be induced in non-infected 
larvae upon starvation and was speculated to aid in the modulation of the 
immune defense, particularly when the host may be suffering from energy 
shortage or stress. Moreover, this mechanism of FOXO-dependent AMP 
regulation is conserved between Drosophila and mammalian systems (Becker 
et al., 2010). The authors propose that this would represent a cross-regulation 
of metabolism and immunity, whereby AMPs could potentially be induced 
under basal physiological conditions in response to an oscillating degree of 
energy within cells and tissues, independent of pathogen recognition.  
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Another novel example of IMD and Toll-independent immune regulation was 
presented by Junell et al. (2010); the authors cited that the transcription factor 
Ventral veinless (Vvl) plays a role in tissue-specific regulation of innate 
immunity in Drosophila, driving the expression of Cec, again independently of 
the Toll and IMD pathways. It was subsequently proposed that Vvl acts in 
concert with other as of yet unknown regulators to control constitutive AMP 
gene expression in a tissue-specific fashion, particularly in immune-competent 
tissues that are continuously exposed to pathogens (Junell et al., 2010). 
However, no further mechanism concerning how Vvl may be driving AMP 
expression has become apparent. Hence, whilst knowledge regarding the 
traditional systemic immune signaling pathways is undoubtedly extensive in 
Drosophila, it must also be acknowledged that it is somewhat incomplete and 
continually expanding, with novel mechanisms described that have not as of 
yet been successfully incorporated into the existing paradigm. 
       
Other examples of novel signaling pathways that may synergise with 
traditional immune signaling pathways come from in vitro studies with S2 cells. 
Niermann-Pick disease type C2a (NPC2a) and Niermann-Pick disease type 
C2e (NPC2e) proteins are induced in response to infection with both E. coli 
and S. aureus in Drosophila larvae and adult flies (Shi et al., 2012). Moreover, 
these proteins were then shown to activate the Dpt promoter in S2 cells when 
stimulated with either Lys- or DAP-type PGN respectively (Shi et al., 2012). 
However, the authors of Shi et al. (2012) do not give any hypothesis for how 
NCP2a and NCP2e may be directly interacting with the established 
components of IMD pathway to regulate AMP expression. Hence, even when 
novel mechanisms can be demonstrated to interact with the established 






1.4 Epithelial responses 
1.4.1 Local immune Response 
     
An area of the immune response on which relatively little information is known 
is the so-called local immune response. Separate from both the systemic and 
cellular responses, this genre of immune response involves the production of 
AMPs localized to the surface epithelia of specific tissues which are in 
continual contact with the external environment (Ferrandon et al., 1998; Tzou 
et al., 2000), such as the gut, trachea, reproductive tract and epithelium of 
Drosophila (Ferrandon et al., 2007). This expression can be classed as either 
constitutive or inducible (Lemaitre and Hoffmann, 2007). For instance, 
constitutive Drs expression has been noted in the salivary glands (Tzou et al., 
2000), and Cec in the male ejaculatory duct (Tzou et al., 2000). This 
expression is regulated by various tissue specific transcription factors, such as 
Caudal (Ryu et al., 2004; Han et al., 2004), in contrast to the NF!B-like 
transcription factors of the systemic Toll and IMD pathways. Inducible local 
AMP expression is triggered by infection with Gram-negative bacteria and 
mediated by the IMD pathway (Tzou et al., 2000; Tingvall et al. 2001); for 
example, both Drosomycin and Diptericin have both been observed to be 
induced in the trachea and gut via the IMD pathway as a result of local 
infection (Basset et al., 2000). However, with this is mind, it remains unclear 
why commensal bacteria of the gut or ingested PGN do not induce chronic 
immune activation in these epithelia (Ha et al., 2009a). One explanation might 
be the scavenging ability of amidase PGRPs, which may sequester PGN 
released by commensal organisms within the gut. Upon infection, PGN titres 
may reach a threshold level above the scavenging capabilities of these 
receptors and thus allow differentiation between commensal and pathogen 
presences (Lemaitre and Hoffmann, 2007). No role for Toll pathway activity in 
the local immune response has been demonstrated thus far; moreover, there 
is no data to suggest that AMPs are induced in epithelia in response to Gram-




1.4.2. Reactive Oxygen Species Production 
      
In mammalian systems, the generation of reactive oxygen species (ROS) is an 
immediate response to infection; a so-called “respiratory burst”, resulting in the 
production of superoxide and hydrogen peroxide and subsequently 
hypochlorous acid, a highly bactericidal compound (Molina-Cruz et al., 2007). 
This is also the case in Drosophila, where infection induces rapid ROS 
production in the gut (Ha et al., 2005a; Ha et al., 2005b; Ha et al., 2009a), 
which may also have microbicidal effects. One protein that is vital in the 
generation of ROS is Dual oxidase (Duox) (Ritsick et al., 2004), which 
demonstrates NADPH oxidase activity (Anh et al., 2011). When Duox is 
inactivated in infected flies via RNAi, ROS production is severely inhibited, 
suggesting that this enzyme is the unique source of epithelial ROS (Ha et al., 
2005b). Moreover, Duox-RNAi flies are highly and rapidly susceptible to oral 
infection of Erwinia carotovora (Ha et al., 2005b; Nehme et al., 2007). The 
host protection conferred by Duox was subsequently demonstrated to be 
modulated via phospholipase C-β, which mobilized intracellular calcium 
required for ROS production via Duox (Ha et al., 2009). In addition to ROS-
mediating killing of microbes, it has subsequently been observed that the 
production of ROS, such as hydrogen peroxide, is also pivotal in the 
recruitment of hemocytes to areas of damage in Drosophila (Moreira et al., 
2010) via calcium-mediated activation of Duox (Razzell et al., 2013).  
     On the other hand, an excessive and prolonged ROS response is 
potentially harmful to any host, causing oxidative stress, loss of cell function 
and eventually apoptosis or necrosis (Nordberg and Arnér, 2001). This 
scenario is prevented in Drosophila by the enzyme Immune Responsive 
Catalase (IRC). Evidence has demonstrated the importance of this enzyme, as 
silencing IRC by RNAi not only results in enhanced ROS production, but also 
increased fly mortality (Ha et al., 2005b). Overall, this is indicative that IRC 
forms the reciprocal half of a Drosophila antioxidant defense system; where a 
fine balance between IRC and Duox activity is required for control of 
microorganisms. This is seemingly critical for microbial control in the gut 
lumen, where it provides an additional defense barrier against ingested 
pathogens, independent of IMD signaling (Ryu et al., 2006). 
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1.5 The Cellular Immune Response 
1.5.1 Hemocyte classification 
     
The cellular response is composed of a collection of innate immune 
mechanisms mediated by a specific group of immune cells termed hemocytes. 
Although three categories of hemocyte are recognized within the current 
literature (Lemaitre and Hoffmann, 2007), the predominant hemocyte sub-
group is undoubtedly the plasmatocyte, which represents 90-95% of all mature 
larval hemocytes (Lemaitre and Hoffmann, 2007); these are professional 
phagocytes (Jiravanichpaisal et al., 2006) and the equivalents of mammalian 
monocyte-macrophage lineage cells (Williams, 2007). This sub-group of 
hemocytes patrols adult and larval Drosophila tissues, engulfing apoptotic 
debris and microbial pathogens (Lanot et al., 2001; Wood and Jacinto, 2007). 
At the pupal stage they play a crucial role by both engulfing and recycling 
superfluous cells during metamorphosis (Lanot et al., 2001), as well as 
providing an immune surveillance system to prevent infection by bacterial 
species that normally results in pupal lethality (Charroux and Royet, 2009). 
Plasmatocytes are also critical in the clotting process in response to 
mechanical injury; plasmatocytes release hemolectin and other proteins that 
subsequently form clot fibres (Lemaitre and Hoffmann, 2007). In Drosophila 
hematopoiesis, mature plasmatocytes arise in two distinct phases: one in the 
head mesoderm during embryogenesis and the second in the lymph gland 
during larval development (Tepass et al., 1994; Evans et al., 2003; Holz et al., 
2003; Meister, 2004). The plasmatocytes derived from embryogenesis persist 
into larval stages, forming the mature circulating hemocytes of this stage of 
development. In contrast, the lymph-derived hemocytes do not circulate until 
metamorphosis under non-immune conditions (Stofanko et al., 2010).  
      
The remaining 5% of total Drosophila hemocytes consist largely of crystal 
cells, which play a critical role in the defense-related melanization process to 
sequester and kill invading microorganisms (Jiravanichpaisal et al., 2006). 
Much rarer are the lamellocytes, which are involved in the encapsulation and 
neutralization of objects too large to be effectively phagocytosed, such as 
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parasitoid eggs (Lemaitre and Hoffmann, 2007). Plasmatocytes, crystal cells 
and lamellocytes are postulated to arise from different lineages of cells 
originating from a common pro-hemocyte stem cell (Lanot et al., 2001; 
Meister, 2003), with differentiation into the distinct hemocyte cell types 
influenced by exposure to differential signaling and transcription factors (Qiu et 
al., 1998; Alfonso and Jones, 2002; Zettervall et al., 2004; Bataille et al., 
2005). Other models suggest that lamellocytes may actually arise from 
plasmatocytes (Sorrentino et al., 2007; Frandsen et al., 2008; Stofanko et al., 
2010).  Interestingly, it must be noted that, in contrast to plasmatocytes, crystal 
cells and lamellocytes have no clear mammalian homologues (Meister, 2004).  
      
Thus whilst hemocytes all ultimately arise from a common pro-hemocyte 
progenitor (Lanot et al., 2001), the roles that the different sub-types of 
hemocytes play within the immune response are distinct and diverse. These 
will now be examined in greater detail.      
 
1.5.2 Opsonisation  
       
Opsonisation is the process whereby foreign organisms or particles are 
marked for destruction; typically, pathogens are coated in phagocytosis 
markers, termed opsonins, which allow their recognition and consequent 
phagocytosis (Owens III and Peppas, 2006). In vertebrate systems, opsonins 
are represented by immunoglobulins and components of the complement 
system (Nakanishi and Shiratsuchi, 2006). However, it is unclear whether 
opsonisation-dependent phagocytosis is active in invertebrate systems, such 
as Drosophila (Nakanishi and Shiratsuchi, 2006), although recent studies have 
identified some potential opsonin candidates (Lagueux et al., 2000; 
Stroschein-Stevenson et al., 2006). Lagueux et al. (2000) determined that the 
Drosophila genome was demonstrated to contain six genes coding for proteins 
that are structurally related to the complement !2-macroglobulin family. Of 
these, five contain a thioester motif and hence are designated as Thioester-
containing proteins (Tep1-5) (Lagueux et al., 2000). Tep6, otherwise known as 
Macroglobulin-complement related (Mcr), is structurally distinct, as it lacks a 
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specific cysteine residue that normally leads to the formation of the 
characteristic Tep thioester (Lagueux et al., 2000). Of these proteins, Tep5 
does not appear to be actively expressed (Lagueux et al., 2000). In terms of 
localisation, Teps have been shown to be actively expressed in many immune 
tissues, such as hemocytes, barrier epithelia and can be induced in the fat 
body (Bou Aoun et al., 2010). Furthermore, Teps were shown to be basally 
expressed but upregulated upon infection in adult flies and larvae (Lagueux et 
al., 2000; De Gregorio et al., 2001; Irving et al., 2005; Dionne et al., 2006). 
Tep2, Tep3 and Tep4 have been suggested to play a role in the opsonisation 
and subsequent phagocytosis of E. coli, S. aureus and C. albicans 
respectively (Nakanishi and Shiratsuchi, 2006; Stroschein-Stevenson et al., 
2006). Tep1 is also upregulated upon infection (Lagueux et al., 2000), which is 
not necessarily surprising given its homologue in the mosquito Anopheles 
gambiae plays a role in the killing of the parasite Plasmodium (Blandin et al., 
2004). Moreover, Mcr was shown to be secreted by S2 cells and able to bind 
to C. albicans with high affinity (Stroschein-Stevenson et al., 2006). Thus, it 
has been postulated that Teps may function as opsonins during the immune 
response to promote phagocytosis, or alternatively as protease inhibitors 
(Lemaitre and Hoffman, 2007). Conversely, other studies have shown that 
members of the Tep family, such as Tep1, 2 and 4, are not required in the 
body cavity of adult flies in order to eliminate a range of bacterial and fungal 
infections, suggesting some form of redundancy or compensation by other 
elements of the immune response (Bou Aoun et al., 2010).  
 
1.5.3 Phagocytosis 
      
Phagocytosis is the process where cells internalize particles (Chung and 
Kocks, 2011) and is crucial for the elimination of apoptotic bodies and invading 
pathogens; it is an ancient mechanism that is evolutionarily conserved 
between Drosophila and mammalian systems (Rabinovitch, 1995; Williams, 
2007). In Drosophila, this process is mediated by the plasmatocytes (Williams, 
2007). In terms of infection, for phagocytosis to proceed successfully, 
receptors on the surface of the plasmatocyte must recognize an invading 
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pathogen. To carry out this function, these receptors either recognize their 
targets directly or via opsonins (Wright et al., 1989). Of the former category, 
studies have uncovered a variety of candidate receptor proteins that are 
required for efficient phagocytosis, including pathogen recognition receptors 
(Kocks et al., 2005; Ulvila et al., 2006). One such protein is the Scavenger 
receptor SR-CI, a pattern recognition receptor that binds to bacteria (Rämet et 
al., 2001). Other scavenger receptors include Peste, a CD36 family member 
which is required for uptake of Mycobacterium fortuitum (Philips et al., 2005), 
and Eater, which is expressed by hemocytes and required to survive infections 
with both Gram-negative and Gram-positive bacteria (Kocks et al., 2005; 
Chung and Kocks, 2011). Eater may also cooperate with AMP expression, 
with studies elucidating that CecA promoted Eater binding to E. coli (Chung 
and Kocks, 2011). In terms of candidate phagocytosis receptors, Williams 
(2007) cites the immunoglobulin superfamily protein Down syndrome cell 
adhesion molecule (Dscam) as one of the most promising potential targets, 
due to its ability to bind bacteria to promote effective phagocytosis (Watson et 
al., 2005) and the potential for its 18000 alternative splice variants produced in 
hemocytes and fat body cells to form a diverse range of pathogen recognition 
receptors (Watson et al., 2005; Williams, 2007). Moreover, screens in S2 cells 
have identified further proteins that are involved in phagocytosis of a variety of 
bacterial species, such as E. coli and S. aureus (Ramet et al., 2002; Pearson 
et al., 2003). These include cytoskeletal proteins, such as SCAR, an activator 
of the Arp2/3 complex which regulates actin filament nucleation (Machesky et 
al., 1999; Welch and Mullins, 2002; Zallen et al., 2002), Nimrod C1, a member 
of the Nimrod family of proteins with EGF-like repeats (Kurucz et al., 2007), 
and PGRP-LC (Ramet et al., 2002).  
      
However, the precise mechanisms by which some elements of phagocytosis 
occur still remain relatively elusive; for example, although candidate 
Drosophila receptors for phagocytosis by plasmatocytes, such as Draper, a 
protein containing a NIM repeat that has been shown to play a role in the 
phagocytosis of S. aureus and apoptotic cells (Freeman et al., 2003; Manaka 
et al., 2004; Cuttell et al., 2008), and Nimrod C1, a transmembrane protein 
with EGF-like repeats (Kurucz et al., 2007), have been reported, how they 
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directly or indirectly recognize bacteria still remains to be clarified (Hashimoto 
et al., 2009). Some progress has recently been made to address this with the 
discovery that lipoteichoic acid may act as a bacterial ligand  (Hashimoto et 
al., 2009), and Pretaporter as a Drosophila apoptotic ligand (Kuraishi et al., 
2009) for the receptor Draper. 
 
1.5.4 Melanisation 
      
Melanisation is an immediate immune response observed at a site of cuticle 
injury or on the surface through which parasites invade the hemocoel 
(Lemaitre and Hoffmann, 2007). This response is thought to play an important 
function in wound healing, sequestration of microorganisms and the 
production of toxic intermediate molecules that are able to kill invading 
pathogens (Ashida, 1990; Nappi and Vass, 1993; Söderhäll and Cerenius, 
1998). At sites of injury in Drosophila larvae, crystal cells solely mediate the 
melanisation response (Lemaitre and Hoffmann, 2007). This is evident in flies 
which exhibit abnormal crystal cells, such as Black cells mutants (Lemaitre 
and Hoffmann, 2007), or those that completely lack crystal cells altogether, 
such as lozenge mutants (Rizki et al., 1980); in these mutant backgrounds, 
melanisation is severely impaired.  
      
The melanisation reaction involves the de novo synthesis and deposition of 
melanin, resulting in a blackening of tissue. A schematic of the responsible 
signaling cascade is shown in Figure 1.6. Whilst it is not explicitly known what 
initiates the cascade in Drosophila, studies in other insect models inferred that 
injury or recognition of microbial ligands, such as PGN, !-(1,3)-glucan, and 
LPS, through pattern recognition receptors may initiate the signaling cascade 
(Ochiai and Ashida, 1999; Ochiai and Ashida, 2000; Ma and Kanost, 2000; 
Lee et al., 2004). In one part of the signaling cascade, the enzyme 
prophenoloxidase (PPO) must be activated to its activated phenoloxidase 
(PO) form; this enzyme is then rapidly released from crystal cells and able to 
catalyse the oxidation of mono and diphenols to orthoquinones to form 




Figure 1.6: Schematic of the Melanisation Reaction. Bacterial ligands are recognized and, 
via serine protease signaling, prophenoloxidase-activating enzyme (PPO-AE) converts 
prophenoloxidase (PPO) to its active phenoloxidase (PO) form. PO can then, along with 
tyrosine hydroxylase convert tyrosine to 3,4-dihydroxyphenylalanine (DOPA). DOPA is 
processed to dopamine by dopa decarboxylase or to dopaquinone by PO. PO subsequently 
converts these two substrates to melanin, via a series of intermediary steps.   
 
      
PPO-activating enzyme (PPO-AE). Data from other insect models has 
suggested that PPO-AE itself exists as a zymogen that is activated by a serine 
protease signaling cascade, initiated by the recognition of microbial ligands 
(Ashida and Brey 1995; Jiang et al., 1998). The remaining strand of the 
melanisation reaction involves the conversion of tyrosine to melanin via 
quinone intermediates. Tyrosine is converted to 3,4-dihydroxyphenylalanine 
(DOPA) by tyrosine hydroxylase or PO (Tang, 2009). DOPA can then be 
converted either to dopamine by dopa decarboxylase (ddc) or dopaquinone by 
PO itself (Tang, 2009). Finally, dopamine and dopaquinone are both converted 
via several intermediate steps into melanin by PO (Tang, 2009). Whilst 
melanin is thought to sequester microbes at wound sites, other quinone and 
ROS intermediates, such as dopaquinone, are postulated to kill 
microorganisms at this location (Christensen et al., 2005). There is also recent 
evidence to suggest that other signaling pathways may play a role in 
mediating the melanisation response. For instance, daw was demonstrated to 
have a role in the inhibition of melanisation; daw knockdown flies exhibited 
melanotic tumours and increased expression levels of serine protease 7 (Sp7), 
an enzyme which is specifically required for infection-induced melanisation 
! ""!
(Clark et al., 2011). Subsequently, experiments where daw was overexpressd 
in adult fat body demonstrated that daw suppressed Sp7 infection-induced 
melanisation, as well as inhibiting Sp7 expression in the absence of any 
infection (Clarke et al., 2011).  
 
Conversely, there has previously been dispute over the importance of 
melanisation in combating infection (Leclerc et al., 2006; Tang et al., 2006). 
Leclerc et al. (2006) demonstrated that flies unable to activate 
prophenoloxidase were not any more or less susceptible to infection with a 
variety of fungal and bacterial species than wild-type controls, proposing the 
notion that melanisation as a whole may not have any significant role in 
immunological defense. However, it must also be acknowledged that this 
study assessed the response of prophenoloxidase mutant flies to a relatively 
limited range of pathogens. Ayres and Schneider (2008) conducted infection 
studies with a much broader range of bacterial pathogens, concluding that 
some bacterial infections, such as Salmonella typhimurium, induced a 
disseminated melanisation response in the fly and that absence of a functional 
phenoloxidase gene greatly impacted on Drosophila resistance and tolerance 
capabilities to such infections. The importance of melanisation to the 
Drosophila immune response can also be inferred from other insect models, 
such as the mosquito Anopheles gambiae, where the melanisation response 
has been implicated to be key in the immune response to infection with 
entomopathogenic fungus (Yassine et al., 2012) and the parasitic protozoan 
Plasmodium (Volz et al., 2006). Thus, it is clear that melanisation may play an 
important role in the Drosophila immune response.  
 
1.5.5 Encapsulation 
      
Encapsulation is the process by which lamellocytes protect against invading 
parasites in the Drosophila larval stage (Lemaitre and Hoffmann, 2007). Wasp 
eggs implanted in larvae are detected by circulating plasmatocytes (Russo et 
al., 1996), and also elicits the release of plasmatocytes from the lymph gland 
(Lanot et al., 2001) and also potentially from the sessile larval population 
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(Zettervall et al., 2004). Regardless of their origin, these plasmatocytes 
subsequently attach to the egg chorion, forming septate junctions and 
effectively separating the egg from the hemocoel (Russo et al., 1996; Williams 
et al., 2005). This action, through a currently unknown mechanism, causes a 
massive differentiation of lamellocytes within the lymph gland (Jung et al., 
2005). These lamellocytes differentiate from pro-hemocytes originating from 
the medullary zone and secondary lobes (Carton and Nappi, 1997; Meister 
and Lagueux, 2003; Jung et al., 2005). The lamellocytes are subsequently 
released from the lymph gland and gather around the egg, forming a multi-
layered capsule structure (Lemaitre and Hoffmann, 2007). It is within this 
capsule that the wasp egg is eventually eliminated, potentially by the local 
production of toxic products, such as ROS (Nappi et al., 1995). The capsule is 
often also accompanied by melanisation, thus intermediate products of the 
melanisation cascade may also play a crucial role in mediating wasp egg 
killing (Nappi et al., 1995). Despite speculation, the precise causes of parasite 
death, as well as the particular molecular mechanisms behind the whole 
process of encapsulation, are not known (Lemaitre and Hoffman, 2007).  
       
However, whilst many elements of the encapsulation process remain 
unspecified, Williams (2007) has proposed that this process must be 
dependent upon adhesion and cell shape change. Thus it has been suggested 
that integrins may function in this process; it has been shown that mutant 
alleles of myospheroid, a !-integrin subunit gene, reduce the efficiency of 
capsule formation with lamellocytes failing to attach to the wasp egg (Irving et 
al., 2005). Also, it has been speculated that members of the Rho GTPase 
protein family, which are responsible for the regulation of cell migration and 
shape change (Barrett et al., 1997; Paladi and Tepass, 2004), may also play a 
role in regulating encapsulation. Rac GTPases Rac1 and Rac2 are required 
for the effective encapsulation of parasitoid wasp eggs (Williams et al., 2005; 
Williams et al., 2006). Moreover, in Rac2 mutant larvae plasmatocytes and 
lamellocytes have been demonstrated to attach to the target wasp eggs but 
fail to spread around it leading to a subsequent failure in capsule melanisation 
(Williams, 2007). Rac 1 and Basket are also crucial for proper encapsulation, 
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but the reason for this requirement remains unknown (Williams et al., 2006). 
Conversely, the depletion of Hemese, a transmembrane glycophorin-like 
protein present on hemocytes and hematopoietic organs, leads to an 
enhanced encapsulation response, which suggests that it plays a role in the 
activation or recruitment of hemocytes (Kurucz et al., 2003). Finally, 
microarray studies have determined that Toll and JAK/STAT signaling is 
activated in response to parasitization and are required for an effective 
encapsulation response (Sorrentino et al., 2002; Wertheim et al., 2005), 
although the precise roles of these pathways in the encapsulation process are 
not defined.  
 
1.5.6 Coagulation 
      
Coagulation has many roles within Drosophila larvae upon septic injury. It 
firstly blocks entry of invading pathogens into the hemocoel, working to seal 
wounds and trap microbes (Theopold et al., 2002; Theopold et al., 2004). This 
response must be rapid, to ensure that fluid loss is minimized, especially in 
larvae where the hemolymph is under great pressure to form the 
hydroskeleton (Bidla et al., 2005). As a result, a clot is rapidly generated at the 
site of wounding in Drosophila larvae; this predominantly comprises fibres of 
hemolectin, a multi-domain protein with similarity to other invertebrate and 
vertebrate clotting factors, which traps circulating plasmatocytes at the wound 
site (Goto et al., 2001). Other proteins that are present in the clot have been 
assessed via proteomic studies (Scherfer et al., 2004; Karlsson et al., 2004). 
One such protein is Fondue, a Toll-pathway regulated hemolymph component, 
without which clotting defects are observed (Scherfer et al., 2006); Fondue is 
required for the cross-linking of clot fibres. However, wounding of larvae and 
flies deficient in fondue or hemolectin does not necessarily lead to increased 
mortality compared to controls (Scherfer et al., 2004; Scherfer et al., 2006), 
although some studies would also suggest that this is not always the case 
(Chang et al., 2012). Other clot proteins include lipophorin, larval serum 
proteins and fat body protein 1 (Karlsson et al., 2004; Scherfer et al., 2004). 
Whilst these proteins clearly function in clot assembly to some degree, their 
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precise roles have not been clearly defined. Further questions remain 
unanswered in terms of the contribution that melanisation may make to this 
process; coagulation is considered as a process independent of melanisation, 
yet some components of the melanisation cascade such as PPO may be 
responsible for the hardening of clots (Karlsson et al., 2004; Bidla et al., 2005; 
Bajzek et al., 2012), and have been shown to form part of the clot matrix 
(Karlsson et al., 2004; Scherfer et al., 2004). Furthermore, this response 
requires the cooperation of plasmatocytes, which have been shown to secrete 
hemolectin (Theopold et al., 2013), and crystal cells which contain PPO 
(Theopold et al., 2013), but the mechanism by which this, and that of the 
activation of the hemocytes themselves, is mediated remains unknown. It is 
possible that wound cues may play a role in this process.  
 
1.5.7 Cross-talk with the Systemic Immune Response  
      
Research has also indicated that the cellular branch of the Drosophila immune 
response may also synergize with the systemic branch, with plasmatocytes 
providing a positive feedback to the fat body in order to further promote the 
systemic immune response and subsequent production of AMPs in Drosophila 
larvae (Agaisse et al., 2003; Charroux and Royet, 2009). Charroux and Royet 
(2009) determined that adult flies depleted of plasmatocytes, mediated by the 
expression of the proapoptotic protein Hid specifically in hemocytes, 
demonstrate a strong susceptibility to infection despite wild-type expression 
levels of AMP genes. This strongly suggests that a deficit in one branch of the 
Drosophila immune response cannot necessarily be compensated for by the 
activities of the other.  
 
In terms of the biological mechanism by which cross-talk between the 
systemic and cellular response may be mediated, Shia et al. (2009) 
demonstrated that the secretion of Spz by hemocytes was required for Toll-
dependent AMP gene transcription in the larval fat body. This finding would 
suggest some involved of the Toll pathway in mediating such cross-talk in 
Drosophila. Furthermore, Brennan et al. (2007) established that psidin, which 
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encodes a lysosomal protein that is required by plasmatocytes to successfully 
degrade engulfed bacteria, was also required for Def expression in the fat 
body. This study subsequently proposed a model whereby hemocytes were 
able to activate AMP production by the fat body upon antigen presentation by 
hemocytes (Brennan et al., 2007). Whilst this study provided a crucial link 
between pathogen detection by the cellular response and subsequent AMP 
production by the fat body, as Kounatidis and Ligoxygakis (2012) note, the 
authors fail to address that the rescue of psidin mutants was performed by 
expressing wild-type psidin using the peroxidasin-Gal4 driver, which could also 
lead to expression in fat body tissue. Therefore, there may also be a 
requirement for psidin in both tissues, despite the authors’ claim that this is 
restricted to plasmatocytes (Kounatidis and Ligoxygakis, 2012). Nevertheless, 
it is clear that interaction between both the systemic and cellular responses in 
Drosophila is required for effective immunity, with both branches working in 
concert to provide protection against microbial challenge (Elrod-Erickson et al., 
2000), although further work is required to precisely elucidate the nature of this 
relationship.  
      
However, other work has led to the proposition that such a connection is 
limited or does not exist. Elrod-Erickson et al. (2000) demonstrated that 
inhibiting the hemocyte phagocytic capacity, via the introduction of polystyrene 
beads within these cells, did not confer significant susceptibility to E. coli 
infections in wild-type flies (Elrod-Erickson et al., 2000); only preventing 
phagocytosis in imd/imd mutant flies had any effect on fly survival to E. coli 
infection (Elrod-Erickson et al., 2000). This would in turn indicate that 
phagocytosis, and hence this area of the cellular response, may play a 
relatively minor role in the overall host defense of Drosophila, and in the 
balance of cellular versus systemic immune branch activity. Moreover, it is 
known that flies with a defective cellular immune response can be rescued 
from the effects of Gram-positive infections via the strengthening of the 
systemic immune response via the overexpression of AMP genes using the 
Gal4UAS system (Nehme et al., 2011), again suggesting that the involvement 
of the cellular response to the overall host defense is not fundamentally 
required, in contrast to the results of Charroux and Royet (2009). However, it 
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must be noted that these studies focused solely on plasmatocytes and their 
phagocytic capacities, and thus their conclusions may not be representative of 
interactions of all elements of the cellular immune response with the systemic 
branch. Therefore, it is clear from the limited and conflicting knowledge 
presented that the precise nature and mechanism of systemic and cellular 
response interaction is not well characterised.   
 
1.6 The Immune Response to Damage  !
Recent studies have demonstrated that an immune response may not be 
generated in response to challenge by pathogens alone; in fact, damage 
signaling may also play a role in the activation of immune mediators such as 
AMPs. This is not a particularly novel concept in itself; it has been previously 
documented that in mammalian systems when no microbial stimulus is 
present, a T-cell immune response is generated (Kono and Rock, 2008). This 
may be triggered as a response to tissue transplants, tumours and 
autoimmune disease (Kono and Rock, 2008). As a result, Matzinger (1994) 
proposed a concept whereby the immune system could respond to damage, 
stress or non-physiological cell death; the so-called “Danger Hypothesis”. This 
concept highlighted how abnormal cell death could be recognized by 
hallmarks termed damage-associated molecular patterns (DAMPs) and thus 
could be interpreted as a universal sign of danger and potentially stimulate 
immune responses (Matzinger, 1994).   
However, it is only relatively recently that any empirical evidence has 
corroborated this hypothesis, particularly in Drosophila and regarding the 
innate immune response. For instance, several genes have been 
demonstrated to be expressed by hemocytes at a wound site generated by 
sterile laser ablation, including phospholipase A1, and Drs (Stramer et al., 
2008). Furthermore, Buchon et al. (2009) demonstrated that stress and cell 
damage induced in the gut of adult flies by Erwinia infection resulted in the 
activation of JAK/STAT signaling and the expression of Dro3. Other 
validations of the danger hypothesis in Drosophila include the observation that 
JNK signaling is activated by tissue damage in tumours and aseptic wounds, 
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leading to the expression and amplification of JAK/STAT activating cytokine 
signaling by the fat body and hemocytes (Pastor-Pareja et al., 2008). 
Localised DNA damage was also shown to induce a systemic response in 
Drosophila larvae by Karpac et al. (2011). UV irradiation of 2nd instar larvae 
triggered the expression of many AMP genes, including AttB, AttC and Def, in 
the fat body via the IMD pathway (Karpac et al., 2011). Moreover, this 
response is limited by insulin/IGF signaling and that a balance between these 
two signaling pathways is required to coordinate proper growth, metabolic 
activities and the response to damage (Karpac et al., 2011). Therefore, when 
taking these results into account, it is possible that an immune response may 
be activated independently of microbial stimulation; hence, the immune 
response itself may be considered a response to damage/non-damage as 
opposed to a response to self/non-self. However, it is not yet entirely clear 
how some of these responses are mediated, and the extent of interplay 
between the immune responses stimulated following damage or microbial 
recognition.  
  
1.7 Drosophila embryos as a Model of Infection  !
Despite the success of Drosophila as an immunity model, the limits of this 
model are appreciable. For example, the outcome of infection experiments is 
often measured by insect death or changes in cell morphology at specific time-
points throughout infection. As a result, crucial information on the early stages 
of infection, particularly early host-pathogen interactions, has previously been 
unattainable, due to the lack of ability to observe infections in real-time. Due to 
the use of adult Drosophila and larvae in previous immunity studies, a real-
time imaging approach has until recently been considered non-viable. A study 
by Vlisidou et al. (2009) addressed this issue by using Drosophila embryos to 
study the early stages of infection with Photorhabdus asymbiotica and 
Escherichia coli via time-lapse confocal microscopy, elucidating much novel 
information; for example, that embryonic hemocytes were able to recognize 
and phagocytose non-pathogenic E. coli and that P. asymbiotica infection led 
to a “frozen” hemocyte phenotype, with a significant reorganization of the actin 
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cytoskeleton (Vlisidou et al., 2009). Moreover, Stramer et al. (2008) further 
used transgenic Drosophila embryos containing reporter constructs to assess 
gene, particularly AMP, induction following sterile wounding; showing 
upregulation of Drs in the fat body, yolk sack and hemocytes of the embryo. 
Thus, although a relatively novel model of immunity and until recently 
overlooked in favour of adult or larval models, Drosophila embryos have 
already demonstrated their ability to generate new insights into immune 
activation and regulation, relieving some of the potential caveats of previous 
studies. However, due to the lack of immunity studies using Drosophila 
embryos, and despite their development being well documented (Hartenstein, 
1993), the ability of embryos to activate immune responses to infection 
remains largely unknown.  
 
1.8 Experimental Aims !
The central aim of this project was to develop a more detailed and intricate 
model of bacterial infection using the Drosophila embryo, and to assess its 
potential as a viable immunity model. Initial aims concentrated on establishing 
whether Drosophila embryos were able to mount an effective AMP response 
to various types of infection, and whether this was mediated via the canonical 
Drosophila systemic immunity pathways. Moreover, a parallel aim was to 
determine if multiple facets of the cellular and systemic response were intact 
and functional within the embryo system, and behaved in a manner which 
mirrored the host defense of the adult fly and larval models. In addition to this 
initial characterization, a further key aim of this project was to determine at 
what stage of development Drosophila embryos begin to demonstrate immune 
competence and what biochemical signaling pathways may drive this 
immunological phenomenon.  
      
Having established the immune capacity of the embryo in terms of its ability to 
respond to bacterial challenge, subsequent project objectives focused on the 
determination of global transcriptome changes within the embryonic system 
upon infection with Gram-negative or Gram-positive microbes, or sterile 
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damage induced by either laser ablation or sterile injection procedures. This 
would enable the identification of the novel genes that were modulated in 
Drosophila upon infection or damage. Another analogous aims was to 
determine the precise role of hemocytes upon either infection or damage 
within the Drosophila embryo; to monitor the transcriptional changes within this 
particular cell type when faced with microbial challenge or sterile damage. 
Ultimately, the aim of this section of the project was to determine if any 
hemocyte-specific infection or damage genes are present in Drosophila.   
 
 
1.9 Project Strategy !
To address these aims, the project strategy initially consisted of a candidate 
approach, whereby live infection studies were combined with molecular 
biology techniques. Drosophila embryo lines containing immune gene reporter 
fusions were used to initially assess embryo immune capabilities. Wild-type 
and immune mutant fly lines were used to assay survival upon bacterial 
infection. Quantitative polymerase chain reaction methodologies were then 
used to determine the relative levels of immune gene expression upon 
treatment with a range of different bacterial species.   
 
To determine the transcriptional changes within the whole embryo and 
specifically in hemocytes upon infection, microarray studies were conducted. 
These were combined with Fluorescence Assisted Cell Sorting (FACS), in 
order to isolate hemocytes for RNA processing. By determining which genes 
were modulated within the embryo upon infection or damage stimuli, induced 
via microinjection of microbes or sterile laser ablation of embryos respectively, 
it would be possible to assess the total infected or wounded transcriptomes of 
the Drosophila embryo. Furthermore, it enabled the investigation of whether 
any novel genes are modulated within the embryo upon infection or damage. 
Combined with the transcriptome data from specifically hemocytes which had 
been in contact with infection stimuli, this approach allowed the possibility of 
identifying the existence of hemocyte-specific infection genes. Further 
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networking analysis was then employed to uncover further trends and patterns 































Chapter 2 – Materials and Methods !
1. Materials  !
1.1 General laboratory reagents !
Halocarbon 700 oil, sodium chloride, potassium chloride, magnesium chloride, 
calcium chloride, sodium phosphate, potassium phosphate, 100% heptane, 
100% ethanol, 100% chloroform, 36% formaldehyde, mowiol, 20-
hydroxyecdysone (5mg), 1,4-diazabiycylo[2.2.2]octane, TritonX-100, Bovine 
Serum Albumin, Goat Serum and Schneiders media without Calcium Chloride 
were purchased from Sigma-Aldrich (Dorset, UK). Phosphate buffered saline 
(PBS) tablets were purchased from Oxoid Ltd. (Cambridge, UK). 
Diethylpyrocarbonate (DEPC)-treated water and endotoxin-free water were 
obtained from Cambio (Cambridge, UK). 25mM dNTP mix was purchased 
from Promega (Madison, USA). Neat commercial bleach (<5% sodium 
hypochlorite) was purchased from The Consortium (Coventry, UK).  
 
1.2 Specific materials !
Qiazol, the Rneasy® Mini Kit and Dneasy® Blood and Tissue Kit were 
purchased from Qiagen (West Sussex, UK). The Superscript III First Strand 
Synthesis System, The QubitTM Quantification Platform and Quant-iTTM assay 
kit were obtained from Invitrogen (Paisley, UK). TurboDNase (2U/µL), 10X 
Dnase Buffer, DNase Inactivation Reagent, RNA later and the RNAqueous 
MicroKit were purchased from Ambion (Austin, USA). Trypsin (100mg), 
collagenase (100mg) and protease from Aspergillus oryzae were obtained 
from Sigma-Aldrich (Dorset, UK). Nylon cell strainers (70µm) for embryo 
collection and for hemocyte FACS experiments (40µm) were ordered from BD 
Biosciences (Oxford, UK). UVette protein-free cuvettes, FemtoJet capillaries 
and microloader tips were purchased from Eppendorf (Stevenage, UK). 
Borosilicate tissue grinders and pestles were obtained from Fisher Scientific 
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(Loughborough, UK). 24x32cm Knittel-Glaser coverslips, 22x22cm and 
18x18cm glass coverslips of thickness 1 were purchased from Scientific 
Laboratory Supplies Ltd. (Nottingham, UK). PetriPerm hydrophobic 
membranes for embryo wounding assays were procured from Pure 
Proteomics (company dissolved). The Experion Automated Electrophoresis 
System, Experion RNA StdSens Analysis Kit and RNA ladder, qPCR plates, 
iTaq SYBR Green supermix and StepOne Real-Time PCR Detection System 
were obtained from Biorad (California, USA). Nunclon cell culture dishes for 
hemocyte extraction and imaging were purchased from Fisher Scientific 
(Loughborough, UK). Primary antibodies were obtained from the 
Developmental Studies Hybridoma Bank (DSHB; Iowa City, USA) or Abcam 
(Cambridge, UK). Further details can be found in Table 2.6. Secondary 
antibodies were obtained from Invitrogen (Paisley, UK).  
      
Apple juice agar plates, embryo glue and fly food were manufactured in house, 
the constituents of which can be located in Appendix 1. Embryo glue was 
manufactured from double sided Scotch tape and 100% heptane. Tungsten 
needles were also manufactured in house, using tungsten wire bought from 
Goodfellow (Huntington, UK).  
 
 
1.3  Bacterial culture materials !
The antibiotics Spectomycin, Rifampicin, Ampicillin and Carbenicillin were 
purchased from Sigma-Aldrich (Dorset, UK). For Luria Bertani (LB) media, 
tryptone, yeast extract and sodium chloride for microbial media were obtained 
from Fisher Scientific (Loughborough, UK). For LB agar, plant agar was 
ordered from Sigma-Aldrich (Dorset, UK). LB media and agar were generated 
and autoclaved in house.  
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1.4 Fly stocks  
A. Gal4 drivers 
The Gal4 fly stocks displayed in Table 2.1 were used to drive expression of 
UAS constructs within embryos.  
 
Table 2.1: Gal4 Fly Stocks used to Drive UAS Construct Expression 
 
Fly stock Source Reference 




Shiga et al., 1996 




Stramer et al., 2005 




Wodarz et al., 1995.  




Lawrence et al., 1995 
w; serpentGal4 
 (w; srpGal4) 
Bloomington Stock 
Centre, Indiana 
Bruckner et al., 2004 
 
 
B. Fluorescent UAS constructs 
Fly stocks containing transgenic UAS constructs driving fluorescent protein 
expression in Table 2.2 were used to observe hemocyte morphology, 
dynamics and phagocytic capabilities.  
 
 
Table 2.2: Fluorescent UAS construct fly lines used 
 
Fly stock Source Reference 
w; uas GFP Bloomington Stock 
Centre 
Yeh et al., 1995 
w;; uas GFP Bloomington Stock 
Centre 
Yeh et al., 1995 





C. Other UAS constructs 
Other transgenic UAS constructs (Table 2.3) were expressed in hemocytes to 
assess the effect of specific genes on hemocyte motility and responses to 
bacteria stimulation.  
 
Table 2.3: Other UAS fly lines used 
 
Fly stock Source Reference 
w; uas Ecdysone 
Receptor -BI Dominant 
Negative 
(w; uas EcR-B1 DN) 
Bloomington Stock 
Centre 




D. GFP fusion lines 
The GFP fusion lines below (Table 2.4) were used to study the localisation 
and time-course of the immune response either within embryos post bacterial 
infection or post wounding via sterile laser ablation.  
 
 
Table 2.4: GFP fusion lines used for infection experiments 
 
Fly stock Source Reference 
w; Drocosin-GFP  
(w; Drc-GFP) 
Gift from J.L. Imler Tzou et al., 1998.  
w; Drosomycin-GFP 
(w; Drs-GFP) 
Gift from B. Stramer.  Ferrandon et al., 1998.  
w; Peptidoglycan 
recognition protein – LC 
– GFP 
(w; PGRP-LC-GFP) 





Table 2.5 illustrates the mutants lines employed: RelishE20 (RelE20), modular 
serine protease (modSP1) and double Persephone1 (psh1) and modSP1 
mutant lines were homozygous for their mutations and hence had no 
requirement for balancers. Ecdysone receptor (EcR) Q50st, EcRM554fs and 
Scar!37 were all balanced using CTG. In these cases, selecting embryos that 
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Table 2.5: Immune mutant lines used 
 
Fly stock Mutation type Source Reference 
w; RelE20 Loss of 
function 
Gift from B. 
Lemaitre 
Hedengren et al., 
1999.  
w;; modSP1 Amorph Gift from B. 
Lemaitre 
Buchon et al., 
2009.  
w, psh1;;modSP1 Amorph Gift from B. 
Lemaitre 
Buchon et al., 
2009.  
w; EcRQ50st Amorph Bloomington Stock 
Centre 
Bender et al., 
1997.  
w; EcRM554fs Amorph Bloomington Stock 
Centre 
Bender et al., 
1997.  
w; SCAR!37 Amorph  Zallen et al., 2002.  
 
 
The list of fly lines generated from the above stock lines can be found in 
Appendix 2.  
 
 
1.5 Bacterial strains  !
Erwinia carotova carotova 15 (Ecc15) was obtained from B. Lemaitre, EPFL, 
Lausanne, Switzerland. Micrococcus luteus, DH5" Escherichia coli, BL-21 
RFP-Escherichia coli, 4134 Salmonella typhimurium and TTO1 Photorhabdus 
luminescens strains were obtained from N. Waterfield, University of Bath, UK. 
Mg1655 Escherichia coli were obtained from the American Type Culture 









Tables 2.6 and 2.7 display the primary and secondary antibodies utilized for 
immunofluorescent staining. Primary antibodies were diluted in 40% glycerol 
to make concentrated stocks. Working stocks were subsequently generated by 
diluting to the required concentration with 0.1% Triton X-100, 1% BSA in PBS 
or 0.1% Triton X-100, 10% Goat Serum in PBS, dependant on requirement. 
 
 
Table 2.6: Primary antibodies 
Antibody Raised in Epitope recognised From Dilution 
Anti-GFP Rabbit GFP Abcam 1:500 





Mouse Common domain in 




Table 2.7 Secondary antibodies 
Antibody Raised in Fluorescence From Dilution 
Anti-rabbit Goat Alexa Fluor 488 Molecular probes 1:500 
Anti-mouse Goat Alexa Fluor 568 Molecular probes 1:500 
Anti-mouse 
IgM 












2.1 Fly stock maintenance and amplification  
 
All Drosophila lines were maintained at the University of Bath, UK at 22°C, 
under standard conditions, on food consisting of yeast extract, malt extract, 
soya flour, corn meal, plant agar and sugar. To amplify fly stocks, vials of flies 
were tipped onto new food in vials every 2-3 days until enough progeny had 
emerged from old containers to establish a laying cage or for use in a genetic 
cross.  
 
2.2 Fly Collection and Genetic Crosses !
Fly crosses were established at 22°C with a minimum of 10 flies. Flies were 
transferred into a vial of standard food with a drop of yeast paste to encourage 
mating. The flies were tipped on to new food and yeast every 2-3 days until a 
sufficient number of progeny were obtained. These progeny were then in turn 
utilized in further crosses or transferred to laying cages.  
 
2.3 Laying cages 
 
To generate Drosophila embryos for studies, laying cages of flies were 
established (Figure 2.1). At least 20 female and 20 male flies of the 
appropriate genotypes were anaesthetized using CO2 and transferred to a 
plastic beaker with holes in the bottom. An apple juice agar plate with a drop of 
yeast paste attached to the side was placed to seal the beaker and secured 
using an elastic band. The beaker was inverted once flies had recovered. The 
laying cages were incubated at 22°C in darkness for 15-16 hours to promote 
mating and embryo deposition onto the agar plates. The agar plates could 




      
Figure 2.1 Schematic of a Laying Cage. To establish a laying cage to procure Drosophila 
embryos, a drop of yeast paste was added to the side of an apple juice agar plate. Flies were 
then anaesthetized using CO2 and placed inside a beaker with holes. The agar plate was then 
used to seal the beaker and the whole apparatus held together using an elastic band. Cages 
would be stored on their side until the flies recovered at which point they would be stored as 
depicted in the schematic. Flies subsequently laid embryos on the agar, which could be 
removed to harvest embryos for experiments.   
 
 
2.4 Drosophila embryo preparation 
 
Embryos were transferred to a 70µm nylon cell strainer by brushing into 
distilled water using a paintbrush and dechorionated by immersing into neat 
commercial bleach for 2 minutes. To remove any traces of bleach, the 
embryos were rinsed 5 times with distilled water in the strainer and then kept 
immersed in distilled water until required.  
 
2.5 Mounting !
A. For imaging 
Embryos of the appropriate stage of development were selected from the cell 
strainer using a tungsten needle (Figure 2.2A), in accordance with the Atlas of 
Drosophila Development (Hartenstein, 1993). Embryos were then placed on 
double sided tape adhered to a glass slide and orientated so their ventral side 
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was exposed. Approximately 5-7 embryos were mounted per slide. Upon 
completing this task, two 22x22mm glass coverslips were adhered to the tape 
on either side of the embryos. Minimal Halocarbon 700 oil was dabbed on top 
of the embryos using a tungsten needle to protect against desiccation. A 
24x32mm glass coverslip was then carefully lowered to rest on top of the 







Figure 2.2: Procedures for mounting Drosophila embryos. Embryos were mounted either 
for imaging (A) or microinjection (B). A: Embryos of the correct developmental stage were 
individually selected directly from the cell strainer onto double sided tape, covered with 
halocarbon oil and a coverslip bridge placed and secured on top. B: Embryos were transferred 
to an apple juice agar plate where those of the correct developmental stage were collected 
and transferred as a group to an agar mounting block. Here they were lined up, transferred to 




B. For microinjection 
 All embryos were transferred from the cell strainer to an apple juice agar plate 
using a paintbrush (Figure 2.2B). Embryos of the correct developmental stage 
were selected and grouped as above until required. These embryos were then 
transferred to a mounting block; a square piece of apple juice agar on a Petri 
dish lid. The embryos were lined parallel to the edges of the agar, with no 
more than 25 embryos per line. Embryos were orientated so that their ventral 
side was in contact with the agar and so that their anterior was facing towards 
the middle of the block. The resulting lines of embryos were lifted from the 
block by placing a 24x32mm coverslip covered with embryo glue on top. The 
coverslips were then adhered to a glass slide using a drop of Halocarbon 700 
oil and desiccated for 8 minutes in a box of silica salt. Upon completing 
desiccation, the line of embryos was covered with halocarbon 700 oil, to 
prevent further embryo desiccation, and the slide stored in a box in humid 
conditions for 10 minutes prior to injection.  
 
 
2.6 Bacterial culture and preparation !
All cultures were isolated from 40% glycerol stocks stored at -80°C by 
streaking onto sterile LB agar plates, with antibiotic where appropriate as 
detailed in Table 2.6. One colony was then selected and sub-cultured 
overnight in 10mL LB media in a sterile falcon tube under the conditions 
detailed in Table 2.6 and with antibiotic where appropriate.  
  
To prepare live bacteria for infection experiments, 1mL of culture was washed 
three times in sterile endotoxin-free PBS. The optical density of the culture at 
600nm (OD600) was measured using a 1:10 dilution of the original culture in 
endotoxin-free PBS in an Uvette cuvette using an Eppendorf Biophotometer. 
The OD600 of the washed bacterial was then readjusted using sterile 
endotoxin-free PBS to the required OD as detailed in Table 2.7. To prepare 
heat killed bacteria for infection assays, 1mL of bacterial culture was washed 
three times in sterile endotoxin-free PBS as above and resuspended in sterile-
endotoxin free PBS to the required OD600 value. The washed culture was then 
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boiled at 95°C in a heat block for 10 minutes to heat kill the bacteria. The 
resulting suspension was centrifuged at maximum speed for 1 minute and the 




Table 2.6: Bacterial strain growth conditions 
 






carotovora 15 (Ecc15) 
30.0 Rifampicin 25.0 
BL 21 
RFP-Escherichia coli 
37.0 Ampicillin 100 
DH5!  
Escherichia coli 
37.0 None - 
Mg1655 
Escherichia coli 
37.0 None - 
Micrococcus luteus 37.0 None - 
TTO1  
Photorhabdus luminescens 
28.0 Rifampicin  25.0 
4134  
Salmonella typhimurium 
37.0 - - 
 
Not all cultures required antibiotic selection, hence those that were grown solely using LB 





Table 2.7: Final OD values of Bacterial Stains 
 
Bacterial strain OD600 Assay 
Erwinia carotovora 
carotovora 15 
0.1 2.9B, 2.9E 
0.5 2.9C 
1 2.10B, 2.10C, 2.14, 
2.15C 
BL21 RFP-Escherichia coli 10 2.9D 
DH5a Escherichia coli 1 2.9A 
Mg1655 Escherichia coli 1 2.9B 








Further details of assay protocols can be found in the corresponding sections as indicated by 
the assay number.  
! "#!
2.7 Microinjection of Drosophila embryos !
Embryos were mounted as described in 2.5B and subsequently injected using 
the Eppendorf FemtoJet microinjector platform. An Eppendorf needle was 
loaded with 5µL of the appropriate culture or control sterile endotoxin-free PBS 
and the tip broken on the edge of the coverslip containing the embryos to 
allow consistent flow of the culture. Embryos subsequently received an 
injection in the anterior region of approximately 3nL of culture or control PBS 
for 1 second at an injection pressure (Pi) of 50-100hPa and compensation 
pressure (Pc) of 20hPa. Post injection, embryos were incubated at 22°C in a 
box containing moistened tissue for the appropriate time period.  
 
 
2.8 Sterile laser ablation of Drosophila embryos 
 
To generate RNA samples of wounded embryos, Drosophila embryos were 
prepared and Stage 15 selected on agar plates as detailed above. All embryos 
were then transferred to a drop of Halocarbon 700 oil on a Petri dish. Embryos 
were then individually transferred using a tungsten needle to PetriPerm 
hydrophobic membranes, flanked by two 18x18cm glass coverslips, and 
orientated ventral side up. Embryos were arranged in a grid of 3 x 10, so that 
30 embryos were contained upon each membrane. The embryos were 
covered with extra Halocarbon 700 oil using a Tungsten needle, to ensure 
embryos were kept hydrated. A 24x32mm glass coverslip was then placed on 
top of the flanking coverslips using tweezers so that the embryos were 
effectively covered. Magic tape was then used to secure the coverslip to the 
membrane. Wounding was performed using a Spectra Physics Nitrogen laser 
attached to a Leica SP5 confocal microscope. Embryos were wounded once in 
the centre of the ventral side. The embryos were then incubated at 25°C for 2 
hours before the coverslip was removed from the membrane. The embryos 
were then transferred to an inverted 40µm cell strainer inside a Petri dish and 
washed once with 100% heptane to remove the Halocarbon 700 oil. Once 
satisfied that the oil had been removed, the embryos were transferred into a 
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sterile microcentrifuge tube and 250µL Qiazol added. The samples were then 
frozen at -80°C until required.  
 
2.9 Infection assays 
 
A. Bacterial Infection of Drosophila embryos to determine the time-course of 
the immune response      
To assess if embryos were able to mount an effective immune response to a 
bacterial stimulus, cohorts of 25 embryos containing the Drosocin-GFP (Drc-
GFP) transgene were selected and processed, before being mounted for 
microinjection as described in Section 2.7. Embryos were microinjected either 
with live or heat killed E. coli (OD600=10) or Ecc15 (OD600=1) as described in 
2.7. Embryos were incubated on their injection apparatus in a box containing 
moist tissue at 22°C for 6 hours post injection, at which point GFP expression 
and localisation was visualized using a Leica M716F fluorescence dissecting 
scope, Leica DC350FX camera and Adobe Photoshop C53 software linked to 
a TWAIN module for Leica DC cameras.  
 
B. Mortality assay 
To assess embryo viability post injection, embryos were employed in a 
mortality assay. Embryos were selected and mounted for injection as 
described in 2.5B and subsequently injected with either sterile endotoxin-free 
PBS or bacterial suspension as detailed in Section 2.7. !100 embryos were 
injected per experimental replicate (n=3). Non-treated control replicates were 
generated by selecting groups of 100 embryos on apple juice agar plates, 
transferring them to clean agar plates using a tungsten needle and arranging 
them in an array of 10x10 lines. Sufficient Halocarbon 700 oil was then used to 
cover them to prevent desiccation. All samples were then stored in parafilm-
sealed humidified boxes at 25°C for the appropriate time period; 24 hours for 
embryos injected at Stage 15 and 30 hours for embryos injected at Stage 11. 
At this time point, mortality was measured by counting the numbers of dead 
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and live larvae and embryos. The total percentage survival was calculated for 
each replicate and a mean value for each treatment and experiment derived.  
 
C. 20-hydroxyecdysone rescue assay 
To assess if 20-hydroxyecdysone (20-HE) could rescue the immune response 
and survival of Stage 11 embryos injected with bacterial species, a rescue 
assay was performed. Drc-GFP Stage 15 and Stage 11 embryos were 
selected and mounted for microinjection as described in 2.5B. Groups of !100 
Stage 15 and Stage 11 embryos were subsequently injected as described in 
2.7 with either sterile endotoxin-free PBS, 25µM 20-HE, Ecc15 (OD=0.5) or 
Ecc15 (OD=0.5) + 25µM 20-HE. The coverslips on which the embryos were 
adhered were removed from their respective slides and transferred to apple 
juice agar plates. Embryos were then incubated at 25°C post infection in a 
humidified container. The time-course, localisation, intensity and numbers of 
Drc-GFP expression within embryos were monitored for 30h post injection, as 
well as the developmental stage of the individual embryo using yolk sac 
morphology. Images of embryos were obtained at 12 hours post infection 
using a Leica M716F fluorescence dissecting scope, Leica DC350FX camera 
and Adobe Photoshop C53 software linked to a TWAIN module for Leica DC 
cameras.  
 
D. Phagocytosis assay 
To determine if bacteria were effectively phagocytosed, embryos containing 
GFP-expressing plasmatocytes were employed in a phagocytosis assay. 
Embryos were dechorionated and maintained in distilled water described 
above. The 70µm cell strainer was subsequently removed from the water and 
dried. Stage 15 embryos were selected directly from the basket using a 
tungsten needle and transferred to double sided tape adhered to lateral edge 
of a 24x32mm coverslip. The embryos were orientated for microinjection in 
accordance with Section 2.5B. The coverslip was then adhered to a glass slide 
using a drop of Halocarbon-700 oil. Embryos were desiccated for 8 minutes in 
a box of silica salt before transference to a box containing moist tissue.  
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Live RFP-E. coli were cultured and prepared as described in Section 2.6. The 
OD600 value was adjusted to a value of 1 using sterile endotoxin-free PBS. 
Embryos were injected as described in 2.7. Post-injection, two 22x22mm were 
adhered in a stack using nail varnish. These were then attached to the slide 
using double-sided tape adjacent to the embryos. A further 22x22mm 
coverslip was attached to the remainder of the embryo coverslip using double 
sided tape. A 24x32mm coverslip was then carefully lowered over the embryos 
to rest on these newly applied supports and secured in place with nail varnish. 
Embryos were then subjected to time-lapse confocal imaging, with the 
parameters defined in Section 2.14.  
 
 
E. Determination of Colony Forming Units Post Infection  
To determine how many Colony Forming Units (CFUs) of bacteria were 
present in embryos 7.5 hours after infection, embryos were microinjected as 
described in 2.7 and incubated at 25°C for 7.5 hours on their injection 
apparatus in a humidified box to allow time for gene transcription to occur. 
After this time period, embryos were removed from the injection apparatus by 
washing slides with 100% heptane using a Pasteur pipette. Embryos were 
washed into a sterile 50mL Falcon tube and excess heptane removed. Using a 
Pasteur pipette, embryos were transferred to a sterile microcentrifuge tube 
and washed once with 1mL of sterile PBS to remove any remaining heptane. 
Embryos were subsequently crushed in 300µL sterile PBS using a sterile 
plastic pestle until no particulate remained. The suspension was spread on to 
LB agar plates in triplicate, with 100µL inoculated on to each plate. LB plates 
were incubated at the appropriate temperature overnight to allow for bacterial 







2.10 Antibody staining  
 
A. Staining of non-treated embryos 
Stage 15 embryos were dechorionated as described previously and 
transferred to a 1:1 mix of 100% heptane and 4% formaldehyde. Embryos 
were then fixed for 20 minutes on a roller before removal of the formaldehyde 
phase. 500µL of 100% methanol was added to remove the embryonic vitelline 
membrane. Subsequently, devitellinised embryos were transferred to a clean 
microcentrifuge tube using a Pasteur pipette and washed three times with 
500µL 100% methanol. Embryos were permeabilised three times with washes 
of 500µL 0.1% Triton-X in PBS (PBT) and subsequently washed three times in 
500µL 0.1% Triton X, 1% BSA in PBS (PATx) for 20 minutes on a roller, to 
block non-specific staining. Embryos were transferred to a clean 
microcentrifuge tube using a Pasteur pipette and excess PATx removed. 
Primary antibodies diluted to the required concentration in PATx, as detailed in 
Table 2.6, were added and the samples incubated overnight on a roller at 4°C. 
Samples were washed three times with PATx for 20 minutes on a roller before 
application of the secondary antibody, diluted as displayed in Table 2.7. 1µL 
FITC-phalloidin was added to stain F-actin as required. Samples were 
incubated with secondary antibody for 2 hours at room temperature on a roller 
before washing three times with PATx as above. 200µL of 1,4-
diazabiycylo[2.2.2]octane (DABCO) was subsequently applied to the samples 
and enabled them to be stored at 4°C until required.  
 
 
B. Staining of treated embryos 
Embryos were injected either with sterile endotoxin-free PBS or Ecc15 and 
incubated at 25°C for 6 hours to allow expression of transgenic constructs. 
After this period, embryos were removed from their injection apparatus as 
described above and collected into a 50mL Falcon tube, from where they were 
transferred using a Pasteur pipette into 1mL of 100% heptane in a glass vial. 
1mL of 4% formaldehyde was added to the vial and the embryos fixed at the 
interphase on a shaker for 20 minutes at room temperature. The embryos 
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were subsequently transferred to an inverted 70µm cell strainer using a 
Pasteur pipette and any excess heptane removed. The embryos were directly 
transferred to double-sided tape and the tape subsequently adhered to a Petri 
dish. PBS was used to cover the embryos to ensure that they remain 
hydrated. Once adhered to the tape, embryos were hand devitilinised using 
tweezers and collected into a microcentrifuge tube using a Pasteur pipette. 
Excess PBS was removed and the embryos were employed in consecutive 
washes of 25%, 50% 75% and 100% methanol in PBS. Immunostaining was 
then carried out as described above.  !!
2.11 Primer design, synthesis and validation !
A. Primer design 
Gene sequences were downloaded from National Center for Biotechnology 
Information (NCBI) website (accessed from http://www.ncbi.nlm.nih.gov/) 
Primer pairs were then designed using the online freeware Primer3 (accessed 
from http://frodo.wi.mit.edu/primer3/) using the table of themodynamic 
parameters from Breslauer et al. (1986) and the search parameters outlined in 
Table 2.8.  
 
 
Table 2.8: Parameters used in Primer Pair Generation 
 
Parameter description Parameter value 
Product size range 80-120bp 
Number to return 20 
Minimum primer Tm 59.0°C 
Optimum primer Tm 60.0°C 
Maximum primer Tm 61.0°C 
Maximum Tm Difference 1.0°C 
Maximum primer GC% 70.0% 
Maximum self complementarity 2-4bp 
Maximum 3’ Self complementarity 0-3bp 
 
Parameters for primer design accounted for a range of primer features, including percentage 




Upon successfully generating primers with acceptable thermodynamic 
properties, the structure of the gene region at 60°C was predicted using Mfold 
freeware (accessed from http://mfold.rna.albany.edu/?q=mfold) using the DNA 
structure application. It was assessed whether the primers would bind to linear 
regions or hairpin loops within the gene structure. If it was the case that the 
primers would bind within hairpin loops, those whose 3’ end extended up a 
hairpin loop structure (Figure 2.3B) were rejected, as this has been shown to 
significantly decrease the efficiency of a PCR reaction (Singh et al., 2000). 
Those whose 3’ ends extended down hairpin loops (Figure 2.3A) were 
accepted for the next phase of validation.  
 
                                
  
Figure 2.3: Primer binding within predicted hairpin loops in target genes. Primers 
annealing to target sequence down a hairpin loop 5’-3’ (A) were progressed through the 




In the final stage of the primer design protocol, the primer sequences were 
entered into the nucleotide Basic Local Alignment Search Tool (BLASTn) 
hosted on the NCBI website (accessed from 
http://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&PAGE_TYPE=BlastHome) 
to determine in silico the range of genes that the primers would theoretically 
identify in PCR reactions, and hence if the primers would bind specifically to 
the gene of interest and if any off-target sequences would also be selected. To 
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do this, the nucleotide collection was screened to identify highly similar 
sequences. If both forward and reverse primers selected the gene of interest 
with high identity and a low expect (E) value, in comparison to other potential 
hits, then the primers sequences were sent for synthesis. The primers 
generated are listed in Table 2.9; further details on themodynamic properties 
of specific primers, the sites of primer binding relative to secondary structures 
and in silico assessment of primer specificity can be viewed in Appendices 3, 
4 and 5 respectively. Primer sequences for internal control and AMP genes 
were provided by B. Lemaitre, EPFL, Lausanne, Switzerland, and are shown 
in Table 2.10. Primer sequences for evaluating ecdysone-related genes, 
accessed from Hackney et al. (2012), are displayed in Table 2.11.  
 
B. Synthesis and Reconstitution 
Primer sets were synthesized by Invitrogen (Paisley, UK) to a 25nmol scale. 
Upon receipt, primers were reconstituted in DEPC-treated water to a 100µM 
concentration. A 10µM working stock in DEPC-treated water was then 
generated for use in quantitative PCR (qPCR) validations and further 
experiments.  
 
C. Genomic DNA (gDNA) isolation 
5 male and 5 female flies were selected to procure approximately 25mg of 
tissue. The Dneasy Blood and Tissue Kit was used to extract the total DNA 
from these flies, using the spin column protocol. The flies were homogenized 
using a sterile plastic pestle in 180µL Buffer ATL to release their DNA. 20µL 
Proteinase K was then added and the whole suspension mixed vigorously by 
vortexing. The suspension was then incubated at 56°C for 3 hours, vortexing 
occasionally, until the tissue was maximally lysed.  After this period of time, 
the sample was vortexed for 15s and 200µL Buffer AL was added and 
vortexed again. 200µL 100% ethanol was introduced to the sample and 
followed by thorough vortexing. The mixture was then transferred into a 
DNeasy Mini spin column placed inside a 2mL collection tube, where the DNA 
would bind to the column membrane. The column was centrifuged at 6000 x g  
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Table 2.9: Immune Primer Sequences generated 
 


















Table 2.10: AMP Gene and Internal Control Gene Primer Sequences 
contributed by B. Lemaitre 
 
Gene target Forward primer (5’-3’) Reverse primer (5’-3’) 
Attacin  CCCGGAGTGAAGGATG GTTGCTGTGCGTCAAG 
Cecropin GAACTTCTACAACATCTTCGT TCCCAGTCCCTGGATT 
Defensin GTTCTTCGTTCTCGTGG CTTTGAACCCCTTGGC 
Diptericin GCTGCGCAATCGCTTCTACT TGGTGGAGTGGGCTTCATG 










Table 2.11: Ecdysone-related Gene Primer Sequences 
  
Gene target Forward primer (5’-3’) Reverse primer (5’-3’) 
Defective in avoidance 


















































for 1 minute and the flow through discarded. The column was transferred to a 
new collection tube and 500µL Buffer AW1 added, before centrifuging and 
discarding the flow through as before. 500µL Buffer AW2 was then added and 
the column centrifuged for 3 minutes at 20000 x g and the flow through 
discarded, to dry the membrane. The column was finally placed into a 1.5mL 
microcentrifuge tube. 100µL Buffer AE was transferred directly onto the 
membrane. The column was incubated at room temperature for 1 minute 
before centrifuging at 6000 x g for 1 minute to elute the purified DNA into the 
microcentrifuge tube. The same process was then repeated using a further 
100µL of Buffer AE to procure maximum DNA yield. The yield of DNA was 
subsequently quantified using an Eppendorf Biophotometer. A 1:50 dilution of 
DNA was performed in an UVette cuvette using DEPC-treated water. DEPC-
treated water was used to calibrate the biophotometer and the OD at 260, 230 
and 280nm measured. The resulting purified DNA sample was then stored at -
80°C until required.  
 
D. Quantitative PCR (qPCR) Validation and analysis 
For primers that were to be employed in qPCR, it was necessary to validate 
their performance and percentage binding efficiency within this assay. This 
included those whose sequences were supplied by B. Lemaitre and from 
Hackney et al. (2012). The gDNA procured in 2.11C was used as the template 
for these reactions. 1:10 and 1:100 dilutions of the gDNA in DEPC-treated 
water were generated, so as to generate a standard curve of gDNA 
amplification. A qPCR reaction mix was generated to test the binding 
efficiency of each primer for each dilution of gDNA. This consisted of 7.5µL 
qPCR supermix, 0.75µL of 10µM stocks of each respective forward and 
reverse primer and 3.5µL of DEPC-treated water for each reaction required. 
12.5µL of each mix was transferred to its corresponding well in a 96-well 
qPCR plate (Figure 2.4). 2.5µL of either neat, 1:10 or 1:100 diluted gDNA was 
then added to the wells A negative control was also included, whereby 2.5µL 
of DEPC-treated water was added to the corresponding reaction mix in place 
of gDNA. Each reaction was replicated in duplicate for each gDNA dilution to 
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ensure accuracy. Finally, the plate was sealed with optical film and centrifuged 
for 5 minutes at 106 x g and 4°C before being transferred into the Biorad 
StepOne qPCR system. Amplification of the gDNA was performed at 40 
cycles, with an initial denaturation phase of 95°C for 2 minutes and then cycles 
of 95°C for 10 seconds and 60°C for 1 minute. Amplification plots were 
generated to study product amplification. Standard curves of threshold cycle 
(Ct) against concentration of gDNA for each primer pair were generated using 
the StepOne software (v2.2.2). Primer efficiency was calculated using 
Equation 1: 
 
   Efficiency (E) = 10(-1/gradient of standard curve)                               Equation 1  
 
Melt curve analysis to assess the specificity of the qPCR product was 
achieved by melting the product at 95°C then reducing the temperature to 




Figure 2.4: Layout of a qPCR plate for primer validation. Coloured squares indicate the 
wells of the plate that contain the primers targeting different genes, or alternate primer 
sequences for the same gene. Each row within a coloured block represents one replicate, 
either 1 or 2. To generate a standard curve to measure efficacy of primer binding, reactions 
containing either a neat (N), 1:10 or 1:100 dilution of gDNA were established. A negative 




2.12 Bacterial infection of Drosophila embryos for RT-qPCR analysis !
A. Microinjection and post-injection processing  
Embryos of the desired developmental stage were selected and mounted for 
microinjection as described in 2.5B. Groups of 200 embryos were injected with 
either sterile endotoxin-free PBS, Mg1655 E. coli, M. luteus or Ecc15 as 
required, in accordance with 2.7. Post-injection, embryos were incubated as 
described in 2.9E. At 2 hours post infection, embryos were removed from their 
injection apparatus, by washing into a 70µm cell strainer using 100% heptane. 
Embryos were subsequently recovered into a sterile microcentrifuge tube 
containing 100µL 100% heptane using a paintbrush. Excess heptane was then 
removed and 250µL Qiazol added. Samples were then snap frozen in dry ice 
and stored at -80°C for at least 24 hours or until required.  
 
B. RNA extraction  
Samples were defrosted on ice and processed using the RNeasy Mini Kit in 
combination with Qiazol. Embryos were homogenised in the 250µL Qiazol in 
which they were frozen, using a sterile plastic pestle, until no particulate 
remained. The volumes of sample were then increased to 1mL with further 
Qiazol and the samples left to incubate at room temperature for 5 minutes. 
200µL 100% chloroform was added to each sample and the mixtures 
vigorously mixed for 15 seconds. Subsequently incubating the mixtures at 
room temperature for 10 minutes allowed for initial phase separation. This was 
followed by centrifugation at 4°C and 15,200 x g for 15 minutes to further aid 
phase separation. The aqueous phase from each sample was transferred into 
individual tubes containing 600µL 70% ethanol and gently mixed. The samples 
were then transferred quickly into individual spin columns inserted into 2mL 
collection tubes. The columns were centrifuged for 20 seconds at 9,300 x g at 
room temperature. The flow through was discarded and the column replaced 
in the collection tube. 500µL Buffer RPE was added to each column and the 
samples were centrifuged as before for 20 seconds. The flow through was 
discarded and this step repeated to was the column membrane. Centrifugation 
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was carried out as before for 2 minutes. The spin column was then placed into 
a clean 2mL tube and centrifuged at full speed for 1 minute at room 
temperature to eliminate any possible carry over of Buffer RPE. The spin 
column was finally placed in a 1.5mL tube and 50µL DEPC-treated water was 
pipetted directly onto the membrane. The samples were then eluted by 
centrifugation at 9,300 x g for 1 minute at room temperature into a clean 
microcentrifuge tube. The resulting RNA was either frozen at -80°C until 
required or applied directly to DNase treatment.  
 
C. TURBO DNase Treatment 
DNase treatment of RNA samples was undertaken to remove any genomic 
DNA present. 5µL 10X TURBO DNase buffer and 2µL TURBO DNase was 
added to all RNA samples and the contents mixed gently. The samples were 
incubated at 37°C in a heat block for 1 hour to allow digestion to occur. 
Following this period, 10µL DNase Inactivation Reagent was added to the 
samples and the suspension mixed well. The samples were subsequently 
incubated at 25°C in a heat block for 5 minutes, during which time they were 
mixed twice, before being centrifuged at 1,000 x g for 1.5 minutes to separate 
the inactivation reagent from the RNA sample itself. The RNA was then 
transferred to a clean tube and the concentration subsequently determined.  
 
D. RNA quantification  
RNA quantification was subsequently performed using the Qubit Quantification 
Platform and Quant-iT assay kit. A working solution of the Quant-iT RNA 
probe was generated by diluting 1:200 in Quant-iT RNA buffer, ensuring 1µL 
of probe for each RNA sample and all RNA standards to be quantified. 199µL 
of working solution was added to 1µL of RNA sample in their respective 
Quant-iT assay tubes. 190µL of working solution was added to 10µL of the 
RNA standard solutions (0 and 10ng/µL RNA concentrations) required for 
platform calibration in Quant-iT assay tubes. All tubes were then vortexed for 
2-3 seconds and incubated at room temperature for 5 minutes. The Qubit 
Quantification platform was calibrated using the standards and the samples 
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subsequently measured. The dilution factor of the assay samples was then 
extrapolated to determine the RNA concentration of the original samples. 
Subject to a satisfactory RNA concentration, the samples were then employed 
in RT-qPCR.  !
E. RT-qPCR 
Upon satisfying RNA validation constraints, the RNA samples were employed 
in RT reactions to generate cDNA using the Superscript III First Strand 
Synthesis System. The amount of RNA per RT reaction was standardized to 
1µg. To this volume of RNA, 1µL of random Oligo(dt)20 primers and 1µL 10mM 
dNTPs were added and the volume made up to 10µL with DEPC-treated water 
in a sterile PCR tube. The mixes were then incubated at 65°C for 5 minutes in 
a PCR block to allow for random primer binding to the RNA and to remove any 
secondary structure before chilling on ice for at least 1 minute. An RT mix was 
generated, consisting of 2µL 10X Buffer, 4µL 25mM MgCl2, 2µL 0.1M DTT, 
1µL RNaseOUT RNase Inhibitor and 1µL Superscript III reverse transcriptase 
per reaction; 10µL was dispensed into each PCR tube. The resulting mixes 
were then incubated in a PCR block at 50°C for 50 minutes and subsequently 
85°C for 5 minutes to inactivate the reverse transcriptase. 1µL RNase H was 
added to each reaction and incubated at 37°C for 20 minutes to degrade any 
remaining RNA. Finally, 180µL DEPC-treated water was then added to give a 
final cDNA concentration of 5ng/µL. The RT reactions were stored on ice, 
ready to be used in qPCR, or frozen at -80°C until required.  
 
qPCR was carried out using the StepOne Real-Time PCR Detection System. 
5µL of cDNA (!25ng) was transferred to each individual well of a 96-well 
qPCR plate using an Eppendorf Research Pro repeat pipettor. A master qPCR 
reaction mix was generated. This consisted of 7.5µL qPCR supermix, 0.75µL 
of 10µM stocks of each respective forward and reverse primer and 3.5µL of 
DEPC-treated water for each reaction required. 12.5µL of each mix was 
transferred to its corresponding well in a 96-well qPCR plate. Plates were 
sealed using optical film and centrifuged for 5 minutes at 4°C at 106 x g. 
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Amplification of the cDNA was performed for 40 cycles, with an initial 
denaturation phase of 95°C for 2 minutes and then cycles of 95°C for 10 
seconds and 60°C for 1 minute. Amplification plots were generated to study 
product amplification.  
 !
2.13 Microarray Studies !
A. Total embryo RNA isolation and quality control 
Groups of 200 Stage 15 w; srp-Gal4, UAS-GFP; crq-Gal4, UAS-GFP embryos 
were mounted and microinjected as detailed in 2.5B, with either sterile 
endotoxin-free PBS, M. luteus (OD=1) or Ecc15 (OD=1). Control, non-infected 
embryo groups were also established by collecting 200 Stage 15 embryos and 
transferring them to a drop of Halocarbon-700 oil on a slide. Each treatment 
was replicated in triplicate. All injected and control samples were incubated at 
25°C for 2 hours to allow for gene transcription to occur. After this time period, 
the embryos were harvested from the injection or incubation apparatus. Non-
infected embryos were transferred to an inverted 70µm cell strainer using a 
tungsten needle and 100µL 100% heptane added to them in a drop-wise 
fashion to remove the Halocarbon 700 oil. Embryos were transferred to 100µL 
100% heptane in a RNase-free microcentrifuge tube using a paintbrush, to 
ensure that all oil was removed. Excess 100% heptane was removed and 
250µL Qiazol added in a fume hood. Samples were then snap frozen in dry ice 
and stored at -80°C until required. 
 
Total RNA was isolated from the samples using the RNeasy Mini Kit as 
described in 2.12B. The quantity and quality of the resulting RNA was 
examined using the Experion Automated Electrophoresis System in 
conjunction with the Experion RNA StdSens Analysis Kit. Before a run, the 
system electrodes were cleaned by inserting a cleaning chip filled with 800µL 
cleaner for 2 minutes before rinsing for 5 minutes and then 60 seconds via a 
cleaning chip filled with 800µL DEPC-treated water. The kit reagents were 
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equilibrated at room temperature for 20 minutes prior to use. After this period, 
600µL RNA gel was transferred into a spin filter tube and centrifuged at 1,500 
x g for 10 minutes. 65µL of gel was then transferred into a microcentrifuge 
tube. 1µL stain was added to the tube and the contents vortexed and 
subsequently foil-wrapped to protect from light. 2µL aliquots of each sample 
and the RNA ladder were transferred to individual microcentrifuge tubes and 
denatured at 70°C for 2 minutes in a heat block before cooling immediately on 
ice for 5 minutes. A chip was primed by pipetting 9µL of filtered gel-stain 
solution into the highlighted gel-strain (GS) well (Figure 2.5). The chip was 
then placed in the priming station and pressure setting B and time setting 1 
used to prime the chip. 9µL of gel-strain solution was pipetted into the other 
GS well and 9µL filtered gel was loaded into the gel (G) well. 5µL of loading 
buffer was transferred into each sample well (1-12, Figure 2.5) as well as the 
ladder (L) well. 1µL of denatured ladder was pipetted into the L well and 1µL of 
each RNA sample into individual sample wells. The chip was then vortexed in 
the vortex station for 1 minute. The chip was then placed within the Experion 
Automated Electrophoresis System and the run started. Progress was 
monitored using the Experion software (V3.20). 
 
                              
Figure 2.5 Schematic to show the layout of Experion Chip (Biorad Laboratories, 2010). 
Gel-stain solution was loaded into the highlighted gel priming (GS) well to prime the chip. 
Further gel-stain was then added via the GS well, and filtered gel added in the well labeled G. 
Denatured RNA ladder was loaded via the specified ladder (L) well, and denatured RNA 




B. Sample preparation for hemocyte microarray studies 
Hemocyte samples were initially prepared in a similar manner to preparation of 
total RNA samples. A minimum of 1000 Stage 15 w; srpGal4, UASGFP; 
crqGAl4, UASGFP embryos were injected with either sterile endotoxin-free 
PBS or Ecc15 as described above before being incubated at 25°C in a 
portable incubator for two hours. Upon completion of this incubation, the 
embryos were washed with 100% heptane to remove halocarbon oil and 
embryo glue and were collected into a 70µm nylon cell strainer. Embryos were 
then transferred in groups of 400 into 900µL Schneiders media in a sterilized 
borosilicate tissue grinder. The embryos were homogenized by four strokes of 
the pestle. The resulting cell suspension was titurated two times and then 
transferred into a sterile microcentrifuge tube. 50µL 2.5% trypsin was added to 
further digest embryo tissue and the suspension mixed. The cell suspension 
was subsequently centrifuged at 800rpm at 4°C for 5 minutes to remove 
debris. The supernatant was removed and passed through a 40µm nylon cell 
strainer into a Petri dish on ice. This was then transferred to a clean 
microcentrifuge tube and centrifuged at 2000rpm for 10 minutes at 4°C. The 
supernatant was discarded and 200µL Seecoff buffer added. The resulting cell 
suspension was then used to determine the yield of hemocytes from this 
process or for creating hemocyte samples for microarray analysis using FACS.  
 
C. Fluorescence Assisted Cell Sorting (FACS) of hemocytes 
Hemocytes samples were collected by FACS within the Flow Cytometry Suite 
of the School of Medical and Vetinary Sciences, University of Bristol, by Dr. A. 
Herman. Cells were counted using a BD Influx Cell Sorter. Measurement of 
specific parameters permitted the development of a FACS protocol that could 
be employed in future sorting experiments, to provide consistent sorting 
between replicates (Figure 2.6). Forward scatter counting (FSC) was utilized 
to count and estimate the size of cells passing through the detector. Side 
scatter counting (SSC) was employed to measure cell complexity and 
granularity. Gating was applied to the population of cells displaying 
appropriate size and complexity. Measurement of trigger pulse width within the 
gated cell population permitted for the further selection of cells that were 
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observed as singlets. Of the singlet cell population, those that displayed GFP-
associated fluorescence, termed GFP-positive (GFP+) cells, were identified. 
Gating was established to count and sort only GFP+ cells that emitted the 
highest levels of GFP-associated fluorescence upon stimulation. As 
hemocytes were the only cell type within the embryos to express GFP, this 
protocol could be employed to effectively isolate hemocytes from a mixed 
population of cells. GFP+ cells were sorted into 200µL RNALater and stored at 
4°C until required. For initial cell characterization experiments, GFP- cells 
were also separately sorted into 200µL RNALater.  
 
 
Figure 2.6: Hemocyte FACS protocol, optimized by Dr. A. Herman. A FACS protocol was 
optimized to efficiently sort GFP-positive (GFP+) hemocytes from a mixed cell suspension. 
Cells of the correct size and complexity were initially gated (A) and from this selected 
population, single cells were identified and a second gate established (B). From the single cell 
population, GFP+ cells were identified and a final gate established (C). The numbers of GFP+ 
cells as a percentage of the total cell population could then be established (D and E). !
D. Hemocyte RNA extraction  
Upon attaining a minimum of 50,000 sorted GFP+ cells for each treatment, the 
samples for each treatment were pooled where necessary and RNA isolated 
from the hemocytes using the RNAqueous Micro Kit. The cell suspensions 
were vortexed vigorously in 100µL Lysis solution. 50µL 100% ethanol was 
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added to each before vortexing briefly. The mixtures were then loaded into 
their respective Micro Filter Cartridge Assembly and centrifuged for 10 
seconds at maximum speed. 180µL of Wash Solution 1 was added and 
centrifugation repeated. Two washes with 180µL of Wash Solution 2/3 were 
performed for each column and centrifugation repeated. The flow through was 
discarded and the columns centrifuged at maximum speed for 1 minute to 
remove any residual fluid and to dry the filter. The columns were then 
transferred to microcentrifuge tubes. 10µL of Elution Solution, preheated to 
75°C, was applied to the centre of each filter and the columns stored for 1 
minute at room temperature. The assembly was then centrifuged at maximum 
speed for 30 seconds to elute the RNA from the filter. This elution step was 
then repeated with a further 10µL Elution solution to maximize RNA yield.  
      
DNase I treatment was then employed to ensure all traces of genomic DNA 
were removed from the resulting RNA samples. 2µL 10X DNase I buffer and 
1µL DNase I was added to each sample. The reaction was incubated at 37°C 
for 20 minutes. 2µL DNase Inactivation Reagent was subsequently added to 
each reaction. The reactions were then centrifuged at maximum speed for 1.5 
minutes to pellet the Inactivation Reagent. RNA was transferred to a fresh 
microcentrifuge tube and stored at -80°C until required. The quality of the 
resulting RNA was examined using the Experion Automated Electrophoresis 
System in conjunction with the Experion RNA StdSens Analysis Kit. 
Quantification of hemocyte RNA was determined using the Qubit 
Quantification Platform and Quant-iT assay kit.  
 
E. Microarray protocol 
All microarray experiments were performed by Dr. B. Fischer at the Cambridge 
Systems Biology Centre, University of Cambridge. All samples were amplified 
using the Switch Mechanism at the 5’ end of Reverse Transcript (SMART) 
amplification method. For the total RNA samples, 100ng of RNA was amplified 
using 18 cycles. For the hemocyte samples, the starting quantity of RNA was 
50ng and thus 24 cycles of amplification was required. The samples were then 
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subjected to quality control protocols to ensure that their quality was sufficient 
for microarray experiments. This included checking for the presence of 
genomic DNA within samples and measuring the optical density of the 
samples at 260, 230 and 280 nm. Upon satisfactory quality control, the 
samples were hybridized to FlyChip arrays. Samples were assigned in a 
random fashion to the Cy3 or Cy5 channels, and this dye swap taken into 
account upon data analysis.  
 
 
2.14 Image acquisition  !
      
To obtain 5X images of whole Drc-GFP and Drs-GFP embryos and flies, a 
Leica DC350FX camera attached to the Leica M716F fluorescence dissecting 
scope, and Adobe Photoshop C53 software linked to a TWAIN module for 
Leica DC cameras were employed. A zoom of 4.0 was used for images of both 
adult flies and embryos. For imaging of immunostained embryos to visualize 
the localisation of Drc-GFP expression and the localization of the ecdysone 
receptor (EcR) in discrete tissues, as well as the presence of PGRP-LC-GFP 
in live embryos, a spinning disk microscope was employed using Volocity 
Image Analysis software (v.6.3).  
 
To obtain z-stack images of embryos employed in the phagocytosis assay, 
imaging was performed on the aforementioned Zeiss-LSM510 confocal laser 
scanning microscope, under 63X objective. Z-stacks with 1µm spacing were 
employed to capture images of labeled hemocytes and bacteria. The resulting 









2.15 Data processing and Statistical analyses !
A. Image data processing  
Image data was processed using the software ImageJ (v1.42q). For 
phagocytosis assay data, orthological projections were employed to determine 
if bacteria had been effectively phagocytosed. The mean values of bacteria 
phagocytosed as a percentage of total bacteria injected were subsequently 
calculated for each comparison group. Orthological projections were also 
employed to assess the localization of Drc-GFP expression with embryos.  
 
B. RT-qPCR data processing  
To process RT-qPCR data pertaining to AMP gene expression, the threshold 
cycle (Ct) for each reaction was recorded and the relative amounts of cDNA 
present for each gene were then calculated using the equation: 
 
NA/NB = 2-!Ct                                                              (Equation 2) 
 
Where Ct is the threshold cycle and NA and NB represent the relative level of 
gene expression. Expression levels for each target gene were calculated with 
reference to the internal control gene, rp49, and subsequently normalized 
according to control levels and the fold difference in expression and standard 
deviation subsequently calculated.  
 
RT-qPCR data pertaining to the relative expression of 20-HE signaling 
components was processed entering the recorded Ct values for each reaction 
into the Relative Expression Software Tool 2009 software (v1.0; Qiagen, UK). 
Analysis of relative gene expression was normalised with reference to rp49 
expression, to compensate for variation.  
 
C. FACS data processing  
Dot plots of FSC and SSC on a linear scale were used to determine cells of 
the appropriate size and complexity, and permitted for initial gating. Heat map 
plots of FSC against trigger pulse width on a linear scale were used to identify 
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and effectively gate singlets within the resulting population. Heat map plots of 
FSC against levels of GFP-associated fluorescence emission (488-GFP) using 
a log scale were utilized to identify and gate the cells expressing the most 
intense levels of GFP-associated signal from the single cell population. 
Histograms were subsequently used to view the GFP+ cell population as a 
fraction of the total cell population and a cytometer function used to calculate 
the percentage of GFP+ cells within the entire cell population.  
 
D. Microarray Data analysis 
Data normalization was performed using Bioconductor software (v.2.12). The 
data generated from total RNA samples was normalized using variance 
stablisation normalization (vsn), based on the work of Huber et al. (2002), 
using a vsn Bioconductor package. For the data originating from hemocyte 
RNA samples, Loess and Quantile (lquant) normalization was performed, 
based on the work of Dudoit et al. (2002), using the Bioconductor limma 
software package.  
       
To assess whether the microarray protocol could identify differential 
expression of genes involved in the immune response between naïve and 
treated samples, the fold differences in expression for members of immune 
gene families was calculated. These included effectors, such as AMPs and 
TEPs, and immune receptors such as PGRPs and GNBPs. Volcano plots 
were used to analyse the numbers of genes displaying significantly differential 
expression between naïve and bacterial treated samples, as well as between 
wounded and non-wounded embryos samples.  
 
Further analysis of the microarray data was performed by Professor S. Dorus, 
Syracuse University, New York, USA; to discriminate between the effects of 
PBS and bacterial treatment in embryos, and to assess the further biological 
relevance of the damage response in laser ablated embryos. Comparisons 
between microarray data from PBS and Gram-negative injected or Gram-
positive injected embryos, or non-wounded and laser ablated embryos were 
conducted to identify damage and infection specific genes, employing 
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hierarchical clustering and heat-mapping to group candidates by function.  The 
eBayes function of the Limma software package (Smyth, 2004) was used to 
adjust the p-values of the microarray data pertaining to laser ablation 
treatment; to correct for probe-wise sample variance and false discovery rates. 
Comparisons were also drawn directly between microarray data for Gram-
positive and Gram-negative infected embryos, to investigate the degree of 
overlap of gene expression upon these differential infections, and to identify 
any potential specific Gram-negative or –positive bacterial response genes. 
Since n=1 for microarray data pertaining to hemocyte transcriptional profiles 
upon PBS or Ecc15 treatment, the 100 genes showing greatest up- or down-
regulation upon either treatment were selected for further analysis.  
 
Networking analysis was performed on the top 100 genes significantly 
upregulated upon wounding, as well as the genes demonstrating the greatest 
modulation in hemocytes upon PBS or Ecc15 treatment, using the freeware 
Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) (v9.05; 
von Mering et al., 2004). Maps of predicted interactions were produced, with 
nodes representing genes and edges the nature of the predicted interaction. 
Confidence values were also calculated for each predicted edge to indicate 
the probability of a true biological interaction.  
 
Gene ontology (GO) analyses were also conducted in the comparison of 
microarray data originating from PBS and bacteria treated embryos, using the 
Gene Ontology Enrichment Analysis Visualisation Tool (Eden et al., 2007; 
Eden et al., 2009) to assign biological process terms. GO analyses pertaining 
to molecular function and cellular component terms were performed using 
STRING. P-values of the enrichment analysis and q-values to represent the 
correction of the p-values for multiple testing were generated.  
 
 
E. Statistical analysis 
For mortality assays, CFU determination assays and the 20-HE rescue assay, 
an unpaired T-Test was used to ascertain statistical significance between 
control and treated groups.  
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For analysis of RT-qPCR data pertaining to immune gene expression, a one-
way ANOVA with a Tukey’s post-test was used to assess statistical 
significance between control and treated groups, as well as between WT and 
mutant embryo groups. To analyse RT-qPCR data related to the expression of 
20-HE signaling components, the Relative Expression Software Tool (REST) 
2009 (Pfaffl 2001; Pfaffl et al., 2002) was used to assess the statistical 
significance of changes in immune gene expression due to levels of efficiency 
observed within primer sets. This method accounted for reaction efficiency and 
reference gene normalization. A hypothesis test was employed to determine 
the probability of the alternate hypothesis, and hence if the differences 
observed between control and sample data was due to chance. This method 
performed a large number of random relocations of samples and controls 
between the groups and then counted the number of times the relative 
expression of the randomly assigned group is greater than the sample data. 
2000 randomisations were applied to the data in this case.  
      
To assess the statistical significance between the numbers of phagocytosed 





Chapter 3 – Characterisation of the Drosophila embryo as a 
Model Immune System to Study Live Bacterial Infection In 
Vivo 
 
3.1 Introduction  
 
3.1.1 Drosophila embryos as an immunity model !
Whilst Drosophila adult fly and larval models, as well as mbn-2 and S2 cells, 
have found increasing application as immunity models to study infection both 
in vivo and in vitro with a wide range of pathogenic bacterial species (Tzou et 
al., 2002; Cheng and Portney, 2003; Needham et al., 2004; Agaisse et al., 
2005; Blow et al., 2005), the Drosophila embryo has only recently emerged as 
a potentially viable immunity model. This has encompassed limited preliminary 
assessment of the embryonic capability to mount systemic and local Cec 
responses upon stimulation with LPS extract (Onfelt Tingvall et al., 2001; 
Tingvall et al., 2001). Furthermore, Vlisidou et al. (2009) assessed the ability 
of embryonic plasmatocytes to effectively phagocytose bacterial species such 
as E. coli and P. asymbiotica; taking advantage of the power of the embryo 
system for live imaging the early host-pathogen interactions. Additionally, 
Stramer et al. (2008) sought to define the genes that are activated in the 
Drosophila embryo, and specifically in hemocytes, upon damage inflicted by 
sterile laser ablation. This study elucidated that Drs was expressed in the 
embryo upon wounding, as well as genes such as Growth Arrest and DNA 
Damage-inducible 45 (GADD45), a stress response gene induced by damage 
which is able to regulate mitogen-activated protein (MAP) kinase signaling 
(Takekawa and Saito, 1998), whose activation at the wound site requires 
hemocytes (Stramer et al., 2008) and is postulated by the authors to have a 
role in epigenetic regulation of wound targets. Despite these studies, a holistic 
and in-depth view of the embryonic immune capacity and the mechanisms by 




Adult and larval immunity models have also allowed for the development of 
techniques and tools to analyse the immune response in Drosophila. These 
typically focus on AMP gene expression after bacterial challenge, as this 
provides an effective read-out of the Drosophila immune response (Lemaitre 
and Hoffmann, 2007). For instance, RT-qPCR has been utilized to assess the 
relative expression of AMPs in gut tissue (Buchon et al., 2009), whole flies and 
larvae (Bischoff et al., 2006; Zaidman-Remy et al., 2006) and S2 cells (Rus et 
al., 2013) post infection. Moreover, Drosophila AMP reporter lines can be used 
to monitor the time-course and localisation of the immune response; flies carry 
a transgenic construct whereby the promoter for a specific AMP is fused to a 
reporter gene, such as GFP or lacZ (Nehme et al., 2007; Romeo and 
Lemaitre, 2008; Gendrin et al., 2009; Junell et al., 2010), hence permitting for 
the observation of AMP gene expression post infection as shown in Figure 3.1.  
 
          
 
Figure 3.1: Transgenic AMP reporter Drosophila lines facilitate the study of immune 
gene expression upon bacterial stimuli. Traditional infection studies have employed adult 
flies carrying transgenic promoter-reporter gene fusions to assess the time-course and 
localisation of immune gene expression post infection. These include the promoters for AMP 
genes such as Drc (A) and Drs (B). The reporter gene in the images displayed is GFP, and 
upon stimulation with an appropriate microbe, reporter expression can be induced. White 




As such, these techniques and resources have the potential for adaptation for 
use alongside the embryo system. However, to gain novel insight into the 
Drosophila immune response, there is also the potential to employ time-lapse 
confocal microscopy so as to study the dynamics of host-pathogens 
interactions in vivo and in real-time. This technique has been previously 
employed within the embryo to study a diverse range of biological processes, 
such as cell migration, wound healing and inflammation, dorsal ventral 
patterning, the diffusion of morphogen gradients and the prioritization of 
damage and developmental signals by hemocytes (Wood et al., 2002; Stramer 
et al., 2005; Moreira et al., 2010; Sample and Shvartsman, 2010; Siekhaus et 
al., 2010; Reeves et al., 2012; Evans et al., 2013).  
 
However, traditional routes of infection employed in conjunction with 
Drosophila adult and larval models, such as oral (Kylsten et al., 1990; Vodovar 
et al., 2005; Liehl et al., 2006; Buchon et al., 2009), topical (De Gregorio et al., 
2001; Ha et al., 2005b) or septic injury (Kylsten et al., 1990; De Gregorio et al., 
2001; Agaisse et al., 2003; Nehme et al., 2011) routes are not necessarily 
applicable to the potential Drosophila embryo model. For embryo injection, 
Tingvall et al. (2001) adopted an injection procedure using fine glass 
capillaries, and Vlisidou et al. (2009) also favoured an injection procedure, but 
utilizing a microinjector for a higher level of precision. However, other 
protocols for the infection of Drosophila embryos by permeabilisation with 
solvents such as hexane and then incubation with bacterial lysates also exist 
(Esfahani et al., 2011). Esfahani et al. (2011) demonstrate that this method of 
infection was able to stimulate an AMP response in large numbers of 
Drosophila embryos, thus representing a high-throughput method for infecting 
large numbers of embryos.     
 
 
3.1.2 Development of the Drosophila immune system during embryogenesis 
 
Other than the aforementioned studies, very little is known about the 
development and capabilities of the immune system within the Drosophila 
embryo, when the system as a whole is activated in concert or how the robust 
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immune competence exhibited in larvae arises. In terms of fat body 
development, precursors separate from the inner mesoderm layer at 
approximately Stage 11 or 12 of development (Hartenstein, 1993; Moore et al., 
1998). The column of fat body precursors subsequently form elongated sheets 
of cells, trapped between the developing visceral musculature and the body 
wall (Hartenstein, 1993), during Stage 13. Hartenstein (1993) cites that some 
specializations of the fat body can be observed at this stage, although other 
studies have demonstrated that the start of terminal fat cell differentiation may 
occur as early as Stage 12 (Hoshizaki et al., 1994). At Stage 17, it has been 
noted that large holes and cleft are visible in the previously solid sheets of 
cells that comprise the fat body structure (Hartenstein, 1993). Moreover, these 
apertures co-localise with regions where other organs, such as the trachea 
and gonads, contact the fat body (Hartenstein, 1993). However, the precise 
timing of fat body maturation to the point where this tissue is fully immune 
competent to raise a systemic response remains relatively uncharacterized; 
previous work by Tingvall et al. (2001) highlighted that AMPs, such as CecA1, 
could be induced in fat body tissue in all three stages of larval life, but not at 
embryonic stages, and lead them to postulate that the fat body requires full 
maturation during the first instar larval stage of development in order to 
facilitate successful induction of AMP genes (Tingvall et al., 2001).   
 
Similarly, relatively little is known about the potential for the embryo to mount a 
local immune response to bacterial infection. Using an embryos that contained 
a transgenic CecA1-lacZ reporter, Onfelt Tingvall et al. (2001) reported that 
embryos were able to activate this construct upon injection with live 
Enterobacter cloacae or LPS extract, and that the response was localized to 
yolk and epidermal tissue. This expression was noted in Stage 14 embryos, 5 
hours after the initial infection (Onfelt Tingvall et al., 2001). Interestingly, 
injection of bacteria into the perivitelline space resulting in a higher frequency 
of embryos exhibiting CecA1-lacZ expression in the yolk (Onfelt Tingvall et al., 
2001), and the authors suggest that this indicates that bacteria must enter the 
perivitelline space in order to mount a response (Onfelt Tingvall et al., 2001). 
Moreover, this response in the yolk requires the GATA site, a consensus 
sequence that has been shown to regulate tissue specificity of AMP gene 
!!
"#!
expression in larvae (Petersen et al., 1999), whereas the epidermal response 
was shown to be unaffected by mutation of the GATA site (Onfelt Tingvall et 
al., 2001). The serpent (srp) gene, which encodes a GATA-binding 
transcription factor, is also required for CecA1-lacZ expression in yolk, but not 
epidermal tissue (Onfelt Tingvall et al., 2001). Taken together, these studies 
suggest that differential transcription regulators are used by the embryo to 
activate the local immune responses of specific tissues (Onfelt Tingvall et al., 
2001).  
 
The development of hemocytes during embryogenesis is vastly better 
documented (reviewed in Wood and Jacinto, 2007). Both embryonic 
plasmatocytes and crystal cells develop in the procephalic mesoderm at Stage 
10 of embryogenesis. From this position, the first plasmatocytes infiltrate the 
germ band and are passively carried by germ band retraction to the posterior 
of the embryo. Further plasmatocytes subsequently leave the head and begin 
to migrate along the dorsal side of the embryo. Subsequently, populations of 
plasmatocytes from the anterior and posterior regions of the embryo migrate 
towards one another along the embryonic midline via the ventral nerve cord, 
and the developing gut until they meet at Stage 14. At Stage 15, the 
plasmatocytes migrate laterally, leaving the embryonic midline, and 
subsequently their migration then becomes random. This plasmatocyte 
migration is invariant (Wood and Jacinto, 2007), and thus can be observed in 
all wild-type Drosophila embryos. During this stereotypical migration, 
embryonic plasmatocytes engage in many crucial developmental functions, 
including the clearance of apoptotic cells throughout the embryos via 
phagocytosis and the secretion of extracellular matrix proteins (Wood and 
Jacinto, 2007). There is also a requirement of plasmatocytes for the correct 
development of organs such as the gut and central nervous system (Olofsson 
and Page, 2005). Few studies have addressed the immune capacity of 
embryonic plasmatocytes. Work by Vlisidou et al. (2009) demonstrated that 
embryonic plasmatocytes at Stage 15 of development do not actively migrate 
towards to invading bacteria but opportunistically recognize, bind and 
phagocytose the pathogens as they are washed over their surfaces in 
extracellular space. However, although these hemocytes exhibit effective  
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Figure 3.2: Developmental migrations of Drosophila embryonic hemocytes, taken from 
Wood and Jacinto (2007). Drosophila embryonic hemocytes first develop in the head 
mesoderm, subsequently migrating along stereotypical routes to populate the embryo. 
Hemocytes leave the head mesoderm at Stage 10 of embryogenesis and infiltrate the germ 
band (1). At Stage 12, germ band retraction transports these hemocytes towards the posterior 
of the embryo, whilst further hemocytes leave the anterior region and migrate along the dorsal 
side of the embryo (2). Hemocytes from the anterior and posterior of the embryo subsequently 
migrate along the ventral nerve cord (3) until these two populations meet at Stage 14 (4). 
Hemocytes continue to migrate along the dorsal side of the embryo, along the developing 
dorsal vessel (5). At Stage 15-16, hemocytes disperse from this stereotypical pattern, and 
begin to migrate in a random fashion, becoming evenly distributed over the embryo. Compass 
represents embryo parameters: A, anterior; P, posterior; D, dorsal; v, ventral.  
 
 
mechanisms to eliminate invading pathogens, they are not immune to 
virulence factors secreted by the infection itself. Infection of Stage 15 embryos 
with a Gram-negative insect pathogen, Photorhabdus asymbiotica, was shown 
to rapidly halt the migration of plasmatocytes via freezing cellular protrusions 
and phagosomes, permitting bacteria to escape phagocytosis (Vlisidou et al., 
2009). This effect was attributed to the cellular internalization of the P. 
asymbiotica toxin Makes Caterpillars Floppy 1 (Mcf1), potentially involving the 
activity of Rac GTPase (Vlisidou et al., 2009).  Conversely, differentiated 
crystal cells form a small cell group that remains clustered around the 
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embryonic proventriculus (Lebestky et al., 2000). Whilst limited studies 
focusing on the response of embryonic plasmatocytes upon infection have 
been conducted, no role has yet been suggested for embryonic crystal cells 
under these conditions, thus the function that they play in this process, if any, 
has yet to be determined. 
 
3.1.3 Regulation of innate immunity via steroid hormone signaling !
Aside from the canonical immune pathways that centre on the Toll-like and 
TNF signaling cascades, steroid hormone and their respective receptors have 
relatively recently been implicated in the regulation of the adaptive and innate 
immune responses in mammalian systems (Chow et al., 2006). For example, 
the glucocorticoid receptor (GR) has been extensively demonstrated to 
repress pro-inflammatory genes, potentially via GR binding to and activation of 
I!B", thus sequestering the NF!B subunit proteins p50/p65 and preventing 
them from initiating the transcription of pro-inflammatory gene targets (Chow 
et al., 2006). However, GR has also been shown to directly associate with 
p65, thus potentially acting as a steric inhibitor and preventing the transcription 
factor’s interaction with DNA (McKay and Cidlowski, 2000). However, GR is 
not exceptional; many other mammalian steroid hormone receptors have been 
linked to pro-inflammatory gene repression and AMP induction, such as the 
oestrogen receptor (ER), vitamin D receptor (VDR), liver X receptor (LXR), 
retinoid X receptor (RXR) and peroxisome proliferator-activated receptor 
(PPAR) (Tontonoz et al., 1998; Gombart et al., 2005; Hong and Tontonoz, 
2008; Jetten, 2009; Baeke et al., 2010; Nunez et al., 2010).  Moreover, this 
mechanism of immune regulation is not restricted to mammalian systems, but 
is a common theme throughout the animal kingdom; for instance, Aguila et al. 
(2013) highlighted the importance of testosterone and 11-ketotestosterone in 
the regulation of professional phagocyte responses, such as phagocytosis, to 
the fish pathogen Vibrio anguillarum in seabream, whilst Watanuki et al. 
(2002) demonstrated the effects of steroids including #-oestradiol and 
progesterone on the negative regulation of phagocytosis, superoxide and nitric 




Drosophila is not an exception to this trend. One such hormone in Drosophila 
that has been implicated in the modulation of innate immunity is 20-
hydroxyecdysone (20-HE). 20-HE is a polyhydroxylated steroid signaling 
molecule (Schwedes and Carney, 2012) that has been shown to control insect 
molting, metamorphosis and other developmental processes via its 
coordinated release into the circulating hemolymph from the prothoracic gland, 
a component of the ring gland, (Pankotai et al., 2010). Whilst 20-HE has 
traditionally been implicated in regulating a range of other developmental 
processes such as reproduction (Carney and Bender, 2000; Schwedes and 
Carney, 2012), lifespan and aging (Simon et al., 2003; Simon et al., 2006; 
Tricoire et al., 2009), as well as adult fly behaviour (Ishimoto et al., 2009; 
Ishimoto and Kitamoto, 2010; Ganter et al., 2011), more recent studies have 
provided evidence that this steroid hormone may also be crucial for immune 
competence, and hence play a role in regulating the Drosophila immune 
response. For instance, a plethora of in vitro studies have suggested that 20-
HE may play a role in modulating both the systemic and cellular responses. It 
was noted that when using S2 cells for immunity studies that 20-HE 
application further enhanced the AMP response in vitro upon a bacterial 
stimulus, as well as altering cell morphology and adherence (Silverman et al., 
2003; Flatt et al., 2008). This was mirrored by results from Dimarcq et al., 
(1997), where the authors used cultured mbn2 cells to show that treatment 
with 20-HE induced a differentiation to a more adherent, macrophage-like 
morphology in this cell line, resulting in an increased phagocytic capacity and 
enhanced ability to express AMP genes, as well as other immune genes such 
as those encoding Scavenger receptors, in response to infection or a bacterial 
elicitor such as PGN. More specific evidence of steroid hormone modulation of 
Drosophila systemic immunity was presented by Zhang and Palli (2009); 
deletion analysis in mbn2 cells identified a cis-regulatory element within the 
Drosophila Dpt promoter that enabled enhanced expression upon 20-HE 
binding after exposure to E. coli PGN. 20-HE was also shown to further 
enhance the PGN-induced expression of other AMP genes, including Drs, 
AttA, Mtk and CecA1 (Zhang and Palli, 2009). In particular, an 8-nucleotide 
region of the element discovered to be present in the promoter regions for 
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each of these AMP genes using in silico promoter analysis (Zhang and Palli, 
2009). However, the precise mechanism by which these 20-HE driven AMP 
responses were mediated remained elusive until the recent discovery by Rus 
et al. (2013) that 20-HE is able to regulate signal transduction via the IMD 
pathway. Microarray analysis demonstrated that expression of several IMD 
signaling components such as dIAP2, Tab2, Relish and Caspar could be 
moderately and significantly induced upon 20-HE stimulation of S2 cells (Rus 
et al., 2013). More interestingly, the expression of PGRP-LC was robustly 
induced upon 20-HE treatment of S2 cells, and 20-HE was subsequently 
demonstrated to control AMP gene induction via two distinct mechanisms (Rus 
et al., 2013). The initial mechanism presented in this work involved the 20-HE 
regulated expression of PGRP-LCx, which was able to drive induction of a 
subset of AMP genes, such as CecA1, AttA and Def (Rus et al., 2013). 
However, the actions of 20-HE in this mechanism could be bypassed by the 
ectopic expression of PGRP-LC itself (Rus et al., 2013). The second 
mechanism described involves the expression of a further subset of AMPs, for 
which 20-HE activity is critically required and cannot be bypassed via ectopic 
PGRP-LC expression, including Dpt, Mtk and Drs. This level of regulation is 
proposed by Rus et al. (2013) to act downstream of Relish, involving classical 
20-HE transcriptional targets. A third mechanism of AMP regulation by 20-HE 
was postulated by Flatt et al. (2008), whereby findings elucidated that the 20-
HE promotion of AMP gene expression may be antagonized by the action of 
Juvenile Hormone (JH), another Drosophila steroid hormone, which seemingly 
acts as an immunosupressor (Flatt et al., 2008). What is not immediately clear 
is how these complex mechanisms interact to modulate the overall systemic 
response.  
 
Nevertheless, the findings of these in vitro studies have subsequently been 
partially confirmed in an in vivo context. For example, in the context of the 
cellular response, Sorrentino et al. (2002) observed a dramatically 
compromised encapsultion response to wasp parasitization in 3rd instar larvae 
with low 20-HE titres, both controlled genetically by the ecdysoneless mutation 
and when 20-HE signaling was blocked. This was accompanied by decreases 
in crystal cell maturation and lamellocyte differentiation post infection 
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(Sorrentino et al., 2002), suggesting that 20-HE signaling is required for a 
complete anti-parasitic response. In a similar vein, Lanot et al. (2001) 
established that plasmatocyte phagocytic activity could be enhanced by 
injecting 3rd instar larvae with 20-HE, highlighting the hormone’s ability to 
regulate the cellular response. In terms of systemic immunity, further studies in 
Drosophila larvae have highlighted that the immune competency of fat body 
cells increases in larval stages under the control of 20-HE signaling (Meister 
and Richards, 1996); a further hint that 20-HE is able to modulate systemic 
immunity in vivo. Finally, Rus et al. (2013) examined the immune role of 20-HE 
signaling components in vivo using adult flies. Depletion of 20-HE signaling 
components and effectors resulted in the decreased expression of Dpt and 
CecA1, as well as PGRP-LC, upon E. coli infection, demonstrating that 20-HE 
signaling can regulate IMD pathway activity in vivo either via the direct effects 
of 20-HE or via 20-HE signaling effectors (Rus et al., 2013). Taken together, 
these results suggest that both the systemic and cellular immune responses in 
Drosophila are regulated via 20-HE signaling. In some cases, 20-HE may 
exert its effects through interaction with the IMD pathway, particularly in 
relation to AMP induction, although how 20-HE may mediate its effects in 
other immune processes, such as the cellular response, remains unclear.  
 
 
3.1.4 20-HE signaling components and effectors 
 
The production of 20-HE is known to be a complex process, which involves a 
multitude of biosynthetic enzymes and the cellular transport machinery (Gilbert 
et al., 2002; Lafont et al., 2004). In the 20-HE biosynthesis in many insect 
models, dietary cholesterol is dehydrogenated in the endoplasmic reticulum 
and then transported to the mitochondria for oxidation (Lafont et al., 2004). 
Subsequently, sequential production of diketol, ketodiol and ketotriol 
intermediates occurs, under the control of Black Box enzymes and 
hydroxylases, before the release of inactive ecdysone into the hemolymph and 
the final ensuing modification to its active form, 20-HE at target tissues (Gilbert 
et al., 2002; Neubueser et al., 2005). However, despite the characterization of 
many steroidogenic enzymes in a range of insect species, the biosynthesis of 
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20-HE at the molecular level in Drosophila is relatively poorly understood. 
However, recent work has attempted to address this deficit. It is now 
established that the steroidogenic hydroxylases involved in Drosophila 20-HE 
biosynthesis are Cytochrome P450 enzymes, which are encoded by members 
of the so-called Halloween family of genes (Neubueser et al., 2005), as 
depicted in Figure 3.3. The Halloween family members involved in ecdysone 
biosynthesis include phantom (phm), disembodied (dib), shadow (sad) and 
shade (shd), which are required for the synthesis of pathway intermediates in 
the prothoracic gland cells of the larval ring gland (Neubueser et al., 2005). 
Phm encodes a hydroxylase which converts ketodiol to ketotriol in the 
intermediate steps of ecdysone synthesis, whereas dib and sad encode 22C-
hydroxylating and 2C-hydroxylating enzymes respectively which further modify 
ketotriol to an inactive form of ecdysone (Neubueser et al., 2005). Inactive 
ecdsyone is subsequently released into the hemolymph and it is converted to 
its active form, 20-HE, at its target peripheral tissues by the 20-
monooxygenase Shd (Petryk et al., 2003). The transcription of the Halloween 
genes itself is controlled by Prothoracicotropic hormone (Ptth), a neuropeptide 
whose release from the brain signals through the receptor Torso to activate 
MAPK signaling and stimulate activity of the prothoracic gland (McBrayer et 
al., 2007; Rewitz et al., 2009; Yamanaka et al., 2013). Moreover, regulation of 
Halloween protein activity may also stem from their requirement of cofactors. 
Each of the Halloween hydroxylases requires an electron pair from NADPH to 
modify their substrates (Neubueser et al., 2005). A recently identified 20-HE 
biosynthesis component, termed Defective in Avoidance of Repellents (Dare), 
may indirectly play a role in this process. Dare is known to be a close 
homologue of vertebrate adrenodoxin reductase (Freeman et al., 1999), which 
transfers electrons from NADPH to adrenodoxin proteins. In turn, adrenodoxin 
donates electrons to steroidogenic cytochrome P450 hydroxylases required for 
ecdysone synthesis (Kozlova and Thummel, 2000). As such, it has been 
suggested that Dare may play a similar role in Drosophila. Concordant with 
this hypothesis is the fact that dare expression is enriched in the larval ring 
gland (Kozlova and Thummel, 2000) the Drosophila endocrine organ 
responsible for ecdysone production, and dare mutant larvae exhibit defects in 
molting and pupariation (Freeman et al., 1999); developmental processes 
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which require ecdysone signaling. Moreover, there is evidence that other 
genes, such as molting defective (mld), ecdysoneless (ecd) and neverland 
(nvd), may encode other factors that are required for 20-HE biosynthesis, but 
their precise molecular roles remain speculative (Gaziova et al., 2004; 
Neubueser et al., 2005; Yoshiyama et al., 2006).       
 
The resulting active 20-HE is then free to bind to its corresponding 
heterodimeric receptor complex, consisting of the proteins Ecdysone Receptor 
(EcR) and Ultraspiricle (Usp) (Yao et al., 1992; Thomas et al., 1993; Yao et al., 
1993); these are orthologs of the mammalian liver X and retinoid X receptors 
respectively (King-Jones and Thummel, 2005). In the absence of 20-HE, EcR 
is heterogeneously distributed between the nucleus and cytoplasm (Nieva et 
al., 2005). Heterodimerisation with Usp stimulates the receptor complex’s 
nuclear transport, where Usp transfers EcR quantitatively into the nucleus 
(Nieva et al., 2005), reminiscent of the recruitment of nuclear recruitment of 
the Vitamin D receptor in mammalian systems (Prüfer et al., 2000). Once 
inside the nucleus, EcR-Usp binds to DNA sequences, known as Ecdysone 
Responsive Elements (EcREs) to facilitate the transcription of downstream 
genes (Schwedes et al., 2011). However, other evidence suggests that when 
20-HE titres are low, EcR-Usp can also exist as an unliganded heterodimer 





                      
 
 
Figure 3.3 Schematic of 20-Hydroxyecdysone Signaling in Drosophila. Cholesterol is 
converted to the inactive form of ecdysone within the prothoracic cells of the ring gland, via the 
production of ketodiol, ketotriol and 2-deoxyecdysone intermediates by Halloween gene 
products Phantom (Phm), Disembodied (Dib), and Shadow (Sad). The activity and 
transcription of the Halloween genes themselves are controlled by Defective in Avoidance of 
Repellents (Dare) and Prothoracicotropic hormone (Ptth) respectively. Inactive ecdysone is 
secreted from the ring gland and converted to its active form, 20-hydroxyecdysone (20-HE) by 
Shade (Shd) at the target tissue. 20-HE is then free to bind the Ecdysone Receptor (EcR)-
Ultraspiricle (Usp) heterordimer receptor complex. The liganded complex translocates to the 
nucleus where it binds with high affinity to elements in DNA, termed Ecdysone Responsive 
Elements (EcREs), which facilitates the transcription of downstream genes, such as Ecdysone 
Inducible Proteins (Eips) 71CD, 78C, 74EF and 93F, as well as other ecdysone responsive 
genes such as HR46, the Broad complex (Br-C), Serpent (Srp) and Pannier (Pnr). To ensure 
that ecdysone signaling is effectively switched off to properly regulate developmental 




Upon subsequent ligand binding, EcR-Usp undergoes a conformational 
change that allows the complex to bind EcREs with greater affinity and recruit 
coactivators to initiate gene expression (Yao et al., 1992; Yao et al., 1993). 
Regardless of the mechanism of EcRE binding, the actions of EcR-Usp initiate 
a highly regulated and temporal pattern of gene activation; some genes are 
activated within minutes of 20-HE exposure, hence are termed ‘early’ 
response genes, whereas others are activated within hours of this event, and 
thus are given the status of ‘delayed early’ response genes (Huet et al., 1995; 
Lan et al., 1999). It has thus been hypothesized that this sequential gene 
activation represents a complex transcriptional hierarchy, to ensure 
appropriate responses and developmental processes are correctly mediated in 
specific target tissues (Ashburner et al., 1974; Thummel, 1995; Chavez et al., 
2000).  
 
The EcR gene itself was demonstrated to give rise to three distinct EcR 
isoforms by Talbot et al. (1993); the authors consequently clarified that all 
three isoforms have common DNA- and hormone-binding domains, but differ 
in their N-terminal regions (Talbot et al., 1993). These isoforms were 
accordingly termed EcR-A, EcR-B1 and EcR-B2 (Talbot et al., 1993) and are 
all able to form heterodimers with Usp (Yao et al., 1992; Talbot et al., 1993; 
Thomas et al., 1993; Yao et al., 1993), hence facilitating downstream signaling 
events. It is postulated that each isoform subsequently directs specific 
responses to 20-HE, potentially explaining each receptor’s ability to activate or 
repress gene transcription and how 20-HE is able to drive such a diverse 
range of tissue and stage specific responses (Mouillet et al., 2001; Schwedes 
et al., 2011). Analysis of the function of specific EcR isoforms indicates that 
EcR-A is a weak activator and strong repressor of transcription, whereas the 
converse is true for EcR-B1 and –B2 (Hu et al., 2003). In larval and pupal 
tissues, the EcR isoforms are present in a diverse range of tissues, with 
isoform-specific tissue distributions spatially correlating with developmental 
fate (Robinow et al., 1993; Talbot et al., 1993; Truman et al., 1994; Bender et 
al., 1997; Schubiger et al., 1998). Whilst the EcR-B1 and –B2 isoforms have 
been demonstrated to play crucial roles in larval molting and neuronal 
remodeling during metamorphosis (Schubiger et al., 1998) and are typically 
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expressed in larva-specific tissues (Watanabe et al., 2010), the EcR-A isoform 
is expressed in proliferative tissues during metamorphosis and is required for 
adult-specific developmental processes (Watanabe et al., 2010), such as 
oogenesis (Carney and Bender, 2000).  
 
Binding of 20-HE ligand to the EcR-Usp complex regulates the expression of 
early response genes, many of which are also transcription factors (Rus et al., 
2013). These include the Ecdysone-induced protein (Eip) 74EF, an E-Twenty 
six domain factor, and Eip71CD, a methionine S-oxide reductase that has 
been implicated in the response to oxidative stress and autophagic cell death 
(Gorski et al., 2003). Several other Eip genes are subsequently activated later, 
as a subset of the delayed-early response genes, such as Eip78C; a nuclear 
hormone receptor that further regulates the 20-HE-mediated transcriptional 
hierarchy (King-Jones and Thummel, 2005). Moreover, recent work by Rus et 
al. (2013) demonstrated that some of these effectors are critical for signal 
transduction and induction of AMP genes via the IMD pathway. These include 
the early inducible transcription factors Eip93F, Eip74EF, Eip78C, Hormone 
Receptor-like in 46 (Hr46) and the Broad complex (Br-C), as well as two GATA 
factors, Serpent (Srp) and Pannier (Pnr) (Rus et al., 2013). Interestingly, 
Eip74EF, Eip78C and Eip75B expression was significantly reduced in 3rd instar 
larvae in response to localized tissue damage (Hackney et al., 2012).  
 
To ensure that ecdysone production is correctly coordinated and in order to 
prevent prolonged exposure to 20-HE, the temporal inactivation of 20-HE to 
ensure correct developmental transitions is vital. One route of metabolism 
entails the oxidation of 20-HE into 3-dehydroecdysteroid by Ecdysone Oxidase 
(Eo) (Takeuchi et al., 2005). The activity of Drosophila Eo was tested in vitro 
using COS7 cells, where conversion of 20-HE into 3-dehydroecdysone was 
noted (Takeuchi et al., 2005). Furthermore, Takeuchi et al. (2005) 
demonstrated that Eo was expression predominantly in midgut of late larval 
instars, temporally equivalent to the 20-HE titre peak, suggesting that Eo may 





3.1.5 20-HE signaling during embryogenesis 
 
Via the aforementioned signaling mechanism, 20-HE is crucial for correct 
development in Drosophila. High 20-HE titres, or pulses, occur throughout the 
Drosophila life cycle, as depicted in Figure 3.3, regulating a range of diverse 
processes, such as the apoptosis of obsolete larval tissues, molting, puparium 
formation and metamorphosis (Kozlova and Thummel, 2003). One such pulse 
occurs during mid-embryogenesis (Figure 3.4A, red box and Figure 3.4B), 
which peaks during germ band retraction at approximately 9 hours after egg-
laying (Maroy et al., 1988; Kozlova and Thummel, 2003). During this period of 
time, 20-HE is required for successful germ band retraction and head 
involution (Maroy et al., 1988). Furthermore, 20-HE has also been 
demonstrated to play a role in cuticle deposition during late embryogenesis 
(Hoffmann and Lagueux, 1985; Chavez et al., 2000). The critical requirement 
for 20-HE to regulate these processes is supported by the fact that embryos 
carrying zygotic mutations in EcR die during embryogenesis (Bender et al., 
1997) and germline clones of EcR null mutants are subsequently arrested 
during oogenesis and thus result in female sterility (Buszczak et al., 1999). 
These results are not surprising, given that components of the 20-HE signaling 
pathway such as EcR and Usp are widely expressed by mid-embryogenesis, 
with activation of the EcR-Usp receptor complex at Stage 13 of development 
in the amnioserosa (Kozlova and Thummel, 2003). However, relatively little is 
known about the precise function of 20-HE at early stages of embryogenesis 
as EcR transcript and protein are deposited maternally, making study 
intrinsically difficult (Talbot et al., 1993). Moreover, the location of 20-HE 
biosynthesis is not well defined in the Drosophila embryo. Studies have 
suggested that the embryonic epidermis may be a source of 20-HE during 
mid-embryogenesis, as expression of sad and dib is concentrated within 
individual epidermal segments at this time-point, coinciding with the 20-HE 
embryonic pulse (Warren et al., 2002). Warren et al. (2002) further 
demonstrate that this pattern then diminishes and, with sad and dib expression 
subsequently concentrated within the ring gland during late embryogenesis, 
suggesting a switch in the localisation of 20-HE synthesis. Nevertheless, in 
light of the evidence that 20-HE is able to regulate innate immunity in 
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Drosophila, its contribution to the embryonic immune capacity remains 
uncharacterized.       
 
3.1.6 Experimental aims 
 
Before the Drosophila embryo model could be employed in any novel dynamic 
imaging studies as defined in Vlisidou et al. (2009), it was important to fully 
characterise the model system; to fully understand and validate its immune 
capacity. Within this broad aim, it was investigated whether Drosophila 
embryos were able to mount both systemic and cellular responses to infection 
and the mechanisms by which these responses were mediated. Moreover, the 
system was subsequently utilized to gain an understanding of how immune 
competence originates within the Drosophila embryo and at what point during 
embryogenesis this occurs. Since 20-HE signaling has such crucial roles in 
embryogenesis and has been implicated in regulating innate immunity in 
Drosophila, it was investigated whether this form of signaling is required for 




             
 
Figure 3.4: 20-HE titres throughout the Drosophila lifecycle. 20-HE titres fluctuate 
dramatically over the Drosophila lifetime (A; taken from Thummel, 2001), with pulses of 20-HE 
coinciding with crucial developmental transitions such as molting, puparium formation, and 
metamorphosis, as indicated by dotted lines. Regarding 20-HE titres during embryogenesis 
(B; taken from Sullivan and Thummel, 2003), a 20-HE pulse is observed to occur during mid-
embryogenesis at approximately Stage 12 of development, at x hours after egg laying. Two 
different sets of 20-HE titre measurements from staged embryos are plotted from Maroy et al. 









3.2.1. Stage 15 embryos are able to mount a robust AMP response to 
bacterial infection 
 
As relatively little was known about the immune capacity of the Drosophila 
embryo, it was initially necessary to determine whether Drosophila embryos 
were able to mount a robust AMP response to bacterial infection. Focusing on 
AMP production post infection gave an effective indication of the immune 
potential of the embryo model system; the activation of these genes has 
previously been used in both adult fly and larval models to provide an accurate 
read-out of the systemic immune response, in terms of response time-course 
and magnitude (Lemaitre et al., 1997). Using a previously established embryo 
microinjection assay (Vlisidou et al., 2009), Stage 15 embryos containing a 
Drosocin-GFP promoter-GFP fusion construct (Drc-GFP) were injected with 
either live or heat-killed DH5! E. coli (OD=1), to determine if AMP gene 
induction could be induced within the embryo upon a bacterial stimulus. The 
resulting Drc-GFP expression was compared to that of control PBS-injected 
Stage 15 embryos; to further elucidate if tissue damage inflicted by the 
microinjection process itself had any effect on Drc expression.  
      
Results showed that Stage 15 Drosophila embryos were able mediate a robust 
immune response to DH5! E. coli infection (Figure 3.5). Extensive expression 
of the Drc-GFP construct was observed in Stage 15 embryos 6 hours post 
infection with either live or heat-killed DH5! E. coli (Figure 3.5B and C), in 
contrast to those which received only a control sterile PBS injection (Figure 
3.5A). The most intense activation of the Drc-GFP construct was noted with 
live E. coli infection (Figure 3.5B). However, the percentage of embryos 
demonstrating a Drc-GFP response post injection with either live or heat-
inactivated DH5! E. coli was not significantly different, suggesting that the 
presence of live bacteria is not strictly required for AMP induction in the Stage 
15 embryo (Figure 3.5H). This phenomenon was not observed solely with 
DH5! E. coli infection, as injection of Stage 15 embryos  
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with other strains of E. coli, such as the Mg1655 E. coli strain (Figure 3.5D), 
and other Gram-negative species such as TTO1 Photorhabdus luminescens 
(Figure 3.5E) and Erwinia carotovora carotovora 15 (Ecc15; Figure 3.5F) also 
induced extensive Drc-GFP expression 6 hours post infection. Injection with 
Salmonella typhimurium elicited a less robust response, with only minor 
expression noted at the same time point (Figure 3.5G).  
 
To further confirm these results and to investigate the relative expression 
levels of a range of AMP genes upon DH5! E. coli infection, RT-qPCR studies 
were performed on infected Stage 15 embryos at 2 hours post injection 
(Figure 3.6A-B). These experiments focused on the Gram-negative AMP 
genes Dpt, and CecA1. Relative levels of gene expression were calculated 
with reference to the internal control gene, rp49, and the fold difference in 
AMP gene expression between treatments was calculated by normalizing 
values to those of non-injected (NI) control groups. Relatively low basal levels 
of individual AMP expression were observed in NI Stage 15 embryos (Figure 
3.6A-B). Upon injection with DH5! E. coli, relative expression levels of Dpt 
and CecA1 genes demonstrated significant increases by 35- and 50-fold 
respectively (p!0.01, T-Test).  
 
Furthermore, it was revealed that bacterial infection itself was not the only 
stimulus of AMP gene expression within the microinjection assay. Expression 
of AMP genes within the PBS-injected embryos also exhibited a significant 
relative increase from non-injected basal levels (Figure 3.6A-B). Whilst the 
induction of the AMP genes under these conditions were not concordant with 
those levels observed in DH5! E. coli-injected embryos, it was clear that 
Stage 15 embryos could nevertheless induce a relatively lower level of AMP 
expression in response to damage inflicted via the microinjection process 
itself. Interestingly, in the case of CecA1 (Figure 3.6B), the levels of 
expression upon PBS injection were observed to be comparable to those in 
DH5! E. coli-injected embryos, with no significant difference in expression 
noted between these treatment groups (Figure 3.6B). This may suggest that 
some individual AMP genes may be more responsive to upstream damage 
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signaling and are more highly expressed under these conditions.  Taken 
together, these results confirm that Stage 15 Drosophila embryos are able to 
mount a robust systemic response to bacterial challenge, as well as damage, 

































Figure 3.5: Stage 15 Drosophila embryos are able to mount a robust Drc-
GFP response to Gram-negative bacterial challenge.  
 
(A-C) Stage 15 Drc-GFP embryos were microinjected with sterile, endotoxin-
free PBS (A), live (B) or heat-killed (C) DH5! E. coli to assess the immune 
potential of Drosophila at this stage of embryogenesis. Whilst no response 
was noted at 6 hours post infection in embryos injected with PBS, those that 
received E. coli inoculum demonstrated extensive expression of Drc-GFP, with 
live E. coli producing the most intense response. (D-G) This response is not 
limited to DH5! E. coli infection, as Mg1655 E. coli (D), TTO1 P. luminescens 
(E) and Ecc15 (F) also promoted a similar Drc-GFP response. Infection with 
4134 S. typhimurium induced a concordant, but weaker response (G). (H) 
Quantification of the percentage of Drc-GFP expressing embryos upon sterile 
endotoxin-free PBS, DH5! E. coli or heat-inactivated DH5! E. coli treatment. 
Injection of both live and heat-inactivated DH5! E. coli significantly increased 
the percentage of responding embryos compared to PBS control treatment, 
but heat-inactivated DH5! E. coli injection stimulated significantly fewer 
embryos than live bacterial infection (Unpaired T-test, n=3 with !25 embryos 
injected per experiment; * Indicates p " 0.05, *** indicates p " 0.001. Error 






Figure 3.6: Stage 15 Drosophila embryos are able to induce AMP gene 
expression upon bacterial infection.  
 
(A-B) Bar graphs showing the fold difference in expression of four 
antimicrobial peptide genes upon injection with PBS or E. coli. Expression 
levels in injected embryos normalised to non-injected (NI) controls. In each 
case, both PBS and E. coli injection significantly increased antimicrobial gene 
expression, with E. coli inducing the greatest level of gene expression. 
However, the induction of antimicrobial genes via PBS injection inferred that 
damage may also play a role in the induction of systemic immune response 
genes, particularly those where the fold increase in expression was large 
(Cec, B). * Indicates p ! 0.05, ** indicates p ! 0.01. All other changes should 





















3.2.2 Drc-GFP expression is localized in tracheal and epidermal tissues within 
the Stage 15 Drosophila embryo upon bacterial infection 
 
Having observed that Stage 15 Drosophila embryos were able to mount a 
robust AMP response to a simple bacterial infection, it was necessary to 
determine the precise localization of this response. Using confocal microscopy 
permitted an initial assessment of the type of cells in which Drc-GFP was 
expressed upon Ecc15 infection (OD=1; Figure 3.7A). In particular, z-stacks 
acquired of infected embryos at 6 hours post infection indicated that these 
cells appeared to be highly present in the anterior region of the embryo, the 
location where the bacterial stimulus was initially administered. In this region, 
intense bands of GFP-positive cells forming an almost segmental pattern were 
noted although no specific pattern of individual Drc-GFP expressing cells was 
apparent (Figure 3.7A), concordant with previous results (Figure 3.5). To 
elucidate the precise localisation site of Drc expression, and hence to identify 
the type of cell expressing the Drc-GFP construct, Stage 15 Drc-GFP embryos 
expressing moesin-cherry (mCherry) in the epithelia, under the control of the 
E22c promoter using the Gal4 UAS system, were infected with Ecc15 (OD=1). 
Z-stack images of the resulting response were obtained, as can be seen in 
Figure 3.7B and C. Co-localisation of the Drc-GFP and E22c>mCherry signals 
was not immediately apparent (Figure 3.7B), although both signals appeared 
to co-exist within the same focal planes. However, upon close examination via 
orthogonal views (Figure 3.7C), it is clear that the Drc-GFP signal originated 
from cells within the epidermal layer of the Stage 15 embryo. This would 
suggest that the cells expressing Drc-GFP within the Stage 15 embryos at 6 
hours post infection are of epidermal origin.  
 
Further to this, immunostaining was performed to determine other principle 
locations of Drc expression within the Stage 15 Drc-GFP embryo at earlier 
time-points post infection (Figure 3.8). Drc-GFP embryos were infected with 
Ecc15 (OD=1) and were fixed at 3 hours post injection. Subsequently, 
embryos were immunostained for GFP, as an inference of Drc expression. In 
light of the finding that the Stage 15 embryo was able to induce AMP 
expression upon damage alone (Figure 3.6), Stage 15 embryos injected with 
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sterile endotoxin-free PBS were also prepared in the same manner; to 
investigate the localization of Drc-GFP expression upon damage stimuli. Non-
injected (NI) Drc-GFP embryos were also immunostained in the same manner 
as an internal control.  
  
Results yielded the interesting observation that Drc-GFP was also expressed 
within the embryonic tracheal network at 3 hours post injection with both sterile 
endotoxin-free PBS and Ecc15, whilst NI embryos lacked any Drc-GFP 
expression (Figure 3.8A). The response itself appeared extensive, with Drc-
GFP expression noted in at least primary and secondary tracheal branches 
along the entire length of the embryo, despite the initial infection being 
localized exclusively in the anterior. This would imply that both damage and 
bacterial infection are able to stimulate an extensive AMP response within 
tracheal cells.  Confirmation of the identity of these cells was obtained via the 
co-immunostaining of Drc-GFP and the trachea luminal maker 2A12 (Figure 
3.8B), where a close co-localisation of Drc-GFP and 2A12 signal was 
observed. Whilst 2A12 staining provided visualization of the tracheal lumen, 
Drc-GFP expression itself appeared to the localized to the tracheal epithelium 
(Figure 3.8B), with Drc-GFP expressing cells apparently surrounding the 
tracheal lumen.  
 
Consequently, the expression of Drc-GFP at 6 hours post infection with Ecc15 
appeared to be localized to cells embedded in the embryonic epidermal tissue. 
This response was shown to be extensive and have some potential segmental 
bias, although no clear pattern between individual expressing cells was 
apparent. This epidermal response was also shown to be supplemented by an 
earlier Drc-GFP response at 3 hours post infection, localized to the tracheal 









Figure 3.7: Stage 15 Drc-GFP expression is localized to the epidermis at 
6 hours post infection 
 
(A) Z-stack imaging of the anterior of an infected Stage 15 embryo 6 hours 
post infection with Ecc15 (OD=1; n=3 where !25 embryos were employed per 
replicate). Drc-GFP expression is extensive, and almost segmental in nature 
although no clear pattern is apparent. (B-C) Z-stack images of Drc-
GFP/e22c>mCherry embryos infected with Ecc15 (OD=1, n=3 where !25 
embryos were employed per replicate). Co-localisation of Drc-GFP (green) 
and e22c>mCherry (red) signals was not immediately apparent (B), although 
orthogonal projections through Drc-GFP/e22c>mCherry embryos shows that 
Drc-GFP expressing cells are embedded within the epidermis of infected 
embryos (C), suggesting that these cells are epidermal in origin. Scale bars 
























Figure 3.8: Damage and Ecc15 Infection induce Drc-GFP expression 
within the tracheal network 
 
(A) Immunostaining for Drc-GFP in Stage 15 embryos at 3 hours post injection 
with sterile endotoxin-free PBS or Ecc15 (OD=1) demonstrated expression of 
the construct in the tracheal network. Non-injected (NI) embryos exhibited a 
lack of Drc-GFP expression in comparison, indicating that the expression 
observed was a result of damage or infection. Scale bars represent 50µm. (B) 
The localization of this expression was confirmed by co-immunostaining for 
Drc-GFP (green) and the tracheal luminal marker 2A12 (red). Scale bars 

































3.2.3. Stage 15 embryos are able to differentiate between different types of 
infection 
 
Having established that the Stage 15 embryo was able to mediate a robust 
systemic AMP response to bacterial challenge, it was assessed whether 
embryos at this stage of embryogenesis were also able to distinguish between 
different types of bacterial pathogen, in a comparable manner to adult fly and 
larval infection models. WT embryos were microinjected either with sterile 
endotoxin-free PBS, Ecc15  (OD=1) or M. luteus (OD=1) and expression of 
AMP genes in response to these treatments at 2 hours post injection assessed 
by RT-qPCR (Figure 3.9). 
 
Whilst those AMP genes typically induced by Gram-negative infection, such as 
AttA, CecA1, Dpt and Drc (Wicker et al., 1990; Dimarcq et al., 1993; Asling et 
al., 1995), were significantly induced by Gram-negative Ecc15 treatment, 
Drosomycin (Drs), a Gram-positive bacterial and fungal AMP gene (Fehlbaum 
et al., 1994; Bischoff et al., 2004), was preferentially induced by M. luteus 
injection (Figure 3.9A-B). Therefore, the basic specificity of AMP gene 
induction that is mediated in response to Gram-negative and Gram-positive 
infection in the Drosophila adult and larval systems is also functional in the 
Stage 15 embryos. However, not all data is indicative of adherence to the 
basic AMP classification determined in other Drosophila models. For instance, 
M. luteus infection did not induce any significant expression of Def, an AMP 
which has been shown to be typically induced upon Gram-positive infections in 
Drosophila (Figure 3.9B). Moreover, Ecc15 infection significantly induced 
expression of both Def and Mtk, AMPs expressed in response to Gram-
positive bacterial and fungal infections respectively (Figure 3.9B)  
 
To ascertain whether this differential response in the Stage 15 embryo was 
mediated via canonical IMD and Toll signaling pathways, Dpt, Drc and Drs 
expression in response to Ecc15 and M. luteus injection was assessed via RT-
qPCR at 2 hours post injection in relishe20 (rele20) and modular serine 
protease1 (modSP1) mutant embryos, whereby IMD and Toll signaling was 
respectively disrupted (Figure 3.10A-C). Dpt and Drs expression in response 
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to sterile PBS injection treatment was also assessed in WT and mutant 
embryos as an internal control. Both Drc and Dpt expression in response to 
Ecc15 infection was completely abolished in rele20 embryos at 2 hours post 
injection (Figure 3.10A-B), with the relative expression of both AMPs 
significantly diminished in comparison to WT levels (p!0.01 and p!0.001 
respectively). In fact, expression levels of Dpt and Drc upon Ecc15 infection 
were not significantly different to those noted upon PBS injection alone (Figure 
3.10A-B). Moreover, this effect on Dpt expression is specific to Ecc15 
infection, as injection with sterile endotoxin-free PBS did not significantly 
induce Drc or Dpt expression in WT or mutant embryos (Figure 3.10A-B). 
Similarly, modSP1 mutant embryos were unable to induce Drs expression to 
WT levels, showing a highly significant reduction in Drs expression upon M. 
luteus infection (p!0.001; Figure 3.9C). Thus, Drs expression within the 
embryo is a direct result of Toll pathway activation.  
 
Moreover, the absence of IMD or Toll signaling was also shown to impact on 
Stage 15 embryo viability post infection. The survival of rele20, modSP1 and 
persephone1 (psh1);;modSP1 double mutant embryos 24 hours after injection 
with either sterile endotoxin-free PBS, DH5! E. coli (OD=1), M. luteus (OD=1), 
Erwinia carotovora carotovora 15 (Ecc15; OD=0.1), or proteases from 
Aspergillus oryzae (1:5000 dilution) was monitored and compared to survival 
levels for WT control embryos (Figure 3.10D). Neither the damage inflicted via 
the microinjection of sterile endotoxin-free PBS nor infection with DH5! E. coli 
significantly affected the survival of WT or immune mutant embryos post 
injection. Conversely, injection with Ecc15 selectively and significantly reduced 
the viability of rele20 mutants compared to WT controls (17% ± 9.64, p!0.01), 
whereas M. luteus injection significantly reduced the survival of both modSP1 
and psh1;;modSP1 mutants compared to WT viability levels (47% ± 8.21, 
p!0.001 and 34% ± 0.707, p!0.001 respectively), confirming that IMD and Toll 
signaling are required in the Stage 15 embryos for effective Gram-negative 
and Gram-positive infection resolution respectively. Interestingly, modSP1 and 
psh1;;modSP1 embryo viability was also decreased upon Ecc15 infection 
compared to that of WT embryos, although this effect was not statistically 
!!
"##!
significant. modSP1 mutant viability was also significantly reduced upon 
injection of A. oryzae proteases (45% ± 2.65, p!0.05). However, whilst 
psh1;;modSP1 survival was decreased by injection with A. oryzae proteases 
(50%), this reduction was determined to not be statistically significant in 
comparison to levels of WT embryo mortality. Therefore, whilst the majority of 
data suggests that the systemic immune response is mediated via the IMD 
and Toll pathways in the embryo, in concordance with adult and larval models, 
this exception would indicate that not all mechanisms operate in the same 
manner in the embryo.  
 
Nevertheless, the ability of the embryo to differentiate between different 
invading pathogens should not be considered as a static process. We 
subsequently sought to determine if Stage 15 embryos were able to 
differentiate between different Gram-negative bacterial species. WT embryos 
were infected either with sterile endotoxin-free PBS, Ecc15 (OD=1) or Mg1655 
E. coli (OD=1) and their subsequent expression of AMP genes 2 hours post 
injection was elucidated by RT-qPCR. Relative fold difference in expression 
was then calculated by normalizing to PBS-injected levels (Figure 3.11). Both 
Mg1655 E. coli and Ecc15 stimulated significant increases in Gram-negative 
AMP expression relative to PBS-injected levels (Figure 3.11A-B, D-E). Further 
to this, the level of expression for each gene was calculated as a proportional 
of the total AMP response, hence providing information about the cocktail of 
AMP genes expressed upon each infection. The induction of the majority of 
Gram-negative AMPs was comparable between the two species, as in the 
cases of AttA, CecA1 and Drc, where no significant difference was noted 
between expression levels in Mg1655 E. coli and Ecc15 treated embryos. The 
one exception is the expression of Dpt which, whilst significantly increased 
upon infection with both species, was more highly induced upon Ecc15 
infection. This may suggest a preference for the induction of Dpt to combat 
Ecc15 invasion. Intriguingly, this trend was also noted with AMPs of other 
classes, which are not typically renowned for expression upon Gram-negative 
bacterial infection. For instance, Mg1655 E. coli and Ecc15 both induced 
significant upregulation of Def expression and Mtk expression (Figure 3.11C 
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and G), which is usually observed in response Gram-positive and fungal 
infection respectively; in both cases, Ecc15 provoked a more intense response 
than Mg1655 E. coli. No significant upregulation of Drs was noted upon 
infection with either species (Figure 3.11F). Nevertheless, when taking into 
account the proportion that individual AMPs contribute to the overall response 
(Figure 3.11H), it is clear that Mg1655 E. coli and Ecc15 infection both induce 
a similar cocktail of AMP gene expression. Both Gram-negative species 
stimulate a preferentially high level of CecA1 expression, with other AMPs 
such as AttA, Def and Dpt induced to similar degrees. Therefore, even though 
in many cases Ecc15 stimulated higher levels of AMP gene expression than 
Mg1655 E. coli, the contribution of each AMP to the total response is relatively 
similar for each bacterium. However, the embryo’s responses to these 
different species are not identical. There appears to be a preference for 
Mg1655 E. coli to stimulate CecA1, AttA and Drs. On the other hand, this data 
confirms that Ecc15 stimulates a greater response of Mtk and Drc than its 
Mg1655 E. coli counterpart.  
 
Collectively, these results allow us to draw the conclusion that WT Stage 15 
Drosophila embryos are able to mount a specific AMP response to bacterial 
infection, that is not only able to distinguish between Gram-negative and 
Gram-positive infections but also is tailored to the individual species of 
invading pathogen, and that this is mediated without any significant 
consequences on subsequent WT embryo survival. Moreover, these 
responses are mediated via the well-characterised canonical IMD and Toll 
signaling pathways that have been shown to play a crucial role in the systemic 











Figure 3.9: Stage 15 Drosophila embryos are able effectively distinguish 
between different types of infection 
 
(A-B) Bar charts displaying relative levels of AMP gene expression in Stage 
15 embryos (n=3, with !200 embryos per experiment) upon treatment with 
either Ecc15 (OD=1) or M. luteus (OD=1). Whilst Ecc15 treatment 
preferentially stimulated Gram-negative AMP expression (A), M. luteus 
infection only significantly induced Drs expression (B). These results confirm 
that the embryo is able to differentiate between different types of infection. 
Surprisingly, Ecc15 treatment also significantly induced Def and Mtk 
expression, which are classified as Gram-positive and fungal AMPs 
respectively, whilst M. luteus did not significantly induce expression of either of 
the aforementioned AMPs (B). * Indicates p " 0.05, ** indicates p " 0.01, and 
*** indicates p " 0.001. All other changes should be considered as not 




















Figure 3.10: AMP gene induction is mediated via canonical immune 
signaling in the Stage 15 Drosophila embryo.  
 
(A-C) Bar charts showing the fold change in expression levels of different AMP 
genes in WT, rele20 and modSP1 embryos upon Gram-negative and Gram-
positive infection, normalised to expression levels observed in PBS injected 
embryos. Dpt expression was completely and significantly inhibited in rele20 
embryos upon Ecc15 infection, in comparison to WT controls (A; One-way 
ANOVA, N= where each replicate consisted of !200 embryos). Moreover, PBS 
injection significantly induced Dpt expression. A similar trend was noted for 
Drc expression when rele20 and WT expression upon Ecc15 infection (B). 
Conversely, Drs expression in modSP1 embryos was highly significantly 
downregulation compared to levels observed in WT embryos (C). (D) Bar 
graph showing viability of Stage 15 wild-type control embryos (WT) and Stage 
15 rele20, modsp1 and psh1;;modSP1 mutant embryos injected with PBS, E. 
coli, Ecc15, M. luteus or proteases from the fungus A. oryzae. Whilst injection 
of PBS or DH5! E. coli did not significantly impact the viability of WT or mutant 
embryos, infection with Ecc15 selectively diminished the survival of rele20 
mutants 24h post infection. Similarly, injection with M. luteus specifically 
decreased the viability of modSP1 and psh1;;modSP1 mutant embryos, 
although injection with A. oryzae proteases (1:2000) only significantly reduced 
the survival of modSP1 mutants. Taken together, these results infer that AMP 
induction in the embryonic systemic immune response is induced via the 
canonical IMD and Toll signaling pathways. 
 
* Indicates p " 0.05, ** indicates p " 0.01, and *** indicates p " 0.001. All other 
changes should be considered as not statistically significant. Error bars 






















Figure 3.11: Stage 15 embryos are able to adapt the AMP response to 
different Gram-negative infections 
 
(A-G) Bar charts showing relative levels of AMP gene expression in sterile 
endotoxin-free PBS, Ecc15 and Mg1655 E. coli injected Stage 15 embryos. 
Both Ecc15 and Mg1655 E. coli significantly induced expression of AttA, 
CecA1, Def, Dpt, Drc and Mtk above PBS injected relative levels (A-E, G). 
Neither infection stimulated significant Drs expression above PBS-injected 
control levels (F). Ecc15 provoked a significantly greater induction of Def, Dpt 
and Mtk expression than Mg1655 infection (C, D, G). (H) When considering 
individual AMP gene expression as a proportion of the total response, both 
bacteria stimulated a high degree of CecA1 expression and moderate levels of 
Dpt and Def expression. However, Ecc15 was shown to stimulate a higher 
proportion of Mtk and Dpt expression than Mg1655 E. coli. Conversely, 
Mg1655 stimulated a high proportion of CecA1, Drs and Def expression. * 
Indicates p ! 0.05, ** indicates p ! 0.01, and *** indicates p ! 0.001. All other 
changes should be considered as not statistically significant. Error bars 































3.2.5 Drosophila embryos are able to mount a robust cellular response to 
bacterial infection that depends on organization of the actin cytoskeleton 
 
To determine if the cellular branch of the immune response was intact and 
able to mediate the clearance of bacterial species within the Drosophila 
embryo, Stage 15 embryos containing GFP-labelled plasmatocytes were 
injected with RFP-expressing E. coli, to determine if plasmatocytes could 
effectively phagocytose bacteria at this stage of development. Moreover, it 
was also investigated whether components of the actin cytoskeleton which 
had been previously demonstrated to play key roles in phagocytosis were 
required for embryonic plasmatoocyte clearance of pathogen. In this case, the 
precise role of SCAR, a component of the Arp2/3 complex which regulates 
actin nucleation (Machesky et al., 1999; Welch and Mullins, 2002; Zallen et al., 
2002), in embryonic phagocytosis was investigated.  
 
Live imaging at 1 hour post injection revealed that Stage 15 embryonic 
hemocytes were able to effectively phagocytose injected RFP-E. coli, with a 
mean value 40% of total bacteria injected at this time-point (Figure 3.12A), 
hence demonstrating that plasmatocytes at Stage 15 of embryogenesis are 
effectively able to recognize and engulf bacteria. However, SCAR!37 mutant 
plasmatocytes phagocytosed RFP-E. coli at significantly reduced levels 
compared to WT, with only 15% of total RFP-E. coli successfully 
phagocytosed at 1 hour post infection (Figure 3.12A). Furthermore, non-
phagocytosed RFP-E. coli were often observed adhered to the surface of 
SCAR!37 mutant plasmatocytes, which is suggestive of an inability to 
phagocytose as opposed to a defect with recognition.  
 
To assess the resulting biological cost of defective clearance, the viability of 
WT and SCAR!37 embryos was monitored for 24 hours after infection with 
either DH5! E. coli or Ecc15 (Figure 3.12B). Infection with Ecc15 resulted in a 
decrease in viability in both WT and SCAR!37 mutant embryos beyond that 
observed for PBS injected control embryos. Crucially, this Ecc15-associated 
mortality was significantly enhanced in SCAR!37 mutants, inferring that a failure 
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in SCAR-dependent phagocytosis substantially compromised the embryonic 
innate immune response as a whole. Interestingly, comparison of non-infected 
(NI) and PBS treated SCAR!37 mutants identified a significant reduction in 
viability in response to this treatment (Figure 3.12B), suggesting that SCAR 
may also play a role in a response to damage or repair processes.  
 
Another interesting feature of the data is that infection with DH5! E. coli did 
not further or significantly reduce the levels of viability of SCAR!37 embryos 
from that observed upon PBS injection (Figure 3.12B). This is in contrast to 
the WT response, whereby infection with DH5! E. coli induces a significant 
decrease in embryo viability (p!0.01, Figure 3.12B). This may suggest that the 
lack of phagocytosis in a SCAR!37 mutant background confers some biological 
benefit. Therefore, the data implies that, in addition to the Stage 15 embryo’s 
systemic capabilities, the cellular branch of the immune response is also 
active and able to mediate the effective clearance of infection at this stage of 
development. This process requires correct organization of the actin 
cytoskeleton in primary phagocytes, as SCAR mutant plasmatocytes are 
unable to effectively clear infective agents. This inability to effectively 
phagocytose invading pathogens ultimately leads to increased mortality, 
















Figure 3.12: SCAR is required for mediating successful phagocytosis in 
the Stage 15 embryo 
 
(A)  Wild-type (WT) or SCAR!37 Stage 15 embryos with hemocytes labeled 
with GFP (green) were injected with RFP-labelled E. coli (red) and imaged at 1 
hour post infection. This revealed a defect in SCAR!37 mutant phagocytosis 
compared to WT controls. A significant reduction was noted in the percentage 
of RFP-E.coli phagocytosed in SCAR mutants (p!0.01, Mann-Whitney U-test, 
n"4 per genotype). Scale bars represent 5µm. (B) Bar graph showing mean 
survival of WT and SCAR!37 non-injected controls (NI) and PBS, DH5" E. coli 
or Ecc15 injected embryos. Injection with PBS, DH5" E. coli or Ecc15 
significantly decreased the viability of Stage 15 SCAR mutant embryos 24 
hours post infection compared to WT counterparts (p!0.01, p!0.05, and 
p!0.01, respectively, Unpaired T-Test; n=3, where "100 embryos were 
employed per experiment). * Indicates p!0.05, ** indicates p!0.01. Error bars 



















3.2.6 Stage 15 embryos are able to respond to bacterial infection using a 
diverse range of immune mechanisms 
 
Following from the notion that multiple immune mechanisms may be intact 
within the embryo and able to facilitate an effective response to infection, RT-
qPCR was used to screen for changes in expression levels of immune genes 
implicated in more diverse roles in the Drosophila immune responses to 
bacterial infection and damage. These included the dopa decarboxylase (ddc), 
masquerade (mas) and Growth Arrest and DNA Damage-inducible 45 
(GADD45) genes, which play roles in melanisation, regulation of serine 
proteases upon infection and damage-induced stress responses respectively 
(Irving et al., 2001; Stramer et al., 2007; Tang, 2009). Relative expression 
levels for each gene upon infection for damage were normalized to non-
infected or PBS-injected levels as appropriate.  
 
Expression of some candidate genes, as in the case of mas, was observed to 
be significantly downregulated upon infection with both Gram-negative and 
Gram-positive microbes, such as Ecc15 and M. luteus (Figure 3.13A; p!0.01 
and p!0.05 respectively), suggesting a role for mas in the Stage 15 innate 
immune response. However, whilst other candidate genes demonstrated 
increases in expression on specific types of infection, such as the 1.56-fold 
induction of GADD45 upon Ecc15 infection (Figure 3.13B), these changes 
were observed to be non-significant. Similarly, ddc expression was apparently 
downregulated upon Ecc15 infection and increased upon injection with M. 
luteus, but in a non-significant manner (Figure 3.13C). Conversely, all relative 
expression levels of all three aforementioned candidate genes were highly and 
significantly increased upon PBS injection, when compared to relative levels in 
NI controls (Figure 3.13D), inferring a role for these genes in the embryonic 
damage response and potential cross-talk between the Drosophila immune 
system and repair mechanisms. Therefore, infection of Stage 15 embryos with 
Gram-negative and Gram-positive bacteria is able to induce a wide range of 
transcriptional responses that are not restricted to AMP gene modulation, and 




Figure 3.13: A diverse range of immune genes are activated within the 
Stage 15 embryo upon bacterial infection and damage 
 
RT-qPCR was used to determine if the activity of other genes implicated in the 
Drosophila immune response was modulated upon bacterial infection (A-C) or 
upon damage (D) in Stage 15 embryos, with relative levels of gene expression 
normalized to control PBS-injected or non-infected (NI) levels where 
appropriate. Masquerade (mas) expression was demonstrated to be 
significantly reduced upon infection with Ecc15 or M. luteus (A; One way 
ANOVA, n=3 with ! 200 embryos per experiment, p"0.01 and p"0.05 
respectively). The expression of Growth Arrest and DNA Damage-inducible 45 
(GADD45) was increased upon Ecc15 infection, although this change was not 
significant (B). Likewise, dopa decarboxylase (ddc) expression was increased 
upon M. luteus and decreased upon Ecc15 infections respectively in a non-
significant manner (C). However, the expression of all three immune genes 
was demonstrated to be highly significantly induced by PBS injection, 
indicating that damage may activate transcription of these candidate genes (D; 
One-way ANOVA, n=3 with ! 200 embryos per replicate). * Indicates p " 0.05, 
** indicates p " 0.01, *** indicates p " 0.001, **** indicates p " 0.0001. Error 








































3.2.7 Stage 11 embryos show reduced immune competency compared to 
Stage 15 embryos 
 
To assess whether embryos at other stages of embryogenesis displayed the 
same level of immune competence demonstrated at Stage 15, the AMP 
response of Stage 11 embryos to Gram-negative bacterial species was 
examined (Figure 3.14). Stage 11 Drc-GFP embryos were injected either with 
DH5! E. coli (OD=1; Figure 3.14A) or Ecc15 (OD=1; Figure 3.14B), and their 
induction of the Drc promoter construct was compared to that of control Stage 
15 Drc-GFP embryos at 6 hours post injection. At 6 hours post infection with 
DH5! E. coli, a stark difference in Drc-GFP was observed; whilst control 
embryos injected at Stage 15 of development displayed an extensive, high 
level of Drc-GFP expression concordant with previous results, no response 
was evident in those embryos injected Stage 11 (Figure 3.14A). Despite this 
difference in Drc-GFP expression, and hence the inferred differential immune 
competence of early and late stage embryos, both cohorts of embryos 
continued to proceed through the stereotypical events of embryogenesis, as 
implied by the invagination of the gut in the embryos injected at Stage 15 and 
yolk sac morphology those injected at Stage 11 (Figure 3.14A). Results at this 
time-point exhibited by embryos injected with Ecc15 show a similar trend; 
whilst embryos injected at Stage 15 of development show a robust, extensive 
Drc-GFP response, embryos injected at Stage 11 do not exhibit any 
expression of the transgene although gross development appears unaffected 
(Figure 3.14B).  
 
Furthermore, this lack of immune capability within the Stage 11 embryo was 
demonstrated by their decreased viability post infection with a variety of Gram-
negative and –positive bacterial species (Figure 3.14C). Groups of !100 Stage 
15 or Stage 11 embryos were selected and received either control sterile 
endoxtoxin-free PBS treatment, or injection with DH5! E. coli (OD=1), Mg1655 
E. coli (OD=1), M. luteus (OD=1) or Ecc15 (OD=0.1). Although Stage 11 
embryo survival to PBS injection was not significantly different to that of the 
Stage 15 embryo, infection of Stage 11 embryos with bacterial species 
significantly decreased their survival to first instar larval stages. Whilst the 
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reduction in viability to non-pathogenic DH5! E. coli infection was relatively 
minor, although significant, in comparison to Stage 15 embryo survival levels 
(62%±3.54, p!0.05), infection with Mg1655 E. coli, M. luteus and Ecc15 highly 
and significantly decreased Stage 11 embryo viability compared to that of 
Stage 15 controls (20%±4.73, p!0.01, 39%±13.6, p!0.001 and 24%±7.00, 
p!0.01 respectively). These latter results are concordant with viability levels 
observed when Stage 15 rele20 and modSP1 embryos infected with Ecc15 and 
M. luteus respectively (Figure 3.10D), further inferring that embryos infected at 
Stage 11 of development behave similarly to embryos afflicted with a 
compromised systemic immune response. Thus not only do earlier stage 
embryos demonstrate a lack of initial immune competence when resolving 
bacterial infections, but this inability may also lead to their eventual demise, 
with a dramatic reduction in embryo viability.   
 
Moreover, this reduction in viability is not due to prolonged overstimulation of 
the Stage 11 immune system, but a specific inability of embryos at this 
developmental stage to mount an effective response. Injection of heat-killed 
Ecc15 (OD=1) into Stage 11 embryos does not appear to affect their 
subsequent viability (Figure 3.14D); in fact, the percentage of Stage 11 
embryos reaching the first larval instar stage upon injection with heat-killed 
Ecc15 is not significantly different to that of PBS injected Stage 11 embryos 
(p"0.05; Figure 3.14E). Thus heat-killing Ecc15 prior to infection reverses its 
detrimental effects on Stage 11 embryo viability, suggesting that the prolonged 
presence and potential recognition of high levels of pathogen alone does not 
affect early stage survival. This evidence is further supported by the fact that 
genetic inactivation of IMD signaling upon Ecc15 infection (OD=1), by mutation 
of PGRP-LC (PGRP-LCE12), does not improve Stage 11 embryo viability 
compared to that of WT Stage 11 embryos (Figure 3.14E). If anything, Stage 
11 PGRP-LCE12 viability is significantly decreased upon Ecc15 infection.    
 
In addition, live embryos containing a PGRP-LC-GFP transgene were imaged 
at different stages using confocal microscopy; to determine if a difference in 
PGRP-LC expression could be observed throughout embryogenesis to further 
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corroborate the notion that early stage embryos were less immune competent 
than those at late stages. No expression of PGRP-LC-GFP was exhibited in 
Stage 10 embryos (Figure 3.14F). Conversely, upon reaching Stage 13 of 
embryogenesis, weak PGRP-LC-GFP expression was detected, localized to 
epidermal cell membranes (Figure 3.14F). This PGRP-LC-GFP expression 
was further enhanced in the Stage 15 embryos, showing a more intense 
signal. This would suggest embryonic immune competence would originate at 
approximately mid-embryogenesis, potentially involving PGRP-LC. As such, 
the biological event which regulates this process must occur within this 
developmental time window.  
 
Taken together, these results suggest that Stage 11 embryos are 
immunologically immature; they do not appear to be able to mount the robust 
immune response to bacterial challenge demonstrated at later stages of 
embryogenesis. Moreover, this inability to respond to infection likely results in 
their increased mortality to infection. This is corroborated by the lack of PGRP-
LC expression within these embryos until Stage 13 of development, 



















Figure 3.14: Stage 11 embryos show a reduced immune competency in 
response to bacterial invasion 
 
(A-B) Stage 15 and Stage 11 Drc-GFP embryos were injected with either E. 
coli or Ecc15, and the expression of Drc-GFP observed at 6 hours post 
injection (!25 embryos per experiment). At 6h post injection, no Drc-GFP 
expression was apparent in Stage 11 embryos injected with either DH5! E. 
coli (A’’) or Ecc15 (B’’), in contrast to the robust response of Stage 15 controls 
(A’ and B’). (C) Bar graph showing mean percentage survival of Stage 15 and 
Stage 11 WT embryos post infection with a range of bacterial species, as well 
as after microinjection with PBS. Stage 11 embryos infected with all bacterial 
species examined showed significantly reduced survival in comparison to the 
survival of Stage 15 controls (Unpaired T-Test, n=3, with ! 100 embryos 
injected per experiment). (D) Bar graph showing mean percentage survival of 
Stage 11 embryos post injection with sterile endotoxin free PBS, live Ecc15 
(OD=0.1) or heat-inactivated Ecc15 (OD=0.1; Ecc15 HI). The effects of Ecc15 
on Stage 11 embryo mortality can be reversed by heat-inactivation of bacteria, 
suggesting that Stage 11 embryo viability is reduced by an inability to 
eliminate infection and not chronic overstimulation of the immune system. (E) 
Bar graph showing mean percentage survival of Stage 15 and Stage 11 
PGRP-LCE12 mutant embryos upon PBS or Ecc15 infection (OD=0.1). Ecc15 
infection significantly reduced Stage 11 survival to infection in comparison to 
PBS injected (p"0.001) and to Stage 15 Ecc15 injected (p"0.01) levels, 
indicating that overstimulation of the Stage 11 immune system is not 
responsible for the increased embryo mortality observed. (F) Live imaging of 
PGRP-LC-GFP embryos. PGRP-LC-GFP fusion protein was not detected until 
Stage 13 of embryogenesis, albeit at very low levels. This expression was 
enhanced at Stage 15 of development, with PGRP-LC-GFP clearing exhibiting 
localization at the cell membrane of epidermal cells (n=3). Scale bars 
represent 20µm. 
 
* Indicates p " 0.05, ** indicates p " 0.01, *** indicates p " 0.001. All other 
changes do not show statistical significance. Error bars represent standard 






3.2.8. 20-Hydroxyecdysone signaling is required for Stage 15 embryo AMP 
gene induction and survival to infection  
 
Having observed that embryos infected at Stage 11 lacked the immune 
competence demonstrated at later stages of development, we postulated that 
this differential ability may arise as a result of the 20-hydroxyecdysone (20-
HE) pulse, which occurs at around Stage 12 of development (Kozlova and 
Thummel, 2003). Since 20-HE signaling is crucial for embryonic development, 
we first verified if Stage 15 embryos containing mutations in the ecdysone 
receptor (EcR) were viable, and moreover if they were more susceptible to 
infection than WT controls. To assess embryo viability, non-infected Stage 15 
heterozygous (EcRQ50st/CTG, EcRM554fs/CTG), homozygous (EcRQ50st/EcRQ50st, 
EcRM55fs/EcRM554fs) and transheterozygous (EcRQ50st/EcRM554fs) EcR mutant 
embryos were selected and monitored for development to first instar larvae 
(Figure 3.15A). EcRQ50st is a mutation selective to the EcR-B1 isoform, 
whereas that of the EcRM554fs mutant is in a common exon, and thus affects all 
three EcR isoforms (Bender et al., 1997). The viability of Stage 15 embryos 
whereby a dominant-negative form of EcR-B1 was expressed using the Gal4-
UAS system either ubiquitously (DaGal4, UAS EcR-B1 DN) or selectively in 
either hemocytes (srpGal4, UAS EcR-B1 DN), epithelia (E22cGal4, UAS EcR-
B1 DN) or tracheal cells (BtlGal4, UAS-EcR-B1 DN) was also assessed 
(Figure 3.15A). Both heterozygous and transheterozygous mutant embryos, as 
well as those expressing the dominant negative form of EcR-B1 in hemocytes 
or tracheal cells, did not show a significant difference in viability in comparison 
to WT embryos. In contrast, EcRM55fs homozygous mutants exhibited a 
dramatic decrease in viability compared to WT controls, with 12%±2.65 of 
embryos selected hatching into first instar larvae (p!0.0001; Figure 3.15A). A 
similar effect was noted with DaGal4, UAS EcR-B1 DN and E22CGal4, UAS 
EcR-B1 DN embryos (21%±17.5, p!0.001 and 25%±13.6 respectively). These 
results are not surprising given the ubiquitous expression of EcR isoforms 
within the embryo by Stage 12 of development, which is particularly enriched 
in the amnioserosa (Figure 3.16A-B). However, whilst EcRQ50st homozygotes 
did display a significantly different viability to WT controls (p!0.05), a high 
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proportion of these embryos survived to first instar larval stages (86% ± 4.36) 
and hence could be utilized in further studies.  
 
Therefore, the susceptibility of Stage 15 EcRQ50st homozygous, 
EcRQ50st/EcRM554fs transheterozygous, srp>EcR-B1 DN and Btl>EcR-B1 DN 
embryos to Ecc15 infection (OD=0.1) was tested (Figure 3.15B). Survival of 
EcRQ50st homozygous and EcRQ50st/EcRM554fs transheterozygous mutant 
embryos was significantly compromised by Ecc15 infection compared to WT 
survival at 24 hours post injection (p!0.01 and p!0.05 respectively), similar to 
the viability of embryos injected with Ecc15 at Stage 11 of development 
(Figure 3.15B). Moreover, EcRQ50st homozygous embryos also displayed a 
small yet significant decrease in viability upon sterile PBS injection alone 
(p!0.05), although this was not the case for the EcRQ50st/EcRM554fs 
transheterozygous mutant embryos. In terms of the location that 20-HE 
signaling is required to mediate effective embryonic survival to infection, no 
significant difference in viability was observed between WT and srp>EcR-B1 
DN embryos (Figure 3.15B), inferring that hemocytes are not required for 
perpetuating 20-HE signaling in this process. Interestingly, the viability of 
Btl>EcR-B1 DN embryos was demonstrated to be selectively reduced upon 
Ecc15 infection in comparison to WT embryos (Figure 3.15B), inferring that the 
presence and functionality of the EcR-B1 isoform in tracheal tissue is required 
to mediate embryonic survival to Ecc15 infection. 
 
Subsequently, we can postulate that 20-HE signaling is integral in the 
embryonic systemic immune response to bacterial infection, and may also play 
a role in resolution of mechanical damage. Moreover, embryos unable to 
mediate effective 20-HE signaling phenocopy the lack of immune capability 
observed in infected Stage 11 embryos, suggesting that 20-HE may play a 
role in the maturation of the systemic immune system in Drosophila embryos. 
In particular, 20-HE signaling in tracheal cells appears to play a crucial role in 




To determine if 20-HE signaling was required for AMP gene induction upon 
infection, infection studies were performed with Stage 15 EcRQ50st 
homozygous mutant embryos and their resulting AMP gene expression 
assessed via RT-qPCR. Compared to WT control embryos, specific AMP gene 
activity was severely and significantly downregulated upon infection with 
Ecc15 (OD=1) in EcRQ50st mutants (Figure 3.17). CecA1, Def, and Mtk all 
demonstrated a lack of induction upon Ecc15 infection within the EcRQ50st 
mutant background (Figure 3.17A). As such, relative levels of expression for 
this subset of AMPs upon Ecc15 infection was not significantly different to 
those stimulated by PBS treatment alone (Figure 3.17A), thus suggesting that 
the direct effects of Ecc15 upon AMP stimulation were effectively disrupted in 
EcRQ50st mutants. Interestingly, the expression of other AMP genes could still 
be induced in EcRQ50st mutants, experiencing a significant upregulation upon 
Ecc15 treatment, including Drc and AttA (Figure 3.17B). Moreover, no 
significant difference in Dpt expression was noted between WT control and 
EcRQ50st mutant embryos (Figure 3.17B). However, when comparing the basal 
levels of Dpt, Drc and AttA expression in non-infected WT and EcRQ50st 
embryos, the levels of gene expression are significantly decreased in EcRQ50st 
mutants (Figure 3.17C), suggesting that EcR-deficient embryos are unable to 
maintain basal levels of these AMPs and are hence compromised even before 
an infection scenario. Therefore, in Stage 15 embryos 20HE signaling is 
required for the expression of a subset of AMP genes, and potentially to 













Figure 3.15: 20-Hydroxyecdysone is crucial for the regulation of the 
Drosophila immune response.  
 
(A) Quantification of viability of non-infected Stage 15 Ecdysone receptor 
(EcR) mutant embryos and Stage 15 embryos expressing a dominant-negative 
form of EcR-B1. Embryos that were heterozygous or transheterozygous for 
either EcR mutation, as well as embryos where a dominant-negative form of 
the EcR-B1 was expressed selectively in hemocytes or tracheal cells under 
the control of the serpent (srp) or breathless (btl) promoters respectively, did 
not show significantly different viability to WT embryos. Homozygous mutant 
embryos and those where dominant-negative EcR-B1 was ubiquitously 
expressed using the daughterless (da) or E22c promoters showed highly 
significantly reduced viability (P!0.05, Unpaired T-Test, n=3 where each 
replicate consisted of "50 embryos). (B) Bar graph showing the effect of 
bacterial infection upon the survival of Stage 15 EcR mutant embryos. The 
viability of EcRQ50st homozygous and EcRQ50st /EcRM554fs transheterozygous 
mutant embryos was significantly reduced upon Ecc15 infection (OD=0.1) 
compared to WT controls. The viability of embryos expressing EcR-B1 DN in 
tracheal cells was also significantly decreased upon Ecc15 infection compared 
to WT controls. The survival of embryos expressing dominant-negative EcR-
B1 receptor in hemocytes (srp>EcR-B1 DN) was not significantly different from 
that of WT embryos, indicating that hemocytes may not play a role in 
perpetuating 20-HE signalling for the maturation of the embryonic immune 
system (Unpaired T-Test, N=3 where each replicate comprises "100 
embryos).  
 
* indicates p ! 0.05, ** indicates p ! 0.01; *** indicates p ! 0.001; **** indicates 















Figure 3.16: The Ecdysone Receptor is expressed ubiquitously in 
Drosophila embryos 
 
(A) Ventral images of the anterior region of Stage 12 embryos co-
immunostained for all isoforms of the ecdysone receptor (EcR; red) and for 
FITC-phalloidin (green). All cells within the embryonic epidermis appeared to 
contain EcR, localized to the cell cytoplasm (n=3). (B) Lateral images of Stage 
12 embryos stained co-immunostained as above. The localisation of EcR 
protein was noted to be particularly enhanced within the amnioserosa of 



















Figure 3.17: AMP gene induction is partially disrupted in EcR 
homozygous mutant embryos 
 
(A-B) Bar graphs showing quantification of AMP gene expression levels in 
EcRQ50st homozygous mutant embryos versus WT controls upon sterile 
endotoxin-free PBS and Ecc15 injection by RT-qPCR. Relative expression 
levels in Ecc15 treated embryos were normalised to PBS-injected levels for 
both WT and mutants. CecA1, Def, Drs and Mtk expression was significantly 
inhibited in EcRQ50st mutants compared to WT controls (A; One-way ANOVA, 
n=3 where !200 embryos were used per experiment). Conversely, expression 
of AttA and Drc was significantly increased in EcRQ50st mutants compared to 
WT embryos upon Ecc15 infection (B). No significant difference in Dpt 
expression was noted when comparing WT and EcRQ50st mutant levels (B). * 
indicates p " 0.05, ** indicates p " 0.01; *** indicates p " 0.001; **** indicates p 



































3.2.9. 20-HE treatment rescues Stage 11 embryo AMP expression 
 
To further investigate the role of 20-HE in the maturation of embryonic 
systemic immunity, Stage 11 Drc-GFP embryos were co-injected with Ecc15 
(OD=0.5) and 20-HE, to test whether treatment with 20-HE could rescue Drc-
GFP expression and survival at this stage of embryogenesis (Figure 3.18A-B). 
The percentage of embryos expressing Drc-GFP upon Ecc15 and 20-HE co-
administration (Ecc15+20-HE) was compared to that of those Stage 11 
embryos receiving Ecc15, 20-HE or sterile PBS treatment alone. These results 
were subsequently compared to those of Stage 15 embryos receiving identical 
treatments. Intriguingly, upon Ecc15+20-HE treatment, a significantly 
increased percentage of Stage 11 Drc-GFP embryos were able to respond to 
Ecc15 infection upon co-administration of 25µM 20-HE when compared to that 
of Stage 11 embryos treated with Ecc15 alone (30%±4.0 compared to 
12%±4.9 respectively, Figure 3.17A and B). Conversely, it should be noted 
that this rescue is not complete; the level of Drc-GFP response in rescued 
embryos does not parallel that of Stage 15 counterparts in terms of the 
percentage of embryos able to respond to infection (Figure 3.18B). 
Nevertheless, those Stage 11 embryos that are effectively rescued exhibit a 
response that appears qualitatively similar to Stage 15 counterparts (Figure 
3.18A), with a similar degree and localization of Drc-GFP expression.  
 
However, 20-HE itself does not appear to significantly induce Drc-GFP 
expression as both Stage 15 and Stage 11 embryos receiving 20-HE 
treatment alone did not significantly respond compared to sterile PBS control 
groups (Figure 3.18A and B). Similarly, co-administration of Ecc15+20-HE to 
immune competent Stage 15 embryos did not significantly increase the 
percentage of embryos able to respond to bacterial stimuli at this stage of 
development, suggesting that there is no further immune advantage to 
applying 20-HE at Stage 15 of development (Figure 3.18B). Nevertheless, it is 
worth noting that both PBS and 20-HE treatment themselves did stimulate a 
low but significant level of Drc-GFP response in Stage 15 embryos (12%±1.4 
and 8%±0.71 respectively; Figure 3.18B), which could be attributed to the 
damage of injection process. Interestingly, this effect is abolished in Stage 11 
!!
"#$!
embryos, permitting the inference that the AMP response to damage at this 
stage is also inhibited and thus 20-HE is also able to mediate AMP expression 
in response to damage alone.  
 
In terms of a developmental advantage, given the role of 20-HE in mediating 
crucial developmental processes, those embryos receiving 20-HE treatment 
did not appear to display perturbations in developmental timing (Figure 3.19). 
At 12 hours post injection, no significant difference in the percentage of Stage 
11 embryos reaching advanced stages of embryogenesis was noted between 
any treatment groups, as determined by gut morphology (p!0.05, Figure 
3.19A). However, treatment with 20-HE upon Ecc15 infection did not rescue 
Stage 11 embryo survival to first larval instar stages. (Figure 3.19B), with only 
9.3%±2.3 versus 12%±.4.0 survival for Ecc15+20-HE and Ecc15 treated 
groups respectively. The viability of these groups was not significantly different 
(p!0.05, Unpaired T-Test), despite 20-HE treatment, and both groups still 
remained highly significantly different to PBS and PBS+20-HE treated controls 
(p"0.0001, Unpaired T-Test). Therefore, whilst 20-HE treatment may rescue 
the Drc-GFP expression of Stage 11 embryos, it does not confer any benefit to 
Stage 11 embryo viability upon Ecc15 infection.  
 
Taken together, these results indicate that the immune immaturity of Stage 11 
embryos can be rescued by application of 20-HE, thus demonstrating a direct 
role for this hormone in the maturation of the embryonic immune response. 
However, 20-HE is not able to induce immune activation itself, requiring a 
bacterial co-stimulus, although there may be a potential role for 20-HE in 
mediating a minor response to damage signals. In any case, there does not 
appear to be any developmental benefit or cost of administration of exogenous 
20-HE treatment itself, and furthermore 20-HE does not protect against Ecc15-








Figure 3.18: 20-HE treatment rescues the AMP response in Stage 11 
embryos 
 
(A-B) Quantification and images of the rescue of Stage 11 embryos with 20-
hydroxyecdysone (20-HE). (A) Ventral images of corresponding Stage 11 and 
Stage 15 Drc-GFP embryos injected with Ecc15 +/- 20-HE. A rescue of Drc-
GFP expression was noted in Stage 11 embryos receiving 20-HE treatment 
upon Ecc15 infection. (B) Graphs showing expression of Drc-GFP transgene 
in Stage 11 and Stage 15 Drc-GFP embryos at 12h post infection with Ecc15 
+/- co-injection with 20-HE. A significantly larger proportion of Stage 11 
embryos that received Ecc15+20-HE treatment expressed Drc-GFP at 12h 
post injection than those receiving Ecc15 treatment alone (p!0.001, Unpaired 
T-Test, N=3 with "100 embryos injected per experiment). In terms of the 
proportion of responsive embryos, 20-HE treatment did not rescue Drc-GFP 
expression to Stage 15 levels. Moreover, the proportion of Stage 11 embryos 
responding to PBS or PBS+20-HE treatment alone was significantly less than 
























Figure 3.19: 20-HE does not confer any developmental or survival benefit 
on Stage 11 embryos infected with Ecc15 
 
(A-B) Cohorts of Stage 11 embryos were treated with either PBS or Ecc15 
(OD=0.5) +/- 20-HE and their development assessed by gut morphology at 12 
hours post treatment. Their subsequent survival to first larval instar stage was 
also observed at 30 hours post treatment (n=3, where !50 embryos were 
employed per replicate). No significant difference was observed in the 
percentage of Stage 11 embryos reaching advanced stages of embryogenesis 
(Stage 16 onwards) between any of the treatment groups (A; p!0.05), 
suggesting that 20-HE does not confer any developmental cost or benefit 
when administered to Stage 11 embryos in its own right or upon Ecc15 
treatment. Injection of 20-HE also does not promote the survival of Stage 11 
embryos infected with Ecc15 (B). No significant change in viability was noted 
between Ecc15 and Ecc15+20-HE treated groups (p!0.05, Unpaired T-Test, 
n=3) and the viability of these groups remained significantly reduced from PBS 
and PBS+20-HE controls respectively (p"0.0001; Unpaired T-Test, n=3), **** 













3.2.10 20-HE signalling is required to control bacterial proliferation upon 
infection 
 
Since administration of 20-HE rescued AMP expression but not the viability of 
Stage 11 embryos infected with Ecc15, it was necessary to assess if bacteria 
were effectively prosecuted under these conditions. To determine if Ecc15 
were effectively eliminated within Stage 11 embryos, cohorts of Stage 11 and 
control Stage 15 embryos were injected with Ecc15 (OD=0.1), incubated for 
7.5 hours to allow for bacterial proliferation and subsequently crushed and the 
resulting suspension spread on LB plates to assess the numbers of colony 
forming units (CFUs) that could be isolated from each test group. Ratios of 
CFU counts between control and test groups were then calculated to 
determine if changes in bacterial burden were significant (Figure 3.20).  
 
Results indicated that 7.5 hours after the initial infection, Stage 11 embryos 
harboured more bacteria than Stage 15 control embryos (Figure 3.20A); this 
would thus indicate that Stage 11 embryos are not able to eliminate bacteria 
as effectively as their more robustly immune Stage 15 counterparts. However, 
due to variability in CFU counts from infected Stage 11 embryos, this 
difference is not significant (p=0.08, Unpaired T-Test). Moreover, it is 
important to note that the bacterial burden in Stage 15 embryos was not 
reduced to undetectable levels (Figure 3.20A), suggesting that even immune 
competent embryos were not able to effectively clear the Ecc15 infection 7.5 
hours after the initial administration. Nonetheless, treatment of Stage 11 
embryos with 20-HE upon Ecc15 infection significantly reduces the bacterial 
burden contained within these embryos compared to controls receiving only an 
Ecc15 infection (p!0.001; Figure 3.20B). Interestingly, this effect can also be 
replicated in Stage 15 embryos, which also experienced a highly significant 
decrease in bacterial burden after an initial co-administration with 20-HE upon 
Ecc15 infection (p!0.0001, Figure 3.20B), implying that 20-HE is can mediate 
effective inhibition of bacterial proliferation within the Drosophila embryo.  
 
Most interestingly, upon assessing the Ecc15 burden in Stage 15 embryos 
expressing a dominant negative form of the EcR-B1 isoform in trachea cells it 
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was discovered that these embryos harboured a significantly greater number 
of bacteria at 7.5 hours post infection than their WT counterparts (p!0.05, 
Unpaired T-Test; Figure 3.20C), inferring the importance of 20-HE signaling in 
the Stage 15 immune response. This effect on Ecc15 burden phenocopied 
that observed in Stage 11 embryos (Figure 3.20A), providing a link between 
20-HE signaling and the immune incompetence exhibited by Stage 11 
embryos. Moreover, it again reinforced the importance of the trachea in 
mediating an effective embryonic immune response to bacterial infection.  
 
Therefore, these results emphasize the importance of 20-HE signaling in 
effective prevention of bacterial proliferation in vivo. More specifically, they 
suggest that 20-HE signaling in the trachea is critical to facilitate the 
maturation of embryonic immune response and ultimately to prevent the 






















Figure 3.20: 20-HE treatment decreases bacterial load in Drosophila 
embryos 
 
(A-B) Groups of Stage 15 and Stage 11 embryos were infected with Ecc15 
(OD=0.1) +/- 25µM 20-HE (n=3, with !50 embryos per treatment group per 
experiment). At 7.5 hours post infection, the embryos were mechanically 
disrupted and the resulting suspension grown on LB agar plates to recover 
bacteria and assess the infection burden via counting of colony forming units 
(CFUs). Stage 11 embryos were determined to have a greater bacterial 
burden than Stage 15 embryos at this time-point (A), but this difference was 
not significant (p!0.05, Unpaired T-Test). Co-administration of 20-HE upon 
Ecc15 infection significantly reduced the bacterial burden in both Stage 15 and 
Stage 11 embryos (B), compared to that observed 7.5 hours after Ecc15 
infection alone (p"0.001 and p"0.0001 respectively, Unpaired T-Test). A 
significantly greater bacterial burden was also recorded in Stage 15 embryos 
expressing a dominant negative form of EcR-B1 in the trachea (btl>EcR-B1 
DN), compared to WT controls (C; p"0.05), demonstrating that the inhibition of 
20-HE signalling in trachea leads to a less effective bacterial clearance. * 











3.2.11 Damage and Ecc15 infection downregulate 20-HE synthesis, 
metabolism and effector gene expression in Stage 15 embryos 
 
Having established that 20-HE is critical for mediating a successful immune 
response to Ecc15, the relative change in expression levels of genes involved 
in 20-HE biosynthesis and metabolism, as well as those encoding 20-HE 
signaling effectors, was assessed upon both sterile PBS injection and Ecc15 
infection in Stage 15 WT embryos using RT-qPCR (Figure 3.21). To assess 
modulation in expression of the candidate genes upon damage alone, relative 
expression levels in PBS injected embryos were compared to those in non-
infected (NI) embryos (Figure 3.21A). Alternatively, to assess the effects of 
Ecc15 infection, comparisons in relative expression levels of candidate genes 
in PBS and Ecc15 injected embryos were performed (Figure 3.21B).  
 
Comparison between relative expression levels in NI and PBS injected Stage 
15 WT embryos revealed that specific genes involved in 20-HE biosynthesis 
are downregulated upon such damage (Figure 3.21A). For example, 
expression of the ptth, phm, nvd and ecd, genes was significantly 
downregulated in PBS injected embryos compared to NI controls (p!0.05). 
This was not true for all genes involved in 20-HE synthesis; those such as 
dare and mld did not exhibit any modulation upon PBS injection. Eo, a 
component of 20-HE metabolism, was also significantly downregulated in PBS 
injected embryos compared to NI controls. Of the eip genes tested, only 
eip78C displayed any modulation upon PBS injection, as eip71CD did not 
exhibit any significant change in relative expression upon treatment. 
Furthermore, on examination on relative expression levels of the 
aforementioned candidates in Ecc15 infected embryos, it was discovered that 
seven genes showed significant modulation in expression levels compared to 
PBS injected embryos (p!0.05; Figure 3.21B). Phm, nvd amd eo expression 
was shown to be further downregulated upon Ecc15 infection, when compared 
to PBS injected expression levels. Moreover, the expression level of ptth was 
significantly increased upon Ecc15 infection compared to that observed upon 
PBS injection alone (Figure 3.21B). Other candidate genes, such as ecd and 
eip78C, did not show any difference in expression upon Ecc15 infection 
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compared to PBS injected levels, suggesting that these genes do not play a 
role in the immune response to bacterial infection. However, the most 
interesting feature of the data was that the remaining three genes exhibiting 
modulation, dare, mld and eip71CD, were downregulated solely upon Ecc15 
treatment, indicating an infection specific interaction (Figure 3.21B).  
 
To determine if this aforementioned modulation in candidate gene expression 
was specific to Ecc15 infection, relative expression levels were subsequently 
assessed in Stage 15 WT embryos treated with Mg1655 E. coli, and similar 
comparisons performed (Figures 3.21C). Interestingly, only four genes 
demonstrated a modulation in expression upon Mg1655 E. coli infection. 
Similar to Ecc15 infection, injection with Mg1655 E. coli also resulted in the 
decreased expression of dare and eo as well as the increased expression of 
ptth in the Stage 15 embryo, suggesting that these changes in host gene 
expression are not specific to Ecc15 infection. However, the magnitude by 
which Ecc15 induced these changes was significantly greater, as can be seen 
in Figure 3.21D. For example, whilst both Mg1655 E. coli and Ecc15 
upregulated ptth expression, the change in expression was significantly 
greater in Ecc15 infected embryos (Figure 3.21D).  
 
Aside from these differential levels of gene modulation, more dramatic 
differences can also be observed. For instance, in contrast to the reduced 
expression noted with Ecc15 infection, Mg1655 E. coli induced increased 
expression of mld (Figure 3.21C). Furthermore, phm, nvd and eip71CD 
expression levels upon Mg1655 E. coli infection were not significantly different 
to those observed in PBS injected embryos, in contrast to the host response 
observed to Ecc15 infection. This would suggest that different Gram-negative 
infections can differentially impact 20-HE signaling, and that Ecc15 infection in 
particular has a more significant impact on the 20-HE signaling in its 
embryonic host than Mg1655 E. coli.  
 
However, not all candidate genes displayed such significant changes in 
expression upon treatment and as such were not as amenable to analysis. For 
instance, the average efficiency values of usp and Eip74EF primer pairs were 
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lower than acceptable thresholds set for RT-qPCR experiments (see Appendix 
6), and these candidate genes were also subsequently excluded from 
analysis.  
 
To summarise, both damage and infection with Gram-negative bacterial 
species are able to modulate expression of genes involved in 20-HE signaling 
within the Stage 15 embryo, with each producing a unique response. Damage 
induced by PBS injection downregulated a number of genes encoding a 
diverse variety of 20-HE signaling components. Infection with either Ecc15 or 
Mg1655 E. coli induced further modulation of candidate genes, with Ecc15 
infection resulting in more numerous significant changes of expression. As 
such, some observed changes in candidate gene expression were specific to 
Ecc15 infection, suggesting that bacterial species are able to induce 
differential responses within the Drosophila embryo with regards to the 20-HE 





















Figure 3.21: Damage and Infection induce modulation of genes 
implicated in 20-HE signaling  
 
(A-C) Comparison of relative levels of expression of candidate genes involved 
in 20-HE signaling in non-infected (NI) and PBS injected, and PBS and 
bacteria injected Stage 15 embryos (n=3, with !200 embryos per replicate). 
Genes involved in 20-HE biosynthesis and metabolism, as well as effector 
genes, are significantly downregulated upon damage induced via PBS 
treatment (A; p!0.05, Hypothesis test). Further gene modulation is observed 
upon treatment with Ecc15 (B) or Mg1655 E. coli (C), compared to that noted 
upon PBS injection. Ecc15 specifically downregulates eip71CD, mld phm and 
nvd, whereas Mg1655 E. coli specifically upregulates mld expression. This can 
be confirmed by direct comparison of gene expression levels upon Mg1655 E. 
coli and Ecc15 infection (D). Expression of mld, ptth, phm, nvd and eip71CD is 
significantly modulated in Ecc15 infected embryos compared to those infected 
with Mg1655 E. coli (p!0.05, Hypothesis test). * indicates a significant 
reduction from control levels with p " 0.05. All other changes should be 
considered as non-significant.  
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3.3 Discussion  
 
3.3.1 Drosophila embryos are able to mount a robust immune response to 
bacterial infection  
 
The primary aim of these studies was to develop the Drosophila embryo as a 
model system to study bacterial infection in vivo; to validate the innate immune 
capacity of the embryo. Initial results via infection of a Drc-GFP reporter line 
suggested that the Stage 15 Drosophila embryo was able to mount a relatively 
robust innate immune response to both basic and more complex bacterial 
infections, such as DH5! E. coli and Ecc15 respectively. This included the 
induction of AMP genes upon infection, localized to the epidermal cells at 6 
hours post infection. As such, this data provides confirmation of the 
preliminary experiments conducted by Onfelt Tingvall et al. (2001), whereby 
epidermal expression of Cec-lacZ reporter was noted in late stage embryos 
upon infection with LPS or E. cloceae B12. However, not all microbial species 
tested induced a robust immune response within the Stage 15 embryo. Our 
results demonstrate that whilst Stage 15 embryos were able to drive a robust 
Drc-GFP expression in response to E. coli sp., Ecc15 and P. luminescens 
infection, injection of S. typhimurium did not induce a significant reporter 
response. S. typhimurium has previously been shown to be a strong inducer of 
the IMD pathway and the melanisation response in adult flies (Ayres and 
Schneider, 2008; Mabery et al., 2010) and thus has been used extensively 
within infection studies in Drosophila models (Takeuchi et al., 2000; Tzou et 
al., 2000; Nagai et al., 2002; Leulier et al., 2003; Brandt et al., 2004; Pham et 
al., 2007; Schneider et al., 2007; Ayres and Schneider, 2009; Jia et al., 2009). 
However, this may not apply within the context of the embryo model, or else 
this result may be due to the initial dose of S. typhimurium administered; a 
bacterial suspension with a OD660 value of 1 was injected into Stage 15 
embryos, whereas infection studies in adult flies have previously utilised 
values of 0.1 (Brandt et al., 2004; Ayres and Schneider, 2008; Gordon et al., 
2008; Ayres and Schneider, 2009), hinting at the high pathogenicity of this 
bacterial species in Drosophila systems. Thus, it is possible that the dose of S. 
typhimurium administered to Stage 15 Drc-GFP embryos was excessive and 
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resulted in rapid embryo pathogenesis and mortality before an effective Drc-
GFP response could be induced.   
 
In terms of the levels of AMP gene induction observed within the embryo, 
changes upon infection were consistent with that observed in previous studies 
in a variety of Drosophila immune models. For instance, AttA was upregulated 
by 22.1-fold and Def by 6.7-fold at 4 hours post infection with Ecc15 within the 
larval gut (Buchon et al., 2009a). This is consistent with the relative values 
observed within the Stage 15 Drosophila embryo upon Ecc15 infection: 9 and 
30-fold for AttA and Def respectively, taking into account the effect of PBS 
injection on AMP gene induction. Studies in adult flies (Liehl et al., 2006; 
Gendrin et al., 2009) and larvae (Zaidman-Remy et al., 2006), also provide 
comparable levels of upregulation of AMP gene expression to that observed 
within the Drosophila embryo model. Thus, this would infer that the embryonic 
AMP response is similarly robust to other Drosophila immunity models.  
 
Moreover, other facets of the Drosophila immune system that have been 
characterized in adult fly and larval systems were also shown to be present 
and functional in the Drosophila embryo; further hinting at the completeness of 
the embryonic immune system. For instance, Stage 15 WT embryos were 
demonstrated to be able to phagocytose RFP-labelled E. coli; a process which 
was dependent upon SCAR, a member Arp2/3 complex responsible for actin 
nucleation. These data would suggest that the cellular branch of the 
Drosophila immune system is functional within the Stage 15 embryo, and 
moreover is relatively effective at mediating bacterial clearance, with 
approximately 40% of individual bacteria phagocytosed at only 1 hour post 
infection. The observed involvement of the Arp2/3 complex protein SCAR, an 
established regulator of actin nucleation (Machesky et al., 1999; Welch and 
Mullins, 2002; Zallen et al., 2002), for successful mediation of embryonic 
phagocytosis of E. coli and survival upon Ecc15 infection is also consistent 
with the in vitro work of Pearson et al. (2002) and Rogers et al. (2003), who 
demonstrated that SCAR is required for internalization of E. coli and S. aureus 
particles by S2 cells respectively. Peltan et al. (2012) also provided evidence 
that SCAR was required for effective phagocytosis of the protozoan parasite 
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Leishmania donovani by mbn-2 cells. Thus, the embryonic cellular response is 
also governed by the same mechanistic principles of other Drosophila immune 
models, thus further demonstrating its potential as a valid immunity model. 
However, it could be argued that due to the defect in migration observed in 
SCAR!37 hemocytes (Evans et al., 2013) might impact on the phagocytic 
potential of these hemocytes; that they are unable to migrate effectively to the 
site of bacterial threat and thus are not able to clear the infection. Thus, in this 
case, the phagocytic defect observed could be an artifact of ineffective cell 
migration. However, considering the observation that bacteria are passively 
washed over hemocytes within the embryo (Vlisidou et al., 2009) and as such 
phagocytosis is due to the opportunistic interaction of hemocyte and pathogen 
to a degree, this would somewhat eliminate dependence of cell migration for 
effective phagocytosis. Furthermore, the fact that SCAR-deficient hemocytes 
were observed to have multiple bacteria adhered to the cell surface would 
support the notion that SCAR mutant hemocytes have a phagocytic defect 
which is separate from cell migration.  
 
In addition to these demonstrations of systemic and cellular functionality, the 
completeness of the embryonic immune model extends beyond the direct 
regulation of the systemic and phagocytic responses. For instance, expression 
of mas was demonstrated to be significantly downregulated upon Ecc15 and 
M. luteus infection. Mas is a gene involved in the regulation of serine 
proteases; the presence of a serine protease domain within the C terminal 
region could imply that it is an antagonist of such enzymes, sequestering 
targets to regulate enzymatic activity (Kwon et al., 2000; Huang et al., 2000; 
Irving et al., 2001). Thus, its significant downregulation at an early time-point 
post infection is consistent with a decrease in serine protease inhibition, so as 
to allow immune pathway activation. Moreover this particular finding also 
demonstrates that higher levels of immune regulation are functional within the 
Stage 15 embryo; further demonstrating the relative completeness of 
embryonic immune regulation. Additionally, GADD45 expression was 
increased upon infection with Ecc15, albeit in an insignificant manner. This 
would be consistent with the results of Stramer et al. (2008), who 
demonstrated that damage inflicted upon embryos by sterile laser ablation and 
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excisional damage in murine repair models induced the expression of 
GADD45. The fact that Ecc15 itself inflicts a significant degree of mechanical 
damage within the host gut upon oral infection that results in a damage 
response to induce AMP expression and stem cell activation (Buchon et al., 
2009a) further corroborates the notion that Ecc15 induces a significant degree 
of damage signaling, which may potentially include activation of GADD45. 
Furthermore, these changes were accompanied by modulation in a third 
candidate gene, ddc, which plays a crucial role in the melanisation response 
(Tang, 2009). The fact that M. luteus induced greater, although insignificant, 
expression of ddc compared to that of Ecc15 would suggest that this particular 
Gram-positive microbe may induce greater levels of melanisation within the 
embryonic system, although no obvious signs of melanisation were detected 
within the infected embryos themselves (data not shown). On the contrary, M. 
luteus has been exhibited to induce melanisation in the mosquito Aedes egypti 
(Hillyer et al., 2003; Hillyer et al., 2005) as well as in adult Drosophila (Ayres 
and Schneider, 2008). Thus, an increase in ddc expression upon M. luteus 
infection within the embryo is not surprising. However, given the non-
significant nature of these latter results, further investigation is required to 
discern if these findings have a true biological basis. In particular, induction of 
GADD45 may be greater with bacterial species that induce greater levels of 
mechanical damage and ddc with strains that have been shown to initiate the 
melanisation cascade in other Drosophila immunity models, such as S. 
typhimurium (Ayres and Schneider, 2008). However, it is interesting that all 
three of these candidate genes were significantly upregulated upon the 
damage induced via PBS injection. This would suggest that these genes are 
important in the immune response mediated within the embryos upon damage 
alone, and also confirms that the immune response to damage within the 
embryo is not limited to solely AMP induction but potentially spans a more 
diverse range of genes, as suggested by previous studies (Stramer et al., 
2008).   
 
Therefore, it is clear that Drosophila embryos are able mount not a robust 
response to infection by a range of pathogens, encompassing the deployment 
of a diverse array of immune mechanisms which are consistent with the 
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immune responses of previously characterized Drosophila adult, larval and cell 
culture models. Moreover, this response is not solely specific to infection but 
can also be induced by damage alone, corroborating previous data that such 
danger signals can also induce an immune response in vivo. Thus, the Stage 
15 Drosophila embryo can be considered as a viable immune model to study 
bacterial infection.  
 
 
3.3.2 Stage 15 Drosophila embryos are able to effectively discriminate 
between different types of infection  
 
As well the confirmation of ability of the Stage 15 embryo to induce an AMP 
response to bacterial infection, results also demonstrated that the Stage 15 
embryonic immune system was able to mimic the ability of Drosophila adult 
and larval systems to effectively distinguish between Gram-negative and 
Gram-positive infections, and interestingly between different Gram-negative 
bacterial species. This was determined by monitoring the induction of different 
AMP gene classes upon Mg1655 E. coli, Ecc15 and M. luteus infections in 
Stage 15 embryos. Similar trends were noted to those of Lemaitre et al. 
(1997), whereby Gram-negative AMPs were induced by infection with strains 
of E. coli and Gram-positive AMPs by M. luteus. Moreover, the observation 
that Dpt upregulation was disrupted in relE20 mutant embryos, and Drs in 
modSP1 mutants, post infection with Ecc15 or M. luteus respectively, is an 
effective demonstration of not only the functionality of the embryonic IMD and 
Toll pathways but also that the embryonic immune system regulates AMP 
expression in a manner concordant with adult flies, larvae and in vitro 
immunity models (Lemaitre et al., 1997; De Gregorio et al., 2001; Irving et al., 
2001; Hoffmann, 2003; Brennan et al., 2004; Lemaitre and Hoffmann, 2007; 
Flatt et al., 2008; Buchon et al., 2009; Valanne et al., 2011). Thus, the 
embryonic AMP response is not aspecific, but utilizes both the IMD and Toll 
signaling pathways to generate disparate AMP responses to differential types 




However, evidence from the embryonic immune model may suggest that the 
sub-divisions of the AMP response in Drosophila may be relatively arbitrary, 
and that the reality of AMP gene induction upon infection may be more 
complex than previously perceived. For instance, Ecc15, a Gram-negative 
bacterium, was noted to stimulate a significant upregulation of Def and Mtk, 
key AMPs induced in response to Gram-positive microbes and fungal species 
respectively, whilst those embryos injected with M. luteus were surprisingly 
noted to lack any significant upregulation of Def. However, these observations 
are not unique to the Drosophila embryo; upregulation of Def upon Gram-
negative bacterial infection has been well documented in other Drosophila 
immunity systems (Lemaitre et al., 1997; Buchon et al., 2009a), whilst there 
are also examples of its clear anti-Gram-positive activity (Rutschmann et al., 
2002; Tzou et al., 2002). Similarly, Mtk has been noted to be highly induced 
upon infection with both Gram-negative and Gram-positive bacterial species, 
as well as during fungal infection (Levashina et al., 1995; Lemaitre et al., 
1997). These phenomena could result from cross-talk between the IMD and 
Toll pathways, as suggested by Tanji et al. (2007). Moreover, other in vivo 
studies have noted that Def expression is not induced by infection of M. luteus; 
Nehme et al. (2011) noted that infection of adult flies with M. luteus did not 
induce Def expression, despite the documented antibacterial activity of Def 
against M. luteus observed in in vitro systems (Dimarcq et al., 1994; Tzou et 
al., 2002). These results, therefore, are not suggestive of anomalies within the 
embryonic immune response, but substantiate the true nature of AMP 
expression within Drosophila; that arbitrary subdivisions of AMPs into rigid 
classes may not always reflect the underlying biology of the system. Moreover, 
it also provides further confirmation that the embryonic immune response to 
bacterial infection closely mirrors that of other Drosophila immunity models.   
 
A further interesting feature of the data was that disruption of either IMD or Toll 
signaling led to a significant decrease in AMP gene transcription upon 
bacterial stimuli, which was not significantly different to the level induced by 
PBS injection alone. However, considering that the damage induced by PBS 
injection was demonstrated to generate a lower level AMP response, it can be 
concluded that damage alone is able to induce an AMP response, but that 
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NF!B-related signaling is not required for this response. This, therefore, poses 
the question of what biological mechanism is regulating the damage-induced 
AMP response within the Drosophila embryo, independent of the IMD and Toll 
signaling cascades. One possible candidate may be the JAK/STAT pathway, 
which has been previously implicated in the response to wounding in larval 
wing discs, as well as after induction of cancerous tumours (Pastor-Pareja et 
al., 2008). Another candidate may be the JNK pathway, as studies have 
shown that JNK activity is upregulated in response to damage inflicted in larval 
wing discs (Pastor-Pareja et al., 2008), as well as demonstrating that JNK 
activity may be regulated by Tak1 (Boutros et al., 2002, thus potentially linking 
IMD pathway signaling and JNK activity. To elucidate whether these pathways 
are required for the damage-induced AMP response in the Drosophila embryo, 
AMP gene transcription in embryos where either JAK/STAT or JNK signaling 
is disrupted could be assessed.   
 
Interestingly, our data would also suggest that different species of pathogen 
are also able to induce more highly specific AMP responses within the embryo 
host. Whilst Ecc15 and Mg1655 E. coli both greatly induced AMP expression, 
differences were observed between the relative levels of distinct AMP 
expression to infer that the embryonic host is able to differentiate between 
different bacterial species and adapt its AMP response accordingly. Whilst no 
studies have looked at this aspect of recognition in great detail, there are 
results within the scientific literature that would hint to corroborate this 
hypothesis. Results from Lemaitre et al. (1997) demonstrated that different 
Gram-negative species induced differential expression of a Dpt-lacZ construct, 
with species such as P. aeruginosa inducing greater expression than Serratia 
marcescens, although this study does not address the contribution of 
individual AMPs to the total host response. Similarly, Nehme et al. (2011) 
observed that differing levels of Drs expression were induced by three different 
bacterial species. Thus, in a preliminary manner, these results would support 
the hypothesis that recognition of bacterial species by the Drosophila immune 
system may be more highly specific than currently understood. Nevertheless, 
it is also clear that the Drosophila embryo system is able to recognize bacterial 
stimuli in a highly efficient manner and subsequently able to translate these 
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stimuli into appropriate immune responses. Taken together, these results 
would suggest that the recognition and signaling pathways of the embryonic 
immune system are as complete and effective as the larval and adult fly 
systems. Moreover, these results provide further confirmation that the 
Drosophila embryo immune system is dynamic; the fact that Stage 15 
embryos can differentiate between two different species of Gram-negative 
bacteria is suggestive of a degree of immune plasticity within the embryonic 
AMP response; a surprisingly complex property for the immune system of a 
developing embryo to display.  
 
 
3.3.3 The epidermis and trachea are primary sites of AMP production within 
the Drosophila embryo 
 
Having established the robust immune potential of the Stage 15 embryo, a 
primary site of Drc-GFP expression was determined to be the embryonic 
epidermis, whereby individual epidermal cells displayed a loosely segmental 
pattern of reporter activation. As such, these observations are consistent with 
the results of Tingvall et al. (2001) and Onfelt Tingvall et al. (2001), whose 
authors also noted epidermal activation of AMP reporter constructs within the 
embryonic epidermis upon treatment with LPS. A more interesting finding was 
that the tracheal network was immune-responsive within the Stage 15 embryo, 
which has not been observed in previous studies of the embryonic immune 
capacity. However, the notion that the tracheal epithelia can mediate AMP 
expression is not novel; previous work by Tzou et al. (2000) using AMP 
reporter lines demonstrated that both Drc and Drs were expressed within the 
tracheae of Drosophila larvae and adults challenged with Ecc15, with Drs 
expression acknowledged to be under the control of IMD signaling. In a similar 
vein, transcriptomic studies have also elucidated that AMPs such as Def, Mtk, 
Drs, AttA and Dpt are expressed at a low basal level in trachea (Wagner et al., 
2008). The tracheal epithelium is also known to express a variety of pattern 
recognition receptors that are required for both Toll and IMD pathway 
functionality (Wagner et al., 2008). Representative of the IMD pathway, a 
variety of PGRP isoforms that are required for activation and modulation of 
!!
"#$!
pathway activity are present in tracheal tissue; these include PGRP-LE and 
PGRP-LC (Wagner et al., 2008). Toll receptors, such as Toll, Toll-7 and Toll-8, 
have also been demonstrated to be present on the tracheal epithelia, 
alongside PGRP-SA and GNBP-1 and -3 (Wagner et al., 2008), suggesting 
the potential for activation of both Toll and IMD signaling within this tissue. 
Thus, given the extensive presence of the systemic immunity recognition 
machinery within the trachea, it is not surprising that Drc-GFP expression was 
noted upon infection within the developing Drosophila embryo. As such, the 
response within the trachea of the Stage 15 embryo parallels that of both adult 
and larval systems.  
 
Furthermore, the fact that expression of the Drc-GFP reporter construct in the 
Stage 15 embryo appeared to be relatively consistent between primary, 
secondary and terminal tracheal branches is concordant with results from 
Wagner et al. (2008), whose authors noted that all airway epithelial cells in 3rd 
instar larvae were relatively homogenous in their expression of a Drs-GFP 
reporter construct upon infection with either Pseudomonas aeruginosa or 
Ecc15, irrespective of their position within the tracheal network and the initial 
site of infection. This activation of the entire tracheal network, as seen in Stage 
15 embryos upon damage and infection with Ecc15, could be due to a spread 
of activation of IMD signaling along tracheal branches in a non-cell 
autonomous fashion, as observed in larval models of infection (Akhouayri et 
al., 2011); originating in the anterior of the embryo and spreading to the entire 
tracheal network in a global response. However, given that the tracheal 
network does not become functional for respiration until the end of 
embryogenesis, when the 1st instar larva emerges (Manning and Krasnow, 
1993; Tsarouhas et al., 2007; Ghabrial et al., 2011), it is interesting to 
speculate as to what advantage AMP expression in the trachea above other 
tissues may provide. It could be speculated that as the tracheal network does 
not perform any respiratory function until the end of embryogenesis, that 
tracheal cells are less constrained in terms of energy or resources and thus 
are able to mount an immune response, in comparison to other immune 
competent tissues which may be required to perform other functions in 
addition to their role in defense. In this sense, it may be advantageous for the 
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embryo to mount an AMP response from a tissue which does not carry this 
burden.  
 
Whilst the epidermal and tracheal Drc-GFP response to bacterial stimuli was 
extensive in terms of coverage and resulted in intense activation of the 
reporter in individual epidermal cells, no activation of Drc-GFP was observed 
within the developing fat body, consistent with the findings of Onfelt Tingvall et 
al. (2001) and Tingvall et al. (2001) whose work suggested that AMP 
responses by the fat body appeared to predominate once reaching first instar 
larval development whilst being absent from Drosophila embryos upon 
bacterial infection. This in turn poses the question of whether the response in 
the Stage 15 embryo is truly a systemic immune response, or whether its 
origins are more closely rooted in a collection of individual yet extensive local 
immune responses, regulated disparately or in concert. Nonetheless, other 
data would suggest that a traditional systemic immune response, with 
signaling mediated as observed in the fat body, is still required in Drosophila 
embryos. For instance, modSP1 and psh1;;modSP1 mutant Stage 15 embryos 
demonstrated a selectively increased susceptibility to injection with M. luteus 
and A. oryzae proteases, as well as significantly reduced Drs expression 
levels upon M. luteus infection, compared to WT or relE20 mutant embryos, 
suggesting involvement of the Toll pathway within the embryonic immune 
response. In contrast, the local AMP responses observed in larval models are 
mediated solely via the IMD pathway (Tzou et al., 2000), with no Toll pathway 
involvement as of yet recorded, even in the expression of Gram-positive or 
fungal AMPs, such as Drs (Ferrandon et al., 1998). Supporting this assertion 
is the fact that not all components required for Toll pathway functionality are 
expressed within immune-responsive tissues, such as the tracheal network; 
whilst spz, Toll, MyD88 and the transcription factors Dif and Dorsal are 
expressed in the airway epithelium, the expression of other essential pathway 
components, such as the adaptor protein Tube and Pelle kinase, is absent 
(Wagner et al., 2008), implying a lack of Toll pathway function in this tissue. In 
contrast, all IMD signaling members required for proper pathway functionality 
were shown to be expressed in the trachea epithelia (Wagner et al., 2008), 
indicative of a preference for IMD signaling in the local AMP response within 
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this tissue. Therefore, if the AMP response in the Stage 15 embryo is truly 
local in nature, this data may represent the first indication of Toll involvement 
in the local immune response. Alternatively, it may be that observation of other 
AMP reporter lines post-infection, aside from the Drc-GFP reporter line used in 
this study or the Cec-lacZ line employed by Tingvall et al. (2001) and Onfelt 
Tingvall et al. (2001) may elucidate an AMP response by the fat body to 
further clarify these results.    
 
Moreover, questions concerning how the individual epidermal and tracheal 
AMP responses are mediated in vivo remain; for instance, whether these 
responses are regulated individually or in concert via an as of yet unidentified 
mechanism. Evidence of tracheal communication to other immune responsive 
tissues, and the resulting impact of this interaction on AMP expression, is 
relatively scarce and the pertinent studies do not provide much information 
about the biological mechanisms behind these phenomena. One study has 
demonstrated that inactivation of Serpin77Ba, which under basal conditions 
inhibits melanisation in tracheal tissue, can induce expression of Drs via the 
Toll pathway in the fat body of 3rd instar larvae (Tang et al., 2008), inferring the 
ability of the trachea to not solely mediate the spread of innate immune 
responses within its own cells, but also to facilitate changes in the immune-
responsiveness of other tissues to adapt to the immune challenge deployed. 
One could speculate that terminal tracheal branches themselves may be 
responsible for communicating the requirement for an AMP response to 
epidermal cells; further propagating the embryonic immune response. It has 
been well established that there is extensive communication between 
epidermal cells and the tracheal network during embryogenesis; permitting 
correct tracheae morphogenesis and growth of tracheal tubes. For instance, 
primary tracheal branches themselves originate from placodes in the 
epidermal ectoderm (Pereanu, 2006). Furthermore, growth of the primary and 
some secondary tracheal tubes is induced by the strategic expression of the 
FGF homologue Bnl in epidermal cells (Pereanu, 2006). Thus, given the close 
spatial and developmental relationship between the epidermis and tracheal 
network, as well as the ability of the tracheal system to propagate AMP 
responses to neighbouring cells within its own network (Wagner et al., 2008), 
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the potential for communication of the innate immune responses upon the 
urgency of infection is relatively plausible. The propagation of the Drc-GFP 
response by the trachea would also potentially explain the earlier activation of 
the Drc-GFP construct in trachea compared to the epidermis, as well as the 
apparent segmental nature of epidermal Drc-GFP expression, as the pattern 
of tracheal branches is itself segmental and highly conserved between 
individuals (Klambt et al., 1992; Wilk, 1996; Chung, 2011). Whilst speculative, 
confirmation of this hypothesis would highlight the importance of the trachea 
as an immune-responsive tissue within the Drosophila embryo. However, 
further work is required to elucidate if this is the case, and by what biological 
mechanism this phenomenon could potentially occur. The precise role of the 
trachea in inciting the expression of AMPs within epidermal tissue could be 
elucidated via monitoring Drc-GFP expression post infection within embryos in 
which trachea function is disrupted, such as those carrying a mutation in the 
breathless (btl) or trachealess (trchl) genes; to determine if the trachea is 
required for epidermal Drc-GFP expression. As such, the Drosophila embryo 
could be a valuable model system for investigating how AMP responses by 
individual tissues are mediated.    
 
3.3.4 20-HE is required to switch on immune competence within the 
Drosophila embryo 
 
Whilst Drosophila embryos at Stage 15 of development were demonstrated to 
be robustly immune competent, those at Stage 11 of embryogenesis were 
demonstrated to be immunologically naïve; starkly lacking the AMP response 
exhibited by Stage 15 embryos post infection with bacterial species, resulting 
in increased mortality. The immune incompetence of Stage 11 embryos could 
be rescued by treatment with 20-HE, mimicking the 20-HE pulse observed 
during embryogenesis. Conversely, the disruption of 20-HE signaling within 
Stage 15 embryos rendered them immune incompetent; an increased 
susceptibility to Ecc15 infection and complete inhibition of a subset of AMP 
genes was noted. Thus, this data suggested that 20-HE facilitates the 
maturation of the embryonic immune system. These in vivo observations are 
supported by previous in vitro studies using S2 cells. These include the 
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observation that S2 cell expression of AMP genes upon stimulation with PGN 
can be enhanced via pre-treatment with 20-HE (Flatt et al., 2008). Moreover, 
the demonstration by Rus et al. (2013) that the expression of PGRP-LC, a 
major receptor for Gram-negative PGN that initiates IMD signaling (Choe et 
al., 2002; Gottar et al., 2002; Leulier et al. 2003; Kaneko et al., 2004; 
Takehana et al., 2004; Kaneko et al., 2006), is regulated by 20-HE in S2 cell 
cultures, as well as the evidence indicating 20-HE involvement in an 
antagonistic relationship with JH to modulate the innate immunity of S2 cells 
(Flatt et al., 2008), further supports the potential for the pulse of 20-HE during 
mid-embryogenesis to act as a regulator of immune system maturation in 
Drosophila embryos. However, the rescue of Stage 11 embryonic immune 
competence was not complete; the percentage of Stage 11 embryos 
demonstrating Drc-GFP expression remained highly significantly different to 
that of Stage 15 controls. This could be due to the rather crude nature of the 
assay; co-injecting 20-HE and Ecc15 did not wholly resemble the natural 20-
HE pulse at Stage 12 and the subsequent infection of bacteria at Stage 15 of 
development that had previously been utilized. As such, an approach whereby 
priming of the Stage 11 embryos using 20-HE and consequent infection at 
Stage 15 may have produced higher levels of response.  
 
Furthermore, manipulation of 20-HE signaling in Drosophila embryos also 
resulted in observations that do not fit within the current paradigm. One result 
which was somewhat contrasting to in vitro work of Rus et al. (2013) was the 
expression of AMP genes in Stage 15 EcRQ50st homozygous mutants. Whilst 
the upregulation of Cec, Mtk and Def gene expression was effectively 
eliminated in Stage 15 EcRQ50st embryos upon Ecc15 infection compared to 
the relatively robust response normally observed in WT embryos, no 
difference was observed in Dpt expression between WT and EcRQ50st 
counterparts. Moreover, Drc and AttA expression was significantly increased 
in EcRQ50st mutants compared to WT. This is somewhat in contrast to the in 
vitro results of Rus et al. (2013), who exhibited that Dpt, Mtk and Drs 
expression upon PGN stimulation in S2 cells required 20-HE pretreatment, 
even upon overexpression of PGRP-LC. Moreover, Cec, AttA and Def 
expression in S2 cultures upon challenge was demonstrated to not strictly 
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require 20-HE pre-treatment, only overexpression of PGRP-LC (Rus et al., 
2013). However, there is some overlap of results from these S2 screens and 
from the Stage 15 Drosophila embryo. For instance, expression of Mtk is 
severely inhibited in both the Stage 15 EcRQ50st mutant embryo and in S2 cells 
not pre-treated with 20-HE. The fact that this result demonstrated the greatest 
significant difference between EcRQ50st mutant and WT embryos would also 
further highlight the relevance of these results. However, the majority of the 
results from the in vitro S2 cell screens of Rus et al. (2013) are not concordant 
with the results from infection studies with Stage 15 EcRQ50st mutant embryos, 
suggesting that 20-HE regulation of innate immunity may vary between in vitro 
and in vivo systems. However, the results attained from EcRQ50st mutant 
embryos also differ from other in vivo studies. Adult flies carrying mutations in 
the EcR ligand-binding domain or in specific EcR introns were shown to have 
a significantly decreased expression of Dpt upon E. coli infection (Rus et al. 
2013), thus suggesting that significant differences may exist between the 20-
HE regulation of immunity at different stages of development.  
 
Of particular interest is the observation that expression of AttA and Drc in 
EcRQ50st mutant embryos was not only induced upon Ecc15 infection, and 
moreover to a level that was significantly higher than that observed in WT 
controls. This is somewhat in agreement with in vitro studies conducted by 
Rus et al. (2013) using S2 cell cultures, where it was witnessed that AttA 
expression did not necessarily require 20-HE pre-treatment of cultures; in this 
case, ectopic expression of PGRP-LC was sufficient to bypass the 
requirement for 20-HE to render S2 cells immune competent. It is difficult to 
assess if the increase of Drc expression witnessed in Stage 15 EcRQ50st 
embryos upon Ecc15 infection compared to WT counterparts has any basis in 
vitro, as the expression of this AMP was not investigated by Rus et al. (2013). 
Another potential explanation for these rather anomalous results may lie in the 
nature of the EcRQ50st mutation. This mutation selectively incapacitates an 
exon of the EcR-B1 isoform, leaving the functionality of the A and B2 isoforms 
intact. It may be possible that some redundancy exists between the isoforms, 
or some transcriptional division permitting the transcription of a subset of AMP 
genes, such as Dpt, Drc and AttA; permitting increased expression of the AMP 
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subset to attempt to compensate for the loss of expression of other AMPs. The 
concept of differential mechanisms to regulate individual AMP genes is not 
novel. Rus et al. (2013) identified two sub-divisions of AMP genes; those that 
required 20-HE signaling and those in which this requirement could be 
bypassed by other mechanisms. Similar divisions may exist within the embryo, 
and inactivating all isoforms of the EcR may allow these to become more 
apparent. However, the fact that basal levels of Dpt, AttA and Drc were 
significantly lower than those observed in WT counterparts is suggestive of a 
compromise in innate immunity even prior to an infective state, which may 
impact on the long-term survival of EcRQ50st embryos, as indicated in the 
viability of mutant embryos post infection with Ecc15. Although the exact 
nature of this compromise remains elusive, these collective results imply that 
20-HE regulation of innate immunity may in fact be far more complex than the 
current paradigm suggests.   
 
Nevertheless, these results also give an important insight into the importance 
and contributions of individual AMP genes to the embryonic immune response. 
The fact that Stage 15 EcRQ50st mutant embryos are highly susceptible to 
infection with Ecc15, with viability post infection reduced to levels normally 
observed with immune-compromised embryos, yet are able to greatly induce 
the expression of both Drc and AttA would suggest that these AMPs are not 
crucial to the embryonic immune response. This also consistent with the work 
of Tzou et al. (2002), who presented data to suggest that overexpression of a 
single Gram-negative AMP gene cannot completely compensate for loss of 
function in IMD/Toll double mutants; hence, a more collective AMP response 
may be required to completely rescue viability of EcRQ50st embryos. 
Alternatively, the biological reason for the dispensable nature of Drc and AttA 
within the embryonic immune response may be clarified by considering their 
antimicrobial mode of action. For Drc, this involves the inactivation of the 
intracellular heat shock protein DnaK, which ultimately leads to disruption of 
bacterial metabolism and cell death (Bikker et al., 2006). As such, the 
timescale of Drc action and effectiveness against bacterial foes may be 
lengthier than that of other AMPs. As such, Drc may play a role in later stages 
of the host response, and its initial involvement for controlling bacterial load 
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relatively limited. Hence, it could be relatively dispensable in the embryonic 
immune response to Ecc15 infection, where fast antimicrobial action to 
respond to bacterial kinetics may be vital. In a similar vein, attacins extracted 
from the giant silk moth Hyalophora cecropia were demonstrated to be more 
efficacious in actively dividing cells, with 10-50% of E. coli remaining after 
prolonged exposure to high levels of attacins in in vitro scenarios (Engstrom et 
al., 1984). Thus, from the perspective of the embryo host, the deployment of 
AttA is relatively risky; investing in innate immune mechanisms, such as AMP 
production, is relatively costly (Yixin et al., 2009) and AttA would only be 
effective after bacteria had begun to actively divide and potentially would not 
eradicate a large proportion of the bacterial threat. As such, it may be that the 
relatively low proportion of AttA induced by Stage 15 embryos upon Ecc15 
infection may reflect this concept. On the other hand, the inhibition of CecA1, 
Mtk, and Def, which could potentially contribute to the high mortality rate of 
EcRQ50st embryos, would suggest that these AMPs play a greater role in the 
host response to Ecc15 infection. Interestingly, CecA1 and Mtk genes are 
amongst a cluster of immune genes that are acutely induced at early time 
points after infection (Boutros et al., 2002) with in vitro screens of CecA 
antibacterial activity elucidating that minimal inhibitory concentrations of this 
AMP can kill all bacteria encountered within 5 minutes of contact. Thus, it may 
be that a rapid response to Ecc15 infection is required within the Stage 15 
embryo to control both bacterial load and deleterious host-pathogen 
interactions. Thus, taking the antibacterial properties of individual AMPs into 
account and given that Stage 15 embryos infected with Ecc15 rely on CecA1 
as a large proportion of their AMP response, supported by more moderate 
proportions of Def and Mtk, it is not particularly surprising that a deficiency in 
these three AMPs may prove fatal for EcRQ50st mutant embryos upon infection.  
 
Of further interest is the location for the requirement of 20-HE signaling and 
thus immune competence in Drosophila embryos to ensure immune 
competence. Expression of a dominant-negative form of the EcR-B1 receptor 
was driven in either hemocytes or the trachea and the susceptibility of the 
resulting Stage 15 embryos to Ecc15 infection observed; to determine if 
inhibition of 20-HE signaling in either of these tissues was required for 
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effective embryonic survival to infection. The observation that Stage 15 
embryos expression the EcR-B1 dominant negative construct in hemocytes 
(srp>EcR-B1 DN) did not exhibit a significantly different viability post infection 
with Ecc15 compared to WT controls suggests that these immune cells may 
not play a significant role within the maturation of the embryonic immune 
system. This finding almost seems counterintuitive, considering that S2 cells, 
which display many characteristics of macrophage-like cells, require 20-HE 
application in order to render them immune-competent (Flatt et al., 2008; Rus 
et al., 2013) and the proposed synergistic relationship between the systemic 
and cellular branches of the Drosophila immune response (Agaisse et al., 
2003; Charroux and Royet, 2009).  
 
More interesting is the observation that EcR-B1 is required in the trachea for 
effective resistance to Ecc15 infection, as determined by the reduced viability 
of Stage 15 embryos expressing EcR-B1 dominant-negative protein under the 
control of the breathless promoter (btl>EcR-B1 DN) as well as the increased 
bacterial load noted in Stage 15 btl>EcR-B1 DN embryos. Aforementioned 
results have demonstrated that the trachea is a major immune-responsive 
responsive tissue within the Stage 15 embryo upon Ecc15 infection, as well as 
playing a role in the local immune response in both larval and adult fly models 
(Tzou et al., 2000). Thus, there appears to be a close relationship between the 
requirement of 20-HE signaling and the immune capacity of tissues within the 
Drosophila embryo, despite the ubiquitous nature of the EcR. Further 
investigation could focus on the transcriptome of btl>EcR-B1 DN embryos; to 
determine if the expression levels of specific AMP and other immune 
candidate genes are concordant with those observed in the EcRQ50st mutant. 
This in turn would facilitate a greater understanding of the precise role of the 
trachea in the maturation of the embryonic immune response. Given the role 
of epidermal cells in directing the growth and development of the embryonic 
tracheal network, it would be interesting to determine if there is any direct 
interaction between tracheal and epidermal tissue in the immune maturation of 
the tracheal network. Furthermore, it has been postulated that the pulse of 20-
HE during mid-embryogenesis may arise from epidermal cells, as opposed to 
the ring gland which is not fully functional until late stages of embryogenesis 
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(Warren et al., 2002), as determined by the expression of 20-HE synthesis 
genes, such as dib and sad. Thus, it would be of interest to assess the 




3.3.5. Ecc15 infection modifies expression of 20-HE signaling components   
 
These results open up more general questions of the precise mechanism of 
Ecc15 killing of the Drosophila embryo. Even relatively immune robust Stage 
15 embryos showed significantly decreased viability to low doses of Ecc15 
compared to both controls and counterparts infected with other species, such 
as E. coli, demonstrating the relatively toxic nature of Ecc15 to the Drosophila 
embryo. This is in contrast to other Drosophila models, whereby Ecc15 
infection does not cause significant mortality (Buchon et al., 2009a). Whilst the 
majority of our studies have been focused on the host response to eradicate 
invading pathogens, it is important to acknowledge that infection is a two-way 
interaction. Hence, it has been acknowledged that, whilst the host may deploy 
a diverse range of responses to eliminate the threat by the pathogen, the 
invading infective agents are also able to subvert the host’s immune response 
machinery for its own benefit to further sustain infection (Jones et al., 2012; 
Baxt et al., 2013; Lutay et al., 2013; Rolando et al., 2013). Thus, it is a logical 
assumption that if the 20-HE signaling confers a great immune advantage on 
the host, then it is also probable that bacteria may have developed 
mechanisms to manipulate this signaling pathway, to the detriment of the host. 
The above data demonstrating the modulation of 20-HE synthesis and effector 
gene expression may be confirmation of this hypothesis. For instance, 
selective downregulation of genes involved in ecdysone synthesis upon Ecc15 
infection, such as that of mld, may represent manipulation of the host 20-HE 
signaling machinery to ultimately downregulate expression of AMPs. 
Downregulation of expression of other candidate genes upon Ecc15 infection, 
such as the 20-HE signaling effector eip71CD, could also indicate that this 
subversive effect on the embryonic immune response could extend beyond 
the expression of AMPs. Eip71CD has been shown to play roles in both the 
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oxidative stress response and the autophagic response to cell death (Sun et 
al., 1999; Gorski et al., 2003; Weissbach et al., 2005). Nevertheless, the 
question remains as to how Ecc15 is able to modulate host gene expression; 
the precise mechanism by which this proposed subversion occurs. It has been 
well established that bacterial species are able to modify host gene expression 
via inducing changes in host DNA topography. For example, Legionella 
pneumophila has been revealed to secrete a virulence factor, RomA, which 
translocates to the infected host cell nucleus and promote a methylation burst, 
dramatically changing the host chromatin landscape and permitting the 
repression of host gene expression (Rolando et al., 2013). Moreover, virulent 
E. coli strains were proven to interfere with RNA polymerase II activity, leading 
to suppression of the host disease-associated response (Lutay et al., 2013). 
Thus it is entirely possible that the manipulation of the embryo’s own 20-HE 
signaling could contribute to the mortality observed within Stage 15 embryos 
upon Ecc15 infection, although the mechanism by which this occurs remains 
an open question. 
 
It is interesting that many of the changes in 20-HE biosynthesis gene 
expression observed were specific to Ecc15 infection, as injection of Mg1655 
E. coli within Stage 15 embryos induced disparate effects on gene expression. 
For instance, mld expression was upregulated upon infection with Mg1655 E. 
coli, whereas expression levels were dramatically downregulated upon Ecc15 
infection in Stage 15 embryos. Furthermore, the downregulation of eip71CD, 
phm and nvd expression observed with Ecc15 infection was not observed 
following Mg1655 E. coli infection in Stage 15 embryos. This not only confirms 
the potentially more pathogenic nature of Ecc15 to Stage 15 Drosophila 
embryos, but also demonstrates that different bacterial species can modify 
host gene expression to differing degrees and thus some of the effects on host 
gene expression exerted by Ecc15 may be species specific. As such, the 
embryo system has aided the identification of candidate genes which may hold 
the key to gaining further knowledge about Ecc15-host dynamics.    
 
Nevertheless, some genes involved in 20-HE biosynthesis, such as ptth, 
exhibited upregulation upon infection with Ecc15, which is not concordant with 
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the above hypothesis of Ecc15 subversion of the host 20-HE signaling 
machinery. This is also the case with the observed downregulation of the 20-
HE metabolism gene eo, indicating that 20-HE should theoretically persist for 
longer within the embryo system. It is possible that these are the true 
embryonic host responses to Ecc15 infection, to increase 20-HE 
concentrations to enhance the embryonic immune response, and for which 
invading Ecc15 bacteria are yet to adapt a suitable subversive response. 
However, it is difficult to draw any reliable conclusions regarding this 
conjecture, as it is difficult to separate the true host transcriptional response 
from those responses that arise due to pathogen subversion due to the nature 
of the data.   
 
Also of note is the data which discloses the apparent decrease in expression 
of 20-HE synthesis, metabolism and effector genes upon damage induced by 
PBS injection of Stage 15 embryos alone, at levels intermediate between 
those observed in non-injected and infected embryos. This encompasses 
decreased expression of ptth, phm, nvd and ecd in terms of 20-HE synthesis 
genes, and the effector gene eip78C. This may reflect the downregulation of 
20-HE synthesis to prevent chronic immune stimulation, which is known to be 
deleterious to the host (Janeway and Medzhitov, 2002; Cario, 2008; 
Medzhitov, 2008; Kambris et al., 2009). If correct, this hypothesis would also 
imply that damage and repair responses may also be regulated via 20-HE 
signaling within the embryo. Further experiments to test this concept may 
involve investigating the involvement of 20-HE in the repair of wounds 
generated by sterile laser ablation or the recruitment of hemocytes to such 





To conclude, the Stage 15 Drosophila embryo is able to mount a relatively 
robust immune response to bacterial infection. This includes the induction of 
AMP genes upon a range of bacterial stimuli; a response which is able to 
effectively discriminate between differential types of bacterial infection, as well 
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as individual bacterial species. This response is mediated via the 
characterized Drosophila systemic immunity pathways and localized to the 
epidermis and trachea. The cellular branch of the Drosophila immune 
response is also functional within the Stage 15 embryo, and appears to be 
under the regulation of mechanisms that are concordant with those observe in 
other Drosophila immunity systems. Moreover the modulation of other immune 
candidate genes would suggest that the Stage 15 embryonic immune system 
is relatively complete and comparable to other Drosophila immunity models. 
Immune competence arises at approximately mid-embryogenesis, under the 
control of the 20-HE pulse, as demonstrated by the partial rescue of AMP 
expression and bacterial clearance in Stage 11 embryos upon 20-HE co-
administration with infective agents, although this does not confer any ultimate 
benefit upon survival to Ecc15 infection itself. This may be due to the 
manipulation of the host 20-HE signaling machinery by Ecc15 itself.!
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Chapter 4: Analysis of the Stage 15 Drosophila Embryo Global 
and Hemocyte Transcriptional Responses to Infection and 
Damage  
 
4.1 Introduction  
 
4.1.1 Drosophila model systems to investigate global transcriptional changes 
upon infection 
 
Transcriptional profiling via microarray studies has revolutionized molecular 
biology over the past decade; permitting research efforts to move away from 
the more limited study of a few related genes, to the more holistic study of 
global cellular activity via the ability to monitor the abundance of thousands of 
transcripts. Hence, the power of microarray technologies has found application 
in numerous research areas, including the study of host-pathogen interactions. 
In fact, Jenner and Young (2006) acknowledge that this technology has greatly 
advanced the understanding of host-pathogen interactions as it has permitted 
the study of the reprogramming of the host transcriptome during infection, a 
central component of the host defense. This is reflected in the vast numbers of 
publications focused on host transcriptional profiling; Jenner and Young (2006) 
cite that in the first 6 years alone after the advent of microarray technology, 
more than 160 papers detailing transcriptional profiling experiments were 
published, involving 25 different host species, 26 different bacterial species, 30 
viral species, yeast and helminth species; demonstrating the power of 
transcriptional profiling to elucidate vast and valuable novel information 
concerning the host-pathogen interaction. As such, transcriptional profiling 
approaches have been employed in a variety of insect model systems to study 
the global transcriptional response to a variety of infective agents, including 
bacterial, fungal and parasitic infections. These include the elucidation of the 
transcriptional profile of the mosquito Aedes aegypti upon infection with the 
dengue virus (Sim and Dimopoulos, 2010), the comparison of transcriptional 
responses driven by human and rodent species of the Plasmodium parasite 
within the mosquito Anopheles gambiae (Dong et al., 2006) and the study of 
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the genes transcribed upon injury in the diamondback moth Plutella xylostella 
(Eum et al., 2007).  
 
Given the prominence of Drosophila as an immunity model, its application in 
such microarray studies has been extensive, with strategies to examine the 
widespread transcriptional changes upon infection in Drosophila 
encompassing both in vitro and in vivo systems. For instance, the 
transcriptional profile of cultured S2 cells upon E. coli infection permitted the 
identification of three novel AMP gene regulators and the initial elucidation of 
JNK as a regulator of AMP gene expression (Kallio et al., 2005). Further 
microarray studies utilized the Drosophila in vitro systems to characterize the 
transcriptional responses of S2 cells to specific yet diverse pathogens, 
including Wolbacchia (Xi et al., 2008), C. albicans (Levitin et al., 2007) and the 
Drosophila C virus (Zhu et al., 2013). Microarray studies have also found wide 
application in the study of the transcriptional response to infection by in vivo 
Drosophila systems. For instance, De Gregorio et al. (2001) used high-density 
oligonucleotide microarrays to study genome-wide transcriptional responses of 
Drosophila adults to E. coli, M. luteus or Beauvaria bassiana stimuli. Similar 
microarray studies were also performed by Irving et al. (2001), whose authors 
used male adult flies to assess the genome-wide transcriptional responses to 
Gram-negative, Gram-positive and fungal pathogens. Further microarray 
strategies employed in Drosophila adult flies involved the comparison of 
transcriptional profiles of Toll and IMD mutants at different time-points post 
infection with a range of bacterial and fungal pathogens, including E. coli, M. 
luteus and E. faecalis and A. fumigatus and B. bassiana respectively (De 
Gregorio et al., 2002). Conversely, Vodovar et al. (2005) employed Drosophila 
3rd instar larvae in microarray studies to elucidate the transcriptional profile 
generated upon Pseudomonas entomophila infection and Wertheim et al. 
(2005) generated the transcriptional profiles of 2nd instar larvae infected with 
the parasitoid Asobara tabida. Nonetheless, whilst there is a plethora of 
studies elucidating the organism-wide transcriptional responses to infection, 
other Drosophila microarray studies have concentrated solely on the 
responses of specific tissue types to invading microorganisms; to attempt to 
spatially resolve the Drosophila immune response. For instance, Buchon et al. 
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(2009a) examined the genes specifically induced in dissected adult guts upon 
oral infection with Ecc15, subsequently demonstrating that immune responses 
in the gut were driven via JAK-STAT and IMD signaling.  
 
However, the application of microarray techniques has not been limited to 
investigating solely infection-related transcriptional changes in Drosophila; 
recent studies have also used cDNA microarrays to attempt to dissect the 
individual responses of the host to infection, stress and damage. The 
microarray studies of Buchon et al. (2009a) revealed that the immune 
response of the Drosophila gut upon oral infection with Ecc15 is mediated by 
IMD and JAK-STAT signaling, but also included the modulation of stress 
response gene expression and an increase in stem cell proliferation. 
Validation experiments further suggested that gut homeostasis is maintained 
via a balance of cell damage due to bacterial killing and repair of the 
epithelium by stem cell division (Buchon et al., 2009a). Furthermore, 
microarray studies examining the transcriptional profiles of flies deficient in 
Mekk1, a MAPK kinase kinase (MAPKK) implicated in environmental stress 
responses (Inoue et al., 2001), determined that Mekk1 regulated Tot stress 
gene expression upon septic injury (Brun et al., 2006), permitting study of the 
interplay between stress and immune responses.  
 
However, despite this apparent wealth of knowledge concerning the 
transcriptional profiles of Drosophila model systems upon infection and 
damage, very little work has been performed to elucidate the global 
transcriptional response of the Drosophila embryo under either of these 
scenarios. The only published account of the embryonic transcriptional profile 
upon damage stimuli is that of Stramer et al. (2008), who compared the 
transcriptional profiles of wounded and unwounded wild-type and hemocyte-
null Stage 15 Drosophila embryos to attempt to identify novel wound- and 
hemocyte-specific genes, as well as to evaluate the ability of mechanical 
damage to induce an innate immune response. This approach permitted the 
identification of GADD45 as a novel inflammation-associated gene, which was 
subsequently validated in murine models, as well as facilitating the 
observation that sterile damage is able to trigger induction of AMP genes 
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(Stramer et al., 2008). Nevertheless, the nature of the embryonic global 
transcriptional responses to different types of infection, and how these 
responses differ to that generated as a result of purely damage stimuli, 
remains elusive.  
 
 
4.1.2 Transcriptional profiling of hemocytes upon bacterial challenge and 
damage stimuli 
 
Moreover, despite the diverse array of genome-wide transcriptional studies 
that have been performed on Drosophila models, relatively few have fully 
addressed the nature of the hemocyte transcriptional response to infection or 
damage. Of these, most have utilized immortalized cell lines that exhibit 
hemocyte-like characteristics, such as the S2 or mbn-2 cell lines, as an 
inference of actual hemocyte transcriptional behavior. For instance, microarray 
studies using mbn-2 cells performed by Johansson et al. (2005) investigated 
the disparate transcriptional profiles resulting from crude LPS or live E. coli 
infection. It was noted that only challenge with E. coli was able to induce 
significant expression of specific sub-sets of genes involved in tissue 
remodeling and stress signaling, whereas induction of AMP gene expression 
was stimulated by both LPS and live bacterial infection (Johansson et al., 
2005). Johansson et al. (2005) thus postulated that hemocytes were able to 
sense and differentially respond to purified bacterial surface molecules and 
infection with actively growing bacteria. However, it must be acknowledged 
that while these in vitro studies provide valuable inferences about hemocyte 
transcriptional responses, they are limited in the sense that such studies 
cannot account for the potential interactions that hemocytes may experience 
with other immune competent tissues upon infection in vivo. Nevertheless, as 
Pinto et al. (2009) note, it has previously been difficult assess the 
transcriptional profiles of these cells in a true in vivo context due to their 
relative scarcity in the circulating hemolymph, their adhesion to multiple 
tissues within the organism and the paucity of effective primary culture 
methodologies to generate sufficient material for genome-wide microarray 
studies. Moreover, looking to other insect models of immunity, this does not 
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appear to be a technical problem that is specific to Drosophila, as there are 
relatively few genome-wide microarray studies assessing the transcriptional 
contribution of hemocytes to the total host response in the A. gambiae (Pinto 
et al., 2009) and A. aegypti (Choi et al., 2012) mosquitos and the army worm 
Spodoptera frugiperda (Barat-Houari et al., 2006). It must also be noted that 
even many mammalian macrophage infection transcriptional profiling studies 
rely on exposing macrophage-like cell lines, such as the mouse macrophage-
like lines RAW264.7 (Eskra et al., 2003) and J774A.1 (Andersson et al., 2006) 
to bacterial species, as opposed to utilizing isolated primary cells. This would 
suggest that the problems associated with undertaking such experiments are 
widespread.  
 
Stramer et al. (2008) used an alterative strategy to address this issue, by 
comparing the transcriptional profiles of wild-type and hemocyte-null 
Drosophila embryos upon damage inflicted via sterile laser ablation; to infer 
the existence of hemocyte-specific wound response genes in vivo whilst 
dispensing of the need to harvest hemocytes from live organisms. This 
approach permitted the assessment of the hemocyte contribution to the total 
unwounded embryo transcriptome and the subsequent discovery of wound-
activated hemocyte genes, such as phospholipase A1 and Drs (Stramer et al., 
2008). However, even this strategy yielded relatively few significantly 
upregulated or downregulated gene candidates for further study, possibly due 
to the effects of dilution of wound-induced genes. Thus, gaining a 
comprehensive view of the transcriptional changes that occur specifically 




4.1.3 Strategies and Statistical considerations in the analysis of microarray 
data 
 
In practice, a combination of strategies enable the effective management of 
the vast quantity of microarray data and permit the identification of candidate 
genes for further study. One such strategy is to assign terms to clusters of 
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gene that demonstrate similar functional attributes. Gene Ontology (GO) 
enables the classification of genes by molecular function, biological process or 
cellular component (Ashburner et al., 2000; Baehrecke et al., 2004), 
subsequently permitting a more functional overview of microarray data. 
Consequently, by combining the qualitative GO attributes and quantitative 
RNA level for microarray experiments, candidate genes can be identified 
without losing the overview of the entire data structure (Baehrecke et al., 
2004). One output of this type of analysis is the treemap, which was 
developed to facilitate the simultaneous visualization of hierarchical clustering 
and the GO framework (Baehrecke et al., 2004). As such, this system of 
ontological categorization has been commonly employed by numerous 
Drosophila microarray studies in order to simplify data and derive meaning 
from results (De Gregorio et al., 2001; Johansson et al., 2005; Schlenke et al., 
2007; Carpenter et al., 2009; Felix et al., 2012).  
 
Another method that can be utilized to identify useful candidates within the 
vast quantity of microarray data is network determination; to assess if there 
are any pair or groups of genes that may interact under particular conditions or 
constraints. One relatively basic resource that can perform this type of 
analysis is the Search Tool for the Retrieval of Interacting Genes/Proteins 
(STRING), which attempts to integrate direct experimental evidence of protein-
protein/gene-gene interactions, functional grouping of proteins/genes into their 
respective pathways and predictions of gene-gene/protein-protein interactions 
(von Mering et al., 2004). A large body of protein-protein associations in 
STRING are imported from other databases, but the resource also contains a 
great quantity of predicted interactions that are produced de novo via 
systematic genetic comparisons. As such, sequenced genomes are 
periodically imported and searched for three genres of genomic context 
associations: conserved genomic neighbourhoods, gene fusion events and co-
occurrence of genes across genomes (von Mering et al., 2004). This 
combination permits the identification of pairs of genes which appear to be 
under common selective pressures in a manner which is greater than 
expected by chance, and which are can therefore assumed to be functionally 
interacting. Furthermore, a confidence or probability score can be assigned to 
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each predicted association, which is derived from benchmarking the 
performance of the predictions against a reference set of validated, true 
associations; in this case, the functional grouping of proteins maintained at the 
Kyoto Encyclopedia of Genes and Genomes (KEGG) (von Mering et al., 
2004). Any predicted associated for which both genes/proteins are assigned to 
the same KEGG pathway is considered as a true, positive interaction, 
meaning that the scores given to associations in STRING represent the 
chance of finding the interacting candidates within the same KEGG pathway 
(von Mering et al., 2004) and reflect the probability that the interaction truly 
exists. 
 
Nevertheless, whilst microarray studies have the potential to identify vast 
numbers of candidate genes for further validation, it must also be 
acknowledged that the intrinsic nature of these experiments also generate 
difficulties when carrying out statistical testing, which must be addressed in 
order to effectively analyse the resulting data. For instance, a crucial 
component in the analysis of gene expression microarray experiments is to 
formulate a list of genes that are differentially expressed upon various 
biological conditions or treatments, which can then be validated through other 
experimental techniques to confirm the biological processes involved (Cheng 
and Pounds, 2007). To determine if genes within these preliminary lists truly 
display significant changes in expression, statistical hypotheses must be 
formulated and tested. One problem associated with this process is that a 
statistical hypothesis must be tested for each gene, and since there are 
typically thousands of genes within transcriptional profile studies this creates 
the requirement for massive multiple hypothesis testing (Cheng and Pounds, 
2007). Since the probability that false-positive errors may occur increases 
dramatically with larger numbers of test genes (Reiner et al. 2003), as in the 
case of genome-wide microarray studies, it is necessary to correct the 
significance values of each result by controlling for the false discovery rate 
(FDR). In practice, this can be implemented via statistical freeware programs, 
such as R (Reiner et al., 2002). Therefore, whilst there are numerous tools 
and resources to simplify the vast quantities of data resulting from microarray 
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experiments, deriving proper biological relevance requires the correct 
application of such statistical practices. 
 
 
4.1.4 Experimental Aims  
 
The final objective of this project was to analyse the content of microarray data 
obtained as detailed in Chapter 2, to assess the nature of the global 
transcriptional changes upon bacterial and damage stimuli within the Stage 15 
embryo as a whole, as detailed in the strategy depicted in Figure 4.1. By 
determining which genes were modulated within the embryo upon infection or 
damage stimuli, induced via microinjection of microbes or sterile laser ablation 
of embryos respectively, it would be possible to assess the total infected or 
wounded transcriptomes of the Drosophila embryo and to identify potential 
novel infection- and damage-specific genes. These would ultimately form 
potential candidate genes for further study. A parallel aim was to more 
specifically assess the contribution of embryonic hemocytes towards the 
embryonic damage and immune responses, by examining the transcriptional 
profile of this immune cell type upon microinjection with sterile endotoxin-free 
PBS or Ecc15. This was achieved by utilizing FACS to isolate hemocytes for 
RNA processing. By comparison of the hemocyte transcriptome to that of the 
total embryonic transcriptome, this would permit the identification of hemocyte-
specific infection genes. To achieve these objectives, the resulting microarray 
data was corrected for FDR and subsequently a combination of hierarchical 











Figure 4.1: Schematic of Microarray strategy employed.  
 
A two-phase strategy was employed to study global gene expression within 
infected and damaged Drosophila embryos. In an initial step (A), microarray 
analysis of the total transcriptome of infected and wounded embryos was 
compared to that of naïve embryos, to determine genes upregulated upon 
damage or infection. In the second phase, results from Step 1 were compared 
to the transcriptomes of hemocytes isolated from infected or damaged 
embryos (B). This allowed the identification of hemocyte-specific damage or 
















































4.2.1 cDNA microarrays are able to detect Immune Gene Modulation within 
the Stage 15 Drosophila Embryo 
 
The primary aim of these experiments was to more closely examine the global 
transcriptional responses to damage and infection within the Stage 15 
Drosophila embryo. To fulfill this aim, cDNA microarray studies were 
performed to compare the transcriptional profiles of PBS, Ecc15 (OD=1) or M. 
luteus (OD=1) injected embryos to those of naïve embryos. By comparing the 
PBS-injected Stage 15 embryo transcriptome to that of the naïve embryo, 
further knowledge could potentially be gathered regarding the embryonic 
response to sterile damage. Moreover, comparison between the bacteria 
injected Stage 15 embryo transcriptomes and the naïve embryos 
transcriptional profile would permit further study of the complexity of the Stage 
15 immune response, as well as the potential identification of any infection 
specific genes. An initial vsn limma normalization was applied to the 
subsequent microarray data, and the fold change in gene expression 
calculated.  
 
Initial analysis sought to determine if changes in expression of immune genes 
previously characterized in other Drosophila systems and previous embryonic 
studies (Chapter 3) could be detected via this methodology (Figures 4.2-4.4). 
As such, the fold change of AMP gene expression upon PBS, Ecc15 and M. 
luteus injection was examined (Figure 4.2). Considering the changes in AMP 
gene expression upon Ecc15 infection (Figure 4.2A), Gram-negative AMP 
genes were observed to be predominantly upregulated via microarray 
analysis. For instance, all Att isoforms demonstrated induction upon Ecc15 
infection. This was particularly notable for the AttA and AttD isoforms. 
Similarly, both Dpt isoforms were preferentially induced upon Ecc15 infection, 
as well as Mtk and the CecA2 and CecC isoforms. Of particular note is the 
large fold change in Def expression detected, of almost 25-fold. Conversely, 
Ecc15 infection did not greatly induce expression of Gram-positive AMPs, 
such as Drs or its isoforms. By contrast, infection with M. luteus appeared to 
! "#$!
preferentially induce greater fold changes in Drs expression within the Stage 
15 embryo, accompanied by decreases in the expression of Gram-negative 
AMPs, such as AttA, AttB, CecA2, CecC and both Dpt class members (Figure 
4.2B). This, therefore, demonstrates that the specificity of the AMP response 
observed within the Drosophila embryos during previous studies can also be 
clearly detected via microarray analysis and when applied to individual AMP 
class genes.  
 
Interestingly, when comparing directly the changes in expression observed 
with Ecc15 or M. luteus treatment to those observed upon PBS injected, three 
different patterns emerged, some of which had not previously been detected. 
When comparing directly levels of AMP gene expression observed with PBS 
and Ecc15 treated embryos, in most cases PBS injection stimulated a lower 
level of AMP gene expression (Figure 4.2A), consistent with previous RT-
qPCR results within the Stage 15 embryo (Chapter 3). The only exceptions of 
this were the downregulated levels of AttA, AttB, CecA2 and DptB recorded 
upon PBS injection. However, in some cases, as with Dro3 and Dro4, Ecc15 
infection induced downregulation and PBS injection initiated an upregulation of 
AMP gene expression (Figure 4.2A), suggesting a preferential role for these 
AMPs in a response to damage rather than infection. Of further interest is the 
pattern detected when comparing fold change of AMP gene expression upon 
M. luteus and PBS treated embryos (Figure 4.2B). In some cases, PBS 
injection stimulated a higher fold change in AMP gene expression than M. 
luteus infection; as in the case of Drs. This would not only infer than these 
AMP genes can be activated upon damage stimuli, but that M. luteus infection 
reduces AMP gene expression induced via PBS injection.  
 
Having established that modulation of AMP gene expression in the Stage 15 
embryo could be effectively detected by the microarray methodology, other 
families of immune genes were subsequently investigated; to potentially 
corroborate to the effects observed regarding AMP gene expression. Gene 
families investigated included the PGRPs, GNBPs (Figure 4.3) and the teps 
(Figure 4.4). In terms of the expression of individual PGRP family members 
upon infection with either Ecc15 (Figure 4.3A) or M. luteus (Figure 4.3B), 
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much variation was noted. For instance, whilst Ecc15 infection promoted an 
increase in PGRP-LC and PGRP-LE expression (Figure 4.3A), M. luteus 
infection resulted in relative downregulation of these PGRP genes (Figure 
4.3B). This is consistent with the current paradigm of Drosophila systemic 
immune signaling, as PGRP-LC and –LE isoforms synergistically function as 
receptors of the IMD pathway (Takehana et al., 2004; Kaneko et al., 2006). 
Thus, it is speculative that by downregulating PGRP-LC expression, the Stage 
15 embryos is able to ensure correct AMP responses according to the 
appropriate pathogen type. Also of interest is the fact that PGRP-LF 
expression appeared highly induced by Ecc15 (Figure 4.3A), and PGRP-SC1 
expression by M. luteus (Figure 4.3B). Furthermore, examination of the 
changes in expression of GNBP genes upon Ecc15 (Figure 4.3A) or M. luteus 
(Figure 4.3B) infection revealed similar patterns. Whilst expression of all 
GNBP genes was downregulated upon M. luteus infection, Ecc15 induced the 
upregulation of only GNBP-3, which is notable considering its role in Toll 
pathway activation (Gottar et al., 2006). This may be suggestive of the 
presence of a feedback mechanism within the Stage 15 embryo that can 
modulate the expression of individual PGRP genes upon different types of 
infection. Conversely, the expression of some PGRP genes remained 
consistent upon infection, regardless of the type of infecting bacterium. For 
instance, expression of PGRP-LA, PGRP-LB, PGRP-SA and PGRP-SC2 was 
seemingly upregulated upon either M. luteus or Ecc15 infection to similar 
degrees (Figure 4.3A-B). Similarly, expression of PGRP-SB2 and PGRP-SD 
was downregulated in a concordant manner by Ecc15 or M. luteus infection 
(Figure 4.3A-B). This may imply that the function of these genes is somewhat 
infection aspecific, as concordant modulation of their expression is observed, 
regardless of microbial genre.  
 
Examination of the expression of PGRP genes upon PBS injection (Figure 
4.3A-B) also permitted insight into the modulation of these genes in response 
to damage stimuli. Of particular interest was the effect of damage on specific 
PGRP genes, whereby this stimulation induced a change in expression that 
was distinct from that observed upon infection. For example, whereas M. 
luteus infection induced the expression of PGRP-SC2, PBS injection was 
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observed to result in downregulation of the PGRP gene, suggesting disparate 
functions for this family member upon damage and infection in the Stage 15 
embryo.   
 
Some of the most interesting results from this preliminary data screening 
concerns the expression of tep genes upon either Ecc15 or M. luteus infection 
(Figure 4.4). In some cases, the fold changes in expression observed with 
Ecc15 or M. luteus infection were relatively concordant. For instance, both 
Ecc15 and M. luteus induced a decrease in Mcr and TepIV expression and an 
increase in TepIII expression to similar degrees (Figure 4.4A-B). Conversely, 
Gram-positive and Gram-negative infections appeared to have a highly 
differential effect on TepI and TepII expression. For example, whilst Ecc15 
infection appeared to induce a decrease in TepI expression (Figure 4.4A), M. 
luteus infection appeared to increase TepI expression (Figure 4.4B). Similarly, 
TepII expression levels were increased by Ecc15 infection (Figure 3A) and 
decreased by M. luteus infection (Figure 4.4B). Furthermore, it is notable that 
the changes in TepI expression were completely independent of PBS injection, 
since this treatment alone did not induce any changes in expression (Figure 
4.4A-B). This would, therefore, permit the inference that individual tep genes 
may perform different roles in the response to Gram-negative or Gram-positive 
pathogens.  
 
Taken together, this data demonstrates that the microarray methodology is 
able to efficiently detect modulation of immune gene expression within the 
Stage 15 embryo, with many of the resulting observations being consistent 
with previous embryonic studies as well as those of other Drosophila immunity 
models. Moreover, the microarray methodology also provides the opportunity 
to study the individual contribution of immune gene family members to the 
Stage 15 embryonic immune response; to gain further knowledge concerning 
the apparently disparate immune responses of the embryo to infection and 
damage. As such, this preliminary analysis provides the basis for more robust 
analytical techniques can now be employed to study the genome-wide 
embryonic transcriptional response to damage and infection stimuli.  
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Figure 4.2: Modulation in AMP gene expression within the Stage 15 
embryo can be detected upon PBS, Ecc15 or M. luteus injection using 
microarray techniques.  
 
(A-B) Preliminary analysis of microarray data to determine if immune gene 
modulation could be detected using this methodology, focusing on AMP 
genes. Data was normalized using vsn limma method, and the fold change 
between naïve and PBS or bacterial levels was calculated to detect if damage 
or infection was able to modulate AMP gene expression. The majority of 
Gram-negative AMP genes were induced upon Ecc15 infection, as well as Def 
(A); concordant with previous RT-qPCR results. Likewise M. luteus infection 
greatly induced the expression of Gram-positive AMP genes such as those 
belonging to the Drs class (B). In terms of the effect of PBS injection upon the 
expression of AMP genes, the trends were less defined, with damage 
downregulating specific AMP gene expression, such as that of the Att class 
(A-B), and upregulating others, including the Drs class of AMP genes (A-B). In 
some cases, the upregulation of AMP genes observed upon PBS expression 
was higher than that induced via microbial challenge, particularly with M. 
luteus (B), suggesting the infection somehow reduces the AMP response 










Figure 4.3: PGRP and GNBP gene expression is modulated upon Gram-
negative and Gram-positive infection  
 
(A-B) Preliminary analysis of microarray data to determine if PGRP and GNBP 
gene modulation could be detected using the microarray methodology. Data 
was normalized using vsn limma method, and the fold change between naïve 
and PBS or bacterial levels was calculated to detect if damage or infection 
was able to modulate PGRP and GNBP gene expression. Ecc15 and M. 
luteus infection produced contrasted effects on the expression of PGRP 
genes; Ecc15 infection upregulated PGRP genes involved in IMD signaling, 
such as PGRP-LC and –LE (A), whereas M. luteus infection downregulated 
the expression of these isoforms (B). However, the expression of some PGRP 
family members remained consistent between the two infection types (PGRP-
LA, -LB. LD, -SA, -SB2; A-B), suggesting a degree of aspecificity within the 
embryonic immune response. Expression of GNBP genes upon M. luteus and 
Ecc15 displayed a similar trend, with GNBP1 and GNBP2 expression 
concordantly downregulated by both infection types (A-B), but GNBP3 
expression upregulated by solely Ecc15 infection (A). PBS injection was also 
able to induce changes in PGRP gene expression, in some cases distinct from 
those observed upon bacterial infection (A-B), thus suggesting that individual 
PGRP genes may be differentially modulated by the embryo upon damage 










Figure 4.4: Expression changes in tep genes upon infection by the Stage 
15 embryo can be detected using microarray analysis.  
 
(A-B) Preliminary analysis of microarray data to determine if modulation of tep 
gene expression could be detected upon PBS, Ecc15 or M. luteus injection 
using this methodology, focusing on AMP genes. Data was normalized using 
vsn limma method, and the fold change between naïve and PBS or bacterial 
levels was calculated. Whilst some tep genes were modulated in a concordant 
manner by Ecc15 and M. luteus infection (TepIII, TepIV and McR; A-B), others 
such as TepI and TepII demonstrated differential modulation upon Ecc15 (A) 
or M. luteus (B) infection, suggestive of different roles for these gene family 
members upon different types of infection. PBS injection also had differential 
effects on the expression of tep family members (A-B), implying that damage 
is able to modulate tep gene expression, and that this modulation is specific to 













4.2.2 Ecc15 and M. luteus upregulate unique and common subsets of genes 
within the Stage 15 embryo 
 
In order to effectively differentiate between changes in expression as a result 
of the injection process and those resulting directly from the bacterial stimulus, 
comparisons between the expression data collated from PBS injected and 
bacterial injected Stage 15 embryos were performed. The log fold-change and 
the FDR corrected significance of observed effects between these data sets 
was subsequently calculated. Genes whose expression was significantly 
modulated upon bacterial treatment were initially sub-divided into those 
experiencing up- or down-regulation. Further categorization permitted the 
identification of Ecc15-unique and M. luteus-unique lists of up-regulated 
genes.  
 
Viewing the list of Ecc15-unique upregulated genes (Table A8.1, Appendix 8), 
there is a clear representation of IMD pathway components. For instance, the 
AMPs AttA, AttC and AttD are selectively and significantly upregulated. 
Furthermore, PGRP-LF, a negative regulator of IMD signaling (Maillet et al., 
2008), was also demonstrated to experience upregulation specifically in 
response to Ecc15 infection. Other immune pathway involvement in the 
response mediated specifically to Ecc15 included the JAK-STAT pathway, 
inferred by the upregulation of Glorund (Glo); a gene implicated in the positive 
regulation of JAK-STAT signaling and wound healing (Muller et al., 2005; 
Campos et al., 2010). Moreover, the upregulation of MAP Kinase-Activated 
Protein Kinase 2 (MAPK-Ak2) inferred that signaling via the JNK pathway may 
also be occurring in response to Ecc15 infection. Further upregulated Ecc15-
unique genes included those involved in the melanisation cascade (pro-
phenoloxidase A1, proPO-A1), phagocytosis (CG5720), the encapsulation of 
foreign targets (Alpha-mannosidase, Alpha-man-I; UDP-GlcNAc:a-3-D-
mannoside-!-1,2-N-acetylglucosaminyltransferase I, Mgat1; glial cells missing, 
gcm2) or autophagy (Autophagy specific gene 9, Atg9; Bruce). Interestingly, 
Bruce has been demonstrated to be a negative regulator of autophagy (Hou et 
al., 2008; Nezis et al., 2010) hence its upregulation would suggest an inhibition 
of the autophagic process, which is not necessarily concordant with the 
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requirements of the embryonic host. The Ecc15-specific upregulation of 
elevated during infection (edin) within the embryo was also notable, since this 
gene has been characterized to be upregulated upon infection but as of yet 
has had no particular function attributed (Vanha-aho et al., 2012). Other genes 
shown to be up-regulated in a Ecc15-specific manner did not have any 
particular immune connotations and their functions appeared relatively 
disparate. These included Hermansky-Pudlak syndrome 4 ortholog (HPS4), 
which is involved in the negative regulation of gene silencing (Lee et al., 
2009), Vacuolar protein sorting 26 (Vps26), which is involved in lysosome 
organization and vacuolar transport (Saftig et al., 2009), and Rab9, which is 
involved in late endosomal vesicular transport (Zhang et al., 2007). 
Furthermore, it is also noteworthy that genes involved in neurotransmitter 
secretion (Rab3 interacting molecule, Rim), dendrite guidance (Sema-2a), 
axonal mitochondrial distribution (milton, milt) and neuron development (sno 
oncogene, snoo) were up-regulated by Ecc15 infection, reflecting a potential 
relationship between Ecc15 infection and nervous system development and 
activity. However, 24% of the genes identified as being uniquely upregulated 
upon Ecc15 infection are currently of unknown function (Table A8.1, 
highlighted in green), and thus it is not possible to comment on their relevance 
to the embryonic Ecc15 transcriptional response.  
 
Similar broad conclusions can be drawn regarding the genes specifically up-
regulated by M. luteus infection (Table A8.2, Appendix 8). M. luteus infection 
of Stage 15 embryos resulted in the specific upregulation of immune genes, 
such as Edysone-inducible gene 71Eh (Eig71Eh); a gene whose precise 
function remains elusive, but encodes a protein which is similar to mammalian 
defensins (Zraly and Dingwall, 2012), thus implying an immune function. TepI 
expression was also demonstrated to be up-regulated specifically as a result 
of M. luteus infection, suggesting a potential specificity in the opsonisation of 
M. luteus upon infection and hinting at an upregulation of JAK-STAT signaling 
upon this type of infection (Lagueux et al., 2000). Moreover, the upregulation 
of CG34127 and CG6652 may suggest a specific impact of M. luteus on 
phagocytosis, since these genes have previously been associated with this 
this process upon C. albicans infection (Stroschein-Stevenson et al., 2006) 
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However, the M. luteus-specific upregulation of genes associated with non-
immune functions would suggest that this type of infection also impacts other 
biological systems within the Stage 15 embryo. For instance, up-regulation of 
the Activating Transcription Factor 2 (Atf-2) and ribosomal protein L8 (RpL8) 
would also indicate an increase in MAPK signaling and insulin signaling 
respectively. The gene hits associated with M. luteus infection also displayed 
an interesting connection to nervous system development, such as 
neurogenesis (threonyl-tRNA synthetase, Aats-thr) and neuron fate 
commitment (brain specific homeobox, bsh), but also to spermatogenesis 
(Male-specific transcript 36Fa, Mst36Fa) and sperm competition (Accessory 
gland protein 53Ea, Acp53Ea). Up-regulated expression of mastermind (mam) 
may also indicate an impact of M. luteus on stem cell differentiation, and 
upregulation of olfactory binding proteins and receptors (Obp57e, Or85d, 
Or98a) may suggest an impact on the sensing of chemical stimuli, such as 
pheromone. It is also of interest that M. luteus specifically upregulated two 
distinct Cytochrome P450 oxygenase (Cyp) genes (Cyp308a1 and Cyp309a1), 
which play roles in the oxidation-reduction process and also display heme 
binding properties (Flybase Curators et al., 2004), as well as a glucose 
transporter (sut3). Similar to the nature of candidates upregulated specifically 
by Ecc15 infection, many genes uniquely upregulated by M. luteus (27%) are 
also still awaiting assignment of both a precise molecular and more broad 
biological function.  
 
To determine the potential overlap of genes up-regulated by both types of 
infection, comparison of the top 200 most significantly up-regulated genes 
upon either Ecc15 or M. luteus infection was performed (Figure 4.5). Of these 
genes, 73 (36.5%) were commonly up-regulated by both Ecc15 and M. luteus 
infection (Figure 4.5A). A list of these common genes can be viewed in Figure 
4.5B. The majority of these genes did not appear to be specific to any immune 
function. For instance, genes involved in regulation of transcription and mRNA 
transport, such as ENL/AF9-related (ear), paired (prd) and small bristles (sbr), 
were commonly up-regulated. The commonly up-regulated genes also had 
functions pertaining to ion transport (Eag-like K+ channel, elk; N,K-ATPase 
Interacting, NKAIN), cellular membrane organization (endophilin B, endoB; 
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four way stop, fws), DNA repair (Snm1; (6-4)photolyase, phr6-4), the response 
to stress (locomotion defects, loco), regulation of the cell cycle (Invadolysin) 
and protein phosphorylation (Protein Kinase-like 17E). The only commonly up-
regulated gene with annotations related to immune functionality was spatzle 4 
(spz4), a ligand for Toll pathway activation. Interestingly, genes implicated in 
the determination of adult lifespan were also commonly up-regulated by M. 
luteus and Ecc15 infection, including snazarus (snz) and the SIFamide 
receptor (NIFR), hinting at a possible impact of these infections upon 
Drosophila aging. Moreover, genes with roles in the development of specific 
tissues were also commonly up-regulated by Ecc15 and M. luteus including 
capricious (caps), a gene implicated in the development of the tracheal system 
(Krause et al., 2006) and motor axon guidance (Kurusu et al., 2008), and 
nimA-like kinase (niki), which is involved in neuron projection morphogenesis 
(Sepp et al., 2008).  
 
Therefore, these results would suggest that, as well as specifically 
upregulating genes with established immune roles, Ecc15 and M. luteus 
infections also appears to induce the expression of genes with more disparate 
functions; highlighting the widespread impact that this infection type has on the 
Stage 15 embryonic transcriptome. Furthermore, it provides an effective 
demonstration that subsets of genes are upregulated specifically in response 
to Gram-positive or Gram-negative infection, or in an aspecific manner, in the 













Figure 4.5: Comparison of Genes Modulated upon Ecc15 and M. luteus 
infection reveals a common subset of Upregulated Genes 
 
(A-B) A common subset of genes is up-regulated by Ecc15 and M. luteus 
infection within the Stage 15 Drosophila embryo. Of the 200 most significantly 
upregulated genes upon either Ecc15 or M. luteus infection, 73 (36.5%) are 
common to both infection types (A). These commonly upregulated genes 
include regulation of transcription, ion transport, cellular membrane 
organization, DNA repair, the response to stress$! regulation of the cell cycle, 
protein phosphorylation, adult lifespan, nervous and tracheal system 
development (B). However 22% of genes implicated in this comparison 
currently have no annotations concerning their molecular function or the 
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change (AU) P value 
Log Fold- 
Change (AU) P value 
AdoR 2.130 0.004 1.154 0.011 
bun 1.674 0.014 2.060 0.002 
caps 1.232 0.021 1.210 0.008 
CG10252 2.418 0.004 2.126 0.001 
CG10321 1.585 0.022 1.627 0.010 
CG10737 1.199 0.017 1.274 0.012 
CG12099 1.405 0.020 1.708 0.005 
CG1233 1.334 0.008 1.533 0.004 
CG12950 1.356 0.009 1.692 0.005 
CG13506 1.291 0.018 1.462 0.012 
CG13843 1.642 0.016 2.670 0.006 
CG16771 1.262 0.009 1.279 0.010 
CG17450 3.941 0.015 2.004 0.015 
CG17838 2.803 0.002 2.474 0.003 
CG2224 1.477 0.015 1.500 0.014 
CG2765 1.352 0.007 1.385 0.010 
CG2943 1.117 0.021 1.078 0.017 
CG31205 3.875 0.010 2.994 0.009 
CG3194 1.573 0.012 1.694 0.009 
CG32549 1.783 0.018 1.511 0.016 
CG3309 1.935 0.013 2.042 0.015 
CG33233 3.415 0.007 2.443 0.011 
CG3419 1.375 0.017 1.507 0.007 
CG34351 1.904 0.002 1.744 0.009 
CG34383 1.423 0.022 1.529 0.018 
CG42327 1.642 0.005 1.721 0.003 
CG42575 1.592 0.012 1.608 0.010 
CG42594 3.182 0.020 2.873 0.010 
CG42750 3.324 0.014 3.583 0.004 
CG43155 2.414 0.009 1.729 0.013 
CG43695 5.879 0.009 4.970 0.000 
CG7139 1.127 0.015 1.189 0.009 
CG7510 1.104 0.022 1.159 0.018 
CG7611 1.661 0.022 1.891 0.009 
CG8516 1.760 0.010 1.669 0.018 
CG8578 1.703 0.010 1.708 0.009 
CG8671 1.372 0.014 1.474 0.005 
CG8757 3.962 0.003 3.559 0.000 
CG8801 1.414 0.016 1.622 0.008 
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CG9121 1.355 0.008 1.597 0.003 
CG9304 1.239 0.012 1.285 0.009 
Dgk 1.410 0.011 1.480 0.009 
Dic3 2.792 0.005 4.573 0.006 
Eaf 1.943 0.016 2.234 0.007 
ear 1.996 0.010 2.322 0.008 
elk 2.353 0.013 2.389 0.002 
endoB 1.254 0.016 1.326 0.010 
fws 1.541 0.013 1.578 0.011 
inaF-BinaF-D 1.397 0.016 1.448 0.012 
Invadolysin 1.502 0.008 1.528 0.010 
Klp68D 1.498 0.006 1.492 0.008 
KP78bKP78a 1.693 0.007 2.321 0.012 
loco 1.610 0.006 1.684 0.002 
Lsp2 3.210 0.003 3.279 0.000 
niki 7.561 0.000 7.108 0.000 
NKAIN 1.477 0.017 1.475 0.014 
Nmdar2 1.291 0.019 1.617 0.009 
osk 2.525 0.008 1.532 0.008 
Patj 2.151 0.005 2.114 0.006 
phr6-4 2.798 0.006 2.466 0.007 
Pi3K68D 0.979 0.022 1.028 0.015 
pigeon 1.714 0.006 1.845 0.003 
Pk17E 1.245 0.014 1.084 0.017 
prd 5.516 0.008 6.255 0.001 
pug 1.273 0.012 1.356 0.016 
Rop 1.560 0.011 1.605 0.012 
sbr 1.440 0.020 1.577 0.017 
SIFR 3.854 0.000 3.092 0.001 
Snm1 1.724 0.006 1.396 0.011 
snz 1.704 0.006 1.743 0.005 
SP2637 1.614 0.013 1.726 0.007 
spz4 1.704 0.008 1.562 0.010 
stmA 1.393 0.007 1.433 0.012 
 














4.2.3. Gene ontology analysis of Ecc15-modulated genes reveals an 
enrichment of genes with roles in neuronal signaling, DNA replication and 
protein trafficking within the Stage 15 embryo 
 
To gain further knowledge concerning the potential function of the genes both 
up- and down-regulated upon Ecc15 infection, and hence of the global 
transcriptional response of the Stage 15 embryo to Gram-negative infection, 
GO analysis was performed on the lists of genes calculated to be significantly 
up- or down-regulated by Ecc15 infection, compared to those modulated by 
PBS infection, after correction for FDR. The Gene Ontology Enrichment 
Analysis and Visualisation Tool (GOrilla) was employed to search for enriched 
GO terms relating to the biological processes associated with the lists of 
genes. The identified GO terms were then sorted based on the significance of 
GO term enrichment below a threshold of p!0.05.  
 
Whilst large numbers of genes upregulated by Ecc15 infection were 
associated with more general GO biological process terms, such as biological 
regulation and single organism transport (Table 4.1), greater insight into the 
potential enrichment of biological processes was attained by observing more 
specific terms. Relatively large numbers of genes were associated with 
transport terms, such as synaptic vesicle function, exocytosis and axon cargo 
transport, suggesting roles in neurotransmitter release or protein trafficking. A 
large number of genes were also attributed with a more GPCR signaling 
function, which could also be widely suggestive of some manner of neuronal 
function. Conversely, only one general GO biological process term was 
enriched within the genes significantly downregulated upon Ecc15 infection 
(Table 4.2); this pertained to the sensation of chemical stimuli, from which is 
was difficult to assign any more precise function.   
 
To attempt to further derive information concerning the collective functions of 
up- and down-regulated genes upon Ecc15 treatment within the Stage 15 
embryo, STRING 9.0 was used to determine if any GO terms relating to 
molecular function and the cellular component concerned could be assigned to 
these genes. Numbers of genes associated with the each distinct GO term 
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were counted and enrichment P-values where p!0.05 were corrected for FDR, 
generating a q-value. Only those terms with a value of q<1.00 were accepted. 
Considering the molecular function GO terms associated with the genes 
whose expression was significantly up-regulated upon Ecc15 infection (Table 
4.3), the list of potential terms generated is extensive; there are terms covering 
a range of molecular functions, suggesting that the precise functions of Ecc15-
upregulated genes are relatively diverse and that the global embryonic 
response to this infection is highly complex. However, broadly speaking, these 
terms could be sub-divided into 4 major functional areas: DNA or RNA binding, 
channel and transporter activity, enzymatic functions and cytoskeletal 
regulation, labeled in red, green, blue and purple in Table 4.3 respectively.  In 
particular, the numbers of genes associated with DNA binding GO terms was 
high; for instance, 87 genes were associated with the more general nucleotide 
binding function, with 65 being more specifically associated with purine 
nucleotide binding. Also of note was the high number of up-regulated genes 
associated with the catalytic activity term (209); scanning Table 4.3, it is clear 
that the associated enzymatic activity is greatly diverse, including 
oxidoreductase, phosphotransferase, monophenol monoxygenase, 
transferase and endopeptidase activity terms. Of further interest was the large 
number of up-regulated genes that demonstrated association with channel and 
transporter actvitiy; 16 of these terms are associated with ion transport, either 
via voltage-gated channels or more generically assigned transmembrane 
transporters. To an extent, the GO cellular component terms assigned to 
Ecc15 up-regulated genes agreed with these proposed molecular function 
(Table 4.5). Whilst Ecc15-upregulated genes appeared to be associated with a 
rather extensive list of cellular components, many were assigned with terms 
relating to the nervous system, such as the synapse, synaptic vesicle, axon 
terminus, neuron projection and synaptic membrane. This potentially agreed 
with the high numbers of genes displaying association with ion channel and 
transporter molecular functions (Table 4.3). Many genes were also attributed 
with terms relating to protein synthesis and export, such as the clarithrin 
coated vesicle, endosome, Golgi apparatus and multivesicular body, which 
may also potentially explain the large numbers of genes associated with 
enzymatic GO molecular terms. Furthermore, genes were associated with the 
! "#$!
nuclear origin of replication recognition complex and the Arp2/3 protein 
complex GO cellular component terms, in concordance with the assignment of 
GO molecular function terms pertaining to DNA binding and cytoskeletal 
protein binding.  
 
Moreover, genes significantly downregulated upon Ecc15 infection also 
demonstrated a high association with transport-related GO molecular functions 
(Table 4.4), with many genes attributed GO terms relating to channel, voltage-
gated ion channel and substrate-specific channel activity. Other genes were 
assigned to terms relating to peptidase or hydrolase activity, suggesting 
enrichment of genes involved in proteolysis. 5 genes were also associated 
with a DNA helicase function, suggesting interaction with DNA in some 
capacity. However, it is notable that the range of molecular functions 
associated with downregulated genes was much smaller than that observed 
with Ecc15-upregulated genes, suggesting a much more concentrated 
response. This is also reflected in the relatively limited number of GO cellular 
component terms associated with genes downregulated upon Ecc15 infection 
(Table 4.6), in contrast to the apparently more extensive distribution of Ecc15 
upregulated genes (Table 4.5). Moreover, Ecc15 downregulated genes further 
functionally contrasted with Ecc15 upregulated genes in terms of the nature of 
the GO cellular terms subsequently assigned to them. Whilst upregulated 
genes were assigned terms associated with neural components, 
downregulated genes were associated with terms relating to extracellular 
space and the chorion (Table 4.6). Moreover, compared to the enrichment of 
upregulated genes within the origin of replication, downregulated genes were 
associated with the GINS complex, a component of the replisome required for 
progression (Kamada, 2012) and within the pre-initiation complex. Hence, 
whilst both Ecc15 upregulated and downregulated genes demonstrated similar 
transporter, channel or DNA interacting functions, their principle localisations 
appeared to be relatively different, suggestive of different functions. Taken 
together, these results suggest that genes upregulated by Ecc15 within the 
Stage 15 embryo are enriched for neuronal, DNA replication and protein 
synthesis and trafficking functions. In contrast, the functionality of Ecc15-
downregulated genes may be much more restricted, with some genes 
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potentially playing a role within the replisome, although the precise nature of 

































Table 4.1: Biological process GO terms associated with genes 




















Exocytosis 7 2.16E-04 2.84E-01 












Table 4.2: Biological process GO terms associated with genes 

























Table 4.3: Molecular function GO terms associated with genes 
upregulated upon Ecc15 infection 
 
GO Molecular Function 
Term 
Number of 




triphosphate binding 66 1.29E-05 9.30E-03 
Nucleotide binding 87 1.77E-05 9.30E-03 
Purine ribonucleotide 
binding 65 2.37E-05 9.30E-03 
Ribonucleotide binding 65 2.37E-05 9.30E-03 
Purine nucleotide binding 65 2.75E-05 9.30E-03 
Small molecule binding 90 7.01E-05 2.07E-02 
ATPase activity, coupled to 
transmembrane movement 
of substances 17 1.72E-04 4.07E-02 
Hydrolase activity, 
catalyzing transmembrane 
movement of substances 17 1.72E-04 4.07E-02 
ATP binding 52 2.61E-04 5.28E-02 
Adenyl ribonucleotide 
binding 52 2.80E-04 5.28E-02 
Adenyl nucleotide binding 52 2.90E-04 5.28E-02 
ATPase activity, coupled to 
movement of substances 16 3.45E-04 5.82E-02 
Transmembrane transporter 
activity 53 5.39E-04 8.49E-02 
Cation channel activity 14 6.73E-04 9.94E-02 
Voltage-gated cation 
channel activity 7 8.61E-04 1.20E-01 
Cation transmembrane 
transporter activity 32 9.58E-04 1.23E-01 
P-P-bond-hydrolysis-driven 
transmembrane transporter 
activity 17 1.11E-03 1.23E-01 
ATPase activity, coupled to 
transmembrane movement 
of ions 11 1.22E-03 1.25E-01 
Potassium channel activity 6 1.33E-03 1.31E-01 
Inorganic cation 
transmembrane transporter 
activity 26 1.72E-03 1.36E-01 
Transporter activity 56 1.80E-03 1.69E-01 
Cation-transporting ATPase 
activity 6 1.97E-03 1.69E-01 
Substrate-specific 
transmembrane transporter 
activity 44 1.98E-03 1.69E-01 
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Catalytic activity 209 2.00E-03 1.69E-01 
SAM domain binding 2 2.20E-03 1.69E-01 
Cyclic nucleotide-dependent 
guanyl-nucleotide exchange 
factor activity 2 2.20E-03 1.74E-01 
O-acyltransferase activity 5 2.44E-03 1.74E-01 
Ion transmembrane 
transporter activity 37 2.45E-03 1.81E-01 
Ion channel activity 18 2.69E-03 1.81E-01 
ATPase activity, coupled to 
transmembrane movement 
of ions, phosphorylative 
mechanism 10 2.81E-03 1.93E-01 
Voltage-gated potassium 
channel activity 5 3.04E-03 1.95E-01 
Kinase activity 29 3.04E-03 2.00E-01 
Nucleoside-triphosphatase 
activity 40 3.41E-03 2.00E-01 
Substrate-specific channel 
activity 18 3.59E-03 2.18E-01 
Metal ion transmembrane 
transporter activity 19 3.79E-03 2.23E-01 
Voltage-gated ion channel 
activity 7 4.09E-03 2.29E-01 
Phosphotransferase activity, 
alcohol group as acceptor 27 4.14E-03 2.33E-01 
Transferase activity, 
transferring phosphorus-
containing groups 37 4.64E-03 2.33E-01 
Pyrophosphatase activity 40 4.66E-03 2.43E-01 
Protein binding 82 4.80E-03 2.43E-01 
Kinesin binding 3 4.84E-03 2.43E-01 
Non-membrane spanning 
protein tyrosine kinase 
activity 3 4.84E-03 2.43E-01 
Substrate-specific 
transporter activity 45 5.11E-03 2.43E-01 
Channel activity 18 5.25E-03 2.48E-01 
Hydrolase activity, in 
phosphorus-containing 
anhydrides 40 5.75E-03 2.48E-01 
Monophenol 
monooxygenase activity 2 6.41E-03 2.66E-01 
Protein histidine kinase 
activity 2 6.41E-03 2.70E-01 
Oxidoreductase activity 2 6.41E-03 2.70E-01 
Two-component sensor 
activity 2 6.41E-03 2.70E-01 
Receptor signaling protein 7 6.70E-03 2.70E-01 
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activity 
Cytoskeletal protein binding 19 9.19E-03 2.78E-01 
Protein kinase activity 21 9.59E-03 3.75E-01 
Transferase activity 65 1.03E-02 3.84E-01 
Transferase activity, 
transferring acyl groups 
other than amino-acyl 
groups 13 1.22E-02 4.06E-01 
Transmembrane receptor 
protein serine/threonine 
kinase activity 2 1.24E-02 4.58E-01 
Transforming growth factor 
beta-activated receptor 
activity 2 1.24E-02 4.58E-01 
Oxidoreductase activity, 
acting on diphenols and 
related substances as 
donors, oxygen as acceptor 2 1.24E-02 4.58E-01 
Protein tyrosine 
phosphatase activity 6 1.30E-02 4.58E-01 
Heat shock protein binding 6 1.62E-02 4.72E-01 
Adenylyltransferase activity 3 1.65E-02 5.79E-01 
Ras guanyl-nucleotide 
exchange factor activity 5 1.79E-02 5.83E-01 
Guanyl-nucleotide exchange 
factor activity 7 1.83E-02 6.23E-01 
GTP binding 14 1.93E-02 6.28E-01 
Divalent inorganic cation 
transmembrane transporter 
activity 6 1.98E-02 6.46E-01 
Calcium-transporting 
ATPase activity 2 2.01E-02 6.46E-01 
Calcium-dependent 
cysteine-type 
endopeptidase activity 2 2.01E-02 6.46E-01 
Structural constituent of 
cytoskeleton 5 2.02E-02 6.46E-01 
Proton-transporting ATPase 
activity, rotational 
mechanism 4 2.10E-02 6.46E-01 
Nucleotidyltransferase 
activity 8 2.40E-02 6.60E-01 
Single-stranded RNA 
binding 4 2.42E-02 7.44E-01 
Actin binding 11 2.54E-02 7.44E-01 
GTPase activity 12 2.62E-02 7.70E-01 
Potassium ion 
transmembrane transporter 
activity 6 2.63E-02 7.78E-01 
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Polynucleotide 
adenylyltransferase activity 2 2.92E-02 7.78E-01 
1-acylglycerol-3-phosphate 
O-acyltransferase activity 2 2.92E-02 8.01E-01 
Transmembrane receptor 
protein tyrosine 
phosphatase activity 2 2.92E-02 8.01E-01 
Phosphotransferase activity, 
nitrogenous group as 
acceptor 2 2.92E-02 8.01E-01 
Carnitine O-acyltransferase 
activity 2 2.92E-02 8.01E-01 
Hydrogen-exporting ATPase 
activity, phosphorylative 
mechanism 6 3.41E-02 8.01E-01 
Calcium ion transmembrane 
transporter activity 5 3.46E-02 9.27E-01 
Guanyl ribonucleotide 
binding 13 3.50E-02 9.29E-01 
Guanyl nucleotide binding 13 3.66E-02 9.29E-01 
Transferase activity, 
transferring acyl groups 13 3.66E-02 9.43E-01 
ATPase activity 23 3.67E-02 9.43E-01 
Alkali metal ion binding 2 3.96E-02 9.43E-01 
Potassium ion binding 2 3.96E-02 9.84E-01 
Pyruvate kinase activity 2 3.96E-02 9.84E-01 
 
Functions highlighted in red, green, blue and purple represent GO terms 
broadly pertaining to DNA or RNA binding, channel and transporter activity, 














Table 4.4: Molecular function GO terms associated with genes 





genes (AU) P-value 
 
q-value 
Hydrolase activity 71 1.14E-03 7.26E-01 
Channel activity 14 1.32E-03 7.26E-01 
Serine-type peptidase 
activity 18 1.60E-03 7.26E-01 
Serine hydrolase 
activity 18 1.73E-03 7.26E-01 
Serine-type 
endopeptidase activity 17 1.86E-03 7.26E-01 
Ion channel activity 13 2.15E-03 7.26E-01 
Substrate-specific 
channel activity 13 2.72E-03 7.91E-01 
DNA helicase activity 5 3.53E-03 7.91E-01 
Ligand-gated ion 
channel activity 8 3.73E-03 7.91E-01 
Peptidase activity, 
acting on L-amino acid 



















Table 4.5: Cellular component GO terms associated with genes 





Genes (AU) P-value 
 
q-value 
Synapse 19 1.36E-04 6.90E-02 
Axon terminus 7 2.74E-04 6.90E-02 
Neuron projection 
terminus 7 2.74E-04 6.90E-02 
Cell projection 20 3.52E-04 6.90E-02 
Axon 11 4.00E-04 6.90E-02 
Terminal button 6 5.93E-04 7.70E-02 
Synapse part 15 6.46E-04 7.70E-02 
Neuron projection 13 7.70E-04 7.70E-02 
Axon part 7 8.04E-04 7.70E-02 
Female germline ring 
canal outer rim 2 2.30E-03 1.63E-01 
Endosome 8 2.40E-03 1.63E-01 
Voltage-gated 
potassium channel 
complex 4 2.65E-03 1.63E-01 
Membrane-bounded 
vesicle 13 2.65E-03 1.63E-01 
Clathrin-coated vesicle 9 3.63E-03 2.09E-01 
Cation channel complex 5 4.08E-03 2.20E-01 
Coated vesicle 10 4.72E-03 2.39E-01 
Cytoplasm 130 5.24E-03 2.51E-01 
Golgi apparatus 14 6.75E-03 3.06E-01 
Presynaptic membrane 3 7.43E-03 3.09E-01 
Synaptic vesicle 8 7.53E-03 3.09E-01 
Vesicle 13 1.06E-02 4.16E-01 
Ion channel complex 6 1.13E-02 4.24E-01 
Golgi apparatus part 9 1.20E-02 4.31E-01 
Cytoplasmic 
membrane-bounded 
vesicle 11 1.34E-02 4.61E-01 
Proton-transporting two-
sector ATPase complex 7 1.55E-02 5.13E-01 
Early endosome 4 1.64E-02 5.16E-01 
Endomembrane system 17 1.71E-02 5.16E-01 
Membrane fraction 3 1.75E-02 5.16E-01 
Protein complex 94 1.89E-02 5.16E-01 
Cell 248 1.92E-02 5.16E-01 
Cell part 248 1.92E-02 5.16E-01 
Glucosidase II complex 2 2.09E-02 5.45E-01 
Cytoplasmic vesicle 11 2.74E-02 6.95E-01 
Female germline ring 2 3.03E-02 7.13E-01 
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canal 
Arp2/3 protein complex 2 3.03E-02 7.13E-01 
Synaptic membrane 5 3.06E-02 7.13E-01 
Golgi membrane 5 3.39E-02 7.69E-01 
Vacuole 7 3.54E-02 7.82E-01 
Cell projection part 8 3.74E-02 8.06E-01 
Multivesicular body 2 4.11E-02 8.06E-01 
Nuclear origin of 
replication recognition 
complex 2 4.11E-02 8.06E-01 
Origin recognition 
complex 2 4.11E-02 8.06E-01 




domain 4 4.31E-02 8.25E-01 
ATP-binding cassette 
(ABC) transporter 






















Table 4.6: Cellular component GO terms associated with genes 





Genes (AU) P-value 
 
q-value 
GINS complex 3 6.52E-05 2.81E-02 
DNA replication 
Preinitiation complex 3 6.52E-05 2.81E-02 
Dynein complex 6 5.62E-04 1.50E-01 
Extracellular space 18 6.96E-04 1.50E-01 
Extracellular region 32 9.29E-04 1.60E-01 
External encapsulating 
structure 6 2.22E-03 3.19E-01 
Chorion 5 2.66E-03 3.28E-01 
























4.2.4. Gene ontology analysis of M. luteus-modulated genes reveals an 
enrichment of genes with roles in defense, ion transport and 
neurotransmission within the Stage 15 embryo 
 
To further assess the potential functions of the genes both up- and down-
regulated upon M. luteus infection, and hence of the global transcriptional 
response of the Stage 15 embryo to Gram-positive infection, GO analysis was 
performed on the lists of genes calculated to be significantly up- or down-
regulated by M. luteus infection, compared to those modulated by PBS 
infection, after correction for FDR. The Gene Ontology Enrichment Analysis 
and Visualisation Tool (GOrilla) was employed to search for enriched GO 
terms relating to the biological processes associated with the lists of genes. 
The identified GO terms were then sorted based on the significance of GO 
term enrichment below a threshold of p!0.05.  
 
In contrast to the more limited biological process GO terms that were enriched 
upon Ecc15 infection of Stage 15 embryo, those enriched by genes both up 
and down-regulated upon M. luteus infection demonstrated a greater diversity 
in terms of biological function; with 29 different GO terms associated with M. 
luteus upregulated genes as opposed to the 7 GO terms enriched by Ecc15 
upregulated genes. However, considering the biological process GO terms 
attributed to genes upregulated by M. luteus infection (Table 4.7), there were 
some similarities with those associated with genes upregulated upon Ecc15 
infection. The presence of terms related to transport, axon cargo transport and 
microtubule based transport, ion transport, ion homeostasis, exocytosis and 
chemical homeostasis are functionally similar to the GO terms enriched by 
Ecc15 upregulated genes. However, in contrast to the limited enrichment 
observed by Ecc15 upregulated genes, M. luteus upregulated genes 
demonstrated an enrichment of GO terms relating to the humoral immune 
response, in particular terms related to the defense response to Gram-positive 
bacterium, which in itself is not particularly surprising. Interestingly, genes 
upregulated upon M. luteus infection also exhibited enrichment for terms 
relating to tracheal network development, such as tube fusion (7) and branch 
fusion, open tracheal system (7), further suggesting that M. luteus may have a 
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direct impact on the development this system. Furthermore, 12 genes were 
associated with a term related to adult locomotory behavior, suggesting that 
M. luteus infection at the embryonic life stage may have a more long-term 
developmental impact on Drosophila development. A smaller number of 
biological process GO terms were enriched by genes downregulated upon M. 
luteus infection in the Stage 15 embryo (Table 4.8). Similar to those enriched 
by Ecc15 downregulated genes, the majority of the GO terms enriched by 
genes downregulated upon M. luteus infection appear to relate to sensory 
processes, such as the detection of chemical stimuli. Nonetheless, a large 
number of genes (27) were also demonstrated to be associated with 
proteolytic functions.  
 
To attempt to further derive information concerning the collective functions of 
up- and down-regulated genes upon M. luteus treatment within the Stage 15 
embryo, STRING 9.0 was used to determine if any GO terms relating to 
molecular function and the cellular component concerned could be assigned to 
these genes. Numbers of genes associated with the each distinct GO term 
were counted and enrichment P-values where p!0.05 were corrected for FDR, 
generating a q-value. Only those terms with a value of q<1.00 were accepted. 
The molecular function GO terms associated with M. luteus upregulated genes 
are relatively extensive (Table 4.9), but not as diverse as those enriched by 
Ecc15 infection. Nevertheless, the nature of molecular function GO terms 
associated with M. luteus upregulated genes corroborated the biological 
process GO. For example, many genes were associated with molecular 
function terms relating to voltage-gated ion channels and transmembrane 
transporters (Table 4.9), reflecting the enrichment of ion homeostasis and 
transport biological process GO terms (Table 4.7). Notably, genes were also 
associated with neurotransmitter release and neuropeptide Y receptor activity, 
suggesting the M. luteus infection may be able to alter neurotransmission 
within the Stage 15 embryo. However, as the q-values for these results are 
equivalent to 1, then these results should be considered as non-significant 
(Table 4.9). Conversely, genes downregulated by M. luteus infection (Table 
4.10) were significantly attributed to a variety of molecular function GO terms 
relating to peptidase activity. Moreover, 6 genes were associated with 
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olfactory receptor activity, potentially shedding light on the enrichment of 
biological process GO terms relating to sensory processes and the detection 
of chemical stimuli (Table 4.8). However, other genes were associated with 
terms relating to structural functions, such as functioning as constituents of 
chitin-based cuticle, which does not necessarily corroborate any biological 
function GO terms associated with these genes.  
 
In terms of the cellular localization of genes modulated upon M. luteus 
infection, large numbers of genes that displayed upregulation of expression 
upon M. luteus treatment were determined to have cytoplasmic, synaptic or 
reproductive tract cellular component ontologies (Table 4.11). Moreover, the 
more specific component cellular component GO terms identified would 
suggest that these genes may be integral in synaptic transmission and protein 
trafficking, relatively consistent with the biological processes and molecular 
function GO data (Tables 4.7 and 4.9). The cellular component GO term with 
the largest number of genes attributed (105) was highly general, relating to a 
cytoplasmic association, and from which it was difficult to attain any further 
functional relevance. Conversely, those genes that were downregulated upon 
M. luteus infection appear to be more highly enriched for extracellular regions 
or membranous components (Table 4.12), in contrast to the cytoplasmic 
associations of M. luteus upregulated genes.  
 
Therefore, this data would collectively indicate that M. luteus infection induces 
genes associated with roles in humoral defense, ion transport and 











Table 4.7: Biological process GO terms associated with genes 


















Biological regulation  206 2.04E-05 2.68E-02 
Axon cargo transport 7 3.15E-05 3.30E-02 

































Tube fusion  7 9.92E-05 3.72E-02 













Exocytosis 8 2.36E-04 6.51E-02 
Ion transport 37 2.46E-04 6.45E-02 
Ion homeostasis 12 2.66E-04 6.66E-02 












Defense response to 16 4.49E-04 9.43E-02 
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bacterium  
Cellular localisation  15 6.01E-04 1.21E-01 






































Table 4.8: Biological process GO terms associated with genes 





Genes (AU) P-value 
 
q-value 
Sensory perception of 
chemical stimulus 15 1.27E-04 2.46E-01 
Proteolysis 27 1.38E-04 2.46E-01 
Detection of chemical 
stimulus 9 1.44E-04 2.46E-01 
Sensory perception 16 5.88E-04 7.56E-01 
Puparial adhesion 3 1.06E-03 7.68E-01 

























Table 4.9: Molecular function GO terms associated with genes 
upregulated upon M. luteus infection 
 
GO Molecular Function 
Term 
Number of 





activity 2 1.34E-03 1.00E+00 
Chitin deacetylase activity 2 1.34E-03 1.00E+00 
Kinesin binding 3 2.38E-03 1.00E+00 
Sugar:hydrogen 
symporter activity 3 2.38E-03 1.00E+00 
Monophenol 
monooxygenase activity 2 3.92E-03 1.00E+00 
Oxidoreductase activity, 
acting on paired donors, 
with incorporation or 
reduction of molecular 
oxygen, another 
compound as one donor, 
and incorporation of one 
atom of oxygen 2 3.92E-03 1.00E+00 
Solute:hydrogen 
symporter activity 3 4.82E-03 1.00E+00 
Purine ribonucleotide 
binding 44 7.75E-03 1.00E+00 
Ribonucleotide binding 44 7.75E-03 1.00E+00 
Purine ribonucleoside 
triphosphate binding 44 7.91E-03 1.00E+00 
Purine nucleotide binding 44 8.41E-03 1.00E+00 
Copper ion 
transmembrane 
transporter activity 2 1.24E-02 1.00E+00 
Guanylate cyclase activity 3 1.31E-02 1.00E+00 
Nucleotide binding 58 1.56E-02 1.00E+00 
G-protein coupled peptide 
receptor activity 5 1.63E-02 1.00E+00 
Neuropeptide receptor 
activity 5 1.63E-02 1.00E+00 
G-protein coupled 
receptor activity 12 1.65E-02 1.00E+00 
Peptide receptor activity 5 1.79E-02 1.00E+00 
Protein 
geranylgeranyltransferase 
activity 2 1.82E-02 1.00E+00 
Phosphotransferase 
activity, nitrogenous group 
as acceptor 2 1.82E-02 1.00E+00 
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Neuropeptide Y receptor 
activity 2 1.82E-02 1.00E+00 
Glucose transmembrane 
transporter activity 3 1.91E-02 1.00E+00 
Voltage-gated ion channel 
activity 5 2.16E-02 1.00E+00 
Signal transducer activity 24 2.31E-02 1.00E+00 
ATP binding 35 2.32E-02 1.00E+00 
Adenyl ribonucleotide 
binding 35 2.42E-02 1.00E+00 
Adenyl nucleotide binding 35 2.46E-02 1.00E+00 
Protein prenyltransferase 
activity 2 2.49E-02 1.00E+00 
Receptor activity 23 2.50E-02 1.00E+00 
Neurotransmitter receptor 
activity 5 3.02E-02 1.00E+00 
Hydrogen ion transporting 
ATP synthase activity, 
rotational mechanism 3 3.05E-02 1.00E+00 
Hexose transmembrane 
transporter activity 3 3.05E-02 1.00E+00 
Transmembrane 
transporter activity 36 3.06E-02 1.00E+00 
Voltage-gated cation 
channel activity 4 3.45E-02 1.00E+00 
Cation transmembrane 
transporter activity 21 3.93E-02 1.00E+00 
Anion channel activity 3 3.97E-02 1.00E+00 
Low-density lipoprotein 
receptor activity 2 4.06E-02 1.00E+00 
Voltage-gated calcium 
channel activity 2 4.06E-02 1.00E+00 
Cargo receptor activity 4 4.14E-02 1.00E+00 
Monosaccharide 
transmembrane 
transporter activity 3 4.48E-02 1.00E+00 
Small molecule binding 59 4.49E-02 1.00E+00 









Table 4.10: Molecular function GO terms associated with genes 









acting on L-amino 
acid peptides 29 4.42E-06 6.08E-03 
Endopeptidase 
activity 25 6.35E-06 6.08E-03 
Peptidase activity 29 8.76E-06 6.08E-03 
Serine-type peptidase 
activity 19 1.17E-05 6.08E-03 
Serine hydrolase 
activity 19 1.29E-05 6.08E-03 
Serine-type 
endopeptidase 
activity 17 5.74E-05 2.26E-02 
Olfactory receptor 
activity 6 1.25E-03 4.23E-01 
Structural constituent 
of chitin-based cuticle 9 1.65E-03 4.86E-01 
Structural constituent 
of cuticle 9 2.03E-03 5.32E-01 
Transmembrane 
signaling receptor 
activity 15 2.92E-03 6.90E-01 
Signaling receptor 
activity 15 4.47E-03 8.88E-01 
Structural molecule 
activity 19 4.51E-03 8.88E-01 
Aspartic-type 
endopeptidase 











Table 4.11: Cellular component GO terms associated with genes 









ring canal outer rim 2 1.36E-03 6.30E-01 
Synapse 14 1.63E-03 6.30E-01 
Cytoplasm 105 2.19E-03 6.30E-01 
Membrane-bounded 
vesicle 10 8.29E-03 6.30E-01 
 
 
Table 4.12: Cellular component GO terms associated with genes 





genes (AU) P-value 
 
q-value 
Extracellular region 25 6.77E-04 3.11E-01 
Membrane part 44 7.21E-04 3.11E-01 
Integral to 
















4.2.5 Damage induced via sterile laser ablation significantly modulates 
expression in genes involved in the immune response, cuticle development 
and RNA splicing in the Stage 15 embryo 
 
A large number of genes exhibited significant changes in expression within the 
Stage 15 embryo as a result of the sterile damage inflicted via laser ablation. 
These changes included both significant upregulation and downregulation of 
gene expression in ablated embryos compared to non-wounded controls. 
Further analysis and the correction of the P-values to account for false 
discovery rates (FDR) permitted the identification of 100 genes whose 
expression was most significantly modulated upon laser wounding in the 
Stage 15 embryo (Table A9.1, Appendix 9).  
 
The genes undergoing the most significant changes in expression include 
members of the Tweedle (Twdl) gene family, which have been implicated in 
the determination of body shape and postulated to be integral to cuticle 
assembly (Guan et al., 2006), with nine members (TwdlY, TwdlV, TwdlK, 
TwdlM. TwdlQ, TwdlB, TwdlX, TwdlG and Twdlbeta) experiencing significantly 
upregulated expression in the embryo upon laser ablation. Moreover, 
members of other gene families implicated in cuticle development were also 
shown to experience highly significant upregulation in expression upon 
wounding.  These include 8 members of the Cuticular Protein (Cpr) family 
(Cpr51A, Cpr62Bb, Cpr62Bc, Cpr65Av, Cpr50Cb, Cpr78Cc, Ccp84Ad and Cpr 
56F) and 3 members of the Larval Cuticle Protein (Lcp) family (Lcp65Ae, 
Lcp65Ag3, and Lcp65Ad). Other notable hits include a significant number of 
small nuclear RNA (snRNA) genes. The most significantly upregulated of 
these genes (snRNA:U5:38ABb snRNA:U5:63BC, snRNA:U5:14B, 
snRNA:U5:38Aba, snRNA:U5:35D, snRNA:U5:23D, snRNA:U5:34A) have all 
been previously implicated as functioning as components of the spliceosome, 
to enable intron splicing from mRNA transcripts (Chen et al., 2005). A 
selection of genes encoding odorant-binding proteins (Obps) that mediate 
olfaction and chemoreception (Galindo and Smith, 2001; Zhou et al., 2004) 
were also observed to exhibit highly significant upregulation upon sterile laser 
ablation of the Stage 15 embryo. However, many genes which were identified 
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as having highly significantly modulated expression upon wounding do not 
currently have any molecular or more general biological function assigned, 
and thus are highlighted in green in Table A9.1. These genes of unknown 
function encompass 41% of the 100 most significantly modulated genes, and 
include the four gene undergoing the most significant changes in expression: 
CG13044, CG32548, CG42305 and CG17325. Interestingly, of the genes 
listed in Table A9.1, the vast majority of significant changes were due to an 
upregulation in expression; only 2 changes out of the most significant 100 are 
a result of downregulation and are indicated in red in Table A9.1. These genes 
are mucin 30E (muc30E), which encodes a component of extracellular matrix 
(Syed et al., 2008), and CG2901, a gene postulated to play a role in synaptic 
target recognition (Kurusu et al., 2008). Therefore, the predominately 
significant upregulation of these genes would hint at the existence of up-
regulated gene regulatory networks in Stage 15 embryos which respond to 
damage stimuli. 
 
In terms of genes previously annotated to play a role in the immune response 
to bacterial infection, only three are present in Table A9.1. These are PGRP-
LD, immune induced molecule 3 (IM3), which has been implicated in Toll 
pathway signaling and extension of lifespan (Bauer et al., 2010), and 
Pherokine-3 (Phk-3), a odour-binding protein which has been suggested to 
play a role in the neutralization of invading bacteria as well as tissue 
remodeling during metamorphosis (Sabatier et al., 2003). Interestingly, vago, a 
gene which plays a crucial role in controlling viral load upon Drosophila C virus 
infection (Deddouche et al., 2008), was also highly significantly induced within 
the Stage 15 embryos upon sterile wounding. Therefore, this provides further 
confirmation that damage alone is able to modulate the expression of the 
embryonic immune machinery and effectors. However, there is a conspicuous 
absence of AMP genes within Table A9.1, suggesting that modulation of AMP 
expression is not a primary response to damage. This is not to say that AMP 
genes are not significantly modulated upon wounding at all; 9 AMP genes 
demonstrated significant upregulation upon wounding (Figure 4.6; p!0.05). 
These included Att, Cec, Drs and Mtk genes. Of these genes, AttA, AttD and 
Dro5 were particularly highly induced by sterile laser ablation, suggesting that 
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there may be a preference for expression of these AMP isoforms upon 
damage stimuli within the Stage 15 embryo.  
 
To further analyse the nature of the 100 most significantly modulated genes, 
gene ontology analyses focusing on biological process, molecular function and 
cellular component attributes were performed via the programmes GOrilla and 
STRING 9.0. This analysis identified 7 different ontological terms that could be 
associated with these genes, relating to their biological function (Table 4.13). 
These ontologies could be broadly sub-divided into those relating to mRNA 
processing and splicing, and those pertaining to cuticle development and body 
morphogenesis, further corroborating that sterile wounding activates gene 
networks that are involved in these processes. In particular, members of the 
Tweedle family of genes were attributed to ontological terms describing chitin-
based cuticle development (Table 4.14). In addition to the contribution of the 
Tweedle family genes to this ontological category, the presence of vermilion 
(v), a gene encoding a tryptophan oxygenase (Baglioni, 1960; Baillie and 
Chovnick, 1971) which has been implicated in the control of tryptophan levels 
in the hemolymph in larvae and eye and cuticle pigmentation in the adult fly 
(Walker et al., 1986), was also present.  
 
When assigning gene ontology terms pertaining to molecular function, the 
resulting functional terms also reflected the importance of cuticle structure and 
integrity within the wounded Stage 15 embryo (Table 4.15). 72 genes were 
observed to be associated with terms related to the structural composition of 
the cuticle or more general structural functions. These findings were further 
corroborated by the assessment of cellular component ontology terms for the 
100 most significantly modulated genes (Table 4.16), which elucidated that 49 
of these genes encode products that are associated with the extracellular 
matrix or extracellular space. However, a further 3 genes were assigned more 
general molecular function terms pertaining to the inhibition of enzyme activity, 
and 2 were attributed fatty-acyl-CoA binding functions (Table 4.15), which may 
suggest roles in energy metabolism or lipid synthesis. Furthermore, 2 genes 
were associated with the microsome ontology term, which may reflect roles in 
protein synthesis for these particular genes. It could be speculated that 
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upregulation of genes involved in these processes may be required to meet 
the energy demands of repair processes within the embryo after wounding. 
 
Subsequently, analysis using STRING to detect known and theorized protein-
protein interactions was performed on the list of candidate genes in Table 
A9.1; to identify any potential gene networks that respond to damage within 
the Stage 15 embryo (Figure 4.7). Considering the 100 most significantly 
modulated wound-responsive genes, one large network of potential protein-
protein interactions was proposed, with three sets of smaller potential 
interactions also identified. Most of the proposed interactions derive from 
evidence of co-expression or co-occurrence, as demonstrated by the black 
and blue edges respectively, with fewer interactions proposed on the basis of 
experimental evidence or collective citation in scientific literature, represented 
by pink and green edges respectively. The large network itself consisted of 
many members of the Twdl and Cpr family members, suggesting that this 
central network may regulate cuticle development post wounding. However, 
not all members of the Twdl family are included within this network; only 
TwdlB, Twdlbeta, TwdlV, TwdlM and TwdlG occupy central positions, with all 
other family members excluded from any network. This may suggest that only 
these 5 family members are central to mediating the cuticle response to 
damage within the embryo.  
 
It is also of interest that this cuticlar network also incorporates a number of 
genes whose molecular function and biological relevance remains unknown, 
which may indicate that these genes may have a role in Drosophila cuticle 
repair, maintenance or development. Table 4.17 displays a list of unannotated 
genes that are inferred to interact with at least one member of the Twdl or Cpr 
families. The probability of these interactions representing actual biological 
interactions was calculated by STRING in accordance with von Mering et al. 
(2005). The majority of the listed unannotated genes appear to have predicted 
interactions with between 3 to 5 Twdl or Cpr family members, with the 
exceptions of CG16885 and CG14752 which are only predicted to interact with 
Cpr62Bc. Furthermore, the probability values that these predictions represent 
actual functional interactions range from 0.423 to 0.991, inferring that it is 
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probable that many of these proposed interactions have a probable functional 
basis. Of particular note are the proposed interactions between CG14147 and 
TwdlB, and CG14752 and Cpr62Bc, which have greater than 90% probability 
of representing actual biological interactions. Thus, it is highly probable that 
these two previously unannotated genes are not only highly significantly 
wound responsive, but also function in conjunction with Twdl and Cpr family 
members to mediate a cuticular response to damage.  
 
Of the other interactions that are independent of the central cuticular network, 
the most interesting are those relating to IM3. This network consists of three 
nodes (IM3, CG17325 and CG6870) and two green edges, indicating that the 
proposed interactions are based upon co-citation within the scientific literature. 
The interaction between IM3 and CG17325 is notable, as the latter was 
observed to experience the fourth most significant upregulation of expression 
within the entire dataset. Thus, this proposed interaction with IM3 may suggest 
an immune function for CG17325. Moreover, upregulation in expression of all 
three of these candidate genes has previously been associated with increases 
in life span (Bauer et al., 2010), thus potentially suggesting interplay between 
damage and the resulting lifespan of the affected embryo. However, the 
probabilities that these predicted functional interactions exist are only 49% and 















Figure 4.6: AMP gene expression is significantly up-regulated upon 
Sterile Laser Ablation of Stage 15 Embryos 
 
Comparison of the non-wounded and sterile laser ablated Stage 15 embryo 
transcriptomes elucidated that 9 AMP genes were significantly upregulated in 
wounded embryos (p!0.05). These included members of the Att, Cec, Drs and 
Mtk classes. The upregulation of AttA, AttD and Dro5 was particularly 
prominent, suggesting a preferential expression of these AMPs is mediated 
















































Table 4.13: Biological Process GO of Wound Modulated Genes 
 
Gene ontology description P value Number of genes 
Body morphogenesis 1.84E-10 8 
Cuticle development 2.81E-07 10 
Chitin-based cuticle 
development 3.00E-07 9 
RNA splicing, via 
transesterification 2.12E-02 8 
RNA splicing 2.37E-02 8 
RNA splicing via 
transesterification with bulged 
adenosine as nucleophile 3.09E-02 8 





















Table 4.14: Chitin-based cuticle development genes modulated upon 
wounding 
 


















Regulation of adult chitin-






















Table 4.15: Molecular Function GO terms associated with Wound 
Modulated Genes 
 
Gene ontology description Number of genes P-value 
Structural constituent of chitin-
based cuticle 21 3.39E-27 
Structural constituent of cuticle 21 6.66E-27 
Structural molecule activity 24 4.14E-19 
Structural constituent of chitin-
based larval cuticle 6 3.62E-08 
Fatty-acyl-CoA binding 2 8.91E-04 





Table 4.16: Cellular Component GO terms associated with Wound 
Modulated Genes 
 
Gene ontology description Number of genes P-value 
Extracellular matrix 10 6.45E-13 
Proteinaceous extracellular 
matrix 9 9.87E-13 
Extracellular region 18 2.75E-12 
Extracellular region part 12 5.46E-09 









Figure 4.7: Network analysis of the most significantly modulated genes 
upon sterile laser ablation of the Stage 15 embryo  
 
STRING 9.0 was utilized to predict networks of genes that may be upregulated 
upon damage stimuli in the Stage 15 embryo. Nodes represent proteins 
products encoded by the 100 most significantly modulated genes within the 
Stage 15 embryo upon sterile laser ablation. Black edges reflect predicted 
interactions based on co-expression evidence. Pink edges represent 
interactions predicted on experimental evidence. Blue edges reflect proposed 
interactions based on evidence of co-occurrence of protein products. Green 
edges are interactions that are predicted on text-mining evidence. One large 
central network was observed, which was dominated by members of the Twdl 
and Cpr families, although also incorporated previously unannotated genes 


















Table 4.17: Interactions between Unannotated Genes and Genes with 








interaction with Twdl or 
Cpr family member (AU) 
CG14147 TwdlB 0.915 
 TwdlBeta 0.887 
 TwdlV 0.811 
 Cpr56F 0.736 
 Cpr51A 0.804 
CG15731 TwdlV 0.621 
 TwdlB 0.872 
 TwdlM 0.750 
CG13041 TwdlB 0.871 
 TwdlBeta 0.423 
 TwdlM 0.881 
 Cpr78Cc 0.685 
 Cpr62Bc 0.445 
CG9083 Twdl B 0.778 
 TwdlM 0.669 
 Cpr51A 0.597 
CG13043 TwdlB 0.627 
 TwdlM 0.591 
 Cpr62Bc 0.475 
CG16885 Cpr62Bc 0.991 
CG14752 Cpr62Bc 0.597 
 
 
Red values highlight results that infer >90% chance that predicted protein-
protein interactions are true positive results.  
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4.2.6 The embryonic transcriptome upon PBS injection shares similarities to 
that induced upon sterile laser ablation and bacterial treatment 
 
To compare the effects of different types of sterile damage on the immune 
response of the Drosophila embryo, Stage 15 embryos were injected with 
PBS, alongside naïve controls and the transcriptional profiles of these 
embryos obtained via microarray studies. Comparison between the naïve and 
PBS injected transcriptomes (n=3) would then allow for identification of genes 
significantly modulated by this type of damage. Analysis of the resulting data 
permitted the identification of the 100 genes showing the greatest log fold up- 
or downregulation upon PBS treatment (Tables A10.1 and A10.2 respectively, 
Appendix 10). Due to variation in the samples, no genes were demonstrated to 
be significantly upregulated upon PBS treatment within the Stage 15 embryo, 
thus results should be viewed with caution.  
 
Considering the top 100 genes upregulated in the Stage 15 embryo upon PBS 
treatment (Table A10.1), many genes involved in cuticle development (28) 
were shown to be upregulated, as in the case of sterile laser ablation 
treatment. This included drop dead (drd), Obstructor-E (obst-E), members of 
the Twdl family, such as TwdlB, TwdlBeta, TwdlK and TwdlM, Cpr family 
members, such as Cpr100A, Cpr6Bc and Cpr65Ea, and Lcp family members, 
such as Lcp65Ac, Lcp65Ae and LcpAg1. Interestingly, other Twdl family 
members were induced upon sterile PBS injection that were not significantly 
induced by sterile laser ablation. These included TwdlC, TwdlD, TwdlL, TwdlN 
and TwdlP. This may indicate that different types of sterile damage may 
initiate differential cuticular responses within the Stage 15 embryo. More 
broadly, it would suggest that cuticle repair is an essential embryonic response 
to damage, regardless of the precise nature of damage or the method of its 
infliction.  
 
In terms of the genes downregulated upon PBS treatment of Stage 15 
embryos (Table A10.2), the range of gene functions was much greater. Two 
Cpr family members (Cpr47Ef and Cpr65Az) were downregulated upon PBS 
treatment, suggesting that the cuticlar response to damage is more complex 
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then simply an upregulatory gene network. Other genes involved in dorsal-
ventral axis specification (pipe, pip; shavenoid; sha), synaptic growth 
(highwire, hiw) and cell proliferation (liquid-facets related; lqfR). Moreover 
genes involved in ecdysone signaling were downregulated upon this form of 
sterile damage, such as Eip71CD and shd, concurrent with previous results 
(Chapter 3). Thus, the observed range of genes downregulated upon damage 
via sterile PBS injection was broader, and may reflect the downregulation of 
processes which are not necessarily required for wound healing.  
 
Comparison between the top 100 genes modulated by PBS injection and 
those modulated by Ecc15 (OD=1) and M. luteus (OD=1) infection was also 
performed; to determine the relative proportion of genes which may be 
modulated by both damage and infection. Transcriptomes of Ecc15, M. luteus 
or PBS injected embryos were compared to those of naïve embryos (n=3), and 
the top 100 genes up- or downregulated upon each of these treatments were 
selected and the content compared (Figure 4.8). These comparisons 
demonstrated that 56% of the top 100 upregulated genes were common to all 
three treatments (Figure 4.8A), suggesting that the majority of most highly 
upregulated genes in the Stage 15 embryos upon these treatments are due to 
sterile damage, and not bacterial infection itself. However, it was also 
interesting to note that further subsets of upregulated genes were only shared 
between the Gram-positive or Gram-negative infected and PBS injected 
transcriptomes; with 12% and 9% of genes shared between Ecc15 and PBS 
injected and M. luteus and PBS injected embryos respectively. A similar trend 
was noted within the top 100 genes downregulated upon these treatments 
(Figure 4.8B). In this case, however, the overlap of genes was much smaller, 
with only 26% of genes showing downregulation upon all three treatments. 
Moreover, the proportion of overlap between PBS and Ecc15 downregulated 
genes was much lower, with only 1% of genes downregulated by both 
treatments. Conversely, PBS and M. luteus downregulated genes 
demonstrated a 17% overlap; an increase proportion compared to that of the 
upregulated genes. Taken together, this could suggest that these two bacterial 
species may have their own specific interactions with the damage response, 
leading to the stimulation and repression of individual gene targets. This 
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observation could be further substantiated by the fact that some genes 
appeared to be upregulated or downregulated solely upon PBS injection 
alone, and not by either injection of Ecc15 or M. luteus (Figure 4.8C); 
permitting the identification of genes which may be crucial to the damage 
response alone. These include structural components of the chitin cuticle 
(Tubby, Tb; Cpr65Ec), Tetraspanin 42Er (Tsp42Er), Cytochrome P450 
enzymes (Cyp4AD1), genes involved in cell adhesion and tissue regeneration 
(Ninjurin A; nijA), and odorant binding proteins (Obp47b).  
 
Therefore, damage inflicted by sterile PBS injection of Stage 15 embryos 
upregulated many families of genes which were also activated by sterile laser 
ablation, indicating that the broad damage response within the Drosophila 
embryo is mediated irrespective of the nature of damage. However, the fact 
that different family members were induced upon sterile laser ablation and 
sterile PBS injection may indicate that there is a greater degree of specificity in 
the damage response itself. Furthermore, comparison of PBS and bacterial 
infected embryo transcriptomes eludicated that a large proportion of genes 
modulated upon these treatments may be due to damage, although subsets of 

















Figure 4.8: Comparison of the top 100 upregulated and downregulated 
genes upon PBS, Ecc15 and M. luteus treatment in Stage 15 embryos.  
 
(A-B) The top 100 genes that were observed to be modulated upon PBS, 
Ecc15 (OD=1) or M. luteus injection (OD=1) were compared to determine the 
potential overlap of gene expression upon these treatments, and to determine 
if any damage specific genes could be identified. Results were normalized to 
naïve transcript levels for these analyses (n=3). In the lists of the top 100 
upregulated genes for each treatment (A), 56% of genes upregulated by PBS 
injection were also upregulated in both Ecc15 and M. luteus treated embryos. 
12% and 9% of genes upregulated by PBS injection were observed to overlap 
with Ecc15 and M. luteus upregulated genes respectively. The top 100 
downregulated genes for each treatment showed a similar trend (B), but to a 
lesser degree; with 26% of genes downregulated in all three treatments, 1% 
downregulated by both PBS and Ecc15 treatment and 17% downregulated by 
both PBS and M. luteus treatment. These comparisons also identified subsets 
of genes which were modulated by PBS injection alone (C), and hence may be 



































































































 4.2.7 Analysis of hemocyte transcriptional profiles upon infection and damage 
stimuli reveals modulation of genes involved in oxidation-reduction, 
transcriptional regulation and tracheal development, but also a lack of potential 
hemocyte-specific gene modulatory networks 
 
To more closely assess the contribution of hemocytes to the total immune 
response of the Drosophila embryo, Stage 15 embryos expressing GFP 
specifically within hemocytes using the Gal4-UAS system were injected either 
with sterile endotoxin-free PBS or Ecc15 (OD=1). The hemocytes from these 
embryos were subsequently isolated by FACS, alongside those from 
equivalent naïve controls. The RNA was extracted from the sorted hemocytes 
and utilized in preliminary microarray studies (n=1), to examine the 
transcriptional profiles of hemocytes upon infection with Ecc15 and 
mechanical damage induced via PBS injection. Analysis of the resulting data 
from these experiments permitted the identification of the 100 genes showing 
the greatest log fold up or downregulation upon either Ecc15 or PBS treatment 
(Tables A11.1, A11.2, A12.1, A12.2; Appendices 11 and 12).  
 
The 100 most highly up- and down-regulated genes within hemocytes upon 
Ecc15 infection can be viewed in Tables A11.1 and A11.2 respectively. 
Considering the 100 most upregulated genes within hemocytes upon Ecc15, 
the highest fold change in expression (11.454-log fold) was noted in the 
Ionotropic receptor 41a (Ir41a), which plays a role as an olfactory receptor and 
has been shown to be derived from ionotropic glutamate receptors (Benton et 
al., 2009; Croset et al., 2010). Other notable hits include genes involved in the 
oxidation-reduction process, such as the oxidoreductase ninaG, Cyp4p1 and 
Cyp4d8. Notably, Cyp4p1 and Cyp4d8 have also been demonstrated to 
possess iron and heme binding properties (Flybase Curators, 2004). Further 
genes were observed to encode proteins involved in transcription and mRNA 
processing, such as the post-translational gene silencer argonaute 3 (AGO3), 
Nuclear export factor 3 (Nfx3), the RNA metabolism regulator Antennapedia 
(Antp) and the regulators of transcription Forkhead Domain 96Ca (fd46Ca), 
poils au dos (pad) and sisterless A (sisA). However, upregulation of genes 
implicated in protein transport, such as Rab9Db, and proteolysis, such as 
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Pepsinogen-like (Pcl), tolloid (tld) and Nep5, was also observed. Interestingly, 
upregulation of genes such as dead end (dnd) and branchless (bnl), which are 
required for tracheal branch fusion (Jiang et al., 2007; Kakihara et al., 2008) 
and morphogenesis of branching epithelia (Affolter and Shilo, 2000) as part of 
tracheal development respectively, may suggest an interplay between the 
tracheal network and hemocytes upon Ecc15 infection. Likewise, the 
hemocyte upregulation of Rfx and Ndc80 may be indicative of interaction with 
the embryonic nervous system upon Ecc15 infection, due to their observed 
roles in neurogenesis (Dubruille et al., 2002; Neumuller et al., 2011). Other 
highly upregulated genes have previously been implicated in cell adhesion 
(brother of ihog, boi), the stress response and life-span (methuselah-like 9, 
mthl9), actin filament organization (RhoGAP18B), anion transport 
(Bestotrophin 1, Best 1; Organic anion transporting polypeptide, Oatp33Eb) 
and DNA double-strand break processing (Meiotic-W8, Mei-W8). Furthermore, 
when assessing the 100 genes experiencing the greatest downregulation in 
hemocytes upon Ecc15 infection (-4.284 to -6.619 log fold-change; Table 
5.22), some findings clearly complement the upregulatory response. For 
instance, downregulation of bru-2, a negative regulator or translation, and ss, 
a negative regulator of transcription, is consistent with the upregulation of 
genes involved in mRNA processing and transcription.  Moreover, the 
downregulation of Serpin43Ab (Spn43Ab) is concordant with large increases 
in serine endopeptidase gene expression observed. Other hits of interest 
include downregulation of gless, which has been implicated in the cellular 
response to stress and as a negative regulator of apoptosis (Grant et al., 
2010). However, it is also notable that not all results would be indicative of an 
effective hemocyte immune response. For example, downregulation of 
inscuteable (insc), which plays a role in survival to bacterial infection (Berkey 
et al., 2009), was observed, alongside substantial decreases in expression 
Hormone Receptor-like in 39 (Hr39), a 20-HE signaling target gene implicated 
in autophagic cell death (Takemoto et al., 2007). Of particular interest is the 
downregulation of wing blisters (wb) and pole hole (phl), whose expression is 
required for correct tracheal development (Martin et al., 1999; Jiang and 
Edgar, 2009), as well as ZAP3 and extra-extra (exex), which are genes 
required for neuron projection morphogenesis and central nervous system 
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development respectively (Odden and Doe, 2001; Broihier and Skeath, 2002; 
Sepp et al., 2008). However, the downregulation of these genes within 
hemocytes is also seemingly in contradiction with the nature of genes 
upregulated in hemocytes upon Ecc15 infection. Moreover, downregulation of 
genes implicated in hemocyte maintenance and proliferation were also 
observed; for instance, Phl, also required for the survival of circulating 
hemocytes in Drosophila (Sackton et al., 2010) and couch potato (cpo), a 
regulator of hemocyte proliferation (Sinenko et al., 2010), were highly 
downregulated in hemocytes upon Ecc15 infection, potentially contraindicating 
the requirements of the embryo host and enabling Ecc15 to proliferate 
unchecked.  
 
The genes most highly modulated upon damage induced by PBS injection 
(Table A12.1, Appendix 12) displayed similar trends in terms of broad function 
to those modulated by Ecc15 infection. For example, many genes involved in 
the oxidation-reduction process were highly upregulated, including laccase2, 
Cyp6t1, Cyp4t1, Cyp316a1 and peroxidase (pxd). Numerous members of the 
Cpr family of genes (Cpr97Ea, Cpr66Cb, Cpr64Aa) were also upregulated in 
hemocytes, possibly suggestive of a role in the repair of damaged cuticle 
following the injection process. Other hits of interest encompassed genes with 
function in phagocytosis (pxd), macroautophagy (Buffy), actin polymerization 
(Verprolin 1, Vrp1; Diaphanous, Dia), 20-HE biosynthesis (neverland, nvd), 
nervous system development (minibrain, mnb; nubbin, nub) and calcium 
binding (Troponin C at 41C, TrpC41C). Of notable interest was the up-
regulation of PGRP-LB, a negative regulator of IMD signaling (Zaidman-Remy 
et al., 2006), and lozenge (lz), a gene required for effective wound healing in 
Drosophila larvae (Galko and Krasnow, 2004). Similar to the nature of genes 
observed to be downregulated in hemocytes upon Ecc15 treatment, negative 
regulators of transcription, such as scratch (scrt) and net, were observed to be 
downregulated upon PBS treatment (Table A12.2, Appendix 12); this may be 
suggestive of a mechanism to maintain the increased levels of transcription 
required by hemocytes to mediate an effective response to damage. 
Interestingly, in addition to those observed to be upregulated upon PBS 
treatment, some genes involved in the oxidation-reduction process were 
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observed to be downregulated upon injection-induced damage; these included 
Protoporphryiogen oxidase (Ppox) and puglist (pug). Also of note was the 
down-regulation of genes involved in the defense response to bacterial 
infection, such as Heat Shock Factor (Hsf), Dorsal Interacting Protein 3 (Dip3) 
and Taspase 3, and genes implicated in the DNA damage response, including 
Xeroderma pigmentosum D ortholog (Xpd). Therefore, the hemocyte 
transcriptional responses to damage and infection show a degree of similarity, 
in that they involve modulation of genes that play roles in some similar 
biological processes, although there appears to be a distinct division of genes 
that are modulated by each of these different stimuli. Moreover, there also 
appears to be a division in the modulation of genes with functions in the same 
biological processes; with some genes experiencing up-regulation and other 
experiencing down-regulation upon the same stimuli.  
 
Intriguingly, of the top 100 genes up-regulated in hemocytes upon Ecc15 
infection or PBS injection, only 11% were observed to be commonly 
upregulated by both treatments (Figure 4.9A). These include genes encoding 
the 20-HE biosynthetic enzyme phantom (phm), the serine endopeptidase 
Corin, the regulator of myoblast fusion M-spondin (mspo), Phosphodiesterase 
1c (PDE1c) and the oxidoreductase CG33093 (Figure 4.9B). A similar trend 
was noted for the most highly downregulated genes in hemocytes upon Ecc15 
or PBS injection; there was 7% overlap in the top 100 hits (Figure 4.9A). 
These common genes encode proteins implicated in lipid and carbohydrate 
metabolism (CG31414, CG31871), neurogenesis (CG42588), tryptophanyl-
tRNA aminoacylation (CG7441) and actin filament organization or regulation of 
cell shape (CG7497) (Figure 4.9B). Therefore, Ecc15 infection and damage 
promote highly disparate profiles of transcriptional modulation within 
hemocytes, in terms of the 100 genes most highly modulated upon these 
treatments, with relatively little overlap. Where overlap of gene modulation 
exists, this would suggest that these genes are not specific infection-
responsive genes, since the damage induced via PBS injection is also able to 
highly stimulate their expression. Thus, these common genes represent 
potential damage-responsive gene targets, contributing to biological processes 
that may be regulated by damage stimuli.  
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STRING analysis to detect known and theorized gene-gene/protein-protein 
interactions was employed on the lists of candidate genes in Tables A11.1, 
A11.2, A12.1 and A12.2; to identify any potential gene networks that are 
responsive to infection and damage stimuli within hemocytes. Surprisingly, 
despite the large fold-changes observed, very few interactions appear to exist 
between the 100 most modulated gene products upon both Ecc15 and PBS 
injection in hemocytes. For instance, considering firstly the network analysis of 
those genes upregulated in hemocytes by Ecc15 infection (Figure 4.10), there 
are only 4 predicted interactions. These are between Phosphodiesterase 1c 
(PDE1c) and Adenylate cyclase 3 (Ac3), Cardioacceleratory peptide (Ccacp) 
and CG11475, and CG18371, a gene encoding a protein with proposed 
acylphosphatase activity (Flybase Curators, 2004), with both CG3085 and 
CG9406, which have been implicated in microtubule organization and calcium 
ion binding respectively (Flybase Curators, 2004). Moreover, none of these 
predictions have a high probability of reflecting true protein-protein interactions 
(Figure 4.10), with the exception of that concerning PDE1c and Ac3. A similar 
lack of interactions was predicted between the genes most significantly 
downregulated upon Ecc15 infection in hemocytes (Figure 4.11). 9 interactions 
were predicted over 4 separate networks, with the probability score for the 
majority of these predictions being relatively low. The largest downregulatory 
network observed consists of 5 nodes and 5 edges, constructed on the 
evidence of co-expression data. CG14814, a gene of unknown function, is the 
central node, with predicted interactions with genes involved in spindle 
assembly (dgt5 and Cks30A), a gene with predicted transposase activity 
(CG4570), and a gene of unknown function, which may also interact with 
Cks30A (CG8924). Thus, CG8924 and CG14814 may potentially play roles in 
cell division and may be co-downregulated upon Ecc15 infection in 
hemocytes. Interestingly, other minor predicted downregulatory networks 
identified implied co-regulation of genes involved in DNA repair (Rad9, 
Spindle-B (spn-B) and CG30169), and in cation transport (Shaker (Sh) and 
Small Conductance Calcium-activated potassium channel (SK)). Therefore, 
STRING analysis of the 100 genes which demonstrated the greatest up or 
downregulation upon Ecc15 infection in hemocytes would suggest an apparent 
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lack of interactions between their resulting protein products, and hence would 
infer an absence of either upregulatory or downregulatory gene networks that 
respond to Ecc15 infection in hemocytes.  
 
However, this effect is not limited to Ecc15 treatment, as hemocyte 
transcription profiles upon PBS injections also display a stark absence of 
potential interactions. The resulting predicted networks of the 100 most highly 
upregulated genes in hemocytes upon PBS injection are relatively few and 
simplistic in nature (Figure 4.12). The largest predicted interaction network 
consists of 4 nodes and 4 edges, the cornerstone of which is Tsp42Ec, an 
uncharacterized tetraspanin-encoding gene. Of the other genes in this 
network, the functions of CG15423 and CG4377 are unknown and that of 
CG3987 remains relatively undefined, although there is evidence to suggest 
that upregulation of this gene may be important in the response to 
parasitisation (Roxstrom-Lindquist et al., 2004) and in mesoderm development 
(Furlong et al., 2001). A predicted interaction between CG33093 and 
CG15829 further highlights the importance of oxidation-reduction reactions 
upon PBS injection, as these genes are proposed to play roles within this 
process (Flybase, 1992; Flybase Curators, 2004). Moreover, the proposed 
network between Zwilch, a gene implicated in mitosis (Williams et al., 2003), 
and two genes of unknown function (CG11120 and CG9023), may further 
highlight the requirement for new cells to replace those damaged in response 
to ROS generated by the damage incurred from injection, as well as permitting 
the preliminary functional annotation of two previously uncharacterized genes. 
Conversely, greater numbers of the most highly downregulated genes within 
hemocytes upon PBS injection form a much more coherent interactive network 
(Figure 4.13), consisting of 12 nodes and 11 edges, representing interactions 
via a combination of co-expression, co-occurrence, experimental, database 
and literature evidence. Moreover, many of the interactions within this central 
network are predicted to be highly probable, as highlighted in red in Figure 
4.13. For example, the interactions between the central elements of the 
network (RpI135, Xpd, Tbp and CG9305) are all estimated to have a 
probability score of !90%. These aforementioned genes play roles within gene 
transcription within Drosophila systems, either as subunits of RNA polymerase 
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I (RpI135), or transcription factors (Xpd and Tbp). Other genes within this 
central network, such as Hsf, CG9630 and Trf also have functions within 
transcriptional processes (Hansen et al., 1997; Chen et al., 2009; Takeda et 
al., 2000), inferring that this structure may represent a downregulatory network 
to modulate transcription. Another highly probable interaction was that 
between synaptojanin (synj) and the inositol 1-2C4-2C5-2C-trisphosphate 
receptor (Itp-r38A), suggesting a role for the downregulation of the 
phosphatidylinositol signaling system upon damage signaling.  
 
Taken together, these results suggest that the hemocyte transcriptional 
response to damage and Ecc15 infection is highly diverse, potentially 
contributing to an array of different biological processes. Whilst there is a 
limited degree of overlap between modulated genes within these responses 
and the biological processes that they potentially mediate, the transcriptional 
profiles of the hemocyte upon damage or infection were distinct. However, the 
apparent lack of hemocyte upregulatory or downregulatory transcriptional 
networks may imply that genes within hemocytes are modulated in individually 

















Figure 4.9: Top 100 genes commonly up- and down-regulated in 
hemocytes upon Ecc15 infection and PBS injection 
 
(A-B) Comparison of genes commonly modulated in hemocytes upon Ecc15 
or PBS treatment. (A) Of the top 100 most significantly up- or down-regulated 
genes in hemocytes upon Ecc15 or PBS injection, only 11% and 7% were 
commonly up or down-regulated respectively, suggesting relatively distinct 
responses by hemocytes to damage and infection. (B) List of genes commonly 
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Figure 4.10: Network analysis of the top 100 genes upregulated in 
hemocytes upon Ecc15 treatment 
 
STRING network analysis demonstrated that very few interactions were 
predicted between genes upregulated in hemocytes by Ecc15 treatment, 
suggesting that expression of these genes is not increased in a large 
upregulatory network. Only 4 predicted interactions were noted, and only that 
between Phosphodiesterase 1c (Pde1c) and Adenylate cyclase 3 (Ac3) was 
predicted to be a highly probable interaction. All other predicted interactions 
were attributed with much lower probability scores, indicating that they are less 
likely to have a true biological basis. Black edges reflect predicted interactions 
based on co-expression evidence. Blue edges reflect proposed interactions 
based on evidence of co-occurrence of protein products. Green edges are 





















Interacting Gene A Interacting Gene B Probability of 
interaction (AU) 
CG3085 CG18371 0.637 
CG9406 CG18371 0.433 
Ccap CG11475 0.401 










Figure 4.11: Network analysis of the top 100 genes downregulated in 
hemocytes upon Ecc15 treatment 
 
STRING network analysis detected the presence of highly simplistic 
downregulatory networks of genes within hemocytes that responded to Ecc15 
treatment. 4 different networks, consisting of a total of 12 nodes were 
identified. Annotations of genes suggested that these minor networks may 
function to regulate processes related to cell division, ion transport and DNA 
repair. However, the majority of interactions depicted were attributed low 
probability scores, with the exception of that between CG30169 and Rad9 
(highlighted in red). Black edges reflect predicted interactions based on co-
expression evidence. Pink edges represent interactions predicted on 


















Interacting Gene A Interacting Gene B Probability of 
interaction (AU) 
Sh SK 0.530 
CG30169 Spn-B 0.428 
 Rad9 0.892 
CG14814 Dgt5 0.565 
 CG4570 0.458 
 Cks30A 0.599 
 CG8924 0.585 
CG8924 Cks30A 0.402 





Figure 4.12: Network analysis of the top 100 genes upregulated in 
hemocytes upon PBS treatment 
 
STRING network analysis of the top 100 genes upregulated in hemocytes 
upon PBS treatment predicted only few interactions between these genes, in 
three different network structures. The functions of these genes may suggest a 
role for these networks in the oxidation-reduction and DNA repair processes. 
However, none of these interactions were attributed with a high probability 
score. Black edges reflect predicted interactions based on co-expression 




















Interacting Gene A Interacting Gene B Probability of 
interaction (AU) 
CG15423 CG3987 0.477 
 Tsp42Ec 0.704 
Tsp42Ec CG3987 0.675 
CG3987 CG4377 0.637 
Cpr97Ea Cpr66Cb 0.595 
CG33093 CG15829 0.470 
Zwilch CG11120 0.417 






Figure 4.13: Network analysis of the top 100 genes downregulated in 
hemocytes upon PBS treatment 
 
STRING network analysis of the top 100 genes downregulated in hemocytes 
upon PBS treatment revealed one predicted network and two individual 
interactions of interest. The network identified consisted of 12 nodes and 11 
edges, and was composed of genes that may have roles in the regulation of 
transcription. Moreover, some of these predicted interactions were associated 
with a probability score of !90% (highlighted in red), validating their existence. 
Black edges reflect predicted interactions based on co-expression evidence. 
Blue edges reflect proposed interactions based on evidence of co-occurrence 
of protein products. Green edges are interactions that are predicted on text-














Interacting Gene A Interacting Gene B Probability of 
interaction (AU) 
Tbp CG9305 0.899 
 Trf 0.750 
 Nej 0.609 
 Hsf 0.593 
 Xpd 0.928 
Nej Glut1 0.899 
Rpl135 Xpd 0.933 
 CG9630 0.706 
 Aats-ile 0.675 
Aats-ile CG7441 0.798 
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 pug 0.573 
Ltp-r83A Synj 0.899 


































4.3.1 Transcriptional profiling confirms the immune potential of the Stage 15 
Drosophila embryos and facilitates the identification of novel infection-
responsive gene for further study 
 
The primary aim of these experiments was to assess the nature of the global 
transcriptional changes upon bacterial and damage stimuli within the Stage 15 
embryo, to identify potential novel infection- and damage-specific genes and 
ultimately to identify potential candidate genes for further study. To achieve 
this objective, the transcriptional profiles of Stage 15 embryos injected either 
with Ecc15, a Gram-negative bacterium, or M. luteus, a Gram-positive 
bacterial species, or sterile PBS were initially compared to that of naïve 
embryos; to detect if infection and damage induced modulation of immune 
genes within the Stage 15 embryo could be detected via the microarray 
methodology. Subsequently, further comparisons between PBS and bacterial 
injected transcriptomes permitted the identification of significantly upregulated 
infection genes that were either unique or common to both types of infection.  
 
This approach confirmed that bacterial species are able to activate a range of 
immune responses within the Stage 15 Drosophila embryo, consistent with 
previous results chapter (Chapter 3). For instance, Ecc15 infection induced 
expression of genes involved in IMD, JAK-STAT and JNK signaling, consistent 
with results from larval gut models (Buchon et al., 2009a; Buchon et al., 
2009b); demonstrating the relatively advanced immune capabilities of the 
Drosophila embryo. Interestingly, Ecc15 infection also induced the expression 
of proPO-A1, a gene involved in the melanisation cascade (Cerenius et al., 
2008). Whilst no melanisation had been noted within embryos upon infection 
(data not shown), this result would corroborate data suggesting that 
modulation of genes involved in the melanisation cascade occurs upon Ecc15 
infection within the embryo (Chapter 3) and thus confirm the notion that 
embryos are capable of mediating a melanisation response. Moreover, 
upregulation of genes involved in encapsulation and autophagy, as well as the 
immune gene edin, would infer that the global immune response in Drosophila 
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embryos is relatively extensive. The transcriptional profile of embryos infected 
with M. luteus further consolidated this paradigm, with the upregulation of 
genes involved in JAK-STAT signaling, opsonisation and phagocytosis. 
Moreover, the fact that genes were identified that responded uniquely to 
Ecc15 or M. luteus infection suggests that the embryo is able to mediate 
complex, distinct immune responses to Gram-negative and Gram-positive 
infections that far surpass the basic differential expression of AMP genes.  
 
Furthermore, one clear advantage of performing microarray screens as 
opposed to the study of individual candidate genes was that this approach 
permitted the investigation of a much wider range of genes in concert, and 
hence identified novel and interesting effects of infection upon the host 
transcriptome. One such interesting result was the upregulation of PGRP-LF 
specifically by Ecc15 infection. PGRP-LF is a negative regulator of the IMD 
signaling cascade (Persson et al., 2007; Maillet et al., 2008; Basbous et al., 
2011); its mechanism of action remains unclear, although evidence suggests 
that it may either act as a decoy receptor for PGN (Persson et al., 2007) or 
compete with PGRP-LC within multimer complexes to bind PGN, hence 
dampening down IMD pathway activation (Basbous et al., 2011). As such, it 
was relatively surprising that PGRP-LF expression was so highly upregulated 
by Ecc15 infection, especially as induction of Gram-negative AMP genes was 
also detected. Since M. luteus infection did not have the same effect on 
PGRP-LF induction, the increase observed must be either Gram-negative or 
Ecc15 specific. Kleino (2010) demonstrated that S2 cells incubated with E. coli 
also induced PGRP-LF expression at 4 hours after application. Thus, one 
possible explanation may be that the embryonic host specifically upregulates 
expression of PGRP-LF to ensure that the acute immune activation required to 
eliminate the pathogen does not lead to a chronically upregulated immune 
state, which could be potentially damaging. The fact that the upregulation 
within the embryo is observed at an earlier time-point post infection (2 hours) 
is potentially a testament to the highly immunogenic nature of Ecc15 itself 
(Basset et al., 2000; Tzou et al., 2000; Foley and O’Farrell, 2004), thus 
necessitating a less prolonged immune response. Alternatively, this early 
upregulation could indicate subversion of the embryo host immune machinery 
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by Ecc15; to dampen down the immune response so that the infection may 
continue to thrive. This paradigm could be similarly applied to the upregulation 
of Bruce, a negative regulator of autophagy (Hou et al., 2008; Nezis et al., 
2010). The observed upregulation of Bruce expression upon Ecc15 infection 
may suggest an inhibition of the autophagic clearance of invading bacteria, 
which is not necessarily concordant with the requirements of the embryonic 
host. However, it is well established that overstimulation of the autophagy 
machinery can subsequently lead to cell death (White, 2008), which also may 
not be favourable for the embryo given the potentially wide and random spatial 
distribution of concentrated bacteria within its tissues. Thus, to determine if 
upregulation of gene candidates such as PGRP-LF and Bruce are a result of 
host subversion by Ecc15 or the host’s response to prevent a run-away 
immune response, further experimental evidence is required. One way to 
address this issue would be to monitor PGRP-LF or Bruce expression in the 
embryo upon infection with a similarly pathogenic Gram-negative bacterium, to 
determine if the changes in PGRP-LF and Bruce are specific to Ecc15.  
 
Furthermore, analysis of the embryo transcriptome upon M. luteus infection 
also yielded novel, interesting results. The observation that TepI expression 
was induced uniquely upon M. luteus infection was of notable interest, as 
relatively little is known about the function of this tep family member in 
Drosophila. The nature of this embryonic expression would suggest that TepI 
is beneficial to the embryo host in mediating an immune response to Gram-
positive infection, and dispensable for the response to Gram-negative 
infection. However, this is in contradiction to previous work by Stroschein-
Stevenson et al. (2005), who found no positive or negative benefits of TepI 
expression on the phagocytosis of E. coli, S. aureus or C. albicans in S2 cells. 
However, it could be argued these results may not be entirely indicative of 
TepI activity or its role in vivo. Moreover, given the fact that producing immune 
effectors is a costly activity for the host (Sadd and Siva-Jothy, 2006; Sorci and 
Faivre, 2009), it would be surprising if the observed upregulation in TepI 
expression did not confer some form of benefit for the embryo upon infection. 
Therefore, further investigation would be required to validate this result and to 
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establish if TepI expression is restricted to the embryonic response to Gram-
positive pathogens.  
 
Interestingly, despite the relatively disparate effects of Ecc15 and M. luteus 
infection on the embryonic transcriptional profile discussed so far, both 
infection types also induced the upregulation of a common subset of genes. 
These genes formed a large proportion of the 200 most significantly 
upregulated genes for each infection type (36.5%). This would broadly suggest 
that a large proportion of the global response to infection is relatively aspecific 
in terms of infection-type. This notion is confirmed by the observation that the 
functions of many of these commonly upregulated genes are not immune-
specific, but nevertheless may suggest a more general response to stress or 
an increase in normal cell operations, possibly to cope with the demands of a 
sudden and urgent global transcriptional change. This perspective is 
confirmed to an extent by the results of De Gregorio et al. (2001), whose 
examination of the transcriptional profile of adult flies after infection with a 
mixture of M. luteus and E. coli also documented modulation of genes with 
more general functions, such as induction of genes encoding lipases and 
lysosomal enzymes. Nevertheless, the majority of remaining gene hits 
reported by De Gregorio et al. (2001) had at least a putative if not clear 
immune annotation. This is in contrast to the results of our microarray study, 
as the only gene with a clear immune function that was commonly upregulated 
by both Ecc15 and M. luteus infections was spz4. Spz4 is a homologue of Spz 
that was discovered by Parker et al. (2001) via iterative searching of the 
Drosophila genome. Due to its sequence similarity to Spz, Spz4 has thus been 
inferred to be capable of activating Toll signaling (Parker et al. 2001). 
Expression studies highlighted that Spz4 is strongly expressed in larvae and 
adults, and has been suggested to play an ancillary role in the response to 
fungal or Gram-positive pathogens (Parker et al., 2001). Therefore, the fact 
that Spz4 expression was upregulated upon both Ecc15 and M. luteus 
infection within the embryo is surprising and it is interesting to speculate about 
the particular role that Spz4 may be playing in these distinct responses. 
Similar to the hypothesis of Parker et al. (2001), Spz4 could potentially be 
providing supporting role in the embryo response to M. luteus; amplifying the 
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amount of ligand available for Toll pathway activation. A possible function for 
Spz4 upon Ecc15 infection may involve the cross-activation of the IMD and 
Toll pathways. There is much evidence to suggest that cross-talk exists 
between the IMD and Toll signaling cascade (Bangham et al., 2006; 
Matskevich et al. 2010), but any mechanistic detail describing how this might 
work in practice remains relatively elusive. Thus, the expression of Spz4 upon 
Ecc15 infection may contribute to this phenomenon. Moreover, this proposed 
role for Spz4 would potentially explain the high levels of Def expression 
consistently noted upon Ecc15 infection, both in the embryo system and in 
other Drosophila immunity models (Lemaitre et al., 1997; Buchon et al., 2009). 
To determine the contribution of Spz4 to the total embryo immune response, 
infection studies could be performed with Spz4-deficient embryos, permitting 
the observation of the viability of these embryos or the AMP gene induction 
post infection.   
 
In a broader context, it is also interesting to speculate if infection by Gram-
positive and Gram-negative bacterial species leads to significantly different 
transcriptomic profiles. Clearly, a common subset of genes is modulated upon 
both Ecc15 and M. luteus infection, indicating that some genes may simply 
respond in a manner that is simply ‘infection’ or ‘non-infection’. However, the 
fact that further different subsets of genes are modulated upon Ecc15 or M. 
luteus infection alone is suggestive that Gram-negative and Gram-positive 
bacterial species may induce their own individual transcriptomic ‘signature’ 
within the host. It is not possible to confirm this notion from the data presented; 
transcriptomic studies could be performed on a wider range of Gram-negative 
and Gram-positive bacterial species, such as Escherichia coli, Salmonella 
typhimurium, Staphylococcus aureus and Enterococcus cloceae, to determine 
if there are genes that are modulated solely in response to Gram-negative and 
Gram-positive infections. It would also permit the identification or confirmation 
of aspecific genes that are modulated upon infection. It may also be interesting 
to correlate differences in host transcriptomic signatures and the degree of 
relatedness between infecting bacteria species; for instance, do more closely 
related species produce more significantly similar transcriptional profiles than 
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more distantly related species, and if so are there marker genes to indicate 
infection by a particular genera of bacteria?  
 
Therefore, these results would suggest that the embryonic global response to 
bacterial infection is relatively comparable to that of other Drosophila immunity 
models, further substantiating the status of the Drosophila embryo as a valid 
immunity model. Moreover, this data highlights the very distinct nature of the 
embryonic response to Gram-negative and Gram-positive infections that is 
more complex and extensive than simply a differential expression of AMP 
genes, leading to the identification of potential candidate genes that may be 
considered for validation by RT-qPCR and further study. In particular, it is 
interesting to speculate of the existence of Gram-positive and Gram-negative 
global transcriptomic signatures, which could be discerned by conducting 




4.3.2 Sterile laser ablation upregulates AMP genes as well as a network of 
cuticular proteins genes 
 
Further microarray studies permitted the comparison of the transcriptional 
profile of Stage 15 embryos wounded by sterile laser ablation to that of non-
wounded embryos; to further examine the range of genes modulated upon 
damage within the Stage 15 embryo and to potentially identify novel wound-
responsive genes. Analysis of the 100 genes demonstrating the most 
significant modulation upon laser ablation revealed significant upregulation of 
genes involved in cuticle development and structure, as well as mRNA 
splicing. Further GO analysis of these genes demonstrated confirmed an 
enrichment of GO terms relating to cuticular functions and extracellular space 
components, highlighting the importance of cuticle development and integrity 
upon wounding. Of particular note was that many of the cuticular genes 
upregulated upon wounding within the embryo appeared to be interacting in an 
upregulatory network, incorporating many genes of unknown function and 
hence permitting the inference of provisional functional annotations for these 
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genes. The cuticle, a structure composed of chitin fibrils embedded in a 
protein-lipid matrix (Cohen, 1987), is essential for maintaining the structural 
integrity of Drosophila larvae (Ostrowski et al., 2002), as well as serving as a 
defense barrier against infection by pathogens (Tzou et al., 2002). Its 
importance is further highlighted by the embryonic lethality observed when any 
one gene required for proper cuticle deposition or morphogenesis is 
zygotically disrupted (Ostrowski et al., 2002). Interestingly, epidermal cells 
deposit the cuticle during Stage 16 of embryogenesis (Ostrowski et al., 2002); 
at a time-point close to the time of wounding by laser ablation at Stage 15. 
Thus, with a significant structural failure of the epidermis, it could be expected 
that genes related to cuticle development might be downregulated as a direct 
result. However, we know that the opposite is true; that genes belonging to the 
Twdl, Cpr and Lcp families that regulate cuticle development are upregulated 
upon laser ablation within the Stage15 embryo. Therefore, it might be 
speculated that expression of genes such as Twdl family members, whose 
protein products are inserted into the cuticular matrix (Guan et al., 2006) and 
thus contribute directly to cuticle deposition, is upregulated in the remaining 
epidermal cells, to compensate for the loss of a significant number of cells that 
would have contributed to cuticle deposition and ultimately to ensure that 
embryo viability is preserved. A further reason for the upregulation of a 
cuticular gene network may be to preserve the structure of the embryo and 
protect against infection from opportunistic pathogens whilst epidermal 
damage is repaired.   
 
Analysis of the wounded embryo transcriptome also provided further 
confirmation that damage alone can stimulate AMP gene induction, and hence 
an immune response, within the Drosophila embryo. In light of the discovery 
that immune gene induction upon infection is greater when accompanied by 
injury (Braun et al., 1998) and that increased survival rates upon bacterial 
infection are noted in flies that have received a previous injury (Apidianakis et 
al., 2005), it could be speculated that induction of AMP genes by injury may 
play a role in priming the host defense to future infection or structural 
compromise of the vitelline membrane which in turn would permit the entrance 
of pathogens into embryo tissue. AMP genes that were significantly induced 
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included members of the Att, Cec, Drs and Mtk AMP classes. This is in 
concordance with the work by Stramer et al. (2008), who demonstrated that 
sterile laser ablation could induce the expression of a Drs-GFP reporter in fat 
body and hemocytes in Drosophila embryos of a similar stage. Moreover, the 
range of AMPs that were significantly upregulated by sterile laser ablation was 
relatively consistent with that observed by Patterson et al. (2013) upon pinch 
wounding of Drosophila embryos. However, the fold changes in expression of 
AMPs upon pinch wounding noted by Patterson et al. (2013) was generally 
much greater than those observed in our sterile ablation system. For instance, 
3.89-fold change in AttA expression was observed upon sterile ablation as 
opposed to the 11.6-fold change observed by Patterson et al. (2013). This 
could be attributed to the nature of damage inflicted; whilst sterile laser 
ablation in embryos removes only one epithelial population in a concentrated 
area, mechanical damage caused by puncturing may lead to much greater 
disruption of multiple layers of tissue, suggesting that AMP production in 
response to damage is proportionate to the level of damage inflicted. 
Regardless of the levels of induction, it is clear that damage induces a 
preferential induction of a subset of AMPs. For example, of the AMP genes 
significantly upregulated by sterile laser ablation, AttA, AttD and Dro5 were 
particularly highly induced. This combination encompasses both Gram-
negative and Gram-positive AMPs, suggesting that there is no bias towards 
the expression of a particular broad AMP class. Further experiments using 
Drosophila transgenic AMP reporter lines would enable the determination of 
the site of expression for these AMP genes upon sterile laser ablation within 
the Stage 15 embryo, and potentially give insight into their individual roles 
upon damage.   
 
However, the range of immune genes upregulated by sterile laser ablation did 
not encompass only those encoding AMPs. Another interesting observation 
was that PGRP-LD expression was significantly upregulated within wounded 
embryos. This is in contrast to the work of Patterson et al. (2013), whose 
authors did not observed any significant increase in PGRP-LD expression 
upon pinch wounding of Drosophila larvae, despite the increased expression 
of many other PGRP genes, including PGRP-LA, LB, LC, LF and SA. 
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Moreover, no significant upregulation of PGRP-LD was noted by Stramer et al. 
(2008) upon sterile laser ablation of Drosophila embryos. Relatively little is 
known about the PGRP-LD gene itself; Werner et al. (2000) revealed that the 
5’ region of the PGRP-LD transcript contains an ORF which is related to the 
human PMI gene. PMI plays a role in the regulation of mitochondrial 
morphogenesis (Rival et al., 2011), thus suggesting that PGRP-LD may have 
a similar role in meeting cellular energy demands, as opposed or in addition to 
being a pattern recognition receptor. However, Werner et al. (2000) also noted 
that PGRP-LD expression was greatly enriched in hemocytes, and combined 
with the observation that PGRP-LD is able to bind PGN (Goto and Kurata, 
2006), this further suggests that PGRP-LD has some immune function. Since 
PGRP-LD does not play a role in phagocytosis (Ramet et al., 2002), and given 
its ability to bind PGN, it could be speculated that PGRP-LD regulates the 
systemic response in some manner. Therefore, the precise role that PGRP-LD 
may be playing upon sterile laser ablation within the Stage 15 embryo is highly 
speculative, but may couple together the regulation of AMP production upon 
wounding with the energy demands of the immune response. The concept of 
cross-regulation of innate immunity and the energy requirements of cells is not 
novel; Becker et al. (2010) demonstrated that metabolism and innate immunity 
could be co-regulated by FOXO in response to the fluctuating energy status of 
cells and tissues, independent of pathogen stimuli. Moreover, Karpac et al. 
(2011) elucidated a relationship between the AMP response to DNA damage 
and both IMD and insulin/IGF signaling, potentially coordinating growth and 
metabolic activities across tissues. Therefore, the notion that PGRP-LD may 
represent part of a similar damage response to sterile laser ablation may be 
well supported. However, due to overlap of the 3’ untranslated region of 
PGRP-LD with an ORF on the opposite DNA strand (Werner et al., 2000) and 
thus the potential for transcription of multiple mRNA species from the same 
region, careful further validation of this potential candidate would be required.  
 
Aside from immune and cuticle related genes, a collection of U5 snRNAs were 
also upregulated in Stage 15 embryos upon sterile laser ablation, inferring an 
upregulation in mRNA splicing. One possible explanation could reside in 
signal-dependent alternate splicing mechanisms, whereby damage signals 
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can result in the increased inclusion of alternate exons; for instance, DNA 
damage to S2 cells has been demonstrated to cause the increased inclusion 
of TAF1 alternate exons (Marengo and Wasserman, 2008). This process relies 
on the stability of splice site complexes, as binding of splice complexes to 
alterative splice sites is often weaker than to constitutive sites (Marengo and 
Wasserman, 2008). U5 snRNAs, such as those upregulated in the embryo 
upon laser ablation, have previously been suggested to play a role in the 
stabilization of exon alignment (Teigelkamp et al., 1995), and thus it may be 
speculated that upregulation of U5 snRNAs by the embryo upon laser ablation 
may permit the increased stabilization of the spliceosome complex at 
alternative exons; shifting the embryonic transcriptional response upon 
damage stimuli. An alternative explanation may take into account the 
enormous transcriptional response within the embryo upon damage stimuli. 
Previous studies have elucidated that hundreds of genes are significantly 
modulated upon wounding or the infliction of damage; 240 genes were 
significantly modulated in larvae damaged by ionizing radiation (van Bergeijk 
et al., 2012). This no exception within the embryo, as 933 genes demonstrated 
significant modulation upon sterile laser ablation. Thus, the upregulation of 
snRNAs may in fact reflect the increased amount of mRNA processing that 
must be carried out by the embryo in order to launch an effective damage 
response. This would therefore imply that processes which provide support 
and maintenance to the damage response and processes that mediate its 
direct effects are of equal importance within the embryo.  
 
Therefore, transcriptional profile analysis of laser-ablated embryos revealed 
that a potential balance between the damage-induced immune response and 
other biological processes, such as those required for correct development, 
maintenance of the transcriptional output and energy homeostasis. Moreover, 
this screening has permitted the identification of range of genes that may play 
as of yet undefined roles in the embryonic response to damage. The 
expression levels of these candidates now require further validation by an 
independent methodology, such as RT-qPCR, to determine if they ultimately 
have any true biological basis. Furthermore, the large proportion of wound-
induced genes that currently have no biological function attributed also 
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represents a substantial list of novel candidate genes, whose expression upon 
sterile laser ablation could firstly be validated by RT-qPCR protocols. 
Subsequently, experiments could be designed to gain a greater understanding 
of their function; for example, knocking-out or overexpressing these genes 
within both non-wounded and wounded embryos would potentially enable the 
elucidation of their potential biological function.  
 
 
4.3.3 Transcriptional profiling provides novel insight into the role of the 
hemocyte upon infection and damage 
 
A parallel aim of this analysis was to more specifically assess the contribution 
of embryonic hemocytes towards the embryonic immune response, by 
examining the transcriptional profile of this immune cell type upon injection 
with Ecc15 or PBS; to assess the immune role of the hemocyte upon infection 
and damage stimuli respectively. One interesting feature of the resulting 
hemocyte transcriptional profiling data was that genes involved in the 
oxidation-reduction processes were induced upon both PBS and Ecc15 
treatment. This included genes encoding various CYPs, ninaG, peroxidase 
and laccase2. This is in contrast to results by Johansson et al. (2005), who 
noted a decrease in expression of Cyp genes in mbn-2 cells upon E. coli 
infection. One potential explanation for this phenomenon may involve ROS 
production. Ecc15 is known to induce the activation of Duox in Drosophila gut 
epithelia and hence H2O2 production, via the release of bacterial-derived uracil 
(Lee et al., 2013). Moreover, Lee et al. (2013) demonstrated that an acute 
ROS response controlled via this mechanism was required for efficient 
elimination of bacteria, whereas chronic activation of this system was 
detrimental to host survival to infection. Thus, the observed increase in 
expression of genes encoding proteins with oxidoreductase activity in 
hemocytes upon Ecc15 infection may potentially contribute to this antibacterial 
response, generating further ROS, whilst upregulation of genes such as 
peroxidase may prevent overexposure of the host tissues to ROS. It is known 
that hemocytes are responsive to ROS signals, such as the hydrogen peroxide 
released from epithelial wounds (Moreira et al., 2010), thus it may not be 
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surprising that they may have a direct transcriptional response to this genre of 
stimuli. Similarly, previous work has demonstrated that wounds release H202 
as a damage cue to recruit hemocytes to wounds (Moreira et al., 2010); 
therefore, upregulation of oxidoreductase genes upon the damage stimuli 
resulting from PBS injection may potentially further amplify this damage 
response via the production of ROS from hemocytes themselves, initiating 
further hemocyte recruitment to damage sites. Moreover, this effect on 
oxidoreducctase gene expression may also be speculatively coupled to an 
increase in expression of genes involved in DNA repair, such as Mei-W8; 
permitting the hemocyte to protect itself against the well-documented 
detrimental effects of ROS on DNA integrity (Henmani and Parihar, 1998; 
Cooke et al., 2003). Interestingly, the Cyp genes upregulated in hemocytes 
upon Ecc15 infection have also previously been associated with heme and 
iron binding activity (Flybase Curators, 2004). Based on the observation that 
bacteria require iron for effective growth (Guerinot, 1994), this may represent 
another form of antibacterial response; Cyps may sequester heme or iron to 
limit the access of Ecc15 bacteria to this crucial resource. The fact that these 
genes are upregulated within hemocytes also corroborates this theory, as the 
Cyp genes in question would potentially be expressed in the ideal location for 
sequestering iron and heme. However, this effect may not be hemocyte-
specific, as the transcriptional profiles of the total embryo response also 
included the upregulation of oxidoreductase encoding genes, some with 
predicted iron binding properties. In this sense, the hemocyte and total 
transcriptomes share a common feature and hence it may be that hemocytes 
play a distinct role within a global embryonic oxidation-reduction response.  
 
Moreover, the hemocyte transcriptome upon Ecc15 infection is similar to that 
of the total embryos in another regard; genes involved in more general 
processes, such as mRNA processing and proteolysis, are also upregulated in 
hemocytes upon infection with Ecc15. Genes involved in proteolysis have 
previously been observed to be upregulated upon microbial challenge of S2 
and mbn-2 cells (Johansson et al., 2005), confirming their importance in the 
hemocyte immune response. Thus, genes encoding endopeptidases, such as 
pcl, tld and Nep5, may have putative functions in the degradation of bacterial 
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components upon phagocytosis. Similar to the reasoning for the increased 
expression of genes involved in mRNA splicing, the upregulation of mRNA 
processing genes may occur to counteract the increased demands placed on 
transcriptional processes within the hemocyte; to efficiently upregulate 
expression of effectors required for the cellular immune response. However, 
this is somewhat at odds with the observation that cells shut down overall 
protein synthesis in response to oxidative stress (Khong and Jan, 2010); a 
situation which hemocytes must clearly be experiencing considering their 
extensive expression of genes involved in oxidation-reduction. Therefore, the 
fact that hemocytes still potentially increase their transcriptional efforts to 
respond to infection stimuli under oxidative stress conditions suggests that an 
immune response is prioritized over a stress response in hemocytes. Previous 
work has documented the ability of hemocytes to prioritise competing signals 
(Moreira et al., 2010), thus this result may represent another link within the 
hemocyte prioritization chain.  
 
However, other results would potentially downplay the role of hemocytes in the 
embryonic immune response. For instance, expression of insc, a gene 
previously characterized to be necessary for survival to V. cholorae infection 
(Berkey et al., 2009), was downregulated in hemocytes upon Ecc15 infection. 
Expression of Hr39, a target of 20-HE signaling and with a role in autophagic 
cell death (Takemoto et al., 2007), was also downregulated in hemocytes 
upon Ecc15 infection. Therefore, these changes may infer the relative 
dispensability of hemocytes, as well as the responses of these genes, within 
the embryonic immune response. However, from the perspective of the host, 
these observations would not accord with survival to Ecc15 infection. Previous 
chapters have cited the potential of Ecc15 to subvert the 20-HE signaling 
machinery of the embryonic host, to potentially switch off the host immune 
response and allow the infection to grow unchecked (Chapter 3). These 
results may suggest a similar phenomenon, especially given that Hr39 is a 
target of 20-HE signaling (Horner and Thummel, 1995), indicating a direct 
interaction between Ecc15 and the hemocyte transcriptional response.  In 
addition, other downregulated genes included wb and phl, which have been 
implicated in tracheal development (Martin et al., 1999; Jiang and Edgar, 
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2009). Given the importance of the trachea in mediating survival to infection 
via 20-HE signaling and reducing bacterial load, these changes may also 
represent an attempt by Ecc15 to inhibit host immunity. A simple manner in 
which this paradigm may be tested would be to conduct mortality studies of 
embryos with deficiencies in these candidate genes post infection with Ecc15; 
to determine if their survival to infection is significantly different to that of WT 
embryos.  
 
In terms of the hemocyte transcriptional response to PBS injection damage, 
the proposed functions of the subsequently modulated genes determined via 
GO analysis were relatively consistent with those of genes modulated upon 
Ecc15 infection in hemocytes; indeed a modest percentage of genes 
upregulated or downregulated were common to both treatments, suggesting 
that damage via injection process has a significant impact on the hemocyte 
transcriptional response. Thus to identify hemocyte-specific infection genes in 
future experiments, it will be important to account for this contribution and to 
compare transcriptional profiles of PBS and Ecc15 treated hemocytes directly 
to compensate for this. However, some interesting features of the PBS treated 
hemocyte transcriptome can still be observed. For instance, it is interesting 
that expression of genes involved in 20-HE synthesis, such as nvd and phm 
was upregulated upon damage induced via PBS injection. This is in contrast to 
work by Hackney et al. (2012), who observed that tissue damage disrupted 
20-HE biosynthesis in first instar larvae but did not propose any theory as to 
why a response of this nature may be occurring. Thus, the differences 
observed between the work of Hackney et al. (2012) and results from 
embryonic hemocytes may infer a hemocyte-specific activation of 20-HE 
signaling. As 20-HE signaling has been demonstrated to play a role in 
activating innate immune-competence within the embryo (Chapter 3), it is 
interesting to speculate that this result may reflect a mechanism by which 
hemocytes are able to produce a local 20-HE response to activate innate 
immune mechanisms.  
 
Taken together, these preliminary results suggest that the hemocyte 
transcriptomes upon infection and damage share characteristics with those of 
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the total embryo, such as the upregulation of genes involved in oxidation-
reduction and mRNA processing. However, there is also evidence to suggest 
that hemocytes may play a more distinct role in the immune responses to 
infection and damage, via the proposed direct interactions between Ecc15 and 
the hemocyte transcriptional response, as well as the potential propagation of 
20-HE signaling upon damage stimuli. However, these results and subsequent 
discussion remain highly speculative since only one replicate of the hemocyte 
microarray experiment has been performed. Addition of data from a further two 
replicates will allow the identification of genes which are significantly 
modulated within hemocytes upon Ecc15 infection and damage induced by 
PBS injection. As a result, networking analysis may result in a more coherent 
network of up- or down-regulated genes. Moreover, the comparison of 
hemocyte and total embryo transcriptional profiles would permit the 





To conclude, analysis of the transcriptional response of the Drosophila embryo 
to infection confirmed the immune potential of this system; that embryos at 
Stage 15 of development are able to mediate a diverse immune response, 
indicative of the activation of many signaling cascades involved in the 
systemic and cellular immune response. Furthermore, wounding via sterile 
laser ablation was also able to mediate a distinct transcriptional response 
within the embryo, including the significant induction of a subset of AMP genes 
and the expression of a network of cuticular genes, as well as genes involved 
in mRNA splicing. Analysis of the hemocyte transcription upon infection and 
damage elucidated that these immune cells may play a role regulation of the 
immune response via 20-HE signaling and production of ROS, although this 
remains speculative and subject to validation. As such, analysis of these 
transcriptional profiles has been successful in identifying candidate genes for 
further validation and study.  
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Chapter 5: Final Discussion 
 
 
The central aim of this project was to develop a more detailed and intricate 
model of bacterial infection using the Drosophila embryo, and to assess its 
potential as a viable immunity model. A further key aim of this project was to 
determine at what stage of development Drosophila embryos begin to 
demonstrate immune competence and what biochemical signaling pathways 
may drive this immunological phenomenon. Having established the immune 
capacity of the embryo in terms of its ability to respond to bacterial challenge, 
subsequent objectives focused on the determination of global and hemocyte-
specific transcriptional changes within the embryonic system upon infection 
with Gram-negative or Gram-positive microbes, or sterile damage induced by 
either laser ablation or sterile injection procedures. This would enable the 
identification of the novel genes that were modulated in Drosophila upon 
infection or damage. 
 
Initial results demonstrated that Drosophila embryos were able to mount an 
effective AMP response to a range of bacterial infections, and that this was 
mediated mostly via the canonical Drosophila systemic immunity pathways. 
Moreover, multiple facets of the cellular and systemic response were observed 
to be functional within the embryo system, operating in a manner that was 
concordant with the host defense mechanisms of the adult fly and larval 
models. Subsequently, it was demonstrated that 20-HE signaling was crucial 
for the maturation of the embryonic immune system, with the 20-HE pulse 
during mid-embryogenesis proposed to switch on embryonic immune 
competence, as detailed in Figure 5.1. Results also implied that bacterial 
pathogens, such as Ecc15, might be able to subvert the embryonic 20-HE 
signaling machinery to prevent their elimination by host defense mechanisms. 
Transcriptional profiling studies identified a range of potential candidate genes 
for further study, such as Ecc15- and M. luteus-unique and common genes, 
genes potentially acting as targets of host immune system subversion for 
Ecc15, and a cuticular gene network which was upregulated upon wounding 
via sterile laser ablation.  
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Figure 5.1: Proposed Model of the Origin of Immune Competence within 
the Drosophila Embryo.  
 
Infection studies carried out within this project enabled the development of a 
model to potentially explain the differences observed in the immune 
competence of early and late stage Drosophila embryos. Embryos at relatively 
early stages of development were demonstrated to be relatively immune 
incompetent, being unable to mount an Drc-GFP response to bacterial 
infection, resulting in high rates of embryo mortality. This was in stark contrast 
to the response of later Stage 15 embryos, which exhibited a highly robust 
AMP response, as well as relatively diverse overall immune response, to 
bacterial species, with subsequently high survival rates to infection. 
Considering the timing of the 20-HE pulse at mid-embryogenesis, as well as 
results which demonstrated that Stage 11 immunity could be rescued via 
treatment with 20-HE, it would infer that the 20-HE pulse may be responsible 
for the maturation of the embryonic immune response. Images of 
embryogenesis were taken from Hartenstein (1993). 20-HE titre values were 










































5.1 AMP expression does not confer any survival benefit upon Ecc15 infection  
 
A large proportion of this project was dedicated to studying the ability of the 
Drosophila embryo to express AMP genes upon bacterial infection, as a read-
out of the embryonic immune potential. However, the resulting data may also 
reveal a novel perspective on the requirement of AMPs, suggesting that AMP 
bacterial killing may not be the most crucial factor in a successful Drosophila 
immune response. For instance, whilst the aforementioned interactions of 
Ecc15 with the host 20-HE signaling machinery may in part have explained the 
moderate mortality associated with this specific bacterial infection in Stage 15 
embryos, it did not fully indicate why Stage 11 embryos continued to exhibit 
high mortality upon co-administration of 20-HE with Ecc15. Upon co-
administration of Ecc15+20HE, no significant improvement to Stage 11 
embryo survival was noted compared to control embryos receiving only Ecc15 
treatment. In fact, Stage 11 survival remained highly significantly different to 
Stage 15 survival upon Ecc15+20-HE treatment despite the rescue of AMP 
expression within these embryos, suggesting that even by bypassing the 
detrimental effects of Ecc15 on 20-HE synthesis and signaling effectors, 
decreasing bacterial load and compensating for the immune naivety of Stage 
11 embryos, that this was not sufficient to rescue the Stage 11 embryo 
viability. Thus, these findings indicate that AMP production does not render the 
Drosophila embryo infallible to infection; in fact, it would indicate that AMPs do 
not confer any intrinsic survival benefit to the Stage 15 embryo upon Ecc15 
infection, and thus do not protect against at least infection by this bacterial 
species. In this sense, this concept is contradictory to previous work carried 
out in the Drosophila model. For example, work by Tzou et al. (2002) 
demonstrated that the genetic overexpression of Def via the Gal4-UAS system 
in imd/spz double mutant flies effectively removed the deleterious effects of S. 
aureus or B. subtilis infection on fly survival, thus demonstrating that 
overexpression of a single AMP in vivo can reverse the effects of 
immunodeficiency. Furthermore, the requirements of Toll and IMD signaling in 
the response to Gram-positive and Gram-negative bacterial infections 
respectively (Lemaitre et al., 1996; Hoffmann and Reichart, 2002; Rutschmann 
et al., 2002; Leulier et al., 2006) would hint at the indispensable contribution of 
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AMPs to the total host response in resistance to bacterial infection. However, 
there is evidence to equally support the idea that AMPs do not confer ultimate 
protection against bacterial infection. For instance, this effect has also been 
observed in mammalian systems; mice treated prophylactically with an 
inducible AMP candidate extracted from Sarcophaga perigrina did not exhibit 
any significantly improved survival upon infection with S. aureus or E. faecalis, 
despite the extracted AMP demonstrating high antibacterial activity in vitro 
(Nakajima et al., 1997; Okuyama-Nishida et al., 2009). Therefore, whilst AMP 
induction is doubtless a cornerstone of an effective Drosophila immune 
response, the degree to which they ultimately protect the host organism and 
contribute to long-term survival remains somewhat conflicted.  
 
Despite the contradictory nature and setting of the data within the current and 
potentially complex paradigm, the question remains as to why Stage 11 
embryo viability is not increased upon 20-HE treatment, despite an apparent 
rescue of AMP expression. It could be argued that treatment with 20-HE, a 
potentially potent immune activator (Flatt et al., 2007; Rus et al., 2013), could 
induce chronic activation of the Stage 11 immune system and lead to eventual 
embryo mortality, given the evidence that chronic or inappropriate activation of 
NF!B-mediated immune responses in both Drosophila and mammalian 
systems can result in a chronic inflammatory state and reduced lifespan 
(DeVeale et al., 2004; Haefner, 2006; Libert et al., 2006; Nylaende et al., 
2006; Ram et al., 2006). However, since Stage 11 embryos treated with 20-HE 
alone did not exhibit any significantly increased mortality, differential 
development or any evident expression of Drc-GFP, this explanation seems 
unlikely. This notion is supported by the fact that heat-inactivation of Ecc15 
does not lead to a significant decrease in Stage 11 embryo viability, 
suggesting that Ecc15-associated mortality is a result of interaction between 
the host and live pathogen, as opposed to a passive overstimulation of the 
systemic immune response.  
 
A further possibility may be that whilst 20-HE treatment was able to enhance 
AMP production in Stage 11 embryos to significantly decrease the bacterial 
burden, it was not able to overcome all effects of Ecc15 infection, with the 
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result that Stage 11 viability was not rescued. From infection studies in 
Drosophila larvae, Ecc15 was shown to cause drastic remodeling of the gut; 
including a dramatic loss of cell numbers and significant decrease in gut width 
(Buchon et al., 2010), to which the developing embryonic gut may prove more 
susceptible than its adult or larval counterparts. Moreover, Ecc15 infection has 
also been demonstrated to induce the expression of enzymes responsible for 
the detoxification of ROS in gut epithelia (Buchon et al., 2009a), suggesting 
that Ecc15 infection prompts a significant host epithelial ROS response. This 
would be consistent with the observations that ROS production by Duox is vital 
for the effective elimination of ingested bacteria within Drosophila gut models; 
a mechanism which involved tight regulation to limit damage to host cells (Ha 
et al., 2005a). This response is acknowledged to be extremely rapid, as 
expression of detoxification genes peak at one hour post infection with Ecc15 
(Buchon et al., 2009). Lee et al. (2013) established that ROS production is 
induced in a Duox-dependent manner as early as one hour post infection with 
Ecc15 in Drosophila gut models; taking into account the time taken for the 
bacterial stimulus to reach its gut target after the initial ingestion, this would 
again support the notion of a rapid ROS response to Ecc15. RT-qPCR results 
would suggest that expression of Duox, the enzyme responsible for epithelial 
ROS production, is downregulated in EcRQ50st mutants, albeit at an 
insignificant level (data not shown). Considering the role of ROS in the rapid 
prosecution of bacteria, this result may suggest that duox expression lies 
downstream of 20-HE signaling through EcR-B1. Therefore, considering the 
necessity of a rapid ROS response upon Ecc15 infection and the nature of the 
co-injection of Ecc15 + 20-HE into Stage 11 embryos, one can speculate that 
this treatment does not permit sufficient time for Stage 11 embryos to initiate 
20-HE signaling and manufacture functional Duox protein before the Ecc15 
infection reaches a threshold of growth which proves inevitably fatal to these 
early embryos. By contrast, this hypothesis would denote that Stage 15 
embryos, having a ready supply of Duox potentially available as a result of the 
20-HE pulse during mid-embryogenesis, would display greater resistance to 
Ecc15 infection via the production of mucosal ROS. However, given the 
inconclusive nature of the RT-qPCR data regarding duox expression in 
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EcRQ50st mutants upon Ecc15 infection, further work would be required to test 
the biological significance of this concept.   
 
In light of the importance of the trachea in mediating the AMP response to 
infection, as well as the requirement of functional EcR-B1 in the Stage 15 
embryonic tracheal network to promote survival to infection and reduction of 
bacterial burden via activation, the hypothetical role of ROS in the eradication 
of Ecc15 infection could be further supported. The trachea is armed with a 
diverse array of antioxidant enzymes (Wagner et al., 2008). Genes related to 
the detoxification of ROS that are actively expressed in the airway epithelium 
include Duox, catalase, two superoxide dismutases, four peroxiredoxins and a 
range of glutathione S-transferases (Wagner et al., 2008), alluding to the 
possibility that the airway epithelium produces a significant quantity of 
epithelial ROS that require subsequent detoxification. Thus, the production of 
ROS in the trachea could potentially be induced upon Ecc15 infection and 
contribute to the host response to eliminate invading bacteria. On the other 
hand, the Drosophila trachea has been demonstrated to upregulate many 
other immune genes which could potentially lie downstream of 20-HE 
signaling and thus ease the burden of Ecc15 infection. For instance, the 
transferrin 1 gene has been demonstrated to be highly and specifically 
expressed within the trachea. Transferrin 1 is an iron-binding protein that is 
required to transport ionic iron (Yoshiga et al., 1999), maintaining iron in 
soluble forms for its ultimate transport to cells for proliferation or biosynthesis 
of iron-requiring enzymes (Aisen, 1994). Due to its ability to bind and thus 
sequester iron, it has been postulated that transferrin may restrict bacterial 
access to iron, which is required for bacterial growth (Guerinot, 1994). This 
theory has been partially confirmed by the observation that transferrin 1 
expression is highly upregulated upon infection in Drosophila (Sackton and 
Clark, 2009); a phenomenon which has been observed in other insect infection 
models, such as the mosquito, Aedes egypti (Beerntsen et al., 1994; Yoshiga 
et al., 1997) and the termite Mastotermes darwiniensis (Thompson et al., 
2002). Its presence at a high concentration in the trachea suggests a vital role 
for iron depletion in the airway epithelium, which could potentially limit the 
growth of most bacterial species (Flo et al., 2004). Moreover, the tracheal 
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network has been demonstrated to express ventral veinless (vvl), a 
transcription factor which has been shown to induce local AMP expression 
(Junell et al., 2010), and thus may also play a role in the elimination of Ecc15 
infection specifically within the trachea. Further RT-qPCR studies to determine 
the transcriptional response of embryos deficient of these candidate genes 
upon infection would be required to elucidate whether activation of either of 
these candidate genes rely on 20-HE signaling within the Drosophila embryo.  
 
 
5.2 The Role of psh in the Embryonic Immune Response 
 
Whilst the majority of Stage 15 embryonic immune responses were 
demonstrated to be concordant with larval and adult fly models, there were a 
few notable exceptions. For instance, previous studies have shown that 
injection of A. oryzae proteases was unable to stimulate Drs expression in 
adult flies in a psh1 mutant background in comparison to a robust WT 
response (Buchon et al., 2009b), which is presumably the reason why 
infection of psh1 mutant flies with Aspergillus fumigatus resulted in a more 
rapid rate of mortality than noted in WT or modSP1 flies (Buchon et al., 2009b). 
This effect on fly mortality was demonstrated to be exacerbated in 
psh1;;modSP1 double mutant flies (Buchon et al. 2009b). Conversely, injection 
of A. oryzae proteases did not significantly reduce the viability of 
psh1;;modSP1 Stage 15 embryos compared to that of WT controls; as such, 
psh1;;modSP1 double mutants demonstrated greater survival levels to 
protease injection than single modSP1 mutants alone, contrary to the results of 
Buchon et al. (2009b). psh is a host serine protease which is activated upon 
recognition of fungal and bacterial virulence factors, such as secreted 
proteases, and subsequently mediates Toll pathway activation and resistance 
to fungal infection (Ligoxygakis et al., 2002; Gottar et al., 2007; El Charmy et 
al., 2008), and hence it would be expected that psh1;;modSP1 mutant embryos 
should be more susceptible to treatment with such agents than WT or relE20 
mutant embryos. The fact that modSP1 mutant embryos demonstrated a 
significant susceptibility to A. oryzae protease injection compared to WT 
embryos would suggest that this branch of the Toll pathway is functional within 
the Stage 15 embryo and able to mediate an appropriate resistant response to 
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fungal proteases. Thus the anomalous response noted in psh1;;modSP1 
embryos cannot be attributed to lack of psh functionality within the developing 
embryo. Therefore, mutation of psh seemingly improves the viability of 
modSP1 embryos post injection with A. oryzae proteases, and may infer that 
there is some biological benefit in lacking the ability to recognize fungal 
proteases within the Drosophila embryo that is distinct from the benefit 
incurred by modSP activation of the Toll pathway. Therefore, one way in which 
to test this hypothesis would be to conduct RT-qPCR experiments focusing on 
the transcription of AMP genes within Stage 15 WT, modSP1 and 
psh1;;modSP1 embryos; to determine levels of AMP gene expression in the 
differential genetic backgrounds. Moreover, the dose of A. oryzae protease 
administered to embryos was low (1:5000) due to the high embryo mortality 
associated with injection of higher concentrations (data not shown), possibly 
leading to the large degree of variation observed between experimental 
replicates. Thus, repeating experiments using an increased dose of protease 




5.3. Infection and damage may exert long-term effects on development of 
embryonic systems and lifespan 
 
It is clear from the data presented that the Stage 15 embryo transcriptome is 
regulated to adapt to the acute effects of infection and damage, and to meet 
the necessary demands that responses to these stimuli place upon the 
embryo. However, other elements of the data would suggest that these stimuli 
also have a much broader, long-term effect on the development of the 
embryos. For instance, infection with Ecc15 or M. luteus induced the 
modulation of genes normally associated with development of the nervous 
system, such as Rim, milt, snoo, bsh, caps, niki and Aats-thr. This is further 
supported by the GO analysis, which demonstrated that genes upregulated by 
Ecc15 were enriched for axon cargo transport and synaptic transmission 
functions and were potentially associated with a variety of neural components, 
such as the axon, synapse and presynaptic terminal. Similar associations 
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were noted between genes upregulated by M. luteus and GO terms relating to 
axon cargo transport function and an association with the synapse and 
membrane bound vesicles, which may be indicative of a role in 
neurotransmitter release. Moreover, the fact that these genes can be 
subdivided into those induced upon either infection with solely Ecc15 (Rim, 
milt, snoo), only M. luteus (bsh, Aats-thr) or commonly by both types of 
infection (niki, caps) may suggest that distinct effects on embryonic nervous 
system development are mediated by individual infections, and that a 
combination of Gram-positive and Gram-negative bacteria also has a distinct 
effect. However, the precise mechanism by which this interaction between the 
immune and nervous systems occurs and the resulting effect this interaction 
has on the embryo is relatively speculative. Whilst the scientific literature has 
acknowledged a potential interaction between the immune and nervous 
systems, few studies have explored this potential interaction in depth. Work in 
vertebrates by Roitt et al. (1993) elucidated that several neuropeptides and 
biogenic amines produced in the central nervous system, such as Met-
enkephalin, were also produced by immunocytes and had effects on 
lymphocyte proliferation and macrophage migration. Lavine and Strand (2002) 
postulated that the simultaneous arrangement of signaling and bacterial killing 
factors released via the processing of the opioid precursor protein could result 
in a rapid antibacterial response as well as a recruitment of immune cells and 
signaling of danger to the CNS. Lavine and Strand (2002) also speculate that 
a similar situation may exist in insects via ENF peptides which are processed 
in a similar manner to opioid precursor protein and are expressed in the CNS, 
fat body and immune cells, including hemocytes (Clark et al., 1998; Hayakawa 
and Noguchi, 1998) This would be consistent with the observation that Stage 
15 embryonic hemocytes also induce transcription of neurogenesis genes, 
such as Rfx and Ndc80, hence indicating a role for the hemocyte in the 
function or development of the nervous system post infection. Given the close 
spatial relationship between hemocytes and the ventral nerve cord within 
Drosophila embryos (Tepass et al., 1994; Evans et al. 2010) and the 
hemocyte’s reported role in the condensation of the central nervous system 
and development of the ventral nerve cord (Olofsson and Page, 2005; Evans 
et al., 2010), it is interesting to speculate that hemocytes may be in a relevant 
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spatial position as well as functionally able to interact with the nervous system, 
merging its roles in nervous system development and cellular immunity. Thus, 
although an interaction between the nervous and immune systems has been 
documented, potentially corroborating results from our embryonic model, 
much more extensive work would be required to determine the precise 
contribution of hemocytes within this process and precisely what effect this 
relationship would have on resulting embryo fitness.  
 
Another potentially interesting feature of this data relates to the upregulation of 
genes encoding odorant binding proteins (OBPs) and Odorant receptors 
(ORs) upon infection, specifically M. luteus infection. Members of the 
invertebrate OBP family are olfactory-specific molecules that are secreted 
from non-neuronal support cells into the lymph of subsets of olfactory sensilla 
(Galindo and Smith, 2001). OBPs are believed to play a role in the delivery of 
hydrophobic odorants through the lymph to the ORs (Carlson, 2001), although 
actual evidence of this concept remains scarce. Drosophila adults deficient in 
even one Obp gene display abnormal long-term olfactory behavioural 
responses to a variety of odorants (Kim et al., 1998; Wang et al., 2001), 
whereas overexpression of specific Or genes has been demonstrated to result 
in an elevation in the adult fly response to subsets of odours (Stortkuhl and 
Kettler, 2001). Thus, the upregulation of Obp family members by M. luteus 
infection within the embryo may represent a link between infection and 
subsequent behavioural responses of the resulting emergent larvae. This 
hypothesis could potentially be tested by assessing the olfactory response of 
larvae emerging post embryonic infection with M. luteus to different subsets of 
odours, and if overexpression or mutation of the Obp genes in question was 
able to alter this response. However, what potential advantage this purported 
change in behavior would confer upon subsequent larvae remains largely 
speculative; it is perhaps reflective of embryonic priming to potentially 
contaminated surroundings. Given that the natural Drosophila habitat for 
oviposition is dominated by decaying organic matter, which is likely to contain 
multiple and potentially harmful bacterial and fungal pathogens, the 
development of such a priming response would be highly beneficial to the 
developing embryo. This hypothesis is partially supported by the observation 
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that C. elegans modifies its olfactory preferences post infection with 
pathogenic bacteria to avoid odours from the pathogen and increase its 
attraction to odours from familiar non-pathogenic bacteria (Zhang et al., 2005).  
 
Moreover, the above results permit the speculation that both infection and 
damage may have more long-term effects, such as an effect on resulting adult 
lifespan. For instance, Ecc15 and M. luteus infection in Stage 15 embryos 
were both demonstrated to upregulate the sorting nexin gene snz. Work by 
Suh et al. (2008) demonstrated that overexpression of snz in fat metabolic 
tissues reduced lifespan, whilst snz mutants exhibit prolonged youthfulness. 
Such results would suggest that infection has a negative effect on Stage 15 
embryo lifespan, although the timescale over which this would potentially 
occur remains unknown. Results from Chapter 3 demonstrate that Stage 15 
embryos are clearly affected by Ecc15 infection in terms of viability post 
infection, although one could argue that this is due to the acute toxic effects of 
the Ecc15 infection, as opposed to long-term effect on lifespan. However, 
considering the fact that fat-storing tissues, such as the fat body, can play a 
role in controlling lifespan (Picard and Guarente, 2005) as well as mediating a 
systemic immune response, it would perhaps not be surprising if there was 
some interplay between these two distinct processes. In fact, previous work 
has suggested that activated immunity appears to repress lifespan in 
Drosophila adults, whereas suppressed immunity appears to slow Drosophila 
aging (Paik et al., 2012). This is a relationship that appears to also work in 
reverse, as studies have suggested that regimes such as dietary restriction 
which can increase lifespan (Bauer et al., 2010) also impairs immune function 
and wound healing in mice (Reed et al., 1996). Thus, the upregulation of snz 
by bacterial infection may simply further highlight the costliness of the immune 
response to the host.  
 
However, it is also clear that the potential effect of infection on the resulting 
lifespan of the fly is more complex than a simple reduction as postulated 
above. For instance, increased levels of another gene upregulated upon 
Ecc15 and M. luteus infection, NIFR, has previously been suggested to reduce 
reproductive behaviours and subsequently extend lifespan of adult flies (Paik 
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et al., 2012). Moreover, increased levels of IM3 expression, which were 
observed upon M. luteus infection alone within the Stage 15 embryos, has 
also been associated with an extension in lifespan (Bauer et al., 2010). Thus, 
the increased levels of these candidate genes are relatively contradictory to 
the increase in expression of snz upon infection in the Drosophila embryo. It 
could be speculated that co-upregulation of genes with positive and negative 
effects on lifespan upon infection permits the host to maintain a balance, so 
that the deleterious effects of an immune response on lifespan are minimized.  
 
The observation that sterile wounding also highly and significantly induces 
expression of IM3 may also lead to the speculation that damage may have a 
positive effect on lifespan. However, this hypothesis is not consistent with the 
observation that increased damage via ROS is a critical causative factor in 
aging (Parkes et al., 1998); considering the mechanical damage caused by 
ROS to cell components (Thannickal and Fanburg, 2000; Landolfo et al., 
2008) and DNA (Henmani and Parihar, 1998; Cooke et al., 2003), as well as 
the observation that wounds release H2O2 (Niethammer et al., 2009; Moreira 
et al., 2010), it is therefore unlikely that the infliction of damage could have a 
positive effect of lifespan via the upregulation of IM3. As such, the observed 
upregulation of IM3 expression by sterile laser ablation in Stage 15 embryos 
must fulfill another function. Previous evidence has suggested that IM3 is 
regulated by the Toll pathway (De Gregorio et al., 2001; Boutros et al., 2002; 
Wertheim et al., 2005), although the precise molecular function of this gene 
remains elusive. Therefore, these results may reinforce the notion that 
damage alone can induce activation of an immune response, potentially via 
the Toll pathway, as opposed to having any long-term effect on Drosophila 
lifespan. Patterson et al. (2013) demonstrated that puncture wounding of 
Drosophila embryos stimulated upregulation genes encoding Toll pathway 
components, including PGRP-SA, serine proteases such as spirit, AMPs such 
as Mtk and immune inducible molecules, such as IM1-4. This would potentially 
corroborate the above data, suggesting a role for Toll in mediating an immune 
response to damage. However, the nature of the puncture wound 
administered by Patterson et al. (2013) does not preclude for bacterial 
infection of the host during or after wounding, as the vitelline membrane of the 
! "#$!
embryo is disrupted. Thus, it would be of interest to compare the 
transcriptional profile of embryos receiving PBS injection with those receiving 
sterile laser ablation treatment, to determine the extent of transcriptional 
overlap between these two different types of damage.  
 
Therefore, as well as identifying candidate genes which may play a role in the 
acute response to infection or damage, the transcriptional studies performed in 
this project have also potentially identified genes which may impact on the 
long-term Stage 15 embryo development, behavior and lifespan. Further 
validation of these results, via RT-qPCR, will be required, as well as 
subsequent studies to assess the impact that these observed changes in gene 
expression may have on embryo functionality and fitness.   
 
 
5.4 Final Conclusions  
 
To conclude, the Drosophila embryo is a viable model system to study 
bacterial infection in vivo; Stage 15 embryos are able to mediate a relatively 
robust and complex response to different types of infection that is mostly 
concordant with defense mechanisms recorded in adult and larval models. 
Studies in the embryo have also permitted novel insight into the Drosophila 
immune response. For instance, whilst AMP production has thus far formed 
the cornerstone of Drosophila immunity studies and is doubtlessly important 
for a successful immune response, data from the embryo would suggest that it 
is not the only or most crucial factor in the elimination of bacterial pathogens. 
Furthermore, transcriptional profiling of infected and wounded embryos would 
suggest that the Drosophila immune response itself may have a long-lasting 
effect, even after the elimination of the pathogen; modulation of genes 
involved in lifespan, nervous system development and olfaction may suggest 
that infection and damage may have long-term effects on Drosophila 
development and behavior. 
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Appendix 1: Fly food and apple juice agar plate constituents 
 
Table A1.1: Fly food constituents 
Constituent Amount per litre 
Yeast extract 17g 
Malt extract 39g 
Maize flour 60g 
Soya flour 9g 
Plant agar 6g 
Sugar 64g 
Nippagin in 100% methanol 1.5g in 15mL 
Propionic acid in 100% ethanol 5.3mL in 7.7mL 
 
 
Table A1.2: Apple juice agar constituents 
Constituent Amount per litre 
Plant agar 20g 
Sucrose 12g 
Apple juice 250mL 













Appendix 2: Fly lines generated 
 
Table A2.1: Fly lines generated for Chapter 3 
Fly line Use 
w; srp-Gal4, UAS-GFP; crq-Gal4, UAS-GFP RT-qPCR; mortality assay, CFU 
count assay  
w; EcRQ50st/CTG Mortality assay 
w; EcRM554fs/CTG Mortality assay 
w; EcRQ50st/EcRM554fs  Mortality assay 
w; EcRQ50st/EcRQ50st Mortality assay; RT-qPCR 
w; EcRM554fs/EcRM554fs Mortality assay 
w; UAS-EcR B1 DN/+; da-Gal4/+ Mortality assay 
w; UAS-EcR B1 DN/srp-Gal4 Mortality assay 
w; UAS EcR-B1 DN/btl-Gal4 Mortality assay; CFU count 
assay 
w; UAS EcR-B1 DN/E22c-Gal4 Mortality assay 
w; srp-Gal4, scar!37/scar!37; crq-Gal4, UAS-
GFP 
Phagocytosis assay, survival 
assay 





Table A2.2: Fly lines used in Chapter 4 
Fly line Use 
w; srp-Gal4, UAS-GFP; crq-Gal4, UAS-GFP Generation of samples for 
microarray; preliminary 
hemocyte sorting studies 





Appendix 3: Thermodynamic properties of Immune Gene 
Primers Generated 
 
Table A3.1 Primers Generated using Primer3 






Pair  3’ 
complementarity 
(AU) 
Ddc F 60.03 50.00 4.00 2.00 
Ddc R 59.97 50.00 4.00 3.00 
GADD45 F 60.37 61.11 4.00 0.00 
GADD45 R 59.96 63.48 3.00 0.00 
Mas F 56.00 43.00 4.00 0.00 















































Appendix 5: In silico assessment of primer specificity 
 
Gene Primer Number of hits 
at high identity 
(AU) 
Gene of interest 
selected? (Y/N) 
Ddc Forward 1 Y 
 Reverse 1 Y 
GADD45 Forward 1 Y 
 Reverse 1 Y 
Mas Forward 1 Y 
























Appendix 6: qPCR primer efficiencies 
 
 
Table A6.1: Primer efficiency values of internal control primers 
Primer pair Mean efficiency (%) Standard deviation (AU) 





Table A6.2: Primer efficiency values of Immune Primers Generated by Primer3 
Primer pair Mean efficiency (%) Standard deviation (AU) 
Ddc 103.73 19.73 
GADD45 148.75 6.33 





Table A6.3: Primer efficiency values of AMP primers 
Primer pair Mean efficiency (%) Standard deviation (AU) 
AttA 88.22 9.78 
CecA1 83.22 12.34 
Def 86.40 1.58 
Dpt 95.78 12.18 
Drc 91.04 6.73 
Drs 101.91 12.78 







Table A6.4: Primer efficiency values for ecdysone signaling primers 
Primer pair Mean efficiency (%) Standard deviation (AU) 
Dare 85.01 1.77 
Ecd 96.95 1.29 
Eip71CD 81.79 0.86 
Eip74EF 76.20 2.42 
Eip78C 84.65 5.79 
Eo 94.03 1.71 
Mld 85.59 12.75 
Nvd 88.38 0.40 
Phm 96.68 7.72 
Ptth 81.59 3.65 
Sad 81.79 12.68 





















Appendix 7: Representative FACS Scatter Plots and Sort Data 
for the Collection of Hemocytes from Naïve, PBS and Ecc15 
treated embryos 
 
      
 
Figure A7.1: Representative Scatter Plots from FACS experiments to 
collect naïve and treated hemocytes for microarray studies. Gating for 
cells that demonstrated the correct size and complexity (A), singularity (B) and 
GFP-positive (GFP+) properties permitted the sorting of GFP-labelled 




Table A7.1: Hemocyte FACS Data quantifying the Percentage of Selected Cell 














Naïve 1 10000 39.17 35.13 9.74 
Naïve 2 10000 38.01 32.56 8.24 
Naïve 3 10000 35.39 33.5 9.26 
Naïve 4 10000 33.84 30.96 6.07 
PBS 1 10000 52.43 49.75 12.9 
PBS 2 10000 45.16 42.09 19.59 
PBS 3 10000 34.45 30.34 13.38 
PBS 4 10000 40.8 36.47 7.78 
Ecc15 1 10000 35.57 30.12 6.08 
Ecc15 2 10000 35.18 30.95 7.75 
 
 





Total number of 
cells (AU) 
Number of GFP+ 
cells (AU) 
Naïve 1 1000 490842 43889 
Naïve 2 1000 390000 23936 
PBS 1 300 109670 13735 
PBS 2 400 402000 31188 
PBS 3 730 266830 16081 
PBS 4 478 103772 13772 
Ecc15 1 400 629000 36290 






Appendix 8: Genes identified via transcriptional profile 
analysis that were uniquely upregulated in the Stage 15 
embryo upon different types of bacterial infection 
 
Table A8.1: Ecc15-unique upregulated genes within the Stage 15 embryo 
Gene Log Fold Change (AU) Adjusted P-value 
Adar 1.102 0.016 
alpha-Man-I 1.641 0.011 
AP-50 1.281 0.008 
Aplip1 1.264 0.018 
Art6 3.239 0.012 
ash1 1.411 0.013 
Atg9 1.468 0.016 
AttA 4.936 0.010 
AttC 3.592 0.005 
AttD 3.867 0.006 
beta'Cop 1.618 0.014 
Bruce 1.338 0.016 
CG10353 1.508 0.017 
CG10505 2.495 0.013 
CG10864 1.190 0.013 
CG11263 2.214 0.004 
CG11349 2.095 0.016 
CG11529 2.372 0.005 
CG11593 1.277 0.011 
CG12162 1.446 0.010 
CG12674 3.124 0.012 
CG12692 2.274 0.013 
CG13079 3.366 0.007 
CG1407 1.089 0.017 
CG14851 3.315 0.010 
CG15450 4.867 0.018 
CG15555 3.048 0.003 
CG15831 1.932 0.015 
CG15841 
CG6555 2.538 0.007 
CG16970 2.214 0.013 
CG18171 1.467 0.017 
CG2316 1.216 0.012 
CG2336 2.553 0.008 
CG31148 4.393 0.002 
CG31178 2.274 0.003 
CG31244 4.248 0.009 
CG31538 2.060 0.011 
CG31935 1.150 0.018 
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CG32079 3.488 0.018 
CG32119 1.284 0.010 
CG32148 2.988 0.003 
CG32246 2.571 0.001 
CG32679 3.441 0.017 
CG32681 2.437 0.011 
CG32732 1.146 0.016 
CG32810 1.364 0.016 
CG33156 1.968 0.011 
CG33232 1.629 0.017 
CG34349 1.686 0.010 
CG3517 2.368 0.003 
CG4165 1.565 0.013 
CG42343 2.035 0.001 
CG42389 1.594 0.013 
CG42684 1.897 0.006 
CG42750 2.687 0.001 
CG43102 1.423 0.008 
CG43689 1.497 0.005 
CG4793 3.486 0.017 
CG4996 1.087 0.013 
CG5068 1.114 0.012 
CG5720  1.334 0.012 
CG7094 3.023 0.002 
CG7180 1.660 0.015 
CG7311 2.879 0.003 
CG7337 1.184 0.011 
CG7816  1.198 0.011 
CG7927 1.165 0.013 
CG8745 1.060 0.016 
CG8918 6.404 0.001 
CG9626 1.222 0.014 
CG9692 2.603 0.004 
Cip4 1.447 0.015 
Cngl 1.699 0.012 
CR10991 2.228 0.010 
CR31386 2.075 0.015 
Dref 1.469 0.008 
Eag 4.121 0.005 
Edin 3.753 0.018 
Fatp 1.077 0.018 
Fili 1.705 0.008 
fl(2)d 1.522 0.013 
Fne 1.342 0.016 
gcm2 1.849 0.016 
Glo 2.229 0.013 
HP5 1.364 0.007 
HPS4 1.347 0.010 
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Hsf 1.174 0.014 
l(3)02640 1.518 0.015 
MAPk-Ak2 1.064 0.017 
Mgat1 1.454 0.012 
Milt 1.252 0.013 
Mst77F 1.859 0.015 
Mun 3.113 0.006 
Na 2.257 0.014 
Orc1 1.678 0.013 
Patr-1 1.091 0.016 
PGRP-LF 1.112 0.013 
Pkd2 3.588 0.009 
PRL-1 1.038 0.016 
proPO-A1 1.078 0.014 
pyd 1.388 0.018 
r-cup 1.922 0.002 
Rab9 3.872 0.011 
RhoGAP1A 1.405 0.016 
Rim 2.406 0.007 
Sema-2a 1.439 0.005 
SIP3 2.794 0.011 
Smg6 1.151 0.014 
Snoo 1.295 0.008 
spaw 1.747 0.009 
TBPH 1.456 0.016 
tkv 1.298 0.015 
Trf4-2 1.965 0.014 
vap 1.176 0.016 
Vha100-3 2.169 0.012 
Vps26 1.507 0.008 
wb 1.565 0.014 
 












Table A8.2: M. luteus-unique upregulated genes in the Stage 15 embryo 
Gene Log Fold Change (AU) Adjusted P-value 
2mit 1.310 0.009 
Aats-thr 1.211 0.018 
Acp53Ea 1.954 0.012 
Amph 1.011 0.022 
aralar1 1.277 0.022 
Arr2 1.448 0.009 
Atf-2 2.281 0.012 
bsh 1.874 0.014 
CG10185 1.650 0.008 
CG10211  1.025 0.018 
CG10494 1.201 0.017 
CG10663 1.343 0.018 
CG10801 1.635 0.012 
CG10814 4.500 0.006 
CG10947 1.042 0.019 
CG11162 4.446 0.003 
CG11665 1.006 0.021 
CG12278 1.218 0.010 
CG12413 1.334 0.013 
CG12703 1.218 0.018 
CG13248 1.252 0.015 
CG13300 1.386 0.014 
CG13325 6.971 0.003 
CG13359 2.402 0.008 
CG13575 2.904 0.018 
CG13611 2.622 0.013 
CG13796 1.847 0.016 
CG13796 2.440 0.009 
CG14183 2.047 0.018 
CG14219 3.178 0.005 
CG14294 2.658 0.005 
CG14383 4.227 0.013 
CG14565 2.407 0.016 
CG14691 2.034 0.002 
CG14778 1.320 0.013 
CG14803 1.559 0.020 
CG15332 3.190 0.019 
CG15625 3.245 0.010 
CG15630 1.273 0.011 
CG15824 4.425 0.014 
CG16800 1.726 0.019 
CG1774 1.356 0.009 
CG18810 4.527 0.011 
CG1950 3.349 0.004 
CG2129 2.891 0.020 
CG2574 2.819 0.004 
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CG30127 2.995 0.002 
CG31050 2.130 0.013 
CG31053 3.123 0.018 
CG3108 1.817 0.011 
CG31089 2.970 0.002 
CG31413 3.008 0.008 
CG31475 1.290 0.011 
CG31698 3.997 0.006 
CG31752 1.954 0.012 
CG32295 2.188 0.006 
CG32668 1.339 0.016 
CG32709 1.853 0.004 
CG33235 3.381 0.001 
CG33262 2.990 0.016 
CG33286 3.904 0.005 
CG34113 1.977 0.015 
CG34127  1.942 0.020 
CG42594 4.222 0.005 
CG42810 2.386 0.008 
CG43347 1.816 0.005 
CG43693 1.038 0.018 
CG5791 2.074 0.021 
CG5877 1.172 0.021 
CG5987 1.872 0.007 
CG6123 1.268 0.021 
CG6133 1.508 0.016 
CG6499 1.811 0.010 
CG6652  2.230 0.016 
CG6839 3.800 0.009 
CG7166 1.144 0.015 
CG8064 1.348 0.016 
CG8172 1.414 0.019 
CG8500 1.143 0.019 
CG8642 3.888 0.015 
CG8784 2.128 0.007 
CG8909 1.207 0.013 
CG9576 1.965 0.019 
CG9602 1.731 0.002 
Clk 2.802 0.017 
Cyp308a1 3.185 0.008 
Cyp309a2 1.528 0.008 
dpr16 2.595 0.021 
Eig71Eh 3.380 0.002 
fusl 1.602 0.017 
gce 2.146 0.016 
Gld 1.442 0.013 
Hil 1.457 0.010 
mam 2.737 0.018 
! "*)!
Mctp 1.552 0.013 
Mst36Fa 2.280 0.010 
nito 2.670 0.022 
Obp57e 2.833 0.006 
Or85d 5.442 0.003 
Or98a 2.457 0.005 
Pif1A 2.824 0.005 
ple 1.195 0.019 
Porin2 2.253 0.006 
PsGEF 2.126 0.002 
RpL8 1.807 0.015 
sut3 5.509 0.015 
Synd 1.145 0.015 
Sytbeta 1.448 0.008 
TepI 5.084 0.007 
Tim17a1 2.696 0.001 
Xpd 1.137 0.021 
 





















Appendix 9: The 100 Most Significantly Modulated Genes 
upon Sterile Laser Ablation of the Stage 15 Embryo  
 
Table A9.1 
Gene name Log Fold Change (AU) Adjusted P-value 
CG13044 3.28 3.65E-07 
CG32548 3.44 1.23E-06 
CG42305 
CG17325 2.75 1.42E-06 
5SrRNA-Psi:CR33363 2.44 2.58E-06 







snRNA:U5:34A 2.38 3.26E-06 
CG10827 2.35 3.27E-06 
Lcp65Ad 3.62 3.35E-06 
Obp56d 2.31 3.36E-06 
CG15650 3.08 3.54E-06 
CG9269 2.24 3.90E-06 
CG15731 2.59 4.22E-06 
CG9757 2.75 4.53E-06 
CG14075 2.27 4.68E-06 
CG7548 3.05 4.87E-06 
CG2816 2.30 4.97E-06 
CG15615 3.13 5.05E-06 
Cpr65Av 2.83 5.55E-06 
obst-E 2.33 5.57E-06 
Cpr62Bc 3.04 7.12E-06 
CG13043 2.15 7.28E-06 
CG8629 3.26 7.58E-06 
CG13038 2.06 7.91E-06 
TwdlV 2.74 8.03E-06 
TwdlK 3.67 8.44E-06 
CG17127 2.81 8.78E-06 
CG5070 3.21 9.27E-06 
TwdlM 2.68 1.01E-05 
CG12546 
CG14452 4.01 1.02E-05 
y 2.11 1.03E-05 
CG7402 2.58 1.03E-05 
CG42808 2.03 1.07E-05 
CG7080 1.97 1.17E-05 
! "+*!
CG32453 2.97 1.27E-05 







snRNA:U5:34A 2.34 1.39E-05 
CG16885 1.93 1.41E-05 
CG15127 1.84 1.42E-05 
Obp56h 2.03 1.44E-05 
Cralbp 
Pmi 
PGRP-LD 2.15 1.51E-05 
CG13218 2.03 1.52E-05 
CG14752 3.02 1.53E-05 
Cpr50Cb 1.88 1.59E-05 
levy 1.95 1.62E-05 
CG8563 1.84 1.65E-05 
CG14147 3.15 1.76E-05 
CG7330 1.94 1.76E-05 







snRNA:U5:34A 2.34 1.89E-05 
CG10657 1.85 1.90E-05 
CG12655 2.21 1.94E-05 
yellow-e 1.92 1.97E-05 
CG9083 3.05 1.99E-05 







snRNA:U5:34A 2.23 2.18E-05 
CG6870 2.16 2.24E-05 
Ccp84Ad 3.05 2.28E-05 
CG13058 1.72 2.34E-05 
obst-E 2.57 2.35E-05 
Cpr62Bb 3.16 2.42E-05 
CG43386 2.04 2.45E-05 
CG31198 1.74 2.69E-05 
! "++!
CG14770 2.00 2.70E-05 
RpLP2 2.15 2.80E-05 
CG15829 1.88 2.82E-05 
Cpr78Cc 2.64 2.88E-05 
CG13102 2.69 2.92E-05 
Muc30E -1.85 2.94E-05 
Phk-3 1.98 2.99E-05 
Cpr51A 1.85 3.01E-05 
Cpr56F 3.66 3.05E-05 
TwdlQ 4.02 3.05E-05 
TwdlB 2.12 3.21E-05 
CG2157 2.27 3.39E-05 
CG13297 1.72 3.67E-05 
Lcp65Ae 2.17 3.72E-05 
CG13285 1.94 3.86E-05 
CG9686 1.96 3.88E-05 
CG4998 1.97 3.95E-05 
CG2162 1.65 4.02E-05 
snRNA:U1:82Eb 1.91 4.13E-05 
Odc1 2.31 4.14E-05 
IM3 1.74 4.18E-05 
TwdlX 1.76 4.18E-05 
b6 2.24 4.20E-05 
Lcp65Ag3 2.28 4.44E-05 
CG13331 2.13 4.47E-05 
CG13049 3.36 4.49E-05 
CG7031 1.74 4.50E-05 
CG30101 1.78 4.59E-05 
TwdlBeta 4.54 4.60E-05 
Vago 1.59 4.66E-05 
Osi10 1.60 4.88E-05 
CG5506 1.86 4.96E-05 
CG2901 -1.89 5.04E-05 
Obp47b 1.65 5.04E-05 
CG13047 2.60 5.25E-05 
TwdlG 1.65 5.31E-05 
CG6055 2.24 5.37E-05 
CG8888 1.61 5.48E-05 
 
Names highlighted in green indicate genes of unknown function. Names 






Appendix 10: 100 Most Modulated Genes upon damage 
inflicted via PBS injection  
 
Table A10.1: 100 Most Upregulated Genes upon PBS injection  
 


































































































































Table A10.2: 100 Most Downregulated Genes upon PBS injection  
 




































































































































Appendix 11: 100 Most Modulated Genes within Hemocytes 
upon Ecc15 Infection  
 
Table A11.1: 100 Most Upregulated Genes within Hemoocytes upon Ecc15 
Infection 

































































































































Table A11.2: 100 Most Downregulated Genes in Hemocytes upon Ecc15 
injection 




































































































































Appendix 12: 100 Most Modulated Genes within Hemocytes 
upon PBS Injection  
 
Table A12.1: 100 Most Upregulated Genes in Hemocytes upon PBS injection 
































































































































Table A12.2: 100 Most Downregulated Genes in Hemocytes upon PBS 
injection 




































































































































Appendix 13: Volcano Plots Demonstrating Significant 
Changes in Global Gene Expression upon Bacterial Infection 
and Damage 
 
                         
 
Figure A12.1: Volcano plots to show significant changes in global gene 
expression upon bacterial infection and damage. After vsn normalization of 
the microarray data sets, the significance of changes in expression between 
Naïve and injected (A-B) or wounded and non-wounded (D) was calculated. 
Blue dots indicate genes whose expression was significantly modulated upon 
treatment compared to Naïve/Unwounded levels (p!0.05). Significant changes 
in gene expression were only noted when comparing non-wounded and 
wounded embryo transcriptional profiles (D), whereas all other treatments did 
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